assays_ss_strn,assays_src_d,assays_ss_cll_tp,assays_vrnt_d,assays_ss_tst_tp,assays_ss_rgnsm,assays_b_frmt,assays_ss_tp,assays_rltnshp_tp,assays_src_ss_d,assays_ss_d,assays_chmbl_d,assays_ss_tss,assays_ss_sbclllr_frctn,assays_dc_d,assays_tss_d,assays_crtd_b,assays_ss_tx_d,assays_dscrptn,assays_cnfdnc_scr,assays_cll_d,assays_td,assays_ss_ctgr
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7524,CHEMBL618647,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7525,CHEMBL618648,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7526,CHEMBL618649,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7527,CHEMBL618650,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7528,CHEMBL618651,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7529,CHEMBL876497,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7530,CHEMBL618652,Lung,,9866,2048.0,Intermediate,10116.0,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7531,CHEMBL618653,Lung,,9866,2048.0,Intermediate,10116.0,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7532,CHEMBL618654,Lung,,9866,2048.0,Intermediate,10116.0,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7533,CHEMBL618655,,,6351,,Intermediate,10116.0,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7534,CHEMBL618656,,,1465,,Intermediate,10116.0,Compound was tested for solubility in water,1,,50597,
,1,,,,,BAO_0000100,P,U,,7535,CHEMBL618657,,,5182,,Intermediate,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),0,,22229,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7536,CHEMBL618658,,,17847,,Intermediate,10116.0,Solubility was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7537,CHEMBL618659,,,15339,,Intermediate,10116.0,solubility in water (ug/mL) at 37 degree C.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7538,CHEMBL618660,,,5202,,Intermediate,10116.0,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7539,CHEMBL618661,,,1088,,Intermediate,10116.0,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7540,CHEMBL873807,,,3169,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7541,CHEMBL618662,,,5353,,Intermediate,10116.0,Half life in Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7542,CHEMBL618663,,,2864,,Intermediate,10116.0,Half life period after 3 mg/kg iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7543,CHEMBL618664,,,2864,,Intermediate,10116.0,Half life period after 3 mg/kg iv administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7544,CHEMBL618665,,,2864,,Intermediate,10116.0,Half life period after 3 mg/kg iv administration in the rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7545,CHEMBL876498,,,6362,,Intermediate,10116.0,Half life period in female Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7546,CHEMBL618666,,,6249,,Intermediate,10116.0,Half life period in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7547,CHEMBL620440,,,3169,,Intermediate,10116.0,Half-life in rats was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7548,CHEMBL620441,,,3169,,Intermediate,10116.0,Half-life in rats with metabolic oxidation,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7549,CHEMBL620442,,,3169,,Intermediate,10116.0,Half-life in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7550,CHEMBL620443,,,17260,,Intermediate,10116.0,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7551,CHEMBL620444,,,17260,,Intermediate,10116.0,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7552,CHEMBL620445,,,17260,,Intermediate,10116.0,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7553,CHEMBL620446,,,17260,,Intermediate,10116.0,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7554,CHEMBL620447,Plasma,,2879,1969.0,Intermediate,10116.0,Biological half-life measured in plasma of rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7555,CHEMBL621129,Plasma,,2879,1969.0,Intermediate,10116.0,Biological half-life measured in plasma of rat; 22-25,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7556,CHEMBL621130,Plasma,,2879,1969.0,Intermediate,10116.0,Biological half-life measured in plasma of rat; 9-16,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7557,CHEMBL873808,,,3184,,Intermediate,10116.0,Compound was evaluated for its half life when administered intravenously in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7558,CHEMBL876598,,,4891,,Intermediate,10116.0,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7559,CHEMBL621131,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7560,CHEMBL621132,,,5656,,Intermediate,10116.0,Half life (T1/2) after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7561,CHEMBL621133,,,4413,,Intermediate,10116.0,Half life of compound after iv administration of 20 mg/kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7562,CHEMBL621312,,,3598,,Expert,10116.0,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7563,CHEMBL621313,,,17267,,Intermediate,10116.0,Half life of compound was determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7564,CHEMBL621314,Blood,,4727,178.0,Intermediate,10116.0,Half life of compound was determined in rat blood,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7565,CHEMBL621315,,,17651,,Intermediate,10116.0,Half life at 1 mg/kg was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7566,CHEMBL621316,,,17651,,Intermediate,10116.0,Half life at 10 mg/kg was determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7567,CHEMBL621317,,,401,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7568,CHEMBL621318,,,4942,,Intermediate,10116.0,Half life in rats in hours,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7569,CHEMBL621319,,,17735,,Intermediate,10116.0,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7570,CHEMBL621377,,,6056,,Intermediate,10116.0,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7571,CHEMBL621378,,,5213,,Intermediate,10116.0,Half life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7572,CHEMBL876599,,,6616,,Intermediate,10116.0,Half life after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7573,CHEMBL621379,,,5937,,Intermediate,10116.0,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7574,CHEMBL621380,Plasma,,5819,1969.0,Intermediate,10116.0,Half life in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7575,CHEMBL621381,Plasma,,5819,1969.0,Intermediate,10116.0,Half life in rat plasma; Not detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7576,CHEMBL618515,,,6803,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7577,CHEMBL618516,,,17804,,Intermediate,10116.0,Half life period of compound was determined after peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7578,CHEMBL618517,,,17804,,Intermediate,10116.0,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7579,CHEMBL618518,,,5948,,Intermediate,10116.0,Half life period in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7580,CHEMBL618519,,,1916,,Intermediate,10116.0,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7581,CHEMBL618698,,,1916,,Intermediate,10116.0,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7582,CHEMBL618862,,,1916,,Intermediate,10116.0,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7583,CHEMBL618863,,,4890,,Intermediate,10116.0,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7584,CHEMBL618864,,,17764,,Intermediate,10116.0,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7585,CHEMBL618865,,,4727,,Intermediate,10116.0,Half life time in rat the dose of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7586,CHEMBL618866,,,17509,,Intermediate,10116.0,Half-life 24 hr after 10 mg/kg iv administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7587,CHEMBL618867,,,17509,,Intermediate,10116.0,Half-life 24 hr after 2 mg/kg iv administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7588,CHEMBL875828,,,6597,,Intermediate,10116.0,Half-life consistent with the observed metabolic steady state in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7589,CHEMBL618868,,,17735,,Intermediate,10116.0,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7590,CHEMBL618869,,,6597,,Intermediate,10116.0,Half-life for oxidative metabolic stability was determined using male human,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7591,CHEMBL618870,,,17670,,Intermediate,10116.0,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7592,CHEMBL618871,Plasma,,1696,1969.0,Intermediate,10116.0,Half-life in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7593,CHEMBL618872,Plasma,,1742,1969.0,Intermediate,10116.0,Half-life in rat plasma was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7594,CHEMBL873816,,,17800,,Intermediate,10116.0,Half-life in rats was determined,1,,50597,
,1,,,,,BAO_0000218,A,U,,7595,CHEMBL618873,,,12923,,Autocuration,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,0,,22224,
,1,,,,,BAO_0000019,A,U,,7596,CHEMBL621602,,,11954,,Autocuration,,Area under curve after oral dose of 0.1 mg//kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7597,CHEMBL621603,,,11954,,Autocuration,,Area under curve after oral dose of 0.3 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7598,CHEMBL621604,,,11954,,Autocuration,,Area under curve after oral dose of 1 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7599,CHEMBL621605,,,11954,,Autocuration,,Area under curve after oral dose of 10 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7600,CHEMBL621606,,,11954,,Autocuration,,Area under curve after oral dose of 23.4 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7601,CHEMBL621607,,,11954,,Autocuration,,Area under curve after oral dose of 3 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,7602,CHEMBL621608,,,11954,,Autocuration,,Area under curve after oral dose of 3.87 mg/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7603,CHEMBL621609,,,5237,,Autocuration,,Area under curve was determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,7604,CHEMBL621610,,,4026,,Autocuration,,Area under curve at a dose of 10 mg/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7605,CHEMBL621611,,,5237,,Intermediate,10116.0,Area under curve was determined; ND=No data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7606,CHEMBL621612,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7607,CHEMBL622308,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7608,CHEMBL622309,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7609,CHEMBL622310,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7610,CHEMBL622311,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7611,CHEMBL622312,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7612,CHEMBL622931,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7613,CHEMBL622932,,,14793,,Intermediate,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7614,CHEMBL622736,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7615,CHEMBL622737,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7616,CHEMBL622738,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7617,CHEMBL622739,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7618,CHEMBL622740,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7619,CHEMBL622741,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7620,CHEMBL622742,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7621,CHEMBL622743,Plasma,,14793,1969.0,Intermediate,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,7622,CHEMBL622744,Plasma,,11637,1969.0,Intermediate,10090.0,AUC in mice,1,,50594,
,1,,,,,BAO_0000019,A,U,,7623,CHEMBL624134,,,11149,,Autocuration,,Area under curve was measured from the graph obtained from concentration Vs time,0,,22224,
,1,,,,,BAO_0000019,A,U,,7624,CHEMBL624135,,,10016,,Autocuration,,Area under curve value of compound per hour after oral administration,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7625,CHEMBL624136,,,17796,,Intermediate,10116.0,Area under curve was determined after oral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7626,CHEMBL624137,,,17796,,Intermediate,10116.0,Area under curve was determined after oral administration in rats; No data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7627,CHEMBL624320,,,17796,,Intermediate,10116.0,Area under curve was determined after oral administration in rats;No data,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7628,CHEMBL624321,,,12923,,Intermediate,9615.0,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7629,CHEMBL624322,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7630,CHEMBL624323,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after iv dose of 5.06 in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7631,CHEMBL624324,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7632,CHEMBL624325,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7633,CHEMBL624326,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7634,CHEMBL624327,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7635,CHEMBL624328,,,15372,,Intermediate,10116.0,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7636,CHEMBL627848,,,14169,,Intermediate,9615.0,Area under curve was determined in Dogs after peroral administration,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7637,CHEMBL627849,,,14169,,Intermediate,10116.0,Area under curve was determined in Rats after peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7638,CHEMBL627850,,,14258,,Intermediate,10116.0,Area under curve was determined in carotid blood of rat when administered intradermally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7639,CHEMBL627851,,,14258,,Intermediate,10116.0,Area under curve was determined in portal blood of rat when administered intradermally,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,7640,CHEMBL627852,,,15011,,Intermediate,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7641,CHEMBL627853,,,15011,,Intermediate,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7642,CHEMBL627854,,,15011,,Intermediate,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7643,CHEMBL627855,,,15011,,Intermediate,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7644,CHEMBL627856,,,15011,,Intermediate,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7645,CHEMBL875339,,,15011,,Intermediate,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7646,CHEMBL627857,,,15011,,Intermediate,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7647,CHEMBL627858,Spleen,,11195,2106.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7648,CHEMBL627859,Blood,,10130,178.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7649,CHEMBL627860,Brain,,10130,955.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7650,CHEMBL627019,Heart,,10130,948.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7651,CHEMBL627020,Liver,,10130,2107.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7652,CHEMBL627021,Lung,,10130,2048.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7653,CHEMBL627022,Muscle tissue,,10130,2385.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7654,CHEMBL627023,,,10130,,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7655,CHEMBL627024,Spleen,,10130,2106.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7656,CHEMBL627025,Thyroid gland,,10130,2046.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7657,CHEMBL627026,Kidney,,10130,2113.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7658,CHEMBL627027,Blood,,10130,178.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7659,CHEMBL627028,Brain,,10130,955.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7660,CHEMBL627029,Heart,,10130,948.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7661,CHEMBL627030,Kidney,,10130,2113.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7662,CHEMBL627031,Liver,,10130,2107.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7663,CHEMBL627032,Lung,,10130,2048.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7664,CHEMBL627033,Muscle tissue,,10130,2385.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7665,CHEMBL627034,,,10130,,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7666,CHEMBL627035,Spleen,,10130,2106.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7667,CHEMBL627036,Thyroid gland,,10130,2046.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7668,CHEMBL875340,Blood,,10130,178.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7669,CHEMBL627037,Heart,,10130,948.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7670,CHEMBL627038,Kidney,,10130,2113.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7671,CHEMBL627039,Liver,,10130,2107.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7672,CHEMBL627040,Muscle tissue,,10130,2385.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7673,CHEMBL624663,Spleen,,10130,2106.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7674,CHEMBL625963,Thyroid gland,,10130,2046.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7675,CHEMBL876799,Brain,,10130,955.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7676,CHEMBL626133,Lung,,10130,2048.0,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7677,CHEMBL626134,,,10130,,Intermediate,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7678,CHEMBL626135,,,6295,,Intermediate,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7679,CHEMBL626136,,,6296,,Intermediate,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7680,CHEMBL626137,,,6296,,Intermediate,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7681,CHEMBL626138,,,6295,,Intermediate,10116.0,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7682,CHEMBL626139,,,6296,,Intermediate,10116.0,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7683,CHEMBL626140,,,17260,,Intermediate,10116.0,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7684,CHEMBL626141,,,17260,,Intermediate,10116.0,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7685,CHEMBL626142,,,17686,,Intermediate,10116.0,C24h in rat p.o. at 20 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7686,CHEMBL627930,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7687,CHEMBL627931,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7688,CHEMBL627932,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7689,CHEMBL627933,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7690,CHEMBL627934,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7691,CHEMBL627935,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7692,CHEMBL627936,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7693,CHEMBL627937,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7694,CHEMBL627938,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7695,CHEMBL627939,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7696,CHEMBL627940,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7697,CHEMBL627941,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7698,CHEMBL876800,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7699,CHEMBL627942,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7700,CHEMBL627943,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7701,CHEMBL627944,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7702,CHEMBL627945,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7703,CHEMBL628584,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7704,CHEMBL628585,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7705,CHEMBL628586,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7706,CHEMBL628587,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7707,CHEMBL628588,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7708,CHEMBL628589,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7709,CHEMBL625304,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7710,CHEMBL625305,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7711,CHEMBL625306,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7712,CHEMBL625307,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7713,CHEMBL625308,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7714,CHEMBL627740,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7715,CHEMBL627741,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7716,CHEMBL627742,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7717,CHEMBL627743,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7718,CHEMBL627744,Blood,,9866,178.0,Intermediate,10116.0,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7719,CHEMBL627745,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7720,CHEMBL627746,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7721,CHEMBL627747,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7722,CHEMBL876810,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7723,CHEMBL627748,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7724,CHEMBL627749,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7725,CHEMBL627750,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7726,CHEMBL618728,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7727,CHEMBL618729,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7728,CHEMBL618730,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7729,CHEMBL618731,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7730,CHEMBL618732,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7731,CHEMBL618733,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7732,CHEMBL618734,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7733,CHEMBL618735,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7734,CHEMBL876602,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7735,CHEMBL618736,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7736,CHEMBL618737,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7737,CHEMBL618738,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7738,CHEMBL618739,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7739,CHEMBL618740,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7740,CHEMBL618741,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7741,CHEMBL618742,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7742,CHEMBL618743,Bone,,9866,10000001.0,Intermediate,10116.0,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7743,CHEMBL618744,Plasma,,17752,1969.0,Intermediate,10116.0,Half-life from rat plasma at a single oral dose of 25 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7744,CHEMBL618745,,,5610,,Intermediate,10116.0,Half-life in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7745,CHEMBL620479,,,5939,,Intermediate,10116.0,Half-life in rat after peroral administration at 10 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7746,CHEMBL620480,,,5939,,Intermediate,10116.0,Half-life in rat after peroral administration at 5 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7747,CHEMBL620481,,,17771,,Intermediate,10116.0,Half-life in rat at a dose of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7748,CHEMBL620482,,,1974,,Intermediate,10116.0,Half-life was evaluated in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7749,CHEMBL876603,,,4239,,Intermediate,10116.0,Half-life was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7750,CHEMBL620483,,,6681,,Intermediate,10116.0,Half-life period for the compound was determined in rats at 50 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7751,CHEMBL620484,,,17752,,Intermediate,10116.0,Half-life period in rats after intravenous administration at 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7752,CHEMBL620485,,,6046,,Intermediate,10116.0,Half-life period in rat at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7753,CHEMBL620486,,,6685,,Intermediate,10116.0,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7754,CHEMBL620487,,,6685,,Intermediate,10116.0,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7755,CHEMBL620488,,,6685,,Intermediate,10116.0,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7756,CHEMBL620489,,,4727,,Intermediate,10116.0,Half-life time in rat the dose of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7757,CHEMBL620490,,,1088,,Intermediate,10116.0,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7758,CHEMBL620491,,,5610,,Intermediate,10116.0,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7759,CHEMBL876604,Plasma,,3032,1969.0,Intermediate,10116.0,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7760,CHEMBL620492,,,5199,,Intermediate,10116.0,Oral half life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7761,CHEMBL620493,,,14941,,Intermediate,10116.0,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7762,CHEMBL620494,,,4408,,Intermediate,10116.0,Pharmacokinetic property (t1/2) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7763,CHEMBL620495,Plasma,,2552,1969.0,Intermediate,10116.0,Plasma elimination half-life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7764,CHEMBL620496,Plasma,,5199,1969.0,Intermediate,10116.0,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7765,CHEMBL620497,Plasma,,15662,1969.0,Intermediate,10116.0,Plasma half life was observed after intravenous administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7766,CHEMBL620498,Plasma,,1465,1969.0,Intermediate,10116.0,Plasma half-life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7767,CHEMBL620499,Plasma,,1446,1969.0,Intermediate,10116.0,Plasma half-life following oral administration in Fisher rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7768,CHEMBL620500,Plasma,,6824,1969.0,Intermediate,10116.0,Plasma half-life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7769,CHEMBL873809,Plasma,,17533,1969.0,Intermediate,10116.0,Plasmatic Half-life after intravenous administration to rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7770,CHEMBL620501,,,5979,,Intermediate,10116.0,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7771,CHEMBL620502,,,4689,,Intermediate,10116.0,Terminal half life after intravenous administration (1 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7772,CHEMBL620503,,,4689,,Intermediate,10116.0,Terminal half life in Rat at a oral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7773,CHEMBL620504,,,2463,,Intermediate,10116.0,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7774,CHEMBL876605,,,4883,,Intermediate,10116.0,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7775,CHEMBL620505,,,4883,,Intermediate,10116.0,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7776,CHEMBL873811,Plasma,,15662,1969.0,Intermediate,10116.0,plasma half life was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7777,CHEMBL624016,,,3598,,Expert,10116.0,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7778,CHEMBL624017,,,4576,,Intermediate,10116.0,Half life of compound determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7779,CHEMBL624018,,,4576,,Intermediate,10116.0,Mean residence time determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7780,CHEMBL624019,,,4576,,Intermediate,10116.0,Plasma half life determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7781,CHEMBL624020,Brain,,4910,955.0,Intermediate,10116.0,Compound was evaluated for Tmax in brain after intravenous administration in male rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7782,CHEMBL624201,,,4891,,Intermediate,10116.0,Compound was evaluated for pharmacokinetic parameter maximum time period,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7783,CHEMBL872528,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7784,CHEMBL624202,,,5974,,Intermediate,10116.0,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7785,CHEMBL624203,,,5974,,Intermediate,10116.0,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7786,CHEMBL624350,,,5974,,Intermediate,10116.0,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7787,CHEMBL621320,,,5974,,Intermediate,10116.0,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7788,CHEMBL621321,,,17582,,Intermediate,10116.0,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7789,CHEMBL621322,,,4026,,Intermediate,10116.0,Maximum time (Tmax) required to reach Cmax in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7790,CHEMBL621323,,,4890,,Intermediate,10116.0,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7791,CHEMBL621324,,,6571,,Intermediate,10116.0,Maximum time of clearance of compound in rats after peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7792,CHEMBL621325,,,4727,,Intermediate,10116.0,Maximum time at the dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7793,CHEMBL875837,Plasma,,17651,1969.0,Intermediate,10116.0,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7794,CHEMBL621326,Plasma,,17651,1969.0,Intermediate,10116.0,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7795,CHEMBL621327,,,14465,,Intermediate,10116.0,Tmax in Guinea pig (PO dose),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7796,CHEMBL621328,,,14941,,Intermediate,10116.0,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7797,CHEMBL621329,,,5960,,Intermediate,10116.0,Pharmacokinetic parameter (Tmax) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7798,CHEMBL621330,,,5022,,Intermediate,10116.0,Pharmacokinetic parameter (Tmax) was estimated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7799,CHEMBL621331,,,4408,,Intermediate,10116.0,Pharmacokinetic property (Tmax) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7800,CHEMBL621332,,,5983,,Intermediate,10116.0,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7801,CHEMBL621333,,,4689,,Intermediate,10116.0,T max in Rat at a oral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7802,CHEMBL621334,,,2792,,Intermediate,10116.0,T max was determined at 10 mg/kg po dose in rats,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,7803,CHEMBL621335,,,15011,,Intermediate,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7804,CHEMBL621336,,,14180,,Intermediate,9615.0,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7805,CHEMBL621337,,,14180,,Intermediate,10116.0,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7806,CHEMBL621338,,,14599,,Intermediate,9615.0,Area under curve was measured after i.v. administration into Beagle dog.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7807,CHEMBL875838,,,14599,,Intermediate,9615.0,Area under curve was measured after iv administration into Beagle dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7808,CHEMBL621339,,,14599,,Intermediate,9615.0,Area under curve was measured after po administration into Beagle dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7809,CHEMBL621340,,,14599,,Intermediate,9615.0,Area under curve was measured after po administration into Beagle dog.,1,,50588,
,1,,,,,BAO_0000218,A,U,,7810,CHEMBL621341,,,15675,,Autocuration,,Area under curve was measured at peroral dose of 3 mg/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7811,CHEMBL621342,,,12706,,Autocuration,,Area under curve was measured by using concentration Vs time,0,,22224,
,1,,,,,BAO_0000019,A,U,,7812,CHEMBL621343,,,12706,,Autocuration,,Area under curve was measured by using concentration Vs time; not tested,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,7813,CHEMBL621344,,,9750,,Intermediate,10090.0,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7814,CHEMBL621345,,,9750,,Intermediate,10090.0,Area under curve(AUC) was measured in mice after oral administration.,1,,50594,
,1,,,,,BAO_0000019,A,U,,7815,CHEMBL621346,,,14691,,Autocuration,,Area under curve(AUC) value of the compound,0,,22224,
,1,,,,,BAO_0000218,A,U,,7816,CHEMBL621347,,,14691,,Autocuration,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7817,CHEMBL621348,,,14691,,Intermediate,9615.0,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,1,,50588,
,1,,,,,BAO_0000019,A,U,,7818,CHEMBL621349,Blood,,2939,178.0,Autocuration,,Area under curve(carotid artery) was determined by the availability in blood,0,,22224,
,1,,,,,BAO_0000019,A,U,,7819,CHEMBL621350,Blood,,2939,178.0,Autocuration,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,0,,22224,
,1,,,,,BAO_0000019,A,U,,7820,CHEMBL875839,Blood,,2939,178.0,Autocuration,,Area under curve(carotid artery) was determined by the availability in blood; No data,0,,22224,
,1,,,,,BAO_0000019,A,U,,7821,CHEMBL620211,Blood,,2939,178.0,Autocuration,,Area under curve(portal vein) was determined by the availability in blood,0,,22224,
,1,,,,,BAO_0000019,A,U,,7822,CHEMBL620212,Blood,,2939,178.0,Autocuration,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,0,,22224,
,1,,,,,BAO_0000019,A,U,,7823,CHEMBL620213,Blood,,2939,178.0,Autocuration,,Area under curve(portal vein) was determined by the availability in blood; No data,0,,22224,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,7824,CHEMBL620214,Plasma,,9552,1969.0,Intermediate,9544.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,50797,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,7825,CHEMBL620215,Plasma,,9552,1969.0,Intermediate,9544.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,50797,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,7826,CHEMBL620216,Plasma,,9552,1969.0,Intermediate,9544.0,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,1,,50797,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7827,CHEMBL620888,Plasma,,9552,1969.0,Intermediate,9615.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7828,CHEMBL620889,Plasma,,9552,1969.0,Intermediate,9615.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",1,,50588,
,1,,,,,BAO_0000019,A,U,,7829,CHEMBL620890,Plasma,,9552,1969.0,Autocuration,,Area under plasma concentration vs time curve observed in rats for 0-3 h,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7830,CHEMBL620891,Plasma,,11911,1969.0,Intermediate,10116.0,Area under plasma time curve determined in male rat,1,,50597,
,1,,,,,BAO_0000019,A,U,,7831,CHEMBL620892,,,16618,,Autocuration,,Area under the MAP curve measured over 5 min.,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,7832,CHEMBL621079,,,14387,,Intermediate,10090.0,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,7833,CHEMBL621080,,,14387,,Intermediate,10090.0,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7834,CHEMBL621081,,,12836,,Intermediate,9615.0,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,1,,50588,
,1,,,,Cricetinae,BAO_0000218,A,N,,7835,CHEMBL621082,,,12836,,Intermediate,10026.0,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,1,,100712,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7836,CHEMBL621083,,,12836,,Intermediate,10116.0,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7837,CHEMBL621084,,,14339,,Intermediate,9615.0,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7838,CHEMBL621085,,,14339,,Intermediate,9615.0,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7839,CHEMBL621086,,,14339,,Intermediate,9615.0,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7840,CHEMBL621087,,,10524,,Intermediate,9615.0,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7841,CHEMBL622607,,,9994,,Intermediate,9615.0,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7842,CHEMBL622608,,,11325,,Intermediate,9615.0,Serum AUC in marmosets (IV dose),1,,50588,
,1,,,,,BAO_0000019,A,U,,7843,CHEMBL624481,,,12536,,Autocuration,,Area under the curve after intravenous administration at a dose of 10 umol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7844,CHEMBL624482,,,12536,,Autocuration,,Area under the curve after intravenous administration at a dose of 2 umol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7845,CHEMBL624483,,,12536,,Autocuration,,Area under the curve after intravenous administration at a dose of 4 umol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7846,CHEMBL624484,,,12536,,Autocuration,,Area under the curve after intravenous administration at a dose of 40 umol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,7847,CHEMBL624485,,,12536,,Autocuration,,Area under the curve after intravenous administration at a dose of 5 umol/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7848,CHEMBL624486,,,15556,,Intermediate,10116.0,Area under the curve for fumarate salt was evaluated in F344 Rats.,1,,50597,
,1,,,,,BAO_0000019,A,U,,7849,CHEMBL624487,,,2809,,Autocuration,,Area under the curve for the compound was calculated.,0,,22224,
,1,,,,,BAO_0000019,A,U,,7850,CHEMBL624488,,,9511,,Autocuration,,Area under the curve in concentration/ time,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7851,CHEMBL624489,,,12818,,Intermediate,10116.0,Area under the curve administered intraintestinal in rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7852,CHEMBL625184,,,12818,,Intermediate,10116.0,Area under the curve administered intravenously in rats.,1,,50597,
,1,,,,,BAO_0000019,A,U,,7853,CHEMBL625185,,,15118,,Autocuration,,Area under the curve during intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,7854,CHEMBL875954,,,15118,,Autocuration,,Area under the curve during intravenous administration; Not determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,7855,CHEMBL625186,,,15118,,Autocuration,,Area under the curve during systemic administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,7856,CHEMBL625187,,,15118,,Autocuration,,Area under the curve during systemic administration; Not determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,7857,CHEMBL625188,,,2632,,Autocuration,,Area under the curve was calculated for the compound.,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7858,CHEMBL625189,,,14346,,Intermediate,9615.0,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,7859,CHEMBL625190,,,14346,,Intermediate,9615.0,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7860,CHEMBL621733,,,14346,,Intermediate,10116.0,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7861,CHEMBL621734,,,14346,,Intermediate,10116.0,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7862,CHEMBL621735,,,11149,,Intermediate,10116.0,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7863,CHEMBL621736,Plasma,,17796,1969.0,Intermediate,10116.0,Clearance of the drug was measured in the plasma of rat; No data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7864,CHEMBL621737,Plasma,,5247,1969.0,Intermediate,10116.0,The pharmacokinetic parameter plasma clearance in vivo in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7865,CHEMBL621738,,,4727,,Intermediate,10116.0,Plasma clearance at the dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7866,CHEMBL622806,,,5654,,Intermediate,10116.0,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7867,CHEMBL623519,,,5654,,Intermediate,10116.0,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7868,CHEMBL623520,,,17260,,Intermediate,10116.0,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7869,CHEMBL623521,,,17065,,Intermediate,10116.0,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7870,CHEMBL623522,,,17671,,Intermediate,10116.0,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7871,CHEMBL623523,,,6672,,Intermediate,10116.0,Clearance rate in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7872,CHEMBL623690,,,6673,,Intermediate,10116.0,Clearance rate in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7873,CHEMBL623691,,,5978,,Intermediate,10116.0,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7874,CHEMBL623692,,,5978,,Intermediate,10116.0,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7875,CHEMBL623693,,,5978,,Intermediate,10116.0,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7876,CHEMBL623694,,,5978,,Intermediate,10116.0,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7877,CHEMBL623695,,,4413,,Intermediate,10116.0,Clearance of compound after iv administration of 20 mg/kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7878,CHEMBL623696,,,2661,,Intermediate,10116.0,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7879,CHEMBL623697,,,2661,,Intermediate,10116.0,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,7880,CHEMBL623698,Plasma,,5005,1969.0,Intermediate,9544.0,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,7881,CHEMBL623699,Plasma,,5005,1969.0,Intermediate,10116.0,Compound was tested for its plasma clearance rate in Sprague Dawley rats,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7882,CHEMBL623700,,,15765,,Intermediate,10116.0,Mean (%CV) PK parameters for CL(mL/min/kg).,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7883,CHEMBL623701,,,3747,,Intermediate,10116.0,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7884,CHEMBL623702,Plasma,,16366,1969.0,Intermediate,10116.0,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7885,CHEMBL623703,,,4199,,Intermediate,10116.0,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7886,CHEMBL623704,,,17267,,Intermediate,10116.0,Plasma clearance in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7887,CHEMBL623705,,,6535,,Intermediate,10116.0,Plasma clearance in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7888,CHEMBL623706,,,6535,,Intermediate,10116.0,Plasma clearance in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7889,CHEMBL623707,,,5041,,Intermediate,10116.0,Plasma clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7890,CHEMBL623708,,,5960,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7891,CHEMBL623709,,,5937,,Intermediate,10116.0,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7892,CHEMBL623710,,,5871,,Intermediate,10116.0,Plasma clearance in rat by iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7893,CHEMBL623711,,,5874,,Intermediate,10116.0,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7894,CHEMBL623712,,,6504,,Intermediate,10116.0,Plasma clearance in rat p.o.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7895,CHEMBL623713,,,6803,,Intermediate,10116.0,Plasma clearance in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7896,CHEMBL623714,,,5041,,Intermediate,10116.0,Plasma clearance was determined; ND denotes no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7897,CHEMBL623715,,,5041,,Intermediate,10116.0,Plasma clearance was determined; ND denotes not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7898,CHEMBL623716,,,1916,,Intermediate,10116.0,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7899,CHEMBL622980,,,5199,,Intermediate,10116.0,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7900,CHEMBL622981,,,16367,,Intermediate,10116.0,Plasma administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7901,CHEMBL622982,,,6362,,Intermediate,10116.0,Plasma clearance of the compound in female Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7902,CHEMBL622983,,,15662,,Intermediate,10116.0,Plasma clearance was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7903,CHEMBL622984,,,6215,,Intermediate,10116.0,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7904,CHEMBL622985,,,1466,,Intermediate,10116.0,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7905,CHEMBL623631,Plasma,,15662,1969.0,Intermediate,10116.0,plasma clearance was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7906,CHEMBL623632,,,4723,,Intermediate,10116.0,In vivo CL/F determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7907,CHEMBL623633,Plasma,,2792,1969.0,Intermediate,10116.0,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7908,CHEMBL623634,Plasma,,2792,1969.0,Intermediate,10116.0,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7909,CHEMBL623635,,,5213,,Intermediate,10116.0,Compound was tested for the lower blood clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7910,CHEMBL621195,,,4687,,Intermediate,10116.0,Evaluated for the low clearance in rat (in vivo),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7911,CHEMBL621196,,,3371,,Intermediate,10116.0,Pharmacokinetic property (CLb)of the compound was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7912,CHEMBL875287,,,4690,,Intermediate,10116.0,Rapid clearance after intravenous administration in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7913,CHEMBL621197,,,5702,,Intermediate,10116.0,Clearance measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7914,CHEMBL621198,Plasma,,740,1969.0,Intermediate,10116.0,Compound was evaluated for plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7915,CHEMBL621199,Plasma,,4853,1969.0,Intermediate,10116.0,Low plasma clearance was calculated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7916,CHEMBL621200,,,5789,,Intermediate,10116.0,Pharmacokinetic property (Clp) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7917,CHEMBL621201,,,4527,,Intermediate,10116.0,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7918,CHEMBL621202,,,4527,,Intermediate,10116.0,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7919,CHEMBL621203,,,6518,,Intermediate,10116.0,Plasma clearance after IV dosing at 0.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7920,CHEMBL621204,,,6518,,Intermediate,10116.0,Plasma clearance after IV dosing at 1 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7921,CHEMBL621205,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7922,CHEMBL621206,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7923,CHEMBL621207,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7924,CHEMBL621208,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7925,CHEMBL621209,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7926,CHEMBL876484,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7927,CHEMBL621210,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7928,CHEMBL621211,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7929,CHEMBL621212,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7930,CHEMBL621213,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7931,CHEMBL621214,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7932,CHEMBL621215,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7933,CHEMBL621216,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7934,CHEMBL621217,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7935,CHEMBL621218,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7936,CHEMBL621219,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7937,CHEMBL621220,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7938,CHEMBL621221,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7939,CHEMBL621222,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7940,CHEMBL621223,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7941,CHEMBL876485,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7942,CHEMBL621224,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7943,CHEMBL621225,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7944,CHEMBL621226,Heart,,9866,948.0,Intermediate,10116.0,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7945,CHEMBL621227,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7946,CHEMBL621228,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7947,CHEMBL621229,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7948,CHEMBL621230,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7949,CHEMBL621231,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7950,CHEMBL621232,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7951,CHEMBL621233,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7952,CHEMBL621234,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7953,CHEMBL621235,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7954,CHEMBL621236,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7955,CHEMBL621237,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7956,CHEMBL876486,Kidney,,9866,2113.0,Intermediate,10116.0,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7957,CHEMBL622436,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7958,CHEMBL622437,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7959,CHEMBL622438,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7960,CHEMBL622439,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7961,CHEMBL622440,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7962,CHEMBL622441,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7963,CHEMBL622442,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7964,CHEMBL622443,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7965,CHEMBL622444,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7966,CHEMBL622445,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7967,CHEMBL622446,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7968,CHEMBL622447,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7969,CHEMBL622448,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7970,CHEMBL622449,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7971,CHEMBL622450,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7972,CHEMBL622451,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7973,CHEMBL622452,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7974,CHEMBL622453,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7975,CHEMBL622454,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7976,CHEMBL622455,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7977,CHEMBL876024,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7978,CHEMBL622456,,,2792,,Intermediate,10116.0,T max was determined at 3 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7979,CHEMBL622457,,,15078,,Intermediate,10116.0,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7980,CHEMBL622458,,,15078,,Intermediate,10116.0,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7981,CHEMBL622459,,,15022,,Intermediate,10116.0,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7982,CHEMBL873343,,,15022,,Intermediate,10116.0,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7983,CHEMBL622460,,,15022,,Intermediate,10116.0,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7984,CHEMBL622461,Plasma,,4576,1969.0,Intermediate,10116.0,Time for maximum plasma concentration determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7985,CHEMBL622462,Plasma,,6681,1969.0,Intermediate,10116.0,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7986,CHEMBL622463,,,16365,,Intermediate,10116.0,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7987,CHEMBL622464,,,16365,,Intermediate,10116.0,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7988,CHEMBL622465,,,16365,,Intermediate,10116.0,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7989,CHEMBL622466,,,16365,,Intermediate,10116.0,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7990,CHEMBL622467,,,16365,,Intermediate,10116.0,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7991,CHEMBL622468,Plasma,,6824,1969.0,Intermediate,10116.0,Time of maximum plasma concentration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7992,CHEMBL876025,Plasma,,6685,1969.0,Intermediate,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7993,CHEMBL622469,Plasma,,6685,1969.0,Intermediate,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7994,CHEMBL622470,Plasma,,6685,1969.0,Intermediate,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7995,CHEMBL622471,,,15662,,Intermediate,10116.0,Time required to reach maximum concentration (Cmax) after oral administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,7996,CHEMBL622472,Plasma,,1742,1969.0,Intermediate,10116.0,Time required to reach maximum concentration in rat plasma,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7997,CHEMBL622473,Plasma,,2774,1969.0,Intermediate,10116.0,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7998,CHEMBL624282,Plasma,,5199,1969.0,Intermediate,10116.0,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,7999,CHEMBL624283,Plasma,,12873,1969.0,Intermediate,10116.0,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8000,CHEMBL624284,Plasma,,12873,1969.0,Intermediate,10116.0,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8001,CHEMBL624285,Plasma,,1916,1969.0,Intermediate,10116.0,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8002,CHEMBL624286,,,16367,,Intermediate,10116.0,Time to reach Cmax after oral administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8003,CHEMBL624287,,,16366,,Intermediate,10116.0,Time to reach Cmax when a dose of 1 mg/kg is administered orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8004,CHEMBL624288,,,216,,Intermediate,10116.0,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8005,CHEMBL624289,Plasma,,6410,1969.0,Intermediate,10116.0,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8006,CHEMBL873344,Plasma,,6410,1969.0,Intermediate,10116.0,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8007,CHEMBL619623,,,6215,,Intermediate,10116.0,Tmax after peroral administration (10 mg/kg) was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8008,CHEMBL621399,,,3598,,Expert,10116.0,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8009,CHEMBL621400,,,4527,,Intermediate,10116.0,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8010,CHEMBL621401,,,17670,,Intermediate,10116.0,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8011,CHEMBL621402,,,1465,,Intermediate,10116.0,Tmax was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8012,CHEMBL621403,,,2552,,Intermediate,10116.0,Tmax was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8013,CHEMBL621121,,,5656,,Intermediate,10116.0,Tmax after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8014,CHEMBL872525,,,17764,,Intermediate,10116.0,Tmax after peroral administration in rats at 2.4 uM/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8015,CHEMBL621122,,,5610,,Intermediate,10116.0,Tmax in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8016,CHEMBL621123,,,6046,,Intermediate,10116.0,Tmax in rat at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8017,CHEMBL621124,,,5874,,Intermediate,10116.0,Tmax in rat by po administration at a dose of 40 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8018,CHEMBL621125,,,17596,,Intermediate,10116.0,Tmax in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8019,CHEMBL621126,,,17804,,Intermediate,10116.0,Tmax was measured in rats after peroral administration at 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8020,CHEMBL621127,,,1908,,Intermediate,10116.0,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8021,CHEMBL621128,,,2959,,Intermediate,10116.0,Tmax value after administration of 20 mg/Kg oral dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8022,CHEMBL618263,,,6757,,Intermediate,10116.0,Tmax value at a dose of 10 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8023,CHEMBL618264,,,6757,,Intermediate,10116.0,Tmax value at a dose of 100 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8024,CHEMBL618265,,,6757,,Intermediate,10116.0,Tmax value at a dose of 50 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8025,CHEMBL618266,Plasma,,4186,1969.0,Intermediate,10116.0,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8026,CHEMBL618267,,,15662,,Intermediate,10116.0,time required to reach maximum concentration (Cmax) after oral administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8027,CHEMBL618450,Urine,,429,1088.0,Intermediate,10116.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8028,CHEMBL618451,Urine,,429,1088.0,Intermediate,10116.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8029,CHEMBL618452,,,5546,,Intermediate,10116.0,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8030,CHEMBL618453,Urine,,3173,1088.0,Intermediate,10116.0,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8031,CHEMBL618454,Urine,,3173,1088.0,Intermediate,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8032,CHEMBL618455,Urine,,3173,1088.0,Intermediate,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8033,CHEMBL618456,,,4257,,Intermediate,10116.0,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8034,CHEMBL618457,,,6011,,Intermediate,10116.0,Compound distribution in rat tissues was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8035,CHEMBL618458,,,5472,,Intermediate,10116.0,Volume of distribution was evaluated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8036,CHEMBL618459,,,14346,,Intermediate,10116.0,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8037,CHEMBL876733,,,14346,,Intermediate,10116.0,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8038,CHEMBL618460,,,14346,,Intermediate,9615.0,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8039,CHEMBL618461,,,14346,,Intermediate,10116.0,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,8040,CHEMBL618462,,,15469,,Autocuration,,Area under the curve was determined after oral administration (300 uM/Kg),0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8041,CHEMBL618463,,,14346,,Intermediate,10116.0,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8042,CHEMBL618464,,,14346,,Intermediate,10116.0,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8043,CHEMBL618465,,,14346,,Intermediate,10116.0,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8044,CHEMBL618466,,,14346,,Intermediate,10116.0,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8045,CHEMBL618467,,,14346,,Intermediate,10116.0,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8046,CHEMBL618468,,,15372,,Intermediate,10116.0,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8047,CHEMBL618469,Plasma,,12935,1969.0,Intermediate,9615.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8048,CHEMBL618470,Plasma,,12935,1969.0,Intermediate,9615.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,1,,50588,
,1,,,,,BAO_0000218,A,U,,8049,CHEMBL618471,,,14813,,Autocuration,,Plasma drug AUC in rat (PO dose),0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8050,CHEMBL618472,,,15792,,Intermediate,10090.0,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,1,,50594,
,1,,,,,BAO_0000218,A,U,,8051,CHEMBL618473,,,3579,,Autocuration,,Area under was determined at a dose of 30 mg/kg,0,,22224,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,8052,CHEMBL621699,,,12487,,Intermediate,9669.0,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,1,,50506,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8053,CHEMBL621700,,,12487,,Intermediate,10116.0,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8054,CHEMBL621701,,,12487,,Intermediate,10116.0,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,1,,50597,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,8055,CHEMBL621702,,,12487,,Intermediate,9669.0,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,1,,50506,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8056,CHEMBL621703,,,12487,,Intermediate,9615.0,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8057,CHEMBL621704,,,12487,,Intermediate,9615.0,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8058,CHEMBL624259,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8059,CHEMBL624260,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8060,CHEMBL624430,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8061,CHEMBL624431,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8062,CHEMBL624432,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8063,CHEMBL624433,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8064,CHEMBL624434,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8065,CHEMBL624435,,,12902,,Intermediate,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,8066,CHEMBL618570,,,12745,,Intermediate,10090.0,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8067,CHEMBL618571,,,12745,,Intermediate,10090.0,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8068,CHEMBL618572,,,12745,,Intermediate,10090.0,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8069,CHEMBL618573,,,12745,,Intermediate,10090.0,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8070,CHEMBL619267,,,12745,,Intermediate,10090.0,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8071,CHEMBL619431,,,12745,,Intermediate,10090.0,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8072,CHEMBL619432,,,12745,,Intermediate,10090.0,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8073,CHEMBL619433,,,12745,,Intermediate,10090.0,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,50594,
,1,,,,,BAO_0000218,A,U,,8074,CHEMBL619434,Plasma,,13298,1969.0,Autocuration,,AUC in mice after oral dose (50 mg/kg),0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8075,CHEMBL619435,Serum,,12226,1977.0,Intermediate,10090.0,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,1,,50594,
,1,,,,,BAO_0000019,A,U,,8076,CHEMBL619436,Plasma,,12634,1969.0,Autocuration,,AUC (0-4 hr) ug/ml/h,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8077,CHEMBL619437,,,14810,,Intermediate,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,1,,50597,
,1,,,,,BAO_0000218,A,U,,8078,CHEMBL619438,,,13889,,Autocuration,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8079,CHEMBL619439,,,10018,,Intermediate,10090.0,Compound was evaluated for Area under curve in mice,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8080,CHEMBL619440,,,8758,,Intermediate,10116.0,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,50597,
,1,,,,,BAO_0000218,F,U,,8081,CHEMBL619441,,,8758,,Autocuration,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8082,CHEMBL619442,,,8758,,Intermediate,10116.0,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,50597,
,1,,,,,BAO_0000019,A,U,,8083,CHEMBL875156,,,2249,,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,0,,22224,
,1,,,,,BAO_0000019,A,U,,8084,CHEMBL619443,,,2249,,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,0,,22224,
,1,,,,,BAO_0000019,A,U,,8085,CHEMBL619444,,,2249,,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,0,,22224,
,1,,,,,BAO_0000019,A,U,,8086,CHEMBL623464,,,2249,,Autocuration,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8087,CHEMBL623465,,,15115,,Intermediate,10090.0,Compound was evaluated for area under curve when administered through oral route in mouse,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8088,CHEMBL623466,,,6518,,Intermediate,10116.0,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8089,CHEMBL623467,,,6518,,Intermediate,10116.0,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8090,CHEMBL623468,,,6249,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8091,CHEMBL622660,,,2463,,Intermediate,10116.0,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8092,CHEMBL622661,,,4969,,Intermediate,10116.0,Plasma clearance rate in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,8093,CHEMBL622662,,,17720,,Intermediate,10116.0,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8094,CHEMBL622663,,,3457,,Intermediate,10116.0,Pharmacokinetic property (total body clearance) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8095,CHEMBL622664,,,5983,,Intermediate,10116.0,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8096,CHEMBL622665,,,6295,,Intermediate,10116.0,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8097,CHEMBL622666,,,6296,,Intermediate,10116.0,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8098,CHEMBL621615,,,17686,,Intermediate,10116.0,Cl in rat i.v. at 2 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8099,CHEMBL621616,,,17764,,Intermediate,10116.0,Clearance of compound after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8100,CHEMBL621617,,,5503,,Intermediate,10116.0,Clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8101,CHEMBL621618,,,4368,,Intermediate,10116.0,Clearance by intravenous administration of 3.4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8102,CHEMBL621619,,,6005,,Intermediate,10116.0,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8103,CHEMBL621620,,,5031,,Intermediate,10116.0,Clearance rate after i.v. administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8104,CHEMBL621786,,,4890,,Intermediate,10116.0,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8105,CHEMBL621787,,,5182,,Intermediate,10116.0,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8106,CHEMBL621788,,,5979,,Intermediate,10116.0,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8107,CHEMBL621789,,,5656,,Intermediate,10116.0,Clearance (Cl) after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8108,CHEMBL621790,,,17804,,Intermediate,10116.0,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8109,CHEMBL621791,Plasma,,4839,1969.0,Intermediate,10116.0,Compound was tested for plasma clearance in rat,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8110,CHEMBL621792,,Microsomes,5041,,Intermediate,10116.0,In vitro microsome metabolism clearance in rat was determined,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8111,CHEMBL621793,,Microsomes,5041,,Intermediate,10116.0,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8112,CHEMBL621794,,,5974,,Intermediate,10116.0,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8113,CHEMBL621795,Plasma,,5496,1969.0,Intermediate,10116.0,In vivo plasma clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8114,CHEMBL621796,,,5739,,Intermediate,10116.0,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,1,,50597,
,1,Hepatocyte,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8115,CHEMBL621797,Liver,,5676,2107.0,Intermediate,10116.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,1,401.0,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8116,CHEMBL621798,,,4239,,Intermediate,10116.0,Pharmacokinetic property (Plasma clearance) was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8117,CHEMBL621799,,,5676,,Intermediate,10116.0,Pharmacokinetic property (clearance) in rat i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8118,CHEMBL621800,,,1918,,Intermediate,10116.0,"Plasma Clearance was evaluated in rats, iv",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8119,CHEMBL621801,,,17800,,Intermediate,10116.0,Plasma clearance (in vivo) in rats was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8120,CHEMBL621802,,,6056,,Intermediate,10116.0,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8121,CHEMBL618596,,,5496,,Intermediate,10116.0,Plasma clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8122,CHEMBL618597,,,5939,,Intermediate,10116.0,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8123,CHEMBL618598,,,5939,,Intermediate,10116.0,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8124,CHEMBL618599,,,17752,,Intermediate,10116.0,Plasma clearance in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8125,CHEMBL618600,,,4576,,Intermediate,10116.0,Plasma clearance rate determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8126,CHEMBL618601,,,6011,,Intermediate,10116.0,Plasma clearance was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8127,CHEMBL618602,,,5510,,Intermediate,10116.0,Plasma clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8128,CHEMBL618603,,,5948,,Intermediate,10116.0,Plasma clearance value in rat,1,,50597,
,1,,,Ex vivo,Rattus norvegicus,BAO_0000218,A,N,,8129,CHEMBL618604,Liver,,6125,2107.0,Intermediate,10116.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8130,CHEMBL618605,,,4839,,Intermediate,10116.0,Clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8131,CHEMBL618606,,,17686,,Intermediate,10116.0,Total body clearance in rat i.v. at 2 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8132,CHEMBL618607,,,6571,,Intermediate,10116.0,Clearance of compound in rats after intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8133,CHEMBL618608,,,3364,,Intermediate,10116.0,Clearance after iv administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8134,CHEMBL618609,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8135,CHEMBL618610,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8136,CHEMBL618611,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8137,CHEMBL618612,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8138,CHEMBL618613,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8139,CHEMBL621076,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8140,CHEMBL621077,,,13569,,Intermediate,10116.0,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8141,CHEMBL621078,,,17670,,Intermediate,10116.0,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8142,CHEMBL621251,,,5970,,Intermediate,10116.0,Clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8143,CHEMBL621252,,,6495,,Intermediate,10116.0,Clearance in rat after oral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8144,CHEMBL621253,,,4590,,Intermediate,10116.0,Clearance in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8145,CHEMBL621254,,,6193,,Intermediate,10116.0,Clearance rate following an oral dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8146,CHEMBL621255,,,2832,,Intermediate,10116.0,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8147,CHEMBL621256,Plasma,,1052,1969.0,Intermediate,10116.0,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8148,CHEMBL621257,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8149,CHEMBL621258,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8150,CHEMBL621259,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8151,CHEMBL621260,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8152,CHEMBL876494,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8153,CHEMBL621261,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8154,CHEMBL621262,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8155,CHEMBL621263,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8156,CHEMBL621264,Liver,,9866,2107.0,Intermediate,10116.0,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8157,CHEMBL621265,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8158,CHEMBL621266,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8159,CHEMBL621267,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8160,CHEMBL621268,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8161,CHEMBL621269,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8162,CHEMBL621270,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8163,CHEMBL621271,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8164,CHEMBL621272,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8165,CHEMBL621273,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8166,CHEMBL621274,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8167,CHEMBL876495,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8168,CHEMBL621275,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8169,CHEMBL621276,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8170,CHEMBL621277,Muscle tissue,,9866,2385.0,Intermediate,10116.0,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8171,CHEMBL621278,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8172,CHEMBL621279,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8173,CHEMBL621280,Intestine,,9866,160.0,Intermediate,10116.0,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8174,CHEMBL621281,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8175,CHEMBL621282,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8176,CHEMBL621283,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8177,CHEMBL621284,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8178,CHEMBL621285,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8179,CHEMBL621286,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8180,CHEMBL623220,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8181,CHEMBL623221,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8182,CHEMBL876029,Spleen,,9866,2106.0,Intermediate,10116.0,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8183,CHEMBL623222,Stomach,,9866,945.0,Intermediate,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8184,CHEMBL623223,Stomach,,9866,945.0,Intermediate,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8185,CHEMBL621445,Stomach,,9866,945.0,Intermediate,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8186,CHEMBL621446,Blood,,13950,178.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8187,CHEMBL621447,Blood,,13950,178.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8188,CHEMBL619681,Blood,,13950,178.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8189,CHEMBL619682,Blood,,13950,178.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8190,CHEMBL619683,Blood,,13950,178.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8191,CHEMBL619684,Brain,,13950,955.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8192,CHEMBL619685,Brain,,13950,955.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8193,CHEMBL619686,Brain,,13950,955.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8194,CHEMBL619687,Brain,,13950,955.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8195,CHEMBL619688,Brain,,13950,955.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8196,CHEMBL619689,Heart,,13950,948.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8197,CHEMBL619690,Heart,,13950,948.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8198,CHEMBL619691,Heart,,13950,948.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8199,CHEMBL619692,,,6062,,Intermediate,10116.0,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8200,CHEMBL619693,,,3598,,Expert,10116.0,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8201,CHEMBL619694,,,1908,,Intermediate,10116.0,Vc value after IV dose at a dose of 5 mg/kg in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8202,CHEMBL619695,,,17596,,Intermediate,10116.0,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8203,CHEMBL619696,,,4891,,Intermediate,10116.0,Compound was evaluated for pharmacokinetic parameter volume of distribution,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8204,CHEMBL619697,,,740,,Intermediate,10116.0,Compound was evaluated for volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8205,CHEMBL619698,,,16366,,Intermediate,10116.0,Steady state volume distribution was determined; steady state(ss),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8206,CHEMBL619699,,,3364,,Intermediate,10116.0,Steady state volume of distribution after iv administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8207,CHEMBL619700,,,2552,,Intermediate,10116.0,Steady state volume of distribution dosing at 3 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8208,CHEMBL619701,,,406,,Intermediate,10116.0,The compound was evaluated for volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8209,CHEMBL619702,,,12500,,Intermediate,10116.0,The compound was tested for volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8210,CHEMBL620335,,,12500,,Intermediate,10116.0,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8211,CHEMBL620336,,,5656,,Intermediate,10116.0,Volume distribution (VD) after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8212,CHEMBL620337,,,17671,,Intermediate,10116.0,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8213,CHEMBL620520,,,1094,,Intermediate,10116.0,Volume distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8214,CHEMBL620521,,,5833,,Intermediate,10116.0,Volume distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8215,CHEMBL875825,,,5939,,Intermediate,10116.0,Volume distribution in rat after peroral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8216,CHEMBL620522,,,5939,,Intermediate,10116.0,Volume distribution in rat after peroral administration at 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8217,CHEMBL620523,,,6005,,Intermediate,10116.0,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8218,CHEMBL620524,,,1696,,Intermediate,10116.0,Volume of distribution in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8219,CHEMBL620525,,,6672,,Intermediate,10116.0,Volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8220,CHEMBL620526,,,6673,,Intermediate,10116.0,Volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8221,CHEMBL620527,,,5871,,Intermediate,10116.0,Volume of distribution in rat by iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8222,CHEMBL620528,,,6803,,Intermediate,10116.0,Volume of distribution in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8223,CHEMBL620529,,,5199,,Intermediate,10116.0,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8224,CHEMBL620530,,,4727,,Intermediate,10116.0,Volume distribution at the dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8225,CHEMBL620531,,,16367,,Intermediate,10116.0,Steady state volume of distribution was determined,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,8226,CHEMBL620532,,,5005,,Intermediate,9544.0,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,8227,CHEMBL620533,,,5005,,Intermediate,10116.0,Compound was tested for its plasma volume distribution in Sprague Dawley rats,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,8228,CHEMBL620534,,,5005,,Intermediate,10116.0,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8229,CHEMBL620535,,,15765,,Intermediate,10116.0,Mean (%CV) PK parameters for Vdss(mL/kg).,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8230,CHEMBL875826,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8231,CHEMBL620536,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8232,CHEMBL620537,,,5334,,Intermediate,10116.0,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8233,CHEMBL618526,,,5334,,Intermediate,10116.0,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8234,CHEMBL618527,,,5739,,Intermediate,10116.0,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8235,CHEMBL618528,,,5789,,Intermediate,10116.0,Pharmacokinetic property (Vdss) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8236,CHEMBL618529,,,4239,,Intermediate,10116.0,Pharmacokinetic property (vdss) was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8237,CHEMBL618530,,,4709,,Intermediate,10116.0,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8238,CHEMBL618531,,,6642,,Intermediate,10116.0,Volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8239,CHEMBL618532,,,5247,,Intermediate,10116.0,The pharmacokinetic parameter volume of distribution in vivo in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,8240,CHEMBL618533,,,17720,,Intermediate,10116.0,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8241,CHEMBL618534,,,17686,,Intermediate,10116.0,Vdss in rat i.v. at 2 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8242,CHEMBL618535,,,4689,,Intermediate,10116.0,Volume distribution after intravenous administration (1 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8243,CHEMBL618536,,,5654,,Intermediate,10116.0,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8244,CHEMBL618537,,,5654,,Intermediate,10116.0,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8245,CHEMBL618538,,,4527,,Intermediate,10116.0,Volume distribution at a dose of 10 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8246,CHEMBL618539,,,4521,,Intermediate,10116.0,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8247,CHEMBL618540,,,6057,,Intermediate,10116.0,Volume distribution was calculated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8248,CHEMBL618541,,,5510,,Intermediate,10116.0,Volume distribution was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8249,CHEMBL618542,,,2938,,Intermediate,10116.0,Volume of distribution after intravenous administration was evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8250,CHEMBL622544,,,6679,,Intermediate,10116.0,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8251,CHEMBL622545,,,6685,,Intermediate,10116.0,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8252,CHEMBL622546,,,6685,,Intermediate,10116.0,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8253,CHEMBL622547,,,6685,,Intermediate,10116.0,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8254,CHEMBL622548,,,5145,,Intermediate,10116.0,Volume of distribution in steady state was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8255,CHEMBL622549,,,6467,,Intermediate,10116.0,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8256,CHEMBL622550,,,6467,,Intermediate,10116.0,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,8257,CHEMBL622551,,,15115,,Intermediate,10090.0,Compound was evaluated for area under curve when administered through oral route to mouse,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8258,CHEMBL622552,,,8758,,Intermediate,10116.0,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8259,CHEMBL622553,,,8758,,Intermediate,10116.0,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,50597,
,1,,,In vivo,,BAO_0000218,F,U,,8260,CHEMBL622554,,,8267,,Autocuration,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8261,CHEMBL622555,,,8267,,Intermediate,9615.0,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,8262,CHEMBL622556,,,14239,,Intermediate,10090.0,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8263,CHEMBL622557,,,14239,,Intermediate,10090.0,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8264,CHEMBL622558,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8265,CHEMBL622559,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,8266,CHEMBL622560,,,10754,,Intermediate,9615.0,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8267,CHEMBL622561,,,14681,,Intermediate,10116.0,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8268,CHEMBL622562,,,14681,,Intermediate,10116.0,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8269,CHEMBL622563,,,14681,,Intermediate,10116.0,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,50597,
,1,,,,,BAO_0000019,A,U,,8270,CHEMBL622564,,,13118,,Autocuration,,Concentration of compound in Central nervous system,0,,22224,
,1,,,,,BAO_0000019,A,U,,8271,CHEMBL622565,,,13118,,Autocuration,,Concentration of compound in Central nervous system; Not detectable,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8272,CHEMBL622566,,,13318,,Intermediate,10090.0,"Concentration of diester in the blood, following oral administration in mice",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8273,CHEMBL624515,,,13318,,Intermediate,10090.0,"Concentration of monoester in the blood, following oral administration in mice",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8274,CHEMBL624516,,,13318,,Intermediate,10090.0,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,1,,50594,
,1,,,,,BAO_0000019,A,U,,8275,CHEMBL624517,,,15692,,Autocuration,,Evaluated for Pharmacokinetic property: Area under the curve,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,8276,CHEMBL624518,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,1,,50594,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8277,CHEMBL624519,,,14839,,Intermediate,9541.0,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8278,CHEMBL624520,,,14839,,Intermediate,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8279,CHEMBL624521,,,14839,,Intermediate,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8280,CHEMBL624522,,,14839,,Intermediate,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8281,CHEMBL624523,,,14839,,Intermediate,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8282,CHEMBL624409,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8283,CHEMBL624410,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8284,CHEMBL624411,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8285,CHEMBL623531,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8286,CHEMBL623532,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8287,CHEMBL623533,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,8288,CHEMBL623534,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,100710,
,1,,,,Mus musculus,BAO_0000218,A,N,,8289,CHEMBL623535,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8290,CHEMBL623536,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8291,CHEMBL623537,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8292,CHEMBL623538,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8293,CHEMBL623539,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8294,CHEMBL623540,,,14839,,Intermediate,10090.0,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8295,CHEMBL623541,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8296,CHEMBL623542,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8297,CHEMBL623543,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8298,CHEMBL623544,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8299,CHEMBL623545,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8300,CHEMBL623546,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8301,CHEMBL623547,Plasma,,5408,1969.0,Intermediate,10116.0,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8302,CHEMBL623548,,,6827,,Intermediate,10116.0,High i.v. clearance in Dawley rats,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8303,CHEMBL623549,Liver,Microsomes,17538,2107.0,Intermediate,10116.0,In vitro clearance in rat liver microsomes,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8304,CHEMBL623550,Liver,Microsomes,6331,2107.0,Intermediate,10116.0,Intrinsic clearance in rat liver microsomes was determined,1,,50597,
,1,Hepatocyte,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8305,CHEMBL875276,Liver,,5948,2107.0,Intermediate,10116.0,Intrinsic clearance in rat hepatocytes was determined,1,401.0,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8306,CHEMBL621872,,,4026,,Intermediate,10116.0,Plasma Clearance was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8307,CHEMBL621873,,,6647,,Intermediate,10116.0,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8308,CHEMBL621874,,,1696,,Intermediate,10116.0,Plasma clearance in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8309,CHEMBL621875,,,6597,,Intermediate,10116.0,Plasma clearance in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8310,CHEMBL621876,,,347,,Intermediate,10116.0,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8311,CHEMBL621877,,,16423,,Intermediate,10116.0,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8312,CHEMBL621878,,,2879,,Intermediate,10116.0,Plasma clearance was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8313,CHEMBL621879,,,4883,,Intermediate,10116.0,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8314,CHEMBL621880,Plasma,,5328,1969.0,Intermediate,10116.0,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8315,CHEMBL621881,,,5160,,Intermediate,10116.0,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8316,CHEMBL621882,,,17582,,Intermediate,10116.0,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8317,CHEMBL875283,,,17651,,Intermediate,10116.0,Total clearance at 1 mg/kg was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8318,CHEMBL621883,,,17651,,Intermediate,10116.0,Total clearance at 10 mg/kg was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8319,CHEMBL621884,,,6596,,Intermediate,10116.0,Clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8320,CHEMBL621885,,,4796,,Intermediate,10116.0,Plasma clearance rate determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8321,CHEMBL621886,,,6850,,Intermediate,10116.0,Clearance of compound in rat was evaluated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8322,CHEMBL621887,Plasma,,5932,1969.0,Intermediate,10116.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8323,CHEMBL621888,,,3371,,Intermediate,10116.0,Pharmacokinetic property (blood clearance) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8324,CHEMBL621889,,,2083,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8325,CHEMBL621890,,,4942,,Intermediate,10116.0,Plasma clearance in rats,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,8326,CHEMBL621891,Liver,Microsomes,6838,2107.0,Intermediate,10116.0,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8327,CHEMBL621892,,,5353,,Intermediate,10116.0,Clearance in Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8328,CHEMBL621893,,,6641,,Intermediate,10116.0,Clearance rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8329,CHEMBL621894,,,6641,,Intermediate,10116.0,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8330,CHEMBL621895,,,6641,,Intermediate,10116.0,Clearance rat; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8331,CHEMBL875284,,,6444,,Intermediate,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8332,CHEMBL618699,,,6444,,Intermediate,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8333,CHEMBL618700,,,6444,,Intermediate,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8334,CHEMBL618701,,,6211,,Intermediate,10116.0,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8335,CHEMBL876600,Plasma,,12873,1969.0,Intermediate,10116.0,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8336,CHEMBL618702,,,6570,,Intermediate,10116.0,Clearance of compound in rat after 1 mg/kg i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8337,CHEMBL618703,,,3341,,Intermediate,10116.0,Compound was evaluated for Hepatic clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8338,CHEMBL618704,,,4891,,Intermediate,10116.0,In vivo clearance after 5 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8339,CHEMBL618705,Plasma,,1094,1969.0,Intermediate,10116.0,Compound was tested for plasma clearance in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8340,CHEMBL618706,,,2938,,Intermediate,10116.0,Hepatic clearance after intravenous administration was evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8341,CHEMBL618707,,,17853,,Intermediate,10116.0,Lower clearance in rat (i.v.) at 0.5 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8342,CHEMBL618708,Plasma,,6049,1969.0,Intermediate,10116.0,Pharmacokinetic parameter expressed as plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8343,CHEMBL618709,,,5789,,Intermediate,10116.0,Pharmacokinetic property (Clp) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8344,CHEMBL618710,,,4514,,Intermediate,10116.0,Plasma clearance in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8345,CHEMBL618711,,,6448,,Intermediate,10116.0,Plasma clearance (Clp) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8346,CHEMBL618712,,,6062,,Intermediate,10116.0,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8347,CHEMBL618713,,,5710,,Intermediate,10116.0,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8348,CHEMBL618714,,,4709,,Intermediate,10116.0,Plasma clearance after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8349,CHEMBL618715,,,4521,,Intermediate,10116.0,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8350,CHEMBL618716,,,1742,,Intermediate,10116.0,Plasma clearance in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8351,CHEMBL876601,,,6057,,Intermediate,10116.0,Plasma clearance measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8352,CHEMBL618717,,,6057,,Intermediate,10116.0,Plasma clearance was calculated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8353,CHEMBL618718,,,5145,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8354,CHEMBL618719,,,5833,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8355,CHEMBL618720,,,6453,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8356,CHEMBL618721,,,6640,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8357,CHEMBL621477,,,6305,,Intermediate,10116.0,Plasma clearance in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8358,CHEMBL621478,,,6642,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8359,CHEMBL621479,,,5472,,Intermediate,10116.0,Plasma clearance was evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8360,CHEMBL621480,,,5472,,Intermediate,10116.0,Plasma clearance was evaluated in rat; Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8361,CHEMBL621481,,,5144,,Intermediate,10116.0,Plasma clearance rate was determined for the compound in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8362,CHEMBL621482,,,6685,,Intermediate,10116.0,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8363,CHEMBL621483,,,6685,,Intermediate,10116.0,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8364,CHEMBL621484,,,6685,,Intermediate,10116.0,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8365,CHEMBL621485,Heart,,13950,948.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8366,CHEMBL621486,Heart,,13950,948.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8367,CHEMBL621487,Intestine,,13950,160.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8368,CHEMBL621488,Intestine,,13950,160.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8369,CHEMBL621489,Intestine,,13950,160.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8370,CHEMBL621490,Intestine,,13950,160.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8371,CHEMBL621491,Intestine,,13950,160.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8372,CHEMBL621492,Kidney,,13950,2113.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8373,CHEMBL621493,Kidney,,13950,2113.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8374,CHEMBL621494,Kidney,,13950,2113.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8375,CHEMBL621495,Kidney,,13950,2113.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8376,CHEMBL621496,Kidney,,13950,2113.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8377,CHEMBL621497,Liver,,13950,2107.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8378,CHEMBL621498,Liver,,13950,2107.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8379,CHEMBL621499,Liver,,13950,2107.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8380,CHEMBL618634,Liver,,13950,2107.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8381,CHEMBL618635,Liver,,13950,2107.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8382,CHEMBL618636,Lung,,13950,2048.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8383,CHEMBL619737,Lung,,13950,2048.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8384,CHEMBL619738,Lung,,13950,2048.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8385,CHEMBL624329,Lung,,13950,2048.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8386,CHEMBL624330,Lung,,13950,2048.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8387,CHEMBL624331,Muscle tissue,,13950,2385.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8388,CHEMBL624332,Muscle tissue,,13950,2385.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8389,CHEMBL624333,Muscle tissue,,13950,2385.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8390,CHEMBL624334,Muscle tissue,,13950,2385.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8391,CHEMBL624335,Muscle tissue,,13950,2385.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8392,CHEMBL620016,Spleen,,13950,2106.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8393,CHEMBL620169,Spleen,,13950,2106.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8394,CHEMBL620170,Spleen,,13950,2106.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8395,CHEMBL620171,Spleen,,13950,2106.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8396,CHEMBL620172,Spleen,,13950,2106.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8397,CHEMBL620173,Stomach,,13950,945.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8398,CHEMBL620174,Stomach,,13950,945.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8399,CHEMBL620175,Stomach,,13950,945.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8400,CHEMBL620176,Stomach,,13950,945.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8401,CHEMBL620177,Stomach,,13950,945.0,Intermediate,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8402,CHEMBL620178,Cerebellum,,13950,2037.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8403,CHEMBL620179,Cerebellum,,13950,2037.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8404,CHEMBL620180,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8405,CHEMBL620181,,,6570,,Intermediate,10116.0,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8406,CHEMBL620182,,,6571,,Intermediate,10116.0,Volume of distribution of compound in rats after intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8407,CHEMBL620183,,,6453,,Intermediate,10116.0,Volume of distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8408,CHEMBL620184,,,6444,,Intermediate,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8409,CHEMBL620185,,,6444,,Intermediate,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8410,CHEMBL620186,,,6444,,Intermediate,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8411,CHEMBL620187,,,5353,,Intermediate,10116.0,Volume of distribution was determined in Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8412,CHEMBL620188,,,5334,,Intermediate,10116.0,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8413,CHEMBL620189,,,5334,,Intermediate,10116.0,Volume of distribution was reported in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8414,CHEMBL620190,,,6641,,Intermediate,10116.0,Volumes of distribution in rat after peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8415,CHEMBL620191,,,6641,,Intermediate,10116.0,Volumes of distribution in rat after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8416,CHEMBL620192,,,6641,,Intermediate,10116.0,Volumes of distribution in rat after po administration; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8417,CHEMBL620193,,,5676,,Intermediate,10116.0,Pharmacokinetic property (Volume) in rat i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8418,CHEMBL620194,,,6410,,Intermediate,10116.0,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8419,CHEMBL876730,,,17670,,Intermediate,10116.0,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8420,CHEMBL620195,,,6495,,Intermediate,10116.0,Volume distribution in rat after oral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8421,CHEMBL620196,,,5408,,Intermediate,10116.0,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8422,CHEMBL620197,,,4883,,Intermediate,10116.0,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8423,CHEMBL620198,,,6647,,Intermediate,10116.0,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8424,CHEMBL620199,,,6495,,Intermediate,10116.0,Volume of distribution in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8425,CHEMBL620200,,,2661,,Intermediate,10116.0,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8426,CHEMBL620201,,,2661,,Intermediate,10116.0,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8427,CHEMBL620202,,,5974,,Intermediate,10116.0,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8428,CHEMBL620203,,,5974,,Intermediate,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8429,CHEMBL620204,,,5974,,Intermediate,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8430,CHEMBL620205,,,5974,,Intermediate,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8431,CHEMBL624664,,,5960,,Intermediate,10116.0,Pharmacokinetic parameter (Vss) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8432,CHEMBL624665,,,5676,,Intermediate,10116.0,Pharmacokinetic property (Volume) in rat i.v.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8433,CHEMBL624666,,,5948,,Intermediate,10116.0,Pharmacokinetic property (Vss) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8434,CHEMBL624667,,,5979,,Intermediate,10116.0,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8435,CHEMBL624668,,,5978,,Intermediate,10116.0,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8436,CHEMBL624669,,,5978,,Intermediate,10116.0,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8437,CHEMBL624670,,,5978,,Intermediate,10116.0,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8438,CHEMBL624671,,,5978,,Intermediate,10116.0,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8439,CHEMBL624672,,,6448,,Intermediate,10116.0,Steady state volume distribution in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8440,CHEMBL624673,Plasma,,12873,1969.0,Intermediate,10116.0,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8441,CHEMBL624674,,,4576,,Intermediate,10116.0,Steady state volume of distribution determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8442,CHEMBL624675,,,17582,,Intermediate,10116.0,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8443,CHEMBL621728,,,1466,,Intermediate,10116.0,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8444,CHEMBL621729,,,5182,,Intermediate,10116.0,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8445,CHEMBL621730,,,5182,,Intermediate,10116.0,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8446,CHEMBL621731,,,6535,,Intermediate,10116.0,Volume distribution in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8447,CHEMBL621732,,,6535,,Intermediate,10116.0,Volume distribution in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8448,CHEMBL621908,,,5041,,Intermediate,10116.0,Volume in steady state distribution value was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8449,CHEMBL875347,,,5041,,Intermediate,10116.0,Volume in steady state distribution value was determined; ND denotes no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8450,CHEMBL621909,,,5041,,Intermediate,10116.0,Volume in steady state distribution value was determined; ND denotes not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8451,CHEMBL621910,,,17065,,Intermediate,10116.0,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8452,CHEMBL621911,,,6597,,Intermediate,10116.0,Volume of distribution at steady state was evaluated in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8453,CHEMBL621912,,,15662,,Intermediate,10116.0,Volume of distribution at steady state was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8454,CHEMBL621913,,,6485,,Intermediate,10116.0,Volume of distribution in steady state was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8455,CHEMBL621914,,,17655,,Intermediate,10116.0,Volume of distribution in steady state was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8456,CHEMBL621915,,,6616,,Intermediate,10116.0,Volume of distribution after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8457,CHEMBL621916,,,1916,,Intermediate,10116.0,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8458,CHEMBL621917,Liver,,16438,2107.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8459,CHEMBL621918,Liver,,16438,2107.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8460,CHEMBL621919,Spleen,,16438,2106.0,Intermediate,10090.0,Biodistribution of compound (oxidized form) in spleen tissue,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8461,CHEMBL621920,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8462,CHEMBL621921,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8463,CHEMBL622401,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8464,CHEMBL875348,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8465,CHEMBL622402,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8466,CHEMBL622403,Blood,,16438,178.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8467,CHEMBL622404,Blood,,16438,178.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8468,CHEMBL622405,Brain,,16438,955.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8469,CHEMBL622406,Brain,,16438,955.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8470,CHEMBL622407,Brain,,16438,955.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8471,CHEMBL622408,Heart,,16438,948.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8472,CHEMBL622409,Heart,,16438,948.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8473,CHEMBL622410,Heart,,16438,948.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8474,CHEMBL622411,Kidney,,16438,2113.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8475,CHEMBL627864,Kidney,,16438,2113.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8476,CHEMBL627865,Kidney,,16438,2113.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8477,CHEMBL627866,Liver,,16438,2107.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8478,CHEMBL627751,Liver,,16438,2107.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8479,CHEMBL627752,Spleen,,16438,2106.0,Intermediate,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8480,CHEMBL627753,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8481,CHEMBL627754,Spleen,,16438,2106.0,Intermediate,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8482,CHEMBL627755,,,12467,,Intermediate,10090.0,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8483,CHEMBL627756,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8484,CHEMBL627757,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8485,CHEMBL627758,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8486,CHEMBL627759,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8487,CHEMBL627760,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8488,CHEMBL627761,Brain,,17208,955.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8489,CHEMBL876811,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8490,CHEMBL627762,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8491,CHEMBL627763,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8492,CHEMBL627764,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8493,CHEMBL627765,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8494,CHEMBL627766,Heart,,17208,948.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8495,CHEMBL627767,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8496,CHEMBL627768,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8497,CHEMBL628422,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8498,CHEMBL628423,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8499,CHEMBL628424,,,5089,,Intermediate,10116.0,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8500,CHEMBL628425,,,5089,,Intermediate,10116.0,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8501,CHEMBL628426,,,4257,,Intermediate,10116.0,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8502,CHEMBL628427,,,6679,,Intermediate,10116.0,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8503,CHEMBL626938,,,5546,,Intermediate,10116.0,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8504,CHEMBL626939,,,6141,,Intermediate,10116.0,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8505,CHEMBL626940,,,5334,,Intermediate,10116.0,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8506,CHEMBL626941,,,5334,,Intermediate,10116.0,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8507,CHEMBL626942,,,5334,,Intermediate,10116.0,Plasma clearance was reported in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8508,CHEMBL876812,,,4689,,Intermediate,10116.0,Plasma clearance after intravenous administration (1 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8509,CHEMBL626943,,,6848,,Intermediate,10116.0,Plasma clearance of compound in rats was evaluated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8510,CHEMBL626944,,,6848,,Intermediate,10116.0,Plasma clearance of compound in rats was evaluated; ND indicates not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8511,CHEMBL626945,,,6467,,Intermediate,10116.0,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8512,CHEMBL626946,,,6467,,Intermediate,10116.0,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8513,CHEMBL626856,,,4956,,Intermediate,10116.0,Plasma clearance rate in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8514,CHEMBL626857,,,5529,,Intermediate,10116.0,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8515,CHEMBL626858,Plasma,,406,1969.0,Intermediate,10116.0,The compound was evaluated for plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8516,CHEMBL627018,Plasma,,17655,1969.0,Intermediate,10116.0,Total plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8517,CHEMBL625331,Blood,,3293,178.0,Intermediate,10116.0,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8518,CHEMBL625332,Blood,,4075,178.0,Intermediate,10116.0,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8519,CHEMBL877590,,,2792,,Intermediate,10116.0,C max was determined at 10 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8520,CHEMBL625333,,,2792,,Intermediate,10116.0,C max was determined at 3 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8521,CHEMBL625334,,,17594,,Intermediate,10116.0,Cmax after repeated oral dose of compound at 1 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8522,CHEMBL625335,,,17594,,Intermediate,10116.0,Cmax after single intravenous bolus of 1 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8523,CHEMBL625336,,,4762,,Intermediate,10116.0,Cmax of compound at 5 mg/kg after po administration was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8524,CHEMBL625337,,,17509,,Intermediate,10116.0,Cmax 24 hr after 10 mg/kg oral administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8525,CHEMBL625338,,,17509,,Intermediate,10116.0,Cmax 24 hr after 2 mg/kg oral administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8526,CHEMBL625339,Plasma,,1466,1969.0,Intermediate,10116.0,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8527,CHEMBL625340,,,6535,,Intermediate,10116.0,Cmax in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8528,CHEMBL625341,,,6535,,Intermediate,10116.0,Cmax in rat after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8529,CHEMBL622687,,,3169,,Intermediate,10116.0,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8530,CHEMBL622688,Plasma,,6515,1969.0,Intermediate,10116.0,Cmax wa determined in rat plasma at 30 mg/kg after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8531,CHEMBL622689,Blood,,11149,178.0,Intermediate,10116.0,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8532,CHEMBL620295,Blood,,11149,178.0,Intermediate,10116.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8533,CHEMBL620296,,,17858,,Intermediate,10116.0,Cmax after 10 mg/kg oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8534,CHEMBL620297,,,6518,,Intermediate,10116.0,Cmax after IV dosing at 0.5 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8535,CHEMBL620298,,,6518,,Intermediate,10116.0,Cmax after IV dosing at 1 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8536,CHEMBL620299,,,4426,,Intermediate,10116.0,Cmax after oral administration at 20 mpk in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8537,CHEMBL620300,,,4426,,Intermediate,10116.0,Cmax after oral administration at 20 mpk in rats; Not performed.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8538,CHEMBL620301,,,4426,,Intermediate,10116.0,Cmax after oral administration at 20 mpk in rats d; Not performed.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8539,CHEMBL620302,,,5656,,Intermediate,10116.0,Cmax after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8540,CHEMBL620303,,,6518,,Intermediate,10116.0,Cmax after oral administration at a dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8541,CHEMBL620304,,,6518,,Intermediate,10116.0,Cmax after oral administration at a dose of 4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8542,CHEMBL620305,,,6113,,Intermediate,10116.0,Cmax in rats after 20 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8543,CHEMBL620306,,,17764,,Intermediate,10116.0,Cmax after peroral administration in rats at 2.4 uM/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8544,CHEMBL620307,,,4756,,Intermediate,10116.0,Cmax at the dose of 2 mg/Kg administered perorally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8545,CHEMBL620308,,,4756,,Intermediate,10116.0,Cmax at the dose of 5 mg/Kg administered perorally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8546,CHEMBL620309,,,6402,,Intermediate,10116.0,Cmax by administering at 20 mg/kg p.o. in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8547,CHEMBL620310,,,5610,,Intermediate,10116.0,Cmax in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8548,CHEMBL620311,,,5207,,Intermediate,10116.0,Cmax in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8549,CHEMBL620312,,,6011,,Intermediate,10116.0,Cmax in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8550,CHEMBL620313,,,6504,,Intermediate,10116.0,Cmax in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8551,CHEMBL620314,,,6046,,Intermediate,10116.0,Cmax in rat at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8552,CHEMBL620315,,,6504,,Intermediate,10116.0,Cmax in rat at the dose of 1 mg/kg i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8553,CHEMBL620316,,,5874,,Intermediate,10116.0,Cmax in rat by po administration at a dose of 40 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8554,CHEMBL620317,,,17686,,Intermediate,10116.0,Cmax in rat p.o. at 20 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8555,CHEMBL620318,,,5836,,Intermediate,10116.0,Cmax in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8556,CHEMBL620319,,,17596,,Intermediate,10116.0,Cmax in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8557,CHEMBL620320,,,16423,,Intermediate,10116.0,Cmax was evaluated after 20 uM/kg of peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8558,CHEMBL620321,,,17804,,Intermediate,10116.0,Cmax was measured in rats after peroral administration at 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8559,CHEMBL620322,,,1908,,Intermediate,10116.0,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8560,CHEMBL620323,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8561,CHEMBL620324,Frontal cortex,,13950,1870.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8562,CHEMBL620325,Frontal cortex,,13950,1870.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8563,CHEMBL620326,Hippocampus,,13950,10000000.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8564,CHEMBL620327,Hippocampus,,13950,10000000.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8565,CHEMBL620328,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8566,CHEMBL620329,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8567,CHEMBL620330,Midbrain,,13950,1891.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8568,CHEMBL875286,Midbrain,,13950,1891.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8569,CHEMBL620331,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8570,CHEMBL620332,,,13950,,Intermediate,10116.0,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8571,CHEMBL620333,Striatum,,13950,2435.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8572,CHEMBL620334,Striatum,,13950,2435.0,Intermediate,10116.0,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8573,CHEMBL621015,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8574,CHEMBL621016,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8575,CHEMBL621191,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8576,CHEMBL621192,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8577,CHEMBL621193,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8578,CHEMBL621194,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8579,CHEMBL624204,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8580,CHEMBL624205,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8581,CHEMBL624206,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8582,CHEMBL624207,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8583,CHEMBL624208,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8584,CHEMBL624209,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8585,CHEMBL624210,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8586,CHEMBL624211,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8587,CHEMBL624212,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8588,CHEMBL624213,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8589,CHEMBL876611,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8590,CHEMBL624214,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8591,CHEMBL624215,Blood,,16434,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8592,CHEMBL624216,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8593,CHEMBL624217,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8594,CHEMBL624218,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8595,CHEMBL624219,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8596,CHEMBL624220,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8597,CHEMBL624221,Blood,,16435,178.0,Intermediate,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8598,CHEMBL624222,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8599,CHEMBL624223,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8600,CHEMBL624224,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8601,CHEMBL624225,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8602,CHEMBL622420,,,17764,,Intermediate,10116.0,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8603,CHEMBL622421,,,5031,,Intermediate,10116.0,Volume of steady state distribution after i.v. administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8604,CHEMBL622422,,,6215,,Intermediate,10116.0,Vss after intravenous administration (5.0 mg/kg) was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8605,CHEMBL622423,,,17671,,Intermediate,10116.0,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8606,CHEMBL622424,,,17752,,Intermediate,10116.0,Vss was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8607,CHEMBL622425,,,6596,,Intermediate,10116.0,Vss in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8608,CHEMBL876612,,,16423,,Intermediate,10116.0,Vss was evaluated after 10 uM/kg of intra arterial administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8609,CHEMBL622426,,,15662,,Intermediate,10116.0,volume of distribution at steady state was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8610,CHEMBL622427,,,6062,,Intermediate,10116.0,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8611,CHEMBL622428,,,5874,,Intermediate,10116.0,Pharmacokinetic (PK) parameter Vz in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8612,CHEMBL622429,,,4942,,Intermediate,10116.0,Volume distribution in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8613,CHEMBL622430,,,17796,,Intermediate,10116.0,Volume of distribution in rat; No data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8614,CHEMBL622431,,,4890,,Intermediate,10116.0,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8615,CHEMBL622432,Ileum,,15765,2116.0,Intermediate,10116.0,% absorption predicted from in vitro rat ileum transport studies,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8616,CHEMBL622433,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8617,CHEMBL622434,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8618,CHEMBL622435,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8619,CHEMBL618748,,,13569,,Intermediate,10116.0,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8620,CHEMBL618749,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8621,CHEMBL618750,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8622,CHEMBL618751,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8623,CHEMBL618752,,,13569,,Intermediate,10116.0,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8624,CHEMBL618753,,,4576,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8625,CHEMBL618754,Plasma,,750,1969.0,Intermediate,10116.0,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8626,CHEMBL618755,,,750,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8627,CHEMBL618756,,,4590,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8628,CHEMBL618757,,,1716,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8629,CHEMBL618758,,,1974,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8630,CHEMBL621088,,,4502,,Intermediate,10116.0,Oral bioavailability in rat (dose 30 mg/kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8631,CHEMBL621089,,,3371,,Intermediate,10116.0,Pharmacokinetic property (cLogP) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,8632,CHEMBL621090,Blood,,9099,178.0,Intermediate,10116.0,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,8633,CHEMBL621091,Blood,,9099,178.0,Intermediate,10116.0,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8634,CHEMBL876731,,,4590,,Intermediate,10116.0,Clearance in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8635,CHEMBL621092,,,3184,,Intermediate,10116.0,Compound was evaluated for its clearance when administered intravenously in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8636,CHEMBL621093,,,16456,,Intermediate,10116.0,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8637,CHEMBL621094,,,4199,,Intermediate,10116.0,Blood: Brain distribution ratio is determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8638,CHEMBL621095,,,4199,,Intermediate,10116.0,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8639,CHEMBL621096,,,4199,,Intermediate,10116.0,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8640,CHEMBL621097,Kidney,,8677,2113.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,8641,CHEMBL621098,,,7449,,Intermediate,10116.0,Percent dose excreted in 0-48 hours administered ip to male rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8642,CHEMBL621099,Cerebellum,,11977,2037.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8643,CHEMBL621100,Cerebellum,,11977,2037.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8644,CHEMBL621101,Cerebellum,,11977,2037.0,Intermediate,10116.0,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8645,CHEMBL621102,Cerebellum,,11977,2037.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8646,CHEMBL876732,Cerebellum,,11977,2037.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8647,CHEMBL621103,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8648,CHEMBL621104,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8649,CHEMBL621105,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8650,CHEMBL621106,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8651,CHEMBL621107,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8652,CHEMBL621108,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8653,CHEMBL621109,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8654,CHEMBL621110,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8655,CHEMBL621111,Kidney,,17208,2113.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8656,CHEMBL622541,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8657,CHEMBL622542,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8658,CHEMBL622543,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8659,CHEMBL624412,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8660,CHEMBL624413,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8661,CHEMBL624414,Liver,,17208,2107.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8662,CHEMBL624415,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8663,CHEMBL624416,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8664,CHEMBL624417,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8665,CHEMBL624418,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8666,CHEMBL624419,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8667,CHEMBL624420,Lung,,17208,2048.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8668,CHEMBL624421,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8669,CHEMBL624422,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8670,CHEMBL624423,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8671,CHEMBL625123,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8672,CHEMBL625124,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8673,CHEMBL625125,Muscle tissue,,17208,2385.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8674,CHEMBL625126,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8675,CHEMBL626947,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8676,CHEMBL626948,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8677,CHEMBL626949,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8678,CHEMBL626950,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8679,CHEMBL626951,Zone of skin,,17208,14.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8680,CHEMBL626952,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8681,CHEMBL626953,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8682,CHEMBL626954,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8683,CHEMBL626955,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8684,CHEMBL626956,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8685,CHEMBL626957,Spleen,,17208,2106.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8686,CHEMBL626958,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8687,CHEMBL626959,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8688,CHEMBL626960,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8689,CHEMBL626961,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8690,CHEMBL627589,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8691,CHEMBL627590,Blood,,17208,178.0,Intermediate,10090.0,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8692,CHEMBL627591,,,3132,,Intermediate,10090.0,Time taken for EC90 was determined when tested in mouse,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8693,CHEMBL627592,,,3132,,Intermediate,10090.0,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8694,CHEMBL627593,,,16597,,Intermediate,10090.0,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8695,CHEMBL627594,,,5727,,Intermediate,10090.0,Half life in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8696,CHEMBL876813,,,5302,,Intermediate,10090.0,Half life period in mouse after 10 mg/Kg dose,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8697,CHEMBL627595,,,5302,,Intermediate,10090.0,Half life period in mouse after 10 mg/kg dose,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8698,CHEMBL627596,,,6348,,Intermediate,10090.0,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8699,CHEMBL627597,,,5964,,Intermediate,10116.0,Cmax value at 5 mg/kg po was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8700,CHEMBL627598,,,6078,,Intermediate,10116.0,Cmax value evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8701,CHEMBL627599,Brain,,5206,955.0,Intermediate,10116.0,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8702,CHEMBL627600,,,2959,,Intermediate,10116.0,Cmax value after administration of 20 mg/Kg oral dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8703,CHEMBL627601,,,5964,,Intermediate,10116.0,Cmax value at 1 mg/kg po in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8704,CHEMBL627776,,,5964,,Intermediate,10116.0,Cmax value at 5 mg/kg po in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8705,CHEMBL627777,,,6757,,Intermediate,10116.0,Cmax value at a dose of 10 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8706,CHEMBL627778,,,6757,,Intermediate,10116.0,Cmax value at a dose of 100 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8707,CHEMBL627779,,,6757,,Intermediate,10116.0,Cmax value at a dose of 50 mg/kg in male SD rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8708,CHEMBL876814,,,17617,,Intermediate,10116.0,Cmax value in rats at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8709,CHEMBL627780,,,1445,,Intermediate,10116.0,Cmax value was evaluated in rats at a dose of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8710,CHEMBL627781,,,6082,,Intermediate,10116.0,Cmax value was determined after peroral administration of 20 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8711,CHEMBL627782,,,1446,,Intermediate,10116.0,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8712,CHEMBL627783,Plasma,,5407,1969.0,Intermediate,10116.0,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8713,CHEMBL627784,Plasma,,2690,1969.0,Intermediate,10116.0,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8714,CHEMBL627785,,,2661,,Intermediate,10116.0,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8715,CHEMBL627786,,,2661,,Intermediate,10116.0,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8716,CHEMBL627787,Plasma,,4891,1969.0,Intermediate,10116.0,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8717,CHEMBL627788,Plasma,,2807,1969.0,Intermediate,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8718,CHEMBL626579,Plasma,,2807,1969.0,Intermediate,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8719,CHEMBL626580,Plasma,,2807,1969.0,Intermediate,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8720,CHEMBL876815,,,3634,,Intermediate,10116.0,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8721,CHEMBL626581,Plasma,,1881,1969.0,Intermediate,10116.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8722,CHEMBL626582,Plasma,,1881,1969.0,Intermediate,10116.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8723,CHEMBL626583,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8724,CHEMBL626205,,,5974,,Intermediate,10116.0,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8725,CHEMBL626206,,,5974,,Intermediate,10116.0,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8726,CHEMBL626207,,,5974,,Intermediate,10116.0,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8727,CHEMBL623882,,,5974,,Intermediate,10116.0,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8728,CHEMBL623883,,,17582,,Intermediate,10116.0,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8729,CHEMBL623884,,,17582,,Intermediate,10116.0,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8730,CHEMBL623885,Plasma,,3032,1969.0,Intermediate,10116.0,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8731,CHEMBL623886,Plasma,,6295,1969.0,Intermediate,10116.0,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8732,CHEMBL623887,,,6619,,Intermediate,10116.0,Maximal concentration in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8733,CHEMBL623888,,,6616,,Intermediate,10116.0,Maximal concentration after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8734,CHEMBL623889,Plasma,,3249,1969.0,Intermediate,10116.0,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8735,CHEMBL623890,Plasma,,17791,1969.0,Intermediate,10116.0,Maximal plasma concentration in rat after oral administration at 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8736,CHEMBL623891,Plasma,,17791,1969.0,Intermediate,10116.0,Cmax in rat plasma after oral dose (50 mg/Kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8737,CHEMBL623892,Plasma,,1360,1969.0,Intermediate,10116.0,Maximal plasma concentration was determined.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8738,CHEMBL623893,Plasma,,2552,1969.0,Intermediate,10116.0,Maximal plasma drug concentration was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8739,CHEMBL877616,,,6571,,Intermediate,10116.0,Maximal concentration in rats after peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8740,CHEMBL623894,,,6570,,Intermediate,10116.0,Maximum concentration in rat after 2 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8741,CHEMBL623895,Plasma,,6567,1969.0,Intermediate,10116.0,Maximum concentration in rat plasma after 5 mg/kg oral gavage,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8742,CHEMBL623896,,,3031,,Intermediate,10116.0,Maximum concentration of compound in rat was evaluated.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8743,CHEMBL623897,,,3436,,Intermediate,10116.0,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8744,CHEMBL623898,,,3436,,Intermediate,10116.0,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8745,CHEMBL623899,,,2083,,Intermediate,10116.0,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8746,CHEMBL623900,,,3436,,Intermediate,10116.0,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8747,CHEMBL623901,,,4527,,Intermediate,10116.0,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8748,CHEMBL623902,,,1974,,Intermediate,10116.0,Maximum concentration was evaluated in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8749,CHEMBL623903,Cerebrospinal fluid,,3307,1359.0,Intermediate,10116.0,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8750,CHEMBL623904,Plasma,,3307,1969.0,Intermediate,10116.0,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8751,CHEMBL877617,Plasma,,1916,1969.0,Intermediate,10116.0,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8752,CHEMBL623905,,,1500,,Intermediate,10116.0,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8753,CHEMBL623906,,,1500,,Intermediate,10116.0,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8754,CHEMBL623907,Plasma,,4186,1969.0,Intermediate,10116.0,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8755,CHEMBL623908,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8756,CHEMBL623909,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8757,CHEMBL623910,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8758,CHEMBL623911,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8759,CHEMBL623912,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8760,CHEMBL624616,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8761,CHEMBL624617,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8762,CHEMBL624618,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8763,CHEMBL624619,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8764,CHEMBL624794,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8765,CHEMBL624795,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8766,CHEMBL623921,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8767,CHEMBL623922,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8768,CHEMBL623923,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8769,CHEMBL623924,,,16434,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8770,CHEMBL623925,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8771,CHEMBL623926,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8772,CHEMBL623927,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8773,CHEMBL623928,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8774,CHEMBL623929,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8775,CHEMBL623930,,,16435,,Intermediate,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8776,CHEMBL623931,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8777,CHEMBL622165,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8778,CHEMBL621249,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8779,CHEMBL621250,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8780,CHEMBL621448,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8781,CHEMBL621449,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8782,CHEMBL621450,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8783,CHEMBL621451,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8784,CHEMBL621452,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8785,CHEMBL621453,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8786,CHEMBL621454,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8787,CHEMBL621455,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8788,CHEMBL621456,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8789,CHEMBL625145,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8790,CHEMBL875847,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8791,CHEMBL625146,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8792,CHEMBL625147,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8793,CHEMBL625148,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8794,CHEMBL625149,Brain,,16434,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8795,CHEMBL625150,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8796,CHEMBL625151,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8797,CHEMBL625152,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8798,CHEMBL625153,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8799,CHEMBL625154,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8800,CHEMBL625155,Brain,,16435,955.0,Intermediate,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8801,CHEMBL625156,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8802,CHEMBL624354,,,11977,,Intermediate,10116.0,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8803,CHEMBL624355,Hippocampus,,11977,10000000.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8804,CHEMBL624356,Hippocampus,,11977,10000000.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8805,CHEMBL624357,Hippocampus,,11977,10000000.0,Intermediate,10116.0,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8806,CHEMBL624358,Hippocampus,,11977,10000000.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8807,CHEMBL624359,Striatum,,11977,2435.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8808,CHEMBL624360,Striatum,,11977,2435.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8809,CHEMBL624361,Striatum,,11977,2435.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8810,CHEMBL624362,Striatum,,11977,2435.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8811,CHEMBL624363,Striatum,,11977,2435.0,Intermediate,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8812,CHEMBL624364,Blood,,11977,178.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8813,CHEMBL624365,Blood,,11977,178.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8814,CHEMBL624366,Blood,,11977,178.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8815,CHEMBL624367,Blood,,11977,178.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8816,CHEMBL624368,Brain,,11977,955.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8817,CHEMBL624369,Brain,,11977,955.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8818,CHEMBL624370,Brain,,11977,955.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8819,CHEMBL625069,Brain,,11977,955.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8820,CHEMBL625070,Brain,,11977,955.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8821,CHEMBL626051,Heart,,11977,948.0,Intermediate,10116.0,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8822,CHEMBL626052,Heart,,11977,948.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8823,CHEMBL626053,Heart,,11977,948.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8824,CHEMBL626054,Heart,,11977,948.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8825,CHEMBL626055,Heart,,11977,948.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8826,CHEMBL626056,Kidney,,11977,2113.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8827,CHEMBL626057,Kidney,,11977,2113.0,Intermediate,10116.0,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8828,CHEMBL625193,Kidney,,11977,2113.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8829,CHEMBL625194,Kidney,,11977,2113.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8830,CHEMBL625195,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8831,CHEMBL625196,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8832,CHEMBL625197,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8833,CHEMBL625198,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8834,CHEMBL627929,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8835,CHEMBL627074,Lung,,11977,2048.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8836,CHEMBL627075,Lung,,11977,2048.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8837,CHEMBL627076,Lung,,11977,2048.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8838,CHEMBL627077,Lung,,11977,2048.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8839,CHEMBL627078,Lung,,11977,2048.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8840,CHEMBL627079,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8841,CHEMBL873824,,,4573,,Intermediate,10090.0,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8842,CHEMBL627080,Plasma,,3132,1969.0,Intermediate,10090.0,Half life in mouse plasma was determined at dose 25 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8843,CHEMBL627081,,,17718,,Intermediate,10090.0,Half life was determined,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8844,CHEMBL627082,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8845,CHEMBL627083,,,5961,,Intermediate,10090.0,Half-life in male mice after 1 mg/kg intravenous dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8847,CHEMBL627085,Plasma,,17731,1969.0,Intermediate,10090.0,Half life in mice plasma,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8848,CHEMBL627086,,,17592,,Intermediate,10090.0,Half life in mouse,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8849,CHEMBL627087,Plasma,,3132,1969.0,Intermediate,10090.0,Half life in mouse plasma at dose 25 mg/kg,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8850,CHEMBL627088,,,17729,,Intermediate,10090.0,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8851,CHEMBL627089,,,17729,,Intermediate,10090.0,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8852,CHEMBL627090,,,17729,,Intermediate,10090.0,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8853,CHEMBL627091,,,3277,,Intermediate,10090.0,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8854,CHEMBL627092,,,3760,,Intermediate,10090.0,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8855,CHEMBL876785,,,3760,,Intermediate,10090.0,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8856,CHEMBL627093,,,2862,,Intermediate,10090.0,Half-life by iv administration in mouse,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8857,CHEMBL627094,,,2862,,Intermediate,10090.0,Half-life by oral administration in mouse,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8858,CHEMBL627095,,,5980,,Intermediate,10090.0,Half-life in mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8859,CHEMBL627096,Brain,,6159,955.0,Intermediate,10090.0,Half-life using mouse brain homogenate,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8860,CHEMBL627097,,,6254,,Intermediate,10090.0,Half-life was measured in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8861,CHEMBL627098,,,6062,,Intermediate,10090.0,Half-life was measured in mouse after an iv dose of 1 mg/kg,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8862,CHEMBL627099,Blood,,1574,178.0,Intermediate,10090.0,Half-life period was determined in mouse blood,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8863,CHEMBL627100,Brain,,56,955.0,Intermediate,10090.0,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8864,CHEMBL627101,Plasma,,993,1969.0,Intermediate,10090.0,Plasma half life in mouse,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8865,CHEMBL627102,,,6652,,Intermediate,10090.0,Stability of the peptide in the presence of mouse serum,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8866,CHEMBL627103,,,17852,,Intermediate,10090.0,Terminal half life of compound was determined in mouse,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8867,CHEMBL627104,,,2675,,Intermediate,10090.0,Terminal half life was evaluated in mice after intravenous administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8868,CHEMBL627105,,,2675,,Intermediate,10090.0,Terminal half life was evaluated in mice after oral administration,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8869,CHEMBL876786,,,499,,Intermediate,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8870,CHEMBL873825,,,499,,Intermediate,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8871,CHEMBL627106,,,499,,Intermediate,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8872,CHEMBL626336,,,14239,,Intermediate,10090.0,half life period is evaluated by administering intravenously at 25 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8873,CHEMBL877462,,,5506,,Intermediate,10090.0,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8874,CHEMBL626337,,,5506,,Intermediate,10090.0,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,8875,CHEMBL626338,,,17734,,Intermediate,10090.0,Half life after intraperitoneal administration of 100 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8876,CHEMBL626339,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8877,CHEMBL626340,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8878,CHEMBL625377,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8879,CHEMBL625378,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,8880,CHEMBL625379,,,17728,,Intermediate,10090.0,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,1,,50594,
,1,,,,Sus scrofa,BAO_0000251,A,U,,8881,CHEMBL625380,,Microsomes,14294,,Autocuration,9823.0,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),0,,22224,
,1,,,,Sus scrofa,BAO_0000251,A,U,,8882,CHEMBL625381,,Microsomes,14294,,Autocuration,9823.0,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),0,,22224,
,1,,,,Sus scrofa,BAO_0000019,A,U,,8883,CHEMBL625382,,,6056,,Autocuration,9823.0,Stability to porcine renal DHP-I,0,,22224,
,1,,,In vivo,Sus scrofa,BAO_0000218,A,U,,8884,CHEMBL873828,,,1317,,Autocuration,9823.0,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,0,,22224,
,1,,,In vivo,Sus scrofa,BAO_0000218,A,U,,8885,CHEMBL625383,,,1317,,Autocuration,9823.0,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,0,,22224,
,1,,,,Sus scrofa,BAO_0000019,A,U,,8886,CHEMBL625384,,,5229,,Autocuration,9823.0,Half-life of the parent prodrug in porcine esterase solution,0,,22224,
,1,,,,Sus scrofa,BAO_0000019,A,U,,8887,CHEMBL625385,,,4231,,Autocuration,9823.0,"First order rate constant, k was determined in in pig liver Esterase",0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8888,CHEMBL625386,Liver,,4231,2107.0,Autocuration,9823.0,Half life of the in pig liver Esterase,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8889,CHEMBL623571,Liver,,5318,2107.0,Autocuration,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8890,CHEMBL623572,Liver,,5318,2107.0,Autocuration,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8891,CHEMBL623573,Liver,,5318,2107.0,Autocuration,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8892,CHEMBL623574,Liver,,3305,2107.0,Autocuration,9823.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8893,CHEMBL623575,Liver,,3305,2107.0,Autocuration,9823.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8894,CHEMBL623749,Liver,,2842,2107.0,Autocuration,9823.0,Half-life in the presence of pig liver esterase(PLE) was evaluated.,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8895,CHEMBL623750,Liver,,2842,2107.0,Autocuration,9823.0,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,0,,22224,
,1,,,In vitro,Sus scrofa,BAO_0000221,A,U,,8896,CHEMBL623751,Liver,,889,2107.0,Autocuration,9823.0,Half-life in vitro in pig liver,0,,22224,
,1,,,,Sus scrofa,BAO_0000221,A,U,,8897,CHEMBL623752,Liver,,1904,2107.0,Autocuration,9823.0,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8898,CHEMBL623753,Plasma,,4186,1969.0,Intermediate,10116.0,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8899,CHEMBL623754,Plasma,,2774,1969.0,Intermediate,10116.0,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8900,CHEMBL623755,Plasma,,1742,1969.0,Intermediate,10116.0,Maximum concentration in rat plasma was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8901,CHEMBL623756,,,3169,,Intermediate,10116.0,Maximum concentration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8902,CHEMBL623757,,,3169,,Intermediate,10116.0,Maximum concentration in rats at 1-2 hours,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8903,CHEMBL623758,,,2081,,Intermediate,10116.0,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8904,CHEMBL623759,Brain,,3307,955.0,Intermediate,10116.0,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8905,CHEMBL623760,,,4727,,Intermediate,10116.0,Maximum concentration at the dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8906,CHEMBL623761,,,6597,,Intermediate,10116.0,Maximum concentration was evaluated in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8907,CHEMBL623762,Plasma,,16365,1969.0,Intermediate,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8908,CHEMBL877594,Plasma,,16365,1969.0,Intermediate,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8909,CHEMBL623763,Plasma,,16365,1969.0,Intermediate,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8910,CHEMBL623764,Plasma,,16365,1969.0,Intermediate,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8911,CHEMBL623765,Plasma,,16365,1969.0,Intermediate,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8912,CHEMBL623766,Blood,,2591,178.0,Intermediate,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8913,CHEMBL623767,Blood,,2591,178.0,Intermediate,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8914,CHEMBL623768,Blood,,2591,178.0,Intermediate,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8915,CHEMBL623769,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8916,CHEMBL623770,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8917,CHEMBL623771,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8918,CHEMBL623772,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8919,CHEMBL623773,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8920,CHEMBL623774,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8921,CHEMBL623775,Plasma,,5978,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8922,CHEMBL623776,,,14465,,Intermediate,10116.0,Cmax in rat (PO dose),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8923,CHEMBL622191,Plasma,,4723,1969.0,Intermediate,10116.0,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8924,CHEMBL622192,Plasma,,4723,1969.0,Intermediate,10116.0,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8925,CHEMBL622193,Plasma,,4576,1969.0,Intermediate,10116.0,Maximum plasma concentration determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8926,CHEMBL622194,Plasma,,12873,1969.0,Intermediate,10116.0,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8927,CHEMBL622195,Plasma,,12873,1969.0,Intermediate,10116.0,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8928,CHEMBL622196,Plasma,,6824,1969.0,Intermediate,10116.0,Maximum plasma concentration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8929,CHEMBL622197,Plasma,,17065,1969.0,Intermediate,10116.0,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8930,CHEMBL622198,Plasma,,2932,1969.0,Intermediate,10116.0,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8931,CHEMBL622199,Plasma,,2932,1969.0,Intermediate,10116.0,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8932,CHEMBL622200,Plasma,,2879,1969.0,Intermediate,10116.0,Maximum plasma concentration of compound was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8933,CHEMBL622201,Plasma,,2864,1969.0,Intermediate,10116.0,Maximum plasma concentration after 20 mg/kg oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8934,CHEMBL623990,Plasma,,16367,1969.0,Intermediate,10116.0,Maximum plasma concentration after oral administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8935,CHEMBL623991,Plasma,,17717,1969.0,Intermediate,10116.0,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8936,CHEMBL623992,Plasma,,17717,1969.0,Intermediate,10116.0,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8937,CHEMBL623993,Plasma,,17717,1969.0,Intermediate,10116.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8938,CHEMBL623994,Plasma,,17717,1969.0,Intermediate,10116.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,8939,CHEMBL623995,Plasma,,17720,1969.0,Intermediate,10116.0,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,8940,CHEMBL623996,Plasma,,17720,1969.0,Intermediate,10116.0,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,8941,CHEMBL623997,Plasma,,17720,1969.0,Intermediate,10116.0,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8942,CHEMBL623998,Plasma,,4516,1969.0,Intermediate,10116.0,Maximum plasma concentration dosed orally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8943,CHEMBL623999,Plasma,,4516,1969.0,Intermediate,10116.0,Maximum plasma concentration dosed orally in rats after 6 hours,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8944,CHEMBL624000,Plasma,,4516,1969.0,Intermediate,10116.0,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8945,CHEMBL624001,Plasma,,5199,1969.0,Intermediate,10116.0,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8946,CHEMBL624002,Plasma,,17538,1969.0,Intermediate,10116.0,Maximum plasma concentration in rat after po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8947,CHEMBL624003,Plasma,,6685,1969.0,Intermediate,10116.0,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8948,CHEMBL624004,Plasma,,6685,1969.0,Intermediate,10116.0,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8949,CHEMBL624005,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8950,CHEMBL624006,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8951,CHEMBL624007,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8952,CHEMBL624008,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8953,CHEMBL624009,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8954,CHEMBL874387,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8955,CHEMBL624010,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8956,CHEMBL624011,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8957,CHEMBL624012,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8958,CHEMBL624013,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8959,CHEMBL624736,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8960,CHEMBL624737,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8961,CHEMBL624738,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8962,CHEMBL624739,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8963,CHEMBL624740,Heart,,16434,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8964,CHEMBL624896,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8965,CHEMBL624897,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8966,CHEMBL624108,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8967,CHEMBL624109,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8968,CHEMBL624110,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8969,CHEMBL624111,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8970,CHEMBL624112,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8971,CHEMBL624113,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8972,CHEMBL619709,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8973,CHEMBL619710,Heart,,16435,948.0,Intermediate,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8974,CHEMBL619711,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8975,CHEMBL619712,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8976,CHEMBL619713,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8977,CHEMBL619714,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8978,CHEMBL619715,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8979,CHEMBL619716,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8980,CHEMBL619717,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8981,CHEMBL619718,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8982,CHEMBL619719,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8983,CHEMBL875329,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8984,CHEMBL619720,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8985,CHEMBL619721,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8986,CHEMBL619722,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8987,CHEMBL619723,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8988,CHEMBL619724,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8989,CHEMBL619725,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8990,CHEMBL619726,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8991,CHEMBL619727,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8992,CHEMBL619728,Kidney,,16434,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,8993,CHEMBL619729,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8994,CHEMBL619730,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8995,CHEMBL619731,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8996,CHEMBL619732,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8997,CHEMBL619733,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8998,CHEMBL619734,Muscle tissue,,11977,2385.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,8999,CHEMBL619735,Zone of skin,,11977,14.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9000,CHEMBL875330,Zone of skin,,11977,14.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9001,CHEMBL628465,Zone of skin,,11977,14.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9002,CHEMBL628466,Zone of skin,,11977,14.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9003,CHEMBL628467,Zone of skin,,11977,14.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9004,CHEMBL628468,Spleen,,11977,2106.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9005,CHEMBL628469,Spleen,,11977,2106.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9006,CHEMBL628470,Spleen,,11977,2106.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9007,CHEMBL628471,Spleen,,11977,2106.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9008,CHEMBL628472,Spleen,,11977,2106.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9009,CHEMBL625191,Thyroid gland,,11977,2046.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9010,CHEMBL625192,Thyroid gland,,11977,2046.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9011,CHEMBL875337,Thyroid gland,,11977,2046.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9012,CHEMBL626341,Thyroid gland,,11977,2046.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9013,CHEMBL626342,Thyroid gland,,11977,2046.0,Intermediate,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9014,CHEMBL621943,Liver,,11977,2107.0,Intermediate,10116.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9015,CHEMBL621944,,,3748,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9016,CHEMBL621945,,,15765,,Intermediate,10116.0,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9017,CHEMBL621946,,,4871,,Intermediate,10116.0,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9018,CHEMBL621947,,,4871,,Intermediate,10116.0,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9019,CHEMBL621948,,,4872,,Intermediate,10116.0,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9020,CHEMBL621949,,,4872,,Intermediate,10116.0,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9021,CHEMBL621950,,,5413,,Intermediate,10116.0,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9022,CHEMBL621951,,,5413,,Intermediate,10116.0,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9023,CHEMBL621952,Blood,,15272,178.0,Intermediate,10116.0,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9024,CHEMBL621953,Liver,,4689,2107.0,Intermediate,10116.0,Stability (%) in rat liver microsomes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9025,CHEMBL621954,,,6057,,Intermediate,10116.0,Area under curve was calculated after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9026,CHEMBL621955,,,6057,,Intermediate,10116.0,Area under the curve was calculated after iv administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9027,CHEMBL621956,,,6057,,Intermediate,10116.0,Area under the curve was calculated in rat after peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9028,CHEMBL621957,,,6211,,Intermediate,10116.0,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9029,CHEMBL621958,,,5710,,Intermediate,10116.0,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9030,CHEMBL621959,,,5710,,Intermediate,10116.0,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9031,CHEMBL621960,,,17853,,Intermediate,10116.0,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9032,CHEMBL621961,,,17853,,Intermediate,10116.0,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9033,CHEMBL621962,,,15765,,Intermediate,10116.0,p value of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,9034,CHEMBL876787,,,15765,,Intermediate,10116.0,p value of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9035,CHEMBL621963,,,15765,,Intermediate,10116.0,p value of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9036,CHEMBL622637,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9037,CHEMBL622638,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9038,CHEMBL626561,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Oryctolagus cuniculus,BAO_0000019,F,U,,9039,CHEMBL626562,,,7991,,Autocuration,9986.0,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9040,CHEMBL626563,,,429,,Autocuration,9986.0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9041,CHEMBL626564,,,429,,Autocuration,9986.0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9042,CHEMBL626565,,,6253,,Autocuration,9986.0,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9043,CHEMBL626566,,,6253,,Autocuration,9986.0,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9044,CHEMBL626567,,,3615,,Autocuration,9986.0,Clearance rate in rabbits,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9045,CHEMBL626568,,,4059,,Autocuration,9986.0,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9046,CHEMBL626569,,,5124,,Autocuration,9986.0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9047,CHEMBL626570,,,5124,,Autocuration,9986.0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9048,CHEMBL626571,,,5124,,Autocuration,9986.0,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9049,CHEMBL626572,,,429,,Autocuration,9986.0,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9050,CHEMBL626573,Plasma,,4059,1969.0,Autocuration,9986.0,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000251,A,U,,9051,CHEMBL626574,Liver,Microsomes,9659,2107.0,Autocuration,9986.0,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000251,A,U,,9052,CHEMBL626575,Liver,Microsomes,9659,2107.0,Autocuration,9986.0,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9053,CHEMBL626576,,,3639,,Autocuration,9986.0,Dose at which bioavailability of intravenously administered compound was tested in rabbit,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9054,CHEMBL626577,,,3639,,Autocuration,9986.0,Dose at which bioavailability of perorally administered compound was tested in rabbit,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9055,CHEMBL626578,,,3639,,Autocuration,9986.0,The compound was tested for its bioavailability in rabbit (by oral dosage).,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9056,CHEMBL625263,,,5124,,Autocuration,9986.0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9057,CHEMBL625264,,,5124,,Autocuration,9986.0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9058,CHEMBL625265,,,5124,,Autocuration,9986.0,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000251,A,U,,9059,CHEMBL625266,,Microsomes,14294,,Autocuration,9986.0,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000251,A,U,,9060,CHEMBL876796,,Microsomes,14294,,Autocuration,9986.0,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9061,CHEMBL625267,,,429,,Autocuration,9986.0,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9062,CHEMBL625268,Plasma,,5124,1969.0,Autocuration,9986.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9063,CHEMBL625269,Plasma,,5124,1969.0,Autocuration,9986.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9064,CHEMBL624689,Plasma,,5124,1969.0,Autocuration,9986.0,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9065,CHEMBL624690,,,429,,Autocuration,9986.0,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9066,CHEMBL624691,Urine,,429,1088.0,Autocuration,9986.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,U,,9067,CHEMBL624692,Urine,,429,1088.0,Autocuration,9986.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9068,CHEMBL624693,,,4059,,Autocuration,9986.0,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9069,CHEMBL624694,,,4137,,Autocuration,9986.0,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,0,,22224,
,1,,,In vitro,Oryctolagus cuniculus,BAO_0000221,A,U,,9070,CHEMBL877596,,,11672,,Autocuration,9986.0,In vitro Biological half-life in crude homogenate of rabbit renal cortex,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000019,A,U,,9071,CHEMBL624695,,,12886,,Autocuration,9986.0,Time within which only 10% of the drug was degraded,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000221,A,U,,9072,CHEMBL624696,Liver,,3853,2107.0,Autocuration,9986.0,Half life period in rabbit liver homogenate,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000019,A,U,,9073,CHEMBL624697,,,3615,,Autocuration,9986.0,Half life value in rabbits,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9074,CHEMBL624698,Blood,,6253,178.0,Autocuration,9986.0,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9075,CHEMBL624699,Blood,,6253,178.0,Autocuration,9986.0,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,U,,9076,CHEMBL624700,,,6077,,Autocuration,9986.0,Half-life period in rabbits following intravenous administration at 2 mg/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9077,CHEMBL622903,Plasma,,17617,1969.0,Intermediate,10116.0,AUC 0-8 hr value in rats at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9078,CHEMBL622904,Plasma,,17594,1969.0,Intermediate,10116.0,AUC after administration at 2000 mg/kg/day in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9079,CHEMBL622905,Plasma,,6149,1969.0,Intermediate,10116.0,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9080,CHEMBL622906,Plasma,,17260,1969.0,Intermediate,10116.0,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9081,CHEMBL622907,Plasma,,17260,1969.0,Intermediate,10116.0,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9082,CHEMBL622908,Plasma,,6644,1969.0,Intermediate,10116.0,AUC in rat after oral administration at 10.5 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9083,CHEMBL622909,Plasma,,6644,1969.0,Intermediate,10116.0,AUC in rat after oral administration at 11.2 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9084,CHEMBL622910,Plasma,,6644,1969.0,Intermediate,10116.0,AUC in rat after oral administration at 9.7 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9085,CHEMBL622911,Brain,,6495,955.0,Intermediate,10116.0,AUC in rat brain after oral administration at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9086,CHEMBL622912,Plasma,,6504,1969.0,Intermediate,10116.0,AUC in rat p.o.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9087,CHEMBL622913,Plasma,,17686,1969.0,Intermediate,10116.0,AUC in rat p.o. at 20 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9088,CHEMBL622914,Plasma,,6495,1969.0,Intermediate,10116.0,AUC in rat plasma after oral administration at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9089,CHEMBL622915,Plasma,,216,1969.0,Intermediate,10116.0,AUC in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9090,CHEMBL622916,Plasma,,1908,1969.0,Intermediate,10116.0,AUC value after IV dose at a dose of 5 mg/kg in rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9091,CHEMBL622917,Plasma,,1908,1969.0,Intermediate,10116.0,AUC value after oral dose at a dose of 10 mg/kg in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9092,CHEMBL622918,Plasma,,6685,1969.0,Intermediate,10116.0,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9093,CHEMBL622919,Plasma,,216,1969.0,Intermediate,10116.0,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9094,CHEMBL622920,Plasma,,6049,1969.0,Intermediate,10116.0,Maximum plasma concentration was evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9095,CHEMBL622921,Plasma,,2463,1969.0,Intermediate,10116.0,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9096,CHEMBL622922,Plasma,,6679,1969.0,Intermediate,10116.0,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9097,CHEMBL622923,Plasma,,6681,1969.0,Intermediate,10116.0,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9098,CHEMBL877604,Plasma,,4890,1969.0,Intermediate,10116.0,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9099,CHEMBL622924,Plasma,,6410,1969.0,Intermediate,10116.0,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9100,CHEMBL622925,Plasma,,6410,1969.0,Intermediate,10116.0,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9101,CHEMBL622926,Plasma,,16366,1969.0,Intermediate,10116.0,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9102,CHEMBL623625,Plasma,,6227,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9103,CHEMBL623626,Plasma,,3598,1969.0,Expert,10116.0,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9104,CHEMBL623627,Plasma,,1465,1969.0,Intermediate,10116.0,Maximum plasma drug concentration was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9105,CHEMBL623628,,,4368,,Intermediate,10116.0,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9106,CHEMBL623629,Plasma,,15662,1969.0,Intermediate,10116.0,Mean peak plasma concentration was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9107,CHEMBL623630,Plasma,,15662,1969.0,Intermediate,10116.0,Mean peak plasma concentration was observed after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9108,CHEMBL623804,,,5355,,Intermediate,10116.0,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9109,CHEMBL623805,,,5355,,Intermediate,10116.0,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9110,CHEMBL623806,Plasma,,1567,1969.0,Intermediate,10116.0,Peak oral plasma concentration was determined in rats by oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9111,CHEMBL623807,Plasma,,4026,1969.0,Intermediate,10116.0,Peak plasma concentration (Cmax) was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9112,CHEMBL623808,Plasma,,6193,1969.0,Intermediate,10116.0,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9113,CHEMBL623809,Plasma,,4026,1969.0,Intermediate,10116.0,Peak plasma concentration (Cmax) in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9114,CHEMBL623810,Plasma,,6485,1969.0,Intermediate,10116.0,Peak plasma concentration at 1 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9115,CHEMBL623811,Plasma,,17655,1969.0,Intermediate,10116.0,Peak plasma concentration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9116,CHEMBL623812,Plasma,,14941,1969.0,Intermediate,10116.0,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9117,CHEMBL877605,,,5394,,Intermediate,10116.0,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9118,CHEMBL623813,,,4408,,Intermediate,10116.0,Pharmacokinetic property (Cmax) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9119,CHEMBL623814,,,5983,,Intermediate,10116.0,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9120,CHEMBL623815,,,4878,,Intermediate,10116.0,Cmax in rat after 3mg/kg oral dose,1,,50597,
Sprague-Dawley,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9121,CHEMBL623816,,,5862,,Intermediate,10116.0,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9122,CHEMBL623145,,,4517,,Intermediate,10116.0,Cmax in rats after 20 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9123,CHEMBL623146,Plasma,,5932,1969.0,Intermediate,10116.0,Cmax in rat plasma after 30mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9124,CHEMBL623147,Plasma,,5436,1969.0,Intermediate,10116.0,Plasma concentration after oral administration of 100 mg/kg to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9125,CHEMBL623042,Brain,,4910,955.0,Intermediate,10116.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9126,CHEMBL623043,,,4950,,Intermediate,10116.0,Tested for the Cmax in rat at 10 mg/kg per orally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9127,CHEMBL623044,,,15078,,Intermediate,10116.0,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9128,CHEMBL623045,,,15078,,Intermediate,10116.0,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9129,CHEMBL623046,,,3360,,Intermediate,10116.0,Bioavailability as oral Cmax in rats at 30 mins,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9130,CHEMBL623226,,,3360,,Intermediate,10116.0,Bioavailability as oral Cmax in rats at 6hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9131,CHEMBL623227,,,15022,,Intermediate,10116.0,The maximum concentration of compound was measured at the dose of 100 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9132,CHEMBL623228,,,15022,,Intermediate,10116.0,The maximum concentration of compound was measured at the dose of 300 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9133,CHEMBL623229,,,15022,,Intermediate,10116.0,The maximum concentration of compound was measured at the dose of 30 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9134,CHEMBL623230,Plasma,,5160,1969.0,Intermediate,10116.0,The maximum plasma levels for the compounds were determined by LC-MS.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9135,CHEMBL623231,Plasma,,15662,1969.0,Intermediate,10116.0,mean peak plasma concentration was observed after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9136,CHEMBL623232,Plasma,,15662,1969.0,Intermediate,10116.0,mean peak plasma concentration was observed after oral administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9137,CHEMBL623233,,,4709,,Intermediate,10116.0,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9138,CHEMBL623234,,,3535,,Intermediate,10116.0,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9139,CHEMBL623235,,,3535,,Intermediate,10116.0,Concentration in plasma (portal) following oral dose in rats at 1 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9140,CHEMBL623236,,,3535,,Intermediate,10116.0,Concentration in plasma (portal) following oral dose in rats at 2 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9141,CHEMBL623237,,,3535,,Intermediate,10116.0,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9142,CHEMBL623238,,,3535,,Intermediate,10116.0,Concentration in plasma (systemic) following oral dose in rats at 1 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9143,CHEMBL623239,,,3535,,Intermediate,10116.0,Concentration in plasma (systemic) following oral dose in rats at 2 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,9144,CHEMBL623240,Plasma,,5005,1969.0,Intermediate,10116.0,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9145,CHEMBL623241,Hypothalamus,,6326,1898.0,Intermediate,10116.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9146,CHEMBL623242,Hypothalamus,,6326,1898.0,Intermediate,10116.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9147,CHEMBL874394,,,6326,,Intermediate,10116.0,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9148,CHEMBL623243,,,6326,,Intermediate,10116.0,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9149,CHEMBL623244,,,17411,,Intermediate,10116.0,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9150,CHEMBL623245,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9151,CHEMBL623246,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9152,CHEMBL623247,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9153,CHEMBL623248,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9154,CHEMBL623249,Kidney,,16435,2113.0,Intermediate,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9155,CHEMBL625072,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9156,CHEMBL625073,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9157,CHEMBL625074,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9158,CHEMBL625075,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9159,CHEMBL625076,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9160,CHEMBL625077,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9161,CHEMBL625078,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9162,CHEMBL874395,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9163,CHEMBL625079,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9164,CHEMBL625080,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9165,CHEMBL625081,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9166,CHEMBL625082,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9167,CHEMBL625083,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9168,CHEMBL625084,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9169,CHEMBL625085,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9170,CHEMBL625086,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9171,CHEMBL625087,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9172,CHEMBL625088,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9173,CHEMBL622205,Liver,,16434,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9174,CHEMBL622206,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9175,CHEMBL622207,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9176,CHEMBL622366,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9177,CHEMBL622367,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9178,CHEMBL875331,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9179,CHEMBL622368,Liver,,16435,2107.0,Intermediate,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9180,CHEMBL622369,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9181,CHEMBL622370,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9182,CHEMBL622371,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9183,CHEMBL622372,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9184,CHEMBL622373,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9185,CHEMBL622374,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9186,CHEMBL622375,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9187,CHEMBL622376,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9188,CHEMBL622377,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9189,CHEMBL622378,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9190,CHEMBL622379,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9191,CHEMBL622380,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9192,CHEMBL622381,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9193,CHEMBL622382,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9194,CHEMBL622383,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9195,CHEMBL875332,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9196,CHEMBL622384,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9197,CHEMBL622385,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9198,CHEMBL622386,Stomach,,6175,945.0,Intermediate,10116.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9199,CHEMBL622387,,,10839,,Intermediate,10116.0,The compound was tested for the plasma binding in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9200,CHEMBL622388,,,16459,,Intermediate,10116.0,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9201,CHEMBL622389,,,16459,,Intermediate,10116.0,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9202,CHEMBL622390,,,16459,,Intermediate,10116.0,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9203,CHEMBL622391,,,16459,,Intermediate,10116.0,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9204,CHEMBL622392,,,16459,,Intermediate,10116.0,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9205,CHEMBL622393,,,16459,,Intermediate,10116.0,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9206,CHEMBL622394,,,3278,,Intermediate,10116.0,Plasma level at 2 hr after administration of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9207,CHEMBL622395,,,3278,,Intermediate,10116.0,plasma level at 2 hr after administration of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9208,CHEMBL622396,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 1 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9209,CHEMBL624894,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 10 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9210,CHEMBL624895,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 10 mins,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9211,CHEMBL624058,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 2 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9212,CHEMBL624059,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 3 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9213,CHEMBL624060,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 3 mins,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9214,CHEMBL624061,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9215,CHEMBL624062,Serum,,4684,1977.0,Intermediate,10116.0,Stability in rat serum measured as % recovery at 5 mins,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9216,CHEMBL624063,,,16456,,Intermediate,10116.0,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9217,CHEMBL624064,,,16456,,Intermediate,10116.0,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9218,CHEMBL624065,Plasma,,723,1969.0,Intermediate,10116.0,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9219,CHEMBL624066,Plasma,,723,1969.0,Intermediate,10116.0,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9220,CHEMBL877490,,,5160,,Intermediate,10116.0,Half life tested in mature male rat at a dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9221,CHEMBL874442,,,4709,,Intermediate,10116.0,Half life after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9222,CHEMBL626890,,,5633,,Intermediate,10116.0,Half life period after administration (30 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9223,CHEMBL626891,,,5302,,Intermediate,10116.0,Half life period in rat after 5 mg/Kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9224,CHEMBL626892,,,5302,,Intermediate,10116.0,Half life period in rat after 5 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9225,CHEMBL626893,,,17791,,Intermediate,10116.0,Half life period was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9226,CHEMBL626894,,,17791,,Intermediate,10116.0,Half life period was evaluated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9227,CHEMBL626895,,,17791,,Intermediate,10116.0,Half life period was evaluated in rat; 0.5-1.0,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9228,CHEMBL626896,,,17791,,Intermediate,10116.0,Half life period was evaluated in rat; 5.9-7.5,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9229,CHEMBL626897,Plasma,,14512,1969.0,Intermediate,10116.0,Half-life in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9230,CHEMBL626898,,,6230,,Intermediate,10116.0,Half-life time in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9231,CHEMBL626899,,,3364,,Intermediate,10116.0,Terminal half-life after iv administration to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9232,CHEMBL626900,,,6874,,Intermediate,10116.0,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9233,CHEMBL626901,,,857,,Intermediate,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9234,CHEMBL626902,,,858,,Intermediate,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9235,CHEMBL626903,,,858,,Intermediate,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9236,CHEMBL874443,,,5355,,Intermediate,10116.0,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9237,CHEMBL626904,,,5355,,Intermediate,10116.0,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9238,CHEMBL626905,,,6305,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9239,CHEMBL873830,Plasma,,13501,1969.0,Intermediate,10116.0,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9240,CHEMBL626906,,,17594,,Intermediate,10116.0,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9241,CHEMBL631076,Plasma,,4186,1969.0,Intermediate,10116.0,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9242,CHEMBL631077,Plasma,,2932,1969.0,Intermediate,10116.0,Biological half-life was measured in plasma of rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9243,CHEMBL631078,,,17065,,Intermediate,10116.0,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9244,CHEMBL631079,,,15765,,Intermediate,10116.0,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9245,CHEMBL631080,,,2713,,Intermediate,10116.0,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9246,CHEMBL631081,,,2661,,Intermediate,10116.0,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9247,CHEMBL631239,,,2661,,Intermediate,10116.0,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9248,CHEMBL631240,Plasma,,740,1969.0,Intermediate,10116.0,Compound was evaluated for plasma half life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9249,CHEMBL631241,Plasma,,6597,1969.0,Intermediate,10116.0,AUC value at a dose of 5 mg/kg (p.o.) in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9250,CHEMBL631242,Plasma,,2959,1969.0,Intermediate,10116.0,AUC value after administration of 20 mg/Kg oral dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9251,CHEMBL631243,Plasma,,17594,1969.0,Intermediate,10116.0,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9252,CHEMBL874444,Plasma,,17596,1969.0,Intermediate,10116.0,AUC0-96 after administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9253,CHEMBL631244,Plasma,,17594,1969.0,Intermediate,10116.0,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9254,CHEMBL631245,,,3293,,Intermediate,10116.0,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9255,CHEMBL627162,,,6757,,Intermediate,10116.0,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9256,CHEMBL627163,,,6757,,Intermediate,10116.0,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9257,CHEMBL627164,,,6757,,Intermediate,10116.0,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9258,CHEMBL627165,Kidney,,5979,2113.0,Intermediate,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9259,CHEMBL627166,,,5979,,Intermediate,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9260,CHEMBL627167,,,5979,,Intermediate,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9261,CHEMBL627822,,,4026,,Intermediate,10116.0,Area under curve (AUC) at a dose of 30 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9262,CHEMBL627823,,,5355,,Intermediate,10116.0,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9263,CHEMBL627824,,,5355,,Intermediate,10116.0,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9264,CHEMBL627825,,,5355,,Intermediate,10116.0,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9265,CHEMBL627826,,,5633,,Intermediate,10116.0,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9266,CHEMBL627827,,,1716,,Intermediate,10116.0,Area under curve (Pharmacokinetic property) was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9267,CHEMBL627828,,,1716,,Intermediate,10116.0,Area under curve (Pharmacokinetic property) of the compound; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9268,CHEMBL627829,,,4689,,Intermediate,10116.0,Area under curve after intravenous administration (1 mg/kg) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9269,CHEMBL627830,,,4527,,Intermediate,10116.0,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9270,CHEMBL627831,,,4527,,Intermediate,10116.0,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9271,CHEMBL627832,,,15662,,Intermediate,10116.0,Area under curve in male SD rats was observed after oral administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9272,CHEMBL627833,,,4413,,Intermediate,10116.0,Area under curve of compound after iv administration of 20 mg/kg dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9273,CHEMBL627834,,,3598,,Expert,10116.0,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9274,CHEMBL628004,,,3598,,Expert,10116.0,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9275,CHEMBL628005,,,5964,,Intermediate,10116.0,Area under curve at 5 mg/kg po was determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9276,CHEMBL628006,,,4689,,Intermediate,10116.0,Area under curve in Rat at a oral dose of 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9277,CHEMBL628007,,,4186,,Intermediate,10116.0,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9278,CHEMBL625676,,,5510,,Intermediate,10116.0,Area under curve was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9279,CHEMBL631309,,,17858,,Intermediate,10116.0,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9280,CHEMBL631310,,,17804,,Intermediate,10116.0,Area under curve after intravenous administration at 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9281,CHEMBL631311,,,6106,,Intermediate,10116.0,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9282,CHEMBL631312,,,5964,,Intermediate,10116.0,Area under curve at 4 hr in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9283,CHEMBL631313,,,4026,,Intermediate,10116.0,Area under curve at a dose of 30 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9284,CHEMBL631314,,,4756,,Intermediate,10116.0,Area under curve at the dose of 2 mg/Kg administered perorally in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9285,CHEMBL631315,,,4756,,Intermediate,10116.0,Area under curve at the dose of 5 mg/Kg administered perorally in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9286,CHEMBL631316,,,5862,,Intermediate,10116.0,Area under curve for a 2-mpk po dose in SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9287,CHEMBL631317,,,5862,,Intermediate,10116.0,Area under curve in SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9288,CHEMBL874471,,,6644,,Intermediate,10116.0,Area under curve in rat after oral administration at 13 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9289,CHEMBL631318,,,5871,,Intermediate,10116.0,Area under curve in rat by po administration at 0-24 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9290,CHEMBL631319,Plasma,,5919,1969.0,Intermediate,10116.0,Area under curve in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9291,CHEMBL631320,,,5939,,Intermediate,10116.0,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9292,CHEMBL631321,,,5939,,Intermediate,10116.0,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9293,CHEMBL631322,,,10,,Intermediate,10116.0,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9294,CHEMBL631323,,,11149,,Intermediate,10116.0,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9295,CHEMBL631324,,,5302,,Intermediate,10116.0,Area under curve value in rat at a dose of 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9296,CHEMBL631325,,,17796,,Intermediate,10116.0,Area under curve was determined after oral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9297,CHEMBL631326,,,4890,,Intermediate,10116.0,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9298,CHEMBL631327,,,6011,,Intermediate,10116.0,Area under curve was determined after peroral administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9299,CHEMBL631328,,,5375,,Intermediate,10116.0,Area under curve was determined at a dose 30 mpk administered orally.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9300,CHEMBL631329,,,17764,,Intermediate,10116.0,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9301,CHEMBL627217,,,4368,,Intermediate,10116.0,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9302,CHEMBL626352,,,5610,,Intermediate,10116.0,Area under curve was determined in male rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9303,CHEMBL626353,,,5833,,Intermediate,10116.0,Area under curve was determined in rat after PO administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9304,CHEMBL626354,,,4257,,Intermediate,10116.0,Area under curve was determined in rat after a 3 mg/kg of oral dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9305,CHEMBL626355,,,5937,,Intermediate,10116.0,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9306,CHEMBL626356,,,5932,,Intermediate,10116.0,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9307,CHEMBL626357,,,5932,,Intermediate,10116.0,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9308,CHEMBL626358,,,17411,,Intermediate,10116.0,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9309,CHEMBL626359,,,17411,,Intermediate,10116.0,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9310,CHEMBL626360,Plasma,,17771,1969.0,Intermediate,10116.0,Peak plasma concentration in rat at a dose of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9311,CHEMBL626361,,,1628,,Intermediate,10116.0,Plasma concentration at 2 hr in rats was evaluated.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9312,CHEMBL626362,,,1628,,Intermediate,10116.0,Plasma concentration at 2 hr in rats was evaluated; Not available,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9313,CHEMBL626363,,,17411,,Intermediate,10116.0,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9314,CHEMBL626970,,,4910,,Intermediate,10116.0,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9315,CHEMBL626971,,,4910,,Intermediate,10116.0,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9316,CHEMBL626972,Plasma,,4910,1969.0,Intermediate,10116.0,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9317,CHEMBL626973,Plasma,,4910,1969.0,Intermediate,10116.0,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9318,CHEMBL626974,Plasma,,4910,1969.0,Intermediate,10116.0,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9319,CHEMBL874592,Plasma,,4910,1969.0,Intermediate,10116.0,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9320,CHEMBL626975,,,5510,,Intermediate,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9321,CHEMBL626976,,,5510,,Intermediate,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9322,CHEMBL626977,,,5510,,Intermediate,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9323,CHEMBL626978,,,5510,,Intermediate,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9324,CHEMBL626979,,,16427,,Intermediate,10116.0,PK study was carried to determine the relative absorption ranking in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9325,CHEMBL626980,Plasma,,4689,1969.0,Intermediate,10116.0,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9326,CHEMBL626981,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9327,CHEMBL626982,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9328,CHEMBL626983,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9329,CHEMBL622522,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9330,CHEMBL622523,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9331,CHEMBL622524,Blood,,11450,178.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9332,CHEMBL622525,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9333,CHEMBL622526,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9334,CHEMBL619849,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9335,CHEMBL619850,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9336,CHEMBL623864,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9337,CHEMBL623865,Brain,,11450,955.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9338,CHEMBL623866,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9339,CHEMBL623867,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9340,CHEMBL877615,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9341,CHEMBL623868,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9342,CHEMBL623869,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9343,CHEMBL623870,Heart,,11450,948.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9344,CHEMBL623871,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9345,CHEMBL623872,Lung,,16434,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9346,CHEMBL622129,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9347,CHEMBL622130,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9348,CHEMBL622131,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9349,CHEMBL622132,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9350,CHEMBL622133,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9351,CHEMBL622134,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9352,CHEMBL622135,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9353,CHEMBL622136,Lung,,16435,2048.0,Intermediate,10116.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9354,CHEMBL622137,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9355,CHEMBL622138,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9356,CHEMBL623017,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9357,CHEMBL623018,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9358,CHEMBL623019,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9359,CHEMBL623020,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9360,CHEMBL623021,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9361,CHEMBL623022,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9362,CHEMBL623023,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9363,CHEMBL623024,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9364,CHEMBL623025,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9365,CHEMBL620545,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9366,CHEMBL620546,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9367,CHEMBL620547,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9368,CHEMBL620548,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9369,CHEMBL620549,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9370,CHEMBL620550,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9371,CHEMBL620551,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9372,CHEMBL620552,Muscle tissue,,16434,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9373,CHEMBL620553,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9374,CHEMBL620554,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9375,CHEMBL875845,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9376,CHEMBL620555,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9377,CHEMBL620556,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9378,CHEMBL620557,Muscle tissue,,16435,2385.0,Intermediate,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9379,CHEMBL620558,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9380,CHEMBL620559,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9381,CHEMBL622939,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9382,CHEMBL622940,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9383,CHEMBL622941,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9384,CHEMBL622942,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9385,CHEMBL622943,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9386,CHEMBL622944,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9387,CHEMBL622945,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9388,CHEMBL622946,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9389,CHEMBL622947,,,3341,,Intermediate,10116.0,Compound was evaluated for terminal half life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9390,CHEMBL622948,Plasma,,3634,1969.0,Intermediate,10116.0,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9391,CHEMBL622949,Plasma,,3634,1969.0,Intermediate,10116.0,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9392,CHEMBL622950,,,4839,,Intermediate,10116.0,Compound was tested for its half life in rat,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,9393,CHEMBL622951,Plasma,,5005,1969.0,Intermediate,9544.0,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000366,A,U,,9394,CHEMBL622952,Plasma,,5005,1969.0,Intermediate,10116.0,Compound was tested for its plasma half life in Sprague Dawley rats,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000366,A,U,,9395,CHEMBL622953,Plasma,,5005,1969.0,Intermediate,10116.0,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9396,CHEMBL873818,Plasma,,1094,1969.0,Intermediate,10116.0,Compound was tested for plasma half-life period in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9397,CHEMBL622954,,,5031,,Intermediate,10116.0,Elimination half life after i.v. administration of compound in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9398,CHEMBL622955,,,6518,,Intermediate,10116.0,Elimination half-life after IV dosing at 0.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9399,CHEMBL875229,,,6518,,Intermediate,10116.0,Elimination half-life after IV dosing at 1 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9400,CHEMBL622956,,,6518,,Intermediate,10116.0,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9401,CHEMBL622957,,,6518,,Intermediate,10116.0,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9402,CHEMBL622958,Brain,,5408,955.0,Intermediate,10116.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9403,CHEMBL622959,Plasma,,5408,1969.0,Intermediate,10116.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9404,CHEMBL622960,Brain,,5408,955.0,Intermediate,10116.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9405,CHEMBL622961,Plasma,,5408,1969.0,Intermediate,10116.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9406,CHEMBL622962,,,4687,,Intermediate,10116.0,Evaluated for the half life in rat (in vivo),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9407,CHEMBL622963,,,6640,,Intermediate,10116.0,Hafl life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9408,CHEMBL622964,,,6640,,Intermediate,10116.0,Hafl life rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9409,CHEMBL622965,,,6641,,Intermediate,10116.0,Hafl life rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9410,CHEMBL622966,,,6640,,Intermediate,10116.0,Hafl life rat; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9411,CHEMBL622967,,,6641,,Intermediate,10116.0,Hafl life rat; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9412,CHEMBL622968,Kidney,,17411,2113.0,Intermediate,10116.0,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9413,CHEMBL622969,Liver,,17411,2107.0,Intermediate,10116.0,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9414,CHEMBL875327,Lung,,17411,2048.0,Intermediate,10116.0,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9415,CHEMBL628638,,,6570,,Intermediate,10116.0,Half life in rat after 1 mg/kg i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9416,CHEMBL628639,,,6570,,Intermediate,10116.0,Half life in rat after 2 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9417,CHEMBL625840,,,17411,,Intermediate,10116.0,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9418,CHEMBL625841,,,4722,,Intermediate,10116.0,Half life of 10 mg/kg oral dose determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9419,CHEMBL625842,,,5978,,Intermediate,10116.0,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9420,CHEMBL625843,,,5978,,Intermediate,10116.0,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9421,CHEMBL625844,,,5978,,Intermediate,10116.0,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9422,CHEMBL873822,,,5978,,Intermediate,10116.0,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9423,CHEMBL625845,,,5978,,Intermediate,10116.0,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9424,CHEMBL627059,,,5978,,Intermediate,10116.0,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9425,CHEMBL627060,,,5978,,Intermediate,10116.0,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9426,CHEMBL627061,,,5978,,Intermediate,10116.0,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9427,CHEMBL627709,,,4762,,Intermediate,10116.0,Half life of compound at 5 mg/kg after po administration was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9428,CHEMBL627710,,,5327,,Intermediate,10116.0,Half life of compound determined after intravenous administration to rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9429,CHEMBL627711,,,4847,,Intermediate,10116.0,Half life of compound was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9430,CHEMBL627712,Plasma,,17720,1969.0,Intermediate,10116.0,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9431,CHEMBL627713,,,4723,,Intermediate,10116.0,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9432,CHEMBL627714,,,4723,,Intermediate,10116.0,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,U,,9433,CHEMBL627889,,,4256,,Intermediate,9541.0,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,9434,CHEMBL627890,,,4256,,Intermediate,10116.0,Half life determined in rat by intravenous administration,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9435,CHEMBL627891,,,4722,,Intermediate,10116.0,Half life determined in rats after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9436,CHEMBL627892,Plasma,,6535,1969.0,Intermediate,10116.0,Half life in rat plasma after administration of 2 mg/kg iv,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9437,CHEMBL627893,Plasma,,6535,1969.0,Intermediate,10116.0,Half life in rat plasma after administration of 2 mg/kg iv,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9438,CHEMBL627894,Plasma,,1435,1969.0,Intermediate,10116.0,Half life in rat plasma was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9439,CHEMBL627895,Plasma,,1435,1969.0,Intermediate,10116.0,Half life in rat plasma was determined; NA means not applicable,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9440,CHEMBL627896,,,5206,,Intermediate,10116.0,Half life in rat was tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9441,CHEMBL627897,Plasma,,6080,1969.0,Intermediate,10116.0,Half life measured in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9442,CHEMBL627898,,,4449,,Intermediate,10116.0,Half life recorded in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9443,CHEMBL627899,,,6057,,Intermediate,10116.0,Half life was calculated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9444,CHEMBL873823,,,6057,,Intermediate,10116.0,Half life was calculated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9445,CHEMBL627900,,,3747,,Intermediate,10116.0,Half life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9446,CHEMBL627901,,,17858,,Intermediate,10116.0,Half life after 10 mg/kg oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9447,CHEMBL627902,,,16365,,Intermediate,10116.0,Half life after administering orally a dose of 10 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9448,CHEMBL627903,,,16365,,Intermediate,10116.0,Half life after administering orally a dose of 30 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9449,CHEMBL627904,,,5031,,Intermediate,10116.0,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9450,CHEMBL627905,,,4722,,Intermediate,10116.0,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9451,CHEMBL627906,,,6078,,Intermediate,10116.0,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9452,CHEMBL627907,,,6078,,Intermediate,10116.0,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9453,CHEMBL876783,,,6078,,Intermediate,10116.0,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9454,CHEMBL627908,,,6078,,Intermediate,10116.0,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9455,CHEMBL627909,,,17065,,Intermediate,10116.0,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9456,CHEMBL627910,,,1353,,Intermediate,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9457,CHEMBL627911,,,1353,,Intermediate,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9458,CHEMBL627912,,,1353,,Intermediate,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9459,CHEMBL627913,,,1353,,Intermediate,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9460,CHEMBL627914,,,1353,,Intermediate,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9461,CHEMBL627915,,,16423,,Intermediate,10116.0,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9462,CHEMBL627916,,,16423,,Intermediate,10116.0,Area under the curve was evaluated after 20 uM/kg of peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9463,CHEMBL627917,,,6062,,Intermediate,10116.0,Area under the curve was measured in rat after an iv dose of 1 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9464,CHEMBL627918,,,6056,,Intermediate,10116.0,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9465,CHEMBL627919,,,5182,,Intermediate,10116.0,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9466,CHEMBL627920,,,6410,,Intermediate,10116.0,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9467,CHEMBL627921,,,6410,,Intermediate,10116.0,Area under the curve was evaluated at an oral dose of 30 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9468,CHEMBL627922,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9469,CHEMBL876784,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9470,CHEMBL627923,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9471,CHEMBL626208,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9472,CHEMBL626209,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9473,CHEMBL626210,,,4723,,Intermediate,10116.0,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9474,CHEMBL627994,Plasma,,2463,1969.0,Intermediate,10116.0,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9475,CHEMBL627995,,,4709,,Intermediate,10116.0,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9476,CHEMBL627996,,,4075,,Intermediate,10116.0,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9477,CHEMBL627997,,,5394,,Intermediate,10116.0,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9478,CHEMBL627998,,,2661,,Intermediate,10116.0,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9479,CHEMBL628640,,,2661,,Intermediate,10116.0,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9480,CHEMBL628641,,,2661,,Intermediate,10116.0,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9481,CHEMBL628642,,,2661,,Intermediate,10116.0,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9482,CHEMBL628643,,,17791,,Intermediate,10116.0,Compound was evaluated for area under the curve expressed as (h*ug/ml),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9483,CHEMBL628644,,,2591,,Intermediate,10116.0,Compound was tested for area under curve in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9484,CHEMBL628645,,,6567,,Intermediate,10116.0,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9485,CHEMBL628646,,,6211,,Intermediate,10116.0,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9486,CHEMBL628647,,,5529,,Intermediate,10116.0,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9487,CHEMBL628648,,,5408,,Intermediate,10116.0,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9488,CHEMBL625358,,,5408,,Intermediate,10116.0,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9489,CHEMBL625359,,,5408,,Intermediate,10116.0,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9490,CHEMBL625360,,,5408,,Intermediate,10116.0,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9491,CHEMBL625361,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9492,CHEMBL625362,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9493,CHEMBL625363,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9494,CHEMBL625364,,,4796,,Intermediate,10116.0,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9495,CHEMBL625365,,,5974,,Intermediate,10116.0,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9496,CHEMBL625366,,,5974,,Intermediate,10116.0,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9497,CHEMBL625367,,,5974,,Intermediate,10116.0,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9498,CHEMBL625368,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9499,CHEMBL625369,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9500,CHEMBL625370,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9501,CHEMBL625371,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9502,CHEMBL625372,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9503,CHEMBL625373,Kidney,,11450,2113.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9504,CHEMBL625374,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9505,CHEMBL877593,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9506,CHEMBL625375,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9507,CHEMBL625376,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9508,CHEMBL621973,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9509,CHEMBL621974,Liver,,11450,2107.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9510,CHEMBL621975,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9511,CHEMBL622166,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9512,CHEMBL622167,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9513,CHEMBL622168,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9514,CHEMBL622169,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9515,CHEMBL622170,Lung,,11450,2048.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9516,CHEMBL622171,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9517,CHEMBL622172,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9518,CHEMBL622173,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9519,CHEMBL622174,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9520,CHEMBL622175,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9521,CHEMBL622176,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9522,CHEMBL622177,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9523,CHEMBL622178,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9524,CHEMBL622179,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9525,CHEMBL622180,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9526,CHEMBL622181,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9527,CHEMBL622182,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9528,CHEMBL622183,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9529,CHEMBL622184,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9530,CHEMBL622185,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9531,CHEMBL622186,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9532,CHEMBL622187,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9533,CHEMBL625002,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9534,CHEMBL622090,,,16434,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9535,CHEMBL622091,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9536,CHEMBL622092,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9537,CHEMBL622093,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9538,CHEMBL622094,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9539,CHEMBL622095,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9540,CHEMBL622264,,,16435,,Intermediate,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9541,CHEMBL622265,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9542,CHEMBL622266,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9543,CHEMBL622267,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9544,CHEMBL622268,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9545,CHEMBL622269,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9546,CHEMBL625071,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9547,CHEMBL621621,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9548,CHEMBL621622,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9549,CHEMBL621623,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9550,CHEMBL621624,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9551,CHEMBL621625,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9552,CHEMBL621626,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9553,CHEMBL621627,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9554,CHEMBL621628,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9555,CHEMBL875328,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9556,CHEMBL621629,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9557,CHEMBL621630,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9558,CHEMBL621631,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9559,CHEMBL621632,Spleen,,16434,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9560,CHEMBL621633,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9561,CHEMBL621634,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9562,CHEMBL621635,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9563,CHEMBL621636,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9564,CHEMBL621637,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9565,CHEMBL621638,Spleen,,16435,2106.0,Intermediate,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9566,CHEMBL618883,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9567,CHEMBL618884,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9568,CHEMBL628627,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9569,CHEMBL628628,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9570,CHEMBL628629,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9571,CHEMBL628630,,,16365,,Intermediate,10116.0,Half life after administering orally a dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9572,CHEMBL628631,,,16365,,Intermediate,10116.0,Half life after administering orally a dose of 3 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9573,CHEMBL628632,,,16365,,Intermediate,10116.0,Half life after administering intravenously a dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9574,CHEMBL628633,,,526,,Intermediate,10116.0,Half life after oral dosing in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9575,CHEMBL628634,,,16365,,Intermediate,10116.0,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9576,CHEMBL627789,,,4368,,Intermediate,10116.0,Half life by intravenous administration of 3.4 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9577,CHEMBL627790,,,3371,,Intermediate,10116.0,Half life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9578,CHEMBL627791,,,6448,,Intermediate,10116.0,Half life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9579,CHEMBL627792,,,6453,,Intermediate,10116.0,Half life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9580,CHEMBL627793,,,4353,,Intermediate,10116.0,Half life in rat after intravenous administration of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9581,CHEMBL627794,Plasma,,4353,1969.0,Intermediate,10116.0,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9582,CHEMBL627795,,,4353,,Intermediate,10116.0,Half life in rat after po administration of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9583,CHEMBL627796,,,4353,,Intermediate,10116.0,Half life in rat after po administration of the compound; ND means Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9584,CHEMBL875335,Plasma,,4353,1969.0,Intermediate,10116.0,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9585,CHEMBL627797,Plasma,,4353,1969.0,Intermediate,10116.0,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9586,CHEMBL627798,,,5789,,Intermediate,10116.0,Half life in rat i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9587,CHEMBL627799,,,17686,,Intermediate,10116.0,Half life in rat i.v. at 2 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9588,CHEMBL627800,,,6495,,Intermediate,10116.0,Half life in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9589,CHEMBL627801,,,484,,Intermediate,10116.0,Half life in rats after intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9590,CHEMBL627802,,,6467,,Intermediate,10116.0,Half life in rats at the dose of 1.0 mpk by i.v. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9591,CHEMBL627803,,,6642,,Expert,10116.0,Half life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9592,CHEMBL873820,,,16367,,Intermediate,10116.0,Half life was evaluated after intravenous administration to rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9593,CHEMBL627804,,,1369,,Intermediate,10116.0,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9594,CHEMBL627805,,,5472,,Intermediate,10116.0,Half life was evaluated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9595,CHEMBL627806,,,6049,,Intermediate,10116.0,Half life was evaluated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9596,CHEMBL627107,,,5472,,Intermediate,10116.0,Half life was evaluated in rat; Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9597,CHEMBL627108,,,16366,,Intermediate,10116.0,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9598,CHEMBL627109,,,11149,,Intermediate,10116.0,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9599,CHEMBL627110,Blood,,11149,178.0,Intermediate,10116.0,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,1,,50597,
,1,,,In vivo,Primates,BAO_0000218,A,U,,9600,CHEMBL627111,,,2891,,Intermediate,9443.0,Half life was measured in monkey at dose of 10 mg/kg by po administration,0,,22224,
,1,,,In vivo,Primates,BAO_0000218,A,U,,9601,CHEMBL627112,,,2891,,Intermediate,9443.0,Half life was measured in monkey at dose of 10 mg/kg by po administration,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,9602,CHEMBL627113,,,2891,,Intermediate,10116.0,Half life was measured in rat at dose of 30 mg/kg by iv administration,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,9603,CHEMBL627114,,,2891,,Intermediate,10116.0,Half life was measured in rat at dose of 30 mg/kg by po administration,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9604,CHEMBL627115,,,4026,,Intermediate,10116.0,Half life (t1/2) was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9605,CHEMBL627116,,,4527,,Intermediate,10116.0,Half life period at a dose of 10 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9606,CHEMBL627117,,,4527,,Intermediate,10116.0,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9607,CHEMBL627118,,,5503,,Intermediate,10116.0,Half life period was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9608,CHEMBL627119,,,4426,,Intermediate,10116.0,Half life period after intravenous administration at 20 mpk in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9609,CHEMBL627120,,,4426,,Intermediate,10116.0,Half life period after intravenous administration at 20 mpk in rats; Not performed.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9610,CHEMBL626922,,,6109,,Intermediate,10116.0,Half life period after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9611,CHEMBL626923,,,5654,,Intermediate,10116.0,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9612,CHEMBL626924,,,5654,,Intermediate,10116.0,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9613,CHEMBL626925,Plasma,,4755,1969.0,Intermediate,10116.0,Half life period in 80% rat plasma at 37 degree Centigrade,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9614,CHEMBL626926,,,5862,,Intermediate,10116.0,Half life period in SD rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9615,CHEMBL626927,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9616,CHEMBL626928,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9617,CHEMBL626929,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9618,CHEMBL626930,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9619,CHEMBL626931,,,5960,,Intermediate,10116.0,Half life period in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9620,CHEMBL626932,,,6103,,Intermediate,10116.0,Half life period in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9621,CHEMBL626933,,,6317,,Intermediate,10116.0,Half life period in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9622,CHEMBL873826,,,6644,,Intermediate,10116.0,Half life period in rat after oral administration at 10.5 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9623,CHEMBL626934,,,6644,,Intermediate,10116.0,Half life period in rat after oral administration at 11.2 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9624,CHEMBL626935,,,6644,,Intermediate,10116.0,Half life period in rat after oral administration at 13 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9625,CHEMBL626936,,,6644,,Intermediate,10116.0,Half life period in rat after oral administration at 9.7 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9626,CHEMBL626937,,,5974,,Intermediate,10116.0,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9627,CHEMBL625906,,,6295,,Intermediate,10116.0,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9628,CHEMBL625907,,,6296,,Intermediate,10116.0,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9629,CHEMBL625908,,,16427,,Intermediate,10116.0,PK study was carried to determine AUC (area under curve) value in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9630,CHEMBL625909,,,16367,,Intermediate,10116.0,Pharmacokinetic parameter AUC after intravenous administration to rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9631,CHEMBL625910,,,16367,,Intermediate,10116.0,Pharmacokinetic parameter AUC after oral administration to rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9632,CHEMBL625911,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9633,CHEMBL625912,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9634,CHEMBL626538,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9635,CHEMBL876794,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9636,CHEMBL626539,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9637,CHEMBL626540,,,16365,,Intermediate,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9638,CHEMBL626541,,,5394,,Intermediate,10116.0,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9639,CHEMBL626542,,,5394,,Intermediate,10116.0,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9640,CHEMBL626543,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9641,CHEMBL626544,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9642,CHEMBL626545,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9643,CHEMBL626546,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9644,CHEMBL626547,,,5334,,Intermediate,10116.0,Pharmacokinetic parameter area under curve was reported,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9645,CHEMBL626548,,,4408,,Intermediate,10116.0,Pharmacokinetic property (AUC) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9646,CHEMBL626549,,,5983,,Intermediate,10116.0,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9647,CHEMBL626550,,,4397,,Intermediate,10116.0,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9648,CHEMBL626551,,,4397,,Intermediate,10116.0,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9649,CHEMBL623777,,,5491,,Intermediate,10116.0,Pharmacokinetic property was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9650,CHEMBL623778,,,5491,,Intermediate,10116.0,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9651,CHEMBL623779,,,5491,,Intermediate,10116.0,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9652,CHEMBL623780,Plasma,,4199,1969.0,Intermediate,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9653,CHEMBL622015,Plasma,,4199,1969.0,Intermediate,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9654,CHEMBL622016,Plasma,,4199,1969.0,Intermediate,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9655,CHEMBL622017,,,5173,,Intermediate,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9656,CHEMBL622018,,,5173,,Intermediate,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9657,CHEMBL622019,,,5173,,Intermediate,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9658,CHEMBL622020,,,5173,,Intermediate,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9659,CHEMBL622021,,,16366,,Intermediate,10116.0,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9660,CHEMBL622022,,,16366,,Intermediate,10116.0,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9661,CHEMBL622023,,,5327,,Intermediate,10116.0,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9662,CHEMBL622024,,,6681,,Intermediate,10116.0,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9663,CHEMBL622693,,,12873,,Intermediate,10116.0,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9664,CHEMBL622694,,,12873,,Intermediate,10116.0,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9665,CHEMBL622695,,,6685,,Intermediate,10116.0,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9666,CHEMBL622696,,,6685,,Intermediate,10116.0,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9667,CHEMBL622697,,,6685,,Intermediate,10116.0,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9668,CHEMBL622874,,,6619,,Intermediate,10116.0,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9669,CHEMBL622875,,,6619,,Intermediate,10116.0,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9670,CHEMBL622876,,,10363,,Intermediate,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9671,CHEMBL622877,,,4796,,Intermediate,10116.0,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9672,CHEMBL622878,,,4910,,Intermediate,10116.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9673,CHEMBL622879,Plasma,,4910,1969.0,Intermediate,10116.0,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9674,CHEMBL877602,,,4839,,Intermediate,10116.0,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9675,CHEMBL622880,,,15078,,Intermediate,10116.0,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9676,CHEMBL622881,,,15078,,Intermediate,10116.0,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9677,CHEMBL622882,,,15078,,Intermediate,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9678,CHEMBL622883,,,15078,,Intermediate,10116.0,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9679,CHEMBL622884,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9680,CHEMBL622885,Thyroid gland,,11450,2046.0,Intermediate,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9681,CHEMBL622886,,,8151,,Intermediate,10116.0,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9682,CHEMBL622887,,,8151,,Intermediate,10116.0,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9683,CHEMBL622888,Urine,,8151,1088.0,Intermediate,10116.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9684,CHEMBL622889,Blood,,8677,178.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9685,CHEMBL622890,Blood,,8677,178.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9686,CHEMBL622891,Blood,,8677,178.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9687,CHEMBL877603,Blood,,8677,178.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9688,CHEMBL622892,Brain,,8677,955.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9689,CHEMBL622893,Brain,,8677,955.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9690,CHEMBL622894,Brain,,8677,955.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9691,CHEMBL622895,Brain,,8677,955.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9692,CHEMBL622896,Brain,,8677,955.0,Intermediate,10116.0,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9693,CHEMBL622897,Heart,,8677,948.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9694,CHEMBL622898,Heart,,8677,948.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9695,CHEMBL622899,Heart,,8677,948.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9696,CHEMBL622900,Kidney,,8677,2113.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9697,CHEMBL624114,Kidney,,8677,2113.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9698,CHEMBL624115,Kidney,,8677,2113.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9699,CHEMBL624116,Kidney,,8677,2113.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9700,CHEMBL624117,Liver,,8677,2107.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9701,CHEMBL624118,Liver,,8677,2107.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9702,CHEMBL624119,Liver,,8677,2107.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9703,CHEMBL624120,Liver,,8677,2107.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9704,CHEMBL624121,Lung,,8677,2048.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9705,CHEMBL624122,Lung,,8677,2048.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9706,CHEMBL624123,Lung,,8677,2048.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9707,CHEMBL624124,Lung,,8677,2048.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9708,CHEMBL624125,Muscle tissue,,8677,2385.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9709,CHEMBL624126,Muscle tissue,,8677,2385.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9710,CHEMBL624127,Muscle tissue,,8677,2385.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9711,CHEMBL624128,Muscle tissue,,8677,2385.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9712,CHEMBL624129,Zone of skin,,8677,14.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9713,CHEMBL624130,Zone of skin,,8677,14.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9714,CHEMBL622340,Zone of skin,,8677,14.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9715,CHEMBL622341,Zone of skin,,8677,14.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9716,CHEMBL622342,Intestine,,8677,160.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9717,CHEMBL622343,Intestine,,8677,160.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9718,CHEMBL622344,Intestine,,8677,160.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9719,CHEMBL622345,Intestine,,8677,160.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9720,CHEMBL622346,Spleen,,8677,2106.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9721,CHEMBL622347,Spleen,,8677,2106.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9722,CHEMBL622348,Spleen,,8677,2106.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9723,CHEMBL622349,Spleen,,8677,2106.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9724,CHEMBL622350,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9725,CHEMBL622351,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9726,CHEMBL622352,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9727,CHEMBL622353,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9728,CHEMBL622354,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9729,CHEMBL622355,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9730,CHEMBL622356,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9731,CHEMBL622357,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9732,CHEMBL622358,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9733,CHEMBL622359,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9734,CHEMBL874393,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9735,CHEMBL622872,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9736,CHEMBL622873,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9737,CHEMBL623047,,,16434,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9738,CHEMBL623048,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9739,CHEMBL623049,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9740,CHEMBL623050,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9741,CHEMBL623051,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9742,CHEMBL623052,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9743,CHEMBL626343,,,16435,,Intermediate,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9744,CHEMBL626344,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9745,CHEMBL626345,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9746,CHEMBL626346,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9747,CHEMBL626347,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9748,CHEMBL626348,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9749,CHEMBL626349,,,16434,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,9750,CHEMBL626350,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9751,CHEMBL626351,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9752,CHEMBL627650,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,9753,CHEMBL627651,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9754,CHEMBL627652,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9755,CHEMBL627653,,,16435,,Intermediate,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9756,CHEMBL627654,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9757,CHEMBL627835,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9758,CHEMBL627836,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9759,CHEMBL627837,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9760,CHEMBL627838,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9761,CHEMBL875338,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9762,CHEMBL627839,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9763,CHEMBL627840,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9764,CHEMBL627841,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9765,CHEMBL627842,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9766,CHEMBL627843,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9767,CHEMBL627844,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9768,CHEMBL627845,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9769,CHEMBL627846,,,5874,,Intermediate,10116.0,Half life period in rat by iv administration at a dose of 3 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9770,CHEMBL627847,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9771,CHEMBL873821,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9772,CHEMBL626079,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9773,CHEMBL626080,Plasma,,1515,1969.0,Intermediate,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9774,CHEMBL626081,Plasma,,5491,1969.0,Intermediate,10116.0,Half life period was evaluated in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9775,CHEMBL875344,Plasma,,5491,1969.0,Intermediate,10116.0,Half life period was evaluated in rat plasma; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9776,CHEMBL626082,,,1918,,Intermediate,10116.0,Half life period was evaluated in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9777,CHEMBL626250,,,1918,,Intermediate,10116.0,"Half life period was evaluated in rats, iv",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9778,CHEMBL626251,,,6113,,Intermediate,10116.0,Half life period after intravenous administration at 5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9779,CHEMBL626252,,,5546,,Intermediate,10116.0,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9780,CHEMBL626253,,,5553,,Intermediate,10116.0,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9781,CHEMBL626254,Plasma,,4188,1969.0,Intermediate,10116.0,Half life stability of compound was evaluated in rat plasma,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9782,CHEMBL626255,,,6215,,Intermediate,10116.0,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9783,CHEMBL626256,,,6141,,Intermediate,10116.0,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9784,CHEMBL626257,,,5182,,Intermediate,10116.0,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9785,CHEMBL626258,,,5182,,Intermediate,10116.0,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9786,CHEMBL626259,,,5710,,Intermediate,10116.0,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9787,CHEMBL626260,,,5789,,Intermediate,10116.0,Half in rat i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9788,CHEMBL875345,,,6011,,Intermediate,10116.0,Half period in rat after intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9789,CHEMBL626261,,,17594,,Intermediate,10116.0,Half-life after repeated oral dose of compound at 1 mg/kg in rats,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,9790,CHEMBL626262,Liver,,12357,2107.0,Intermediate,10116.0,Half-life measured in in vitro Cathepsin B assay in rat liver,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9791,CHEMBL626263,,,5210,,Intermediate,10116.0,Half-life of compound was determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9792,CHEMBL625270,,,17596,,Intermediate,10116.0,Half-life at 10 mg/kg in rat upon intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9793,CHEMBL625271,,,6672,,Intermediate,10116.0,Half-life determined in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9794,CHEMBL625272,,,6673,,Intermediate,10116.0,Half-life determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9795,CHEMBL625273,Brain,,4910,955.0,Intermediate,10116.0,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9796,CHEMBL625274,Plasma,,3741,1969.0,Intermediate,10116.0,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9797,CHEMBL625275,,,17671,,Intermediate,10116.0,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9798,CHEMBL625276,Plasma,,4910,1969.0,Intermediate,10116.0,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9799,CHEMBL625277,Plasma,,17537,1969.0,Intermediate,10116.0,Half-life in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9800,CHEMBL625278,Plasma,,4965,1969.0,Intermediate,10116.0,Half-life in rat plasma was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9801,CHEMBL625279,Plasma,,17537,1969.0,Intermediate,10116.0,Half-life in rat plasma; Not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9802,CHEMBL625280,Serum,,6124,1977.0,Intermediate,10116.0,Half-life in rat serum,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9803,CHEMBL876797,Serum,,6124,1977.0,Intermediate,10116.0,Half-life in rat serum; na is not available,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9804,CHEMBL625281,,,6078,,Intermediate,10116.0,Half-life was calculated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9805,CHEMBL873827,Plasma,,17668,1969.0,Intermediate,10116.0,Half-life was calculated in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9806,CHEMBL625282,,,3185,,Intermediate,10116.0,Half-life was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9807,CHEMBL625283,,,4883,,Intermediate,10116.0,Half-life was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9808,CHEMBL625284,,,2959,,Intermediate,10116.0,Half-life after administration of 20 mg/Kg oral dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9809,CHEMBL625285,,,4029,,Intermediate,10116.0,Half-life after administration of 3.2 mg/kg intravenously in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9810,CHEMBL625286,,,4029,,Intermediate,10116.0,Half-life after intravenous administration in female rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9811,CHEMBL625287,,,4029,,Intermediate,10116.0,Half-life after intravenous administration in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9812,CHEMBL625288,,,6180,,Intermediate,10116.0,Half-life after intravenous dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9813,CHEMBL625289,Liver,,1557,2107.0,Intermediate,10116.0,Half-life in a rat liver homogenate preparation,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9814,CHEMBL625290,Plasma,,12500,1969.0,Intermediate,10116.0,Half-life in plasma of rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9815,CHEMBL876798,Plasma,,12500,1969.0,Intermediate,10116.0,Half-life in plasma of rat at dose of 3-10 mgkg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9816,CHEMBL625291,,,5064,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9817,CHEMBL625292,,,5145,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9818,CHEMBL625293,,,5147,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9819,CHEMBL622832,,,5833,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9820,CHEMBL622833,,,6596,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9821,CHEMBL622834,,,17655,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9822,CHEMBL622835,,,6495,,Intermediate,10116.0,Half-life in rat after oral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9823,CHEMBL622836,,,17538,,Intermediate,10116.0,Half-life in rat after po administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9824,CHEMBL622837,,,17538,,Intermediate,10116.0,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9825,CHEMBL622838,,,10,,Intermediate,10116.0,Half-life in rat at 3 mg/kg dose administered intravenously,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9826,CHEMBL622839,Brain,,17669,955.0,Intermediate,10116.0,Half-life in rat brain homogenate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9827,CHEMBL622840,Plasma,,17065,1969.0,Intermediate,10116.0,Half-life in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9828,CHEMBL622841,,,4333,,Intermediate,10116.0,Half-life in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9829,CHEMBL622842,,,6827,,Intermediate,10116.0,Half-life in Dawley rats,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,9830,CHEMBL622843,Plasma,,889,1969.0,Intermediate,10116.0,Half-life in vitro in rat plasma,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,9831,CHEMBL622844,Plasma,,889,1969.0,Intermediate,10116.0,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9832,CHEMBL622845,,,3747,,Intermediate,10116.0,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9833,CHEMBL622846,,,15022,,Intermediate,10116.0,The area under the curve of compound was measured at the dose of 100 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9834,CHEMBL622847,,,15022,,Intermediate,10116.0,The area under the curve of compound was measured at the dose of 300 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9835,CHEMBL622848,,,15022,,Intermediate,10116.0,The area under the curve of compound was measured at the dose of 30 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9836,CHEMBL622849,,,3360,,Intermediate,10116.0,Bioavailability as oral AUC in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9837,CHEMBL622850,Plasma,,5334,1969.0,Intermediate,10116.0,The plasma concentration versus time curve (AUC) was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9838,CHEMBL876807,,,17411,,Intermediate,10116.0,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9839,CHEMBL622851,,,17411,,Intermediate,10116.0,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9840,CHEMBL622852,,,17411,,Intermediate,10116.0,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9841,CHEMBL622853,,,6570,,Intermediate,10116.0,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9842,CHEMBL622854,,,6570,,Intermediate,10116.0,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9843,CHEMBL622855,,,17411,,Intermediate,10116.0,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9844,CHEMBL622856,Plasma,,14941,1969.0,Intermediate,10116.0,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9845,CHEMBL622857,Plasma,,14941,1969.0,Intermediate,10116.0,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9846,CHEMBL622858,Plasma,,17538,1969.0,Intermediate,10116.0,AUC in rat after po administration at a dose of 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9847,CHEMBL622859,Plasma,,17752,1969.0,Intermediate,10116.0,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9848,CHEMBL622860,,,17509,,Intermediate,10116.0,Area under curve value 24 hr after 10 mg/kg iv administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9849,CHEMBL622861,,,17509,,Intermediate,10116.0,Area under curve value 24 hr after 10 mg/kg oral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9850,CHEMBL622862,,,17509,,Intermediate,10116.0,Area under curve value 24 hr after 2 mg/kg iv administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9851,CHEMBL622863,,,17509,,Intermediate,10116.0,Area under curve value 24 hr after 2 mg/kg oral administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9852,CHEMBL623817,,,17509,,Intermediate,10116.0,Area under curve value 6 hr after po administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9853,CHEMBL623818,,,17717,,Intermediate,10116.0,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9854,CHEMBL623819,,,17717,,Intermediate,10116.0,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9855,CHEMBL623820,,,17717,,Intermediate,10116.0,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9856,CHEMBL623821,,,17717,,Intermediate,10116.0,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9857,CHEMBL623822,Plasma,,6642,1969.0,Intermediate,10116.0,AUC normalized for dose (AUCN) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9858,CHEMBL623823,,,6640,,Intermediate,10116.0,Area under curve in rat after p.o. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9859,CHEMBL623824,,,6641,,Intermediate,10116.0,Area under curve in rat after p.o. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9860,CHEMBL623825,,,6641,,Intermediate,10116.0,Area under curve in rat after p.o. administration; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9861,CHEMBL622070,,,6641,,Intermediate,10116.0,Area under curve in rat after peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9862,CHEMBL622071,,,3603,,Intermediate,10116.0,Area under curve (carotid artery) value of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9863,CHEMBL622072,,,3550,,Intermediate,10116.0,Bioavailability expressed as the area under curve of rat carotid artery,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9864,CHEMBL622073,,,15662,,Intermediate,10116.0,Area under curve in male SD rats was observed after intravenous administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9865,CHEMBL622074,,,17720,,Intermediate,10116.0,Area under curve of the compound was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9866,CHEMBL622075,,,5407,,Intermediate,10116.0,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9867,CHEMBL622076,Plasma,,17752,1969.0,Intermediate,10116.0,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9868,CHEMBL622077,Plasma,,17752,1969.0,Intermediate,10116.0,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9869,CHEMBL622078,,,3603,,Intermediate,10116.0,Area under curve (portal vein) value of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9870,CHEMBL622079,,,3550,,Intermediate,10116.0,Bioavailability expressed as the area under curve of rat portal vein,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9871,CHEMBL622080,Plasma,,17655,1969.0,Intermediate,10116.0,Area Under plasma concentration time curve in rat upon peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9872,CHEMBL877612,,,17582,,Intermediate,10116.0,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9873,CHEMBL622081,,,17582,,Intermediate,10116.0,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9874,CHEMBL622082,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9875,CHEMBL622083,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats after iv administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9876,CHEMBL622084,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats; 30-80,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9877,CHEMBL622085,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats; 50-60,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9878,CHEMBL622086,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats; no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9879,CHEMBL622087,,,17791,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats; peptide,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9880,CHEMBL622088,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9881,CHEMBL622089,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9882,CHEMBL623685,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9883,CHEMBL623686,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9884,CHEMBL623687,Stomach,,8677,945.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9885,CHEMBL623688,Stomach,,8677,945.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9886,CHEMBL623689,Stomach,,8677,945.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9887,CHEMBL622485,Stomach,,8677,945.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9888,CHEMBL622486,Thyroid gland,,8677,2046.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9889,CHEMBL877613,Thyroid gland,,8677,2046.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9890,CHEMBL622487,Thyroid gland,,8677,2046.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9891,CHEMBL622488,Thyroid gland,,8677,2046.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9892,CHEMBL622489,Heart,,8677,948.0,Intermediate,10116.0,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9893,CHEMBL622490,Urine,,6899,1088.0,Intermediate,10116.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9894,CHEMBL622491,Urine,,6899,1088.0,Intermediate,10116.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9895,CHEMBL622492,Liver,,6899,2107.0,Intermediate,10116.0,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9896,CHEMBL622493,Urine,,6899,1088.0,Intermediate,10116.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9897,CHEMBL622494,Urine,,6899,1088.0,Intermediate,10116.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9898,CHEMBL622495,Muscle tissue,,8677,2385.0,Intermediate,10116.0,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9899,CHEMBL622496,,,6899,,Intermediate,10116.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9900,CHEMBL622497,Urine,,6899,1088.0,Intermediate,10116.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9901,CHEMBL622498,,,2189,,Intermediate,10116.0,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9902,CHEMBL624918,Urine,,2189,1088.0,Intermediate,10116.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9903,CHEMBL624919,Urine,,2189,1088.0,Intermediate,10116.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9904,CHEMBL624920,Blood,,10839,178.0,Intermediate,10116.0,Biodistribution of compound in rat blood after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9905,CHEMBL624921,Blood,,10839,178.0,Intermediate,10116.0,Biodistribution of compound in rat blood after 5 min of administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9906,CHEMBL624922,Brain,,10839,955.0,Intermediate,10116.0,Biodistribution of compound in rat brain after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9907,CHEMBL624923,Heart,,10839,948.0,Intermediate,10116.0,Biodistribution of compound in rat heart after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9908,CHEMBL624924,Heart,,10839,948.0,Intermediate,10116.0,Biodistribution of compound in rat heart after 5 min of administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9909,CHEMBL624925,Kidney,,10839,2113.0,Intermediate,10116.0,Biodistribution of compound in rat kidney after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9910,CHEMBL624926,Kidney,,10839,2113.0,Intermediate,10116.0,Biodistribution of compound in rat kidney after 5 min of administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9911,CHEMBL624927,Liver,,10839,2107.0,Intermediate,10116.0,Biodistribution of compound in rat liver after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9912,CHEMBL874402,Liver,,10839,2107.0,Intermediate,10116.0,Biodistribution of compound in rat liver after 5 min of administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9913,CHEMBL624928,Lung,,10839,2048.0,Intermediate,10116.0,Biodistribution of compound in rat lung after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9914,CHEMBL624929,Lung,,10839,2048.0,Intermediate,10116.0,Biodistribution of compound in rat lung after 5 min of administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9915,CHEMBL624930,Muscle tissue,,10839,2385.0,Intermediate,10116.0,Biodistribution of compound in rat muscle after 5 min of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9916,CHEMBL624931,Muscle tissue,,10839,2385.0,Intermediate,10116.0,Biodistribution of compound in rat muscle after 5 min of administration.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9917,CHEMBL624932,Heart,,4043,948.0,Intermediate,10116.0,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9918,CHEMBL624933,Heart,,4043,948.0,Intermediate,10116.0,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9919,CHEMBL624934,Liver,,4043,2107.0,Intermediate,10116.0,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9920,CHEMBL624935,Liver,,4043,2107.0,Intermediate,10116.0,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9921,CHEMBL624936,,,4043,,Intermediate,10116.0,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9922,CHEMBL624937,,,4043,,Intermediate,10116.0,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9923,CHEMBL624938,Spleen,,4043,2106.0,Intermediate,10116.0,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9924,CHEMBL624939,Spleen,,4043,2106.0,Intermediate,10116.0,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9925,CHEMBL624940,,,4043,,Intermediate,10116.0,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9926,CHEMBL874403,,,4043,,Intermediate,10116.0,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9927,CHEMBL624941,,,1446,,Intermediate,10116.0,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9928,CHEMBL624942,Urine,,9971,1088.0,Intermediate,10116.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9929,CHEMBL624943,Urine,,9971,1088.0,Intermediate,10116.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9930,CHEMBL624944,,,5765,,Intermediate,10116.0,% Bioavailability after 1 day of the drug administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9931,CHEMBL624945,,,5765,,Intermediate,10116.0,% Bioavailability after 4 day of the drug administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9932,CHEMBL624946,,,4257,,Intermediate,10116.0,Absolute bioavailability was evaluated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9933,CHEMBL624947,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9934,CHEMBL624948,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9935,CHEMBL624949,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9936,CHEMBL622025,Kidney,,13091,2113.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9937,CHEMBL622026,Kidney,,13091,2113.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9938,CHEMBL622027,Kidney,,13091,2113.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9939,CHEMBL622028,Kidney,,13091,2113.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9940,CHEMBL622029,Liver,,13091,2107.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9941,CHEMBL622208,Liver,,13091,2107.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9942,CHEMBL622209,Liver,,13091,2107.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9943,CHEMBL622210,Liver,,13091,2107.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9944,CHEMBL622211,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9945,CHEMBL622212,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9946,CHEMBL622213,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9947,CHEMBL874404,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9948,CHEMBL620452,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9949,CHEMBL620453,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9950,CHEMBL620454,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9951,CHEMBL624067,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9952,CHEMBL624068,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9953,CHEMBL624069,Female gonad,,13091,992.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9954,CHEMBL624070,Female gonad,,13091,992.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9955,CHEMBL624071,Female gonad,,13091,992.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9956,CHEMBL624072,Uterus,,13091,995.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9957,CHEMBL624073,Uterus,,13091,995.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9958,CHEMBL624788,Uterus,,13091,995.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9959,CHEMBL624789,Uterus,,13091,995.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9960,CHEMBL624790,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9961,CHEMBL624791,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9962,CHEMBL624792,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9963,CHEMBL624793,,,13091,,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9964,CHEMBL877491,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9965,CHEMBL624957,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9966,CHEMBL624958,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9967,CHEMBL624959,Muscle tissue,,13091,2385.0,Intermediate,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9968,CHEMBL624960,,,11977,,Intermediate,10116.0,Dissociation constant was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9969,CHEMBL624961,,,14941,,Intermediate,10116.0,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9970,CHEMBL624962,,,15078,,Intermediate,10116.0,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9971,CHEMBL624963,,,15078,,Intermediate,10116.0,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9972,CHEMBL624964,,,4755,,Intermediate,10116.0,Observed rate constant in 80% rat plasma at 37 degree Centigrade,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9973,CHEMBL624965,,,589,,Intermediate,10116.0,LogP value was evaluated in the in situ rat gut perfusion assay,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9974,CHEMBL624966,,,17582,,Intermediate,10116.0,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9975,CHEMBL624967,,,5031,,Intermediate,10116.0,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9976,CHEMBL624968,,,17764,,Intermediate,10116.0,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9977,CHEMBL624969,,,17720,,Intermediate,10116.0,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,9978,CHEMBL624970,,,2862,,Expert,10116.0,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9979,CHEMBL624971,,,16423,,Intermediate,10116.0,Half-life was evaluated after 10 uM/kg of intra arterial administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9980,CHEMBL624972,,,16423,,Intermediate,10116.0,Half-life was evaluated after 20 uM/kg of peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9981,CHEMBL624973,,,6005,,Intermediate,10116.0,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9982,CHEMBL624974,Plasma,,2938,1969.0,Intermediate,10116.0,Half-life was evaluated in plasma of rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9983,CHEMBL624975,,,6410,,Intermediate,10116.0,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9984,CHEMBL877492,,,6410,,Intermediate,10116.0,Half-life was evaluated in rats at an oral dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9985,CHEMBL624976,,,6062,,Intermediate,10116.0,Half-life was measured in rat after an iv dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9986,CHEMBL624977,,,6571,,Intermediate,10116.0,Half-life period of compound in rats after peroral administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9987,CHEMBL626848,Plasma,,3136,1969.0,Intermediate,10116.0,Half-life period of compound was measured in rat plasma.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9988,CHEMBL626849,Plasma,,3136,1969.0,Intermediate,10116.0,Half-life period of compound was measured in rat plasma; ND is not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9989,CHEMBL626850,Plasma,,3136,1969.0,Intermediate,10116.0,Half-life period of compound was measured in rat plasma; not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9990,CHEMBL626851,,,4521,,Intermediate,10116.0,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9991,CHEMBL626852,,,5871,,Intermediate,10116.0,Half-life period in rat by iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9992,CHEMBL626853,,,6077,,Intermediate,10116.0,Half-life period in rats following intravenous administration at 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9993,CHEMBL626854,,,6679,,Intermediate,10116.0,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,9994,CHEMBL627486,,,5144,,Intermediate,10116.0,Half-life period was determined for the compound in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9995,CHEMBL627487,,,4498,,Intermediate,10116.0,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9996,CHEMBL627488,,,4498,,Intermediate,10116.0,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9997,CHEMBL627489,,,1908,,Intermediate,10116.0,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9998,CHEMBL627490,,,6211,,Intermediate,10116.0,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,9999,CHEMBL873829,,,5529,,Intermediate,10116.0,Half-life was determined in rat after intravenous administration (0.5 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10000,CHEMBL627655,,,6444,,Intermediate,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10001,CHEMBL625994,,,6444,,Intermediate,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10002,CHEMBL625995,,,6444,,Intermediate,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10003,CHEMBL625996,,,5207,,Intermediate,10116.0,Half-life in rat,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10004,CHEMBL625850,Plasma,,530,1969.0,Intermediate,10116.0,In vitro half life in rat plasma,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10005,CHEMBL625851,Plasma,,1116,1969.0,Intermediate,10116.0,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10006,CHEMBL625852,,,3219,,Intermediate,10116.0,In vitro half life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10007,CHEMBL625853,,,6109,,Intermediate,10116.0,In vivo half life period after intravenous administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10008,CHEMBL625854,,,17582,,Intermediate,10116.0,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10009,CHEMBL874450,,,17582,,Intermediate,10116.0,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10010,CHEMBL625855,,,5974,,Intermediate,10116.0,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10011,CHEMBL625856,,,5974,,Intermediate,10116.0,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10012,CHEMBL625857,,,5974,,Intermediate,10116.0,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10013,CHEMBL873831,,,5974,,Intermediate,10116.0,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10014,CHEMBL625858,,,17853,,Intermediate,10116.0,Longer half-life in rat (i.v.) at 0.5 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10015,CHEMBL625859,,,17853,,Intermediate,10116.0,Longer half-life in rat (p.o.) at 2.0 mpk,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10016,CHEMBL625860,,,3457,,Intermediate,10116.0,Pharmacokinetic property (half life) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10017,CHEMBL625861,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10018,CHEMBL625862,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10019,CHEMBL625863,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10020,CHEMBL625864,,,2792,,Intermediate,10116.0,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10021,CHEMBL625865,,,5739,,Intermediate,10116.0,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10022,CHEMBL625866,,,15765,,Intermediate,10116.0,Pharmacokinetic half time was determined intravenously in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10023,CHEMBL625867,Plasma,,6567,1969.0,Intermediate,10116.0,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10024,CHEMBL625868,Plasma,,2448,1969.0,Intermediate,10116.0,Plasma half life of hydrolysis of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10025,CHEMBL625869,Plasma,,5423,1969.0,Intermediate,10116.0,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10026,CHEMBL874451,Plasma,,4853,1969.0,Intermediate,10116.0,Plasma half life period was calculated in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10027,CHEMBL625870,Plasma,,4514,1969.0,Intermediate,10116.0,Plasma half-life in Sprague-Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10028,CHEMBL625871,Plasma,,4514,1969.0,Intermediate,10116.0,Plasma half-life in Sprague-Dawley rats; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10029,CHEMBL625872,Plasma,,1500,1969.0,Intermediate,10116.0,Plasma half-life in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10030,CHEMBL625873,Plasma,,1500,1969.0,Intermediate,10116.0,Plasma half-life in rats; <MQL,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10031,CHEMBL625874,Plasma,,5334,1969.0,Intermediate,10116.0,Plasma half-life period (0-8 h) was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10032,CHEMBL625875,Plasma,,5334,1969.0,Intermediate,10116.0,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10033,CHEMBL625876,Plasma,,5334,1969.0,Intermediate,10116.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10034,CHEMBL631258,Plasma,,5334,1969.0,Intermediate,10116.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10035,CHEMBL631259,Plasma,,4956,1969.0,Intermediate,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10036,CHEMBL631260,Plasma,,4956,1969.0,Intermediate,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10037,CHEMBL631261,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10038,CHEMBL631262,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10039,CHEMBL631263,Blood,,7768,178.0,Intermediate,10116.0,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10040,CHEMBL631264,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10041,CHEMBL631265,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10042,CHEMBL631266,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10043,CHEMBL631267,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10044,CHEMBL631268,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10045,CHEMBL631269,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10046,CHEMBL631270,,,7768,,Intermediate,10116.0,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10047,CHEMBL631271,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10048,CHEMBL631272,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10049,CHEMBL631273,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10050,CHEMBL631274,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10051,CHEMBL631275,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10052,CHEMBL626984,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10053,CHEMBL626985,Heart,,7768,948.0,Intermediate,10116.0,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10054,CHEMBL626986,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10055,CHEMBL626987,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10056,CHEMBL626988,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10057,CHEMBL626989,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10058,CHEMBL626990,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10059,CHEMBL626991,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10060,CHEMBL626992,Liver,,7768,2107.0,Intermediate,10116.0,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10061,CHEMBL626993,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10062,CHEMBL874593,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10063,CHEMBL626994,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10064,CHEMBL626995,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10065,CHEMBL626190,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10066,CHEMBL626191,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10067,CHEMBL626364,Lung,,7768,2048.0,Intermediate,10116.0,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10068,CHEMBL626365,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10069,CHEMBL626366,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10070,CHEMBL626367,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10071,CHEMBL626368,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10072,CHEMBL626369,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10073,CHEMBL626370,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10074,CHEMBL626371,,,4498,,Intermediate,10116.0,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10075,CHEMBL626372,,,4498,,Intermediate,10116.0,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10076,CHEMBL626373,,,3603,,Intermediate,10116.0,Bioavailability after a dose of 10 mg/kg p.o.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10077,CHEMBL626374,,,6215,,Intermediate,10116.0,Bioavailability after peroral administration (10 mg/kg) was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10078,CHEMBL626375,,,5710,,Intermediate,10116.0,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10079,CHEMBL626376,,,5710,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10080,CHEMBL626377,,,5676,,Intermediate,10116.0,Bioavailability in rat po was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10081,CHEMBL626378,,,17667,,Intermediate,10116.0,Bioavailability of compound at 10 mg/kg in rat after oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10082,CHEMBL626379,,,17667,,Intermediate,10116.0,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10083,CHEMBL626380,,,6848,,Intermediate,10116.0,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10084,CHEMBL626381,,,6848,,Intermediate,10116.0,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10085,CHEMBL626382,,,17267,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10086,CHEMBL626383,,,6362,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley) (female),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10087,CHEMBL874652,,,17671,,Intermediate,10116.0,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10088,CHEMBL626384,,,17671,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10089,CHEMBL626385,,,4333,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10090,CHEMBL626386,,,6077,,Intermediate,10116.0,Bioavailability in rat at an oral dose of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10091,CHEMBL626387,,,3278,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10092,CHEMBL626388,,,5964,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10093,CHEMBL626389,,,4884,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10094,CHEMBL626390,,,4905,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10095,CHEMBL626391,,,4884,,Intermediate,10116.0,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10096,CHEMBL626392,,,6850,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10097,CHEMBL626393,,,2864,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10098,CHEMBL623026,,,5780,,Intermediate,10116.0,Bioavailability was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10099,CHEMBL623027,,,1465,,Intermediate,10116.0,Bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10100,CHEMBL623028,,,5199,,Intermediate,10116.0,Bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10101,CHEMBL623029,,,5765,,Intermediate,10116.0,Bioavailability in rat after 1 day dosing,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10102,CHEMBL623030,,,5765,,Intermediate,10116.0,Bioavailability in rat after 4 day dosing,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10103,CHEMBL623031,,,6518,,Intermediate,10116.0,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10104,CHEMBL623032,,,6518,,Intermediate,10116.0,Bioavailability after IV dosing at 1 mg/kg in rat; no data,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10105,CHEMBL623033,,,6518,,Intermediate,10116.0,Bioavailability after oral administration at a dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10106,CHEMBL623034,,,6518,,Intermediate,10116.0,Bioavailability after oral administration at a dose of 4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10107,CHEMBL623035,,,2083,,Intermediate,10116.0,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10108,CHEMBL623036,,,17260,,Intermediate,10116.0,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10109,CHEMBL623037,,,4956,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10110,CHEMBL623038,,,4368,,Intermediate,10116.0,Bioavailability by intravenous administration of 3.4 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10111,CHEMBL874385,Plasma,,17752,1969.0,Intermediate,10116.0,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10112,CHEMBL623039,,,1446,,Intermediate,10116.0,Bioavailability in rat (Fisher) (fasted),1,,50597,
,1,,,In vivo,Primates,BAO_0000218,A,U,,10113,CHEMBL623040,,,2891,,Intermediate,9443.0,Bioavailability in monkey after po administration of 10 mg/kg dose,0,,22224,
,1,,,In vivo,Primates,BAO_0000218,A,U,,10114,CHEMBL623041,,,2891,,Intermediate,9443.0,Oral bioavailability in monkey (dose 10 mg/kg),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10115,CHEMBL623741,,,6672,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10116,CHEMBL623742,,,6673,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10117,CHEMBL623743,,,17655,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10118,CHEMBL623744,,,17796,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10119,CHEMBL623745,,,17853,,Intermediate,10116.0,Bioavailability in rat (dose 2.0 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10120,CHEMBL623746,,,4521,,Intermediate,10116.0,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10121,CHEMBL623747,,,4940,,Intermediate,10116.0,Oral bioavailability in rat (dose 5 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,10122,CHEMBL623748,,,2891,,Intermediate,10116.0,Bioavailability in rat after po administration of 30 mg/kg dose,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,10123,CHEMBL623916,,,2891,,Intermediate,10116.0,Bioavailability in rat after po administration of 30 mg/kg dose,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10124,CHEMBL623917,,,4521,,Intermediate,10116.0,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10125,CHEMBL623918,,,17686,,Intermediate,10116.0,Bioavailability in rat (dose 2 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10126,CHEMBL874386,,,17796,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10127,CHEMBL623919,Plasma,,17796,1969.0,Intermediate,10116.0,Bioavailability in rat; Only traces detected in rat plasma,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10128,CHEMBL623920,,,5064,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10129,CHEMBL623148,,,5147,,Intermediate,10116.0,Bioavailability upon oral administration of compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10130,CHEMBL623149,,,1916,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10131,CHEMBL623150,,,6049,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10132,CHEMBL623151,,,1445,,Intermediate,10116.0,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10133,CHEMBL623152,,,1445,,Intermediate,10116.0,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10134,CHEMBL623153,,,2862,,Expert,10116.0,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10135,CHEMBL623154,,,2862,,Expert,10116.0,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10136,CHEMBL623155,,,4194,,Intermediate,10116.0,In vitro and metabolic stability was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10137,CHEMBL623156,,,4194,,Intermediate,10116.0,In vitro metabolic stability in rat hepatocytes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10138,CHEMBL623157,,,5486,,Intermediate,10116.0,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,1,,50597,
,1,Hepatocyte,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10139,CHEMBL623158,Liver,,17582,2107.0,Intermediate,10116.0,Metabolic rate for compound was observed in rat hepatocytes,1,401.0,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10140,CHEMBL623159,,,5600,,Intermediate,10116.0,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10141,CHEMBL874390,,,14294,,Intermediate,10116.0,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10142,CHEMBL623160,,,14294,,Intermediate,10116.0,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10143,CHEMBL623161,,,14294,,Intermediate,10116.0,Metabolism of compound in rat S9 microsomes; Trace,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10144,CHEMBL623162,,,17847,,Intermediate,10116.0,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10145,CHEMBL623163,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10146,CHEMBL623164,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10147,CHEMBL623165,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10148,CHEMBL623166,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10149,CHEMBL624983,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10150,CHEMBL624984,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10151,CHEMBL624985,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10152,CHEMBL622970,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10153,CHEMBL622971,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10154,CHEMBL622972,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10155,CHEMBL622973,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10156,CHEMBL622974,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10157,CHEMBL622975,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10158,CHEMBL622976,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10159,CHEMBL622977,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10160,CHEMBL624351,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10161,CHEMBL624352,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10162,CHEMBL624353,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10163,CHEMBL622397,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10164,CHEMBL622398,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10165,CHEMBL622399,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10166,CHEMBL622400,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10167,CHEMBL628428,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10168,CHEMBL628590,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10169,CHEMBL628591,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10170,CHEMBL628592,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10171,CHEMBL628593,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10172,CHEMBL875333,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10173,CHEMBL628594,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10174,CHEMBL628595,Plasma,,4969,1969.0,Intermediate,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10175,CHEMBL628596,Plasma,,6737,1969.0,Intermediate,10116.0,Stability in rat plasma was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10176,CHEMBL628597,Plasma,,6737,1969.0,Intermediate,10116.0,Stability in rat plasma was determined; ND= no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10177,CHEMBL628598,Plasma,,5089,1969.0,Intermediate,10116.0,Tested for plasma half life period in rat (0-8 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10178,CHEMBL628599,Plasma,,5089,1969.0,Intermediate,10116.0,Tested for plasma half life period in rat (0-8 hr); Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10179,CHEMBL628600,,,1466,,Intermediate,10116.0,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10180,CHEMBL628601,,,1466,,Intermediate,10116.0,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10181,CHEMBL628602,,,4950,,Intermediate,10116.0,Tested for the half life in rat,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10182,CHEMBL628603,,,2412,,Intermediate,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10183,CHEMBL628604,,,2412,,Intermediate,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10184,CHEMBL628605,,,2412,,Intermediate,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10185,CHEMBL628606,,,2412,,Intermediate,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,10186,CHEMBL628607,,,2412,,Intermediate,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10187,CHEMBL628608,,,15022,,Intermediate,10116.0,The biological half life the compound was measured at the dose of 100 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10188,CHEMBL628609,,,15022,,Intermediate,10116.0,The biological half life the compound was measured at the dose of 30 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10189,CHEMBL628610,Plasma,,406,1969.0,Intermediate,10116.0,The compound was evaluated for plasma half life period in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10190,CHEMBL873819,,,15078,,Intermediate,10116.0,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10191,CHEMBL628611,,,15078,,Intermediate,10116.0,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10192,CHEMBL628612,,,5247,,Intermediate,10116.0,The pharmacokinetic parameter half-life period in vivo in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10193,CHEMBL628613,,,5041,,Intermediate,10116.0,"The pharmacokinetic property, Half-life was determined",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10194,CHEMBL628614,,,5041,,Intermediate,10116.0,"The pharmacokinetic property, Half-life in rat in vivo",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10195,CHEMBL628615,,,5041,,Intermediate,10116.0,"The pharmacokinetic property, Half-life was determined; ND denotes no data",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10196,CHEMBL628616,,,5041,,Intermediate,10116.0,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10197,CHEMBL627924,Plasma,,3918,1969.0,Intermediate,10116.0,The plasma half life period in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10198,CHEMBL627925,Liver,,2906,2107.0,Intermediate,10116.0,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10199,CHEMBL627926,,,6467,,Intermediate,10116.0,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10200,CHEMBL627927,,,5510,,Intermediate,10116.0,t1/2 (apparent elimination)of the compound was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10201,CHEMBL627928,,,3788,,Intermediate,10116.0,t1/2 value in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10202,CHEMBL627539,,,17796,,Intermediate,10116.0,Half life in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10203,CHEMBL876790,Plasma,,12873,1969.0,Intermediate,10116.0,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10204,CHEMBL858186,,,5983,,Intermediate,10116.0,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10205,CHEMBL627540,,,15765,,Intermediate,10116.0,Half-life period in fasted rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10206,CHEMBL627541,,,2661,,Intermediate,10116.0,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10207,CHEMBL627715,,,2661,,Intermediate,10116.0,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10208,CHEMBL627716,,,429,,Intermediate,10116.0,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10209,CHEMBL627717,,,17655,,Intermediate,10116.0,Maximum time required to achieve Cmax was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10210,CHEMBL627718,,,17717,,Intermediate,10116.0,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10211,CHEMBL627719,,,17717,,Intermediate,10116.0,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10212,CHEMBL627720,,,17717,,Intermediate,10116.0,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10213,CHEMBL627721,,,6570,,Intermediate,10116.0,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10214,CHEMBL627722,,,6570,,Intermediate,10116.0,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10215,CHEMBL627723,,,5978,,Intermediate,10116.0,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10216,CHEMBL626058,,,5978,,Intermediate,10116.0,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10217,CHEMBL626059,,,5978,,Intermediate,10116.0,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10218,CHEMBL626060,,,5978,,Intermediate,10116.0,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10219,CHEMBL626061,Plasma,,17720,1969.0,Intermediate,10116.0,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10220,CHEMBL876791,,,4723,,Intermediate,10116.0,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10221,CHEMBL626062,,,4723,,Intermediate,10116.0,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10222,CHEMBL626063,,,4756,,Intermediate,10116.0,Tmax at the dose of 2 mg/Kg administered perorally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10223,CHEMBL626064,,,4756,,Intermediate,10116.0,Tmax at the dose of 5 mg/Kg administered perorally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10224,CHEMBL626065,Plasma,,17720,1969.0,Intermediate,10116.0,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10225,CHEMBL626066,Plasma,,17720,1969.0,Intermediate,10116.0,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10226,CHEMBL626067,,,1466,,Intermediate,10116.0,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10227,CHEMBL626068,,,7449,,Intermediate,10116.0,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10228,CHEMBL626069,,,7449,,Intermediate,10116.0,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10229,CHEMBL626070,,,7449,,Intermediate,10116.0,Percent total excretion of 3-methoxyacetaminophen glucuronide,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10230,CHEMBL626071,,,7449,,Intermediate,10116.0,Percent total excretion of N-methoxyacetaminophen glucuronide,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10231,CHEMBL626072,,,7449,,Intermediate,10116.0,Percent total excretion of N-methoxyacetaminophen sulfate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10232,CHEMBL626073,,,7449,,Intermediate,10116.0,Percent total excretion of acetaminophen,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10233,CHEMBL626741,Thyroid gland,,7768,2046.0,Intermediate,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10234,CHEMBL626742,,,17655,,Intermediate,10116.0,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10235,CHEMBL626743,,,17735,,Intermediate,10116.0,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10236,CHEMBL876792,,,5960,,Intermediate,10116.0,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10237,CHEMBL626744,,,17735,,Intermediate,10116.0,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10238,CHEMBL626745,,,7116,,Intermediate,10116.0,Compound was tested for antidiuretic activity in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10239,CHEMBL626746,Plasma,,4878,1969.0,Intermediate,10116.0,AUC in rat after 3mg/kg oral dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10240,CHEMBL626747,,,5939,,Intermediate,10116.0,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10241,CHEMBL626748,,,5939,,Intermediate,10116.0,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10242,CHEMBL626749,,,16367,,Intermediate,10116.0,Bioavailability administered orally at a dose of 10 mg/kg to rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10243,CHEMBL626750,,,16366,,Intermediate,10116.0,Oral Bioavailability was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10244,CHEMBL626751,,,4426,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10245,CHEMBL626913,,,4426,,Intermediate,10116.0,Oral bioavailability in rat; Not performed.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10246,CHEMBL626914,,,5041,,Intermediate,10116.0,Bioavailability,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10247,CHEMBL626915,,,5041,,Intermediate,10116.0,Bioavailability was determined; ND denotes no data,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10248,CHEMBL626916,,,1500,,Intermediate,10116.0,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10249,CHEMBL626917,,,1500,,Intermediate,10116.0,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10250,CHEMBL626918,,,17409,,Intermediate,10116.0,Binding towards rat plasma protein at 10 uM,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10251,CHEMBL626919,,,17409,,Intermediate,10116.0,Binding towards rat plasma protein at 100 uM,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10252,CHEMBL626920,,,2959,,Intermediate,10116.0,Bioavailability in rat (dose 20 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10253,CHEMBL621976,,,13501,,Intermediate,10116.0,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10254,CHEMBL877599,,,6567,,Intermediate,10116.0,Bioavailability in rat after 5 mg/kg oral gavage,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10255,CHEMBL621977,,,6571,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10256,CHEMBL621978,,,6715,,Intermediate,10116.0,Bioavailability in rat (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10257,CHEMBL621979,,,6715,,Intermediate,10116.0,Bioavailability in rat (dose 3 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10258,CHEMBL621980,,,2932,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10259,CHEMBL621981,,,4171,,Intermediate,10116.0,Bioavailability of the compound in rats after administration of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10260,CHEMBL621982,,,17509,,Intermediate,10116.0,Bioavailability after administration of 10 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10261,CHEMBL882953,,,17509,,Intermediate,10116.0,Bioavailability after administration of 2 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10262,CHEMBL621983,,,4527,,Intermediate,10116.0,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10263,CHEMBL621984,,,4026,,Intermediate,10116.0,Bioavailability in dogs was determined; high,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10264,CHEMBL621985,,,6659,,Intermediate,10116.0,Bioavailability in monkey after intravenous administration at 1 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10265,CHEMBL621986,,,6659,,Intermediate,10116.0,Bioavailability in monkey after peroral administration at 10 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10266,CHEMBL621987,,,6659,,Intermediate,10116.0,Bioavailability in rat after intravenous administration at 1 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,10267,CHEMBL877600,,,6659,,Intermediate,10116.0,Bioavailability in rat after intravenous administration at 2 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10268,CHEMBL621988,,,6659,,Intermediate,10116.0,Bioavailability in rat after peroral administration at 30 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,F,N,,10269,CHEMBL621989,,,6659,,Intermediate,10116.0,Bioavailability in rat after peroral administration at at 100 mpk,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10270,CHEMBL621990,,,6597,,Intermediate,10116.0,Bioavailability in rats was evaluated,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10271,CHEMBL621991,,,1202,,Intermediate,10116.0,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10272,CHEMBL621992,,,1202,,Intermediate,10116.0,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10273,CHEMBL621993,,,1202,,Intermediate,10116.0,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10274,CHEMBL621994,,,1202,,Intermediate,10116.0,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10275,CHEMBL621995,,,5207,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10276,CHEMBL621996,,,5970,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10277,CHEMBL621997,,,17538,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10278,CHEMBL621998,,,17538,,Intermediate,10116.0,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10279,CHEMBL621999,,,1466,,Intermediate,10116.0,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10280,CHEMBL622000,,,2879,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10281,CHEMBL622001,,,2879,,Intermediate,10116.0,Bioavailability was measured in rat after oral administration; 2-4,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10282,CHEMBL622002,,,2879,,Intermediate,10116.0,Bioavailability was measured in rat after oral administration; 3-7,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10283,CHEMBL622003,,,3777,,Intermediate,10116.0,Bioavailability in rat (intraduodenal administration),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10284,CHEMBL877601,,,3777,,Intermediate,10116.0,Bioavailability in rat (intraduodenal administration),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10285,CHEMBL624871,,,3777,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10286,CHEMBL622004,,,3777,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10287,CHEMBL882954,,,5423,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10288,CHEMBL622005,,,16365,,Intermediate,10116.0,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10289,CHEMBL622006,,,16365,,Intermediate,10116.0,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10290,CHEMBL622007,,,4239,,Intermediate,10116.0,Bioavailability was measured in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10291,CHEMBL622008,,,5438,,Intermediate,10116.0,Bioavailability was reported,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10292,CHEMBL622009,,,5334,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10293,CHEMBL622010,,,5334,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10294,CHEMBL622011,,,4199,,Intermediate,10116.0,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10295,CHEMBL622012,,,4199,,Intermediate,10116.0,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10296,CHEMBL622013,,,4199,,Intermediate,10116.0,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10297,CHEMBL622014,,,4890,,Intermediate,10116.0,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10298,CHEMBL624749,,,2792,,Intermediate,10116.0,Bioavailability was determined at 3 mg/kg po dose in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10299,CHEMBL624750,,,5529,,Intermediate,10116.0,Oral bioavailability in rat (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10300,CHEMBL624751,,,6685,,Intermediate,10116.0,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10301,CHEMBL624752,,,6685,,Intermediate,10116.0,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10302,CHEMBL624753,,,6685,,Intermediate,10116.0,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10303,CHEMBL624754,,,6005,,Intermediate,10116.0,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10304,CHEMBL624755,,,6410,,Intermediate,10116.0,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10305,CHEMBL624756,,,6410,,Intermediate,10116.0,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10306,CHEMBL624757,,,6103,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10307,CHEMBL624758,,,6410,,Intermediate,10116.0,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10308,CHEMBL622270,,,6410,,Intermediate,10116.0,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10309,CHEMBL622271,,,5353,,Intermediate,10116.0,Bioavailability in rat (Sprague-Dawley),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10310,CHEMBL622272,,,4727,,Intermediate,10116.0,Bioavailability in rat at the dose of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10311,CHEMBL622273,,,17804,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10312,CHEMBL622274,,,5809,,Intermediate,10116.0,Bioavailability in rat (cannulated) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10313,CHEMBL622275,,,17804,,Intermediate,10116.0,Bioavailability value of compound in rats was determined after peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10314,CHEMBL622276,,,3634,,Intermediate,10116.0,Oral bioavailability in rat (dose 20 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10315,CHEMBL622277,,,3341,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10316,CHEMBL622278,,,2690,,Intermediate,10116.0,Oral bioavailability in rat (dose 5 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10317,CHEMBL622279,,,3184,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10318,CHEMBL622280,,,740,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10319,CHEMBL624083,,,1806,,Intermediate,10116.0,Compound was evaluated for oral bioavailability in rats; 15-27 %,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10320,CHEMBL624084,,,4891,,Intermediate,10116.0,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10321,CHEMBL624085,,,3634,,Intermediate,10116.0,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10322,CHEMBL624086,,,64,,Intermediate,10116.0,Compound was tested for bioavailability in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10323,CHEMBL624087,,,4839,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10324,CHEMBL624088,,,1094,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,10325,CHEMBL624089,,,5005,,Intermediate,9544.0,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,10326,CHEMBL624090,,,5005,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10327,CHEMBL624091,,,4687,,Intermediate,10116.0,Evaluated for the bioavailability in rat (in vivo),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10328,CHEMBL624092,,,17804,,Intermediate,10116.0,F value of compound in rats was determined after peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10329,CHEMBL624093,,,5974,,Intermediate,10116.0,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10330,CHEMBL624094,,,5974,,Intermediate,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10331,CHEMBL624095,,,5974,,Intermediate,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10332,CHEMBL624096,,,5974,,Intermediate,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10333,CHEMBL624097,,,1088,,Intermediate,10116.0,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10334,CHEMBL624098,,,1742,,Intermediate,10116.0,Maximum fall in carotid flow in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10335,CHEMBL874392,,,4689,,Intermediate,10116.0,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10336,CHEMBL624099,,,2463,,Intermediate,10116.0,Oral bioavailability in rat (dose 5 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10337,CHEMBL624100,,,5654,,Intermediate,10116.0,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10338,CHEMBL624101,,,5654,,Intermediate,10116.0,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10339,CHEMBL624102,,,6874,,Intermediate,10116.0,Oral bioavailability in rat (male Wistar),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10340,CHEMBL624103,,,5633,,Intermediate,10116.0,Oral bioavailability after administration (30 mg/kg) in rat; good,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10341,CHEMBL624104,,,5496,,Intermediate,10116.0,Oral bioavailability at the dose of 2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10342,CHEMBL624105,,,2358,,Intermediate,10116.0,Oral bioavailability determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10343,CHEMBL624106,,,16456,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10344,CHEMBL624107,,,5302,,Intermediate,10116.0,Oral bioavailability in rat (dose single 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10345,CHEMBL623943,,,5302,,Intermediate,10116.0,Oral bioavailability in rat (dose single 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10346,CHEMBL623944,,,5302,,Intermediate,10116.0,Oral bioavailability in rat (dose 5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10347,CHEMBL623945,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10348,CHEMBL623946,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10349,CHEMBL623947,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10350,CHEMBL623948,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10351,CHEMBL623949,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10352,CHEMBL623950,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10353,CHEMBL874398,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10354,CHEMBL623951,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10355,CHEMBL623952,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10356,CHEMBL623953,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10357,CHEMBL623954,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10358,CHEMBL623955,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10359,CHEMBL623956,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10360,CHEMBL627807,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10361,CHEMBL627808,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10362,CHEMBL627809,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10363,CHEMBL627810,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10364,CHEMBL627811,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10365,CHEMBL627812,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10366,CHEMBL627813,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10367,CHEMBL627814,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10368,CHEMBL875336,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10369,CHEMBL627815,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10370,CHEMBL627816,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10371,CHEMBL627817,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10372,CHEMBL627818,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10373,CHEMBL627819,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10374,CHEMBL627820,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10375,CHEMBL627821,,,11020,,Intermediate,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10376,CHEMBL628464,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10377,CHEMBL626239,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10378,CHEMBL626240,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10379,CHEMBL626241,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10380,CHEMBL626242,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10381,CHEMBL626243,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10382,CHEMBL626244,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10383,CHEMBL626907,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10384,CHEMBL626908,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10385,CHEMBL626909,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10386,CHEMBL626910,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10387,CHEMBL875342,,,7449,,Intermediate,10116.0,Percent total excretion of acetaminophen cysteine conjugate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10388,CHEMBL626911,,,7449,,Intermediate,10116.0,Percent total excretion of acetaminophen glucuronide,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10389,CHEMBL626912,,,7449,,Intermediate,10116.0,Percent total excretion of acetaminophen sulfate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,10390,CHEMBL627065,,,7449,,Intermediate,10116.0,Percent total excretion of acetaminophen-mercapturic acid,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10391,CHEMBL627066,Urine,,3172,1088.0,Intermediate,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10392,CHEMBL627067,,,16456,,Intermediate,10116.0,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,ratrat,BAO_0000218,A,U,,10393,CHEMBL627068,Muscle tissue,,10839,2385.0,Autocuration,8656.0,Biodistribution of compound in rat muscle after 5 min of administration,0,,22224,
,1,,,In vivo,ratrat,BAO_0000218,A,U,,10394,CHEMBL627069,Muscle tissue,,10839,2385.0,Autocuration,8656.0,Biodistribution of compound in rat muscle after 5 min of administration.,0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10395,CHEMBL627070,,,5334,,Autocuration,9940.0,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10396,CHEMBL627071,,,5334,,Autocuration,9940.0,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10397,CHEMBL627072,,,5334,,Autocuration,9940.0,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10398,CHEMBL627073,,,5334,,Autocuration,9940.0,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10399,CHEMBL625387,,,5334,,Autocuration,9940.0,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10400,CHEMBL625388,,,5334,,Autocuration,9940.0,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10401,CHEMBL625389,Plasma,,5334,1969.0,Autocuration,9940.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),0,,22224,
,1,,,In vivo,Ovis aries,BAO_0000218,A,U,,10402,CHEMBL875343,Plasma,,5334,1969.0,Autocuration,9940.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),0,,22224,
,1,,,,Serpentes,BAO_0000218,A,N,,10403,CHEMBL876795,,,1735,,Intermediate,8570.0,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1,,50497,
,1,,,,Serpentes,BAO_0000218,A,N,,10404,CHEMBL626552,,,1469,,Intermediate,8570.0,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1,,50497,
,1,,,,Serpentes,BAO_0000218,A,N,,10405,CHEMBL626553,,,1336,,Intermediate,8570.0,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1,,50497,
,1,,,,Homo sapiens,BAO_0000366,A,U,,10406,CHEMBL626554,Plasma,,12403,1969.0,Autocuration,9606.0,The human biological plasma half life of the compound,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10407,CHEMBL626555,Urine,,8151,1088.0,Intermediate,10116.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10408,CHEMBL626556,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10409,CHEMBL626557,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10410,CHEMBL626558,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10411,CHEMBL626559,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10412,CHEMBL626560,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10413,CHEMBL876803,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10414,CHEMBL627964,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10415,CHEMBL627965,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10416,CHEMBL627966,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10417,CHEMBL627967,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10418,CHEMBL627968,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10419,CHEMBL627969,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10420,CHEMBL627970,,,8004,,Intermediate,10116.0,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10421,CHEMBL627971,Blood,,8004,178.0,Intermediate,10116.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10422,CHEMBL627972,Blood,,8004,178.0,Intermediate,10116.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,1,,50597,
,1,,,,Homo sapiens,BAO_0000357,B,D,,10423,CHEMBL856029,,,15917,,Expert,9606.0,Dissociation constant against binding to human cyclophilin A,9,,180,
,1,,,,Bos taurus,BAO_0000019,B,H,,10424,CHEMBL627973,,,12396,,Expert,9913.0,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,8,,11591,
,1,,,,,BAO_0000019,A,U,,10425,CHEMBL627974,,,7065,,Autocuration,,-Log C was determined by performing the electroshock minimum test,0,,22224,
,1,,,,,BAO_0000019,A,U,,10426,CHEMBL627975,,,7065,,Autocuration,,-Log C was determined by performing the foot shock test,0,,22224,
,1,,,,,BAO_0000019,A,U,,10427,CHEMBL627976,,,7065,,Autocuration,,-Log C was determined by performing the incl screen test,0,,22224,
,1,,,,,BAO_0000019,A,U,,10428,CHEMBL627977,,,7065,,Autocuration,,-Log C was determined by performing the maximum electroshock test,0,,22224,
,1,,,,,BAO_0000019,A,U,,10429,CHEMBL627978,,,7065,,Autocuration,,-Log C was determined by performing the pentylenetetrazole test,0,,22224,
,1,,,,,BAO_0000019,A,U,,10430,CHEMBL627979,,,12415,,Autocuration,,Tested for experimental arotinoid inhibitory dose,0,,22224,
,1,,,,,BAO_0000019,A,U,,10431,CHEMBL876804,,,10256,,Autocuration,,Negative log transformed activity,0,,22224,
,1,,,,,BAO_0000019,A,U,,10432,CHEMBL627980,,,7991,,Autocuration,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",0,,22224,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10433,CHEMBL627981,,,14342,,Intermediate,10141.0,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,1,,50512,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10434,CHEMBL627982,,,14342,,Intermediate,10141.0,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,1,,50512,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10435,CHEMBL627983,,,14342,,Intermediate,10141.0,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,1,,50512,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10436,CHEMBL627984,Ileum,,14342,2116.0,Intermediate,10141.0,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,1,,50512,
,1,,,,,BAO_0000100,P,U,,10437,CHEMBL627985,,,6047,,Autocuration,,Solubility in water was determined; values expressed as -log,0,,22229,
,1,,,,,BAO_0000019,A,U,,10438,CHEMBL627986,,,17269,,Autocuration,,Ratio of Kcat to that of Km was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,10439,CHEMBL627987,,,10026,,Autocuration,,Observed first order rate constant,0,,22224,
,1,,,,,BAO_0000019,A,U,,10440,CHEMBL627988,,,14583,,Autocuration,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10441,CHEMBL627989,,,2661,,Intermediate,10116.0,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10442,CHEMBL627990,,,2661,,Intermediate,10116.0,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10443,CHEMBL876805,,,4029,,Intermediate,10116.0,Oral Bioavailability after administration of 10 mg/kg in male rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10444,CHEMBL627991,,,17735,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10445,CHEMBL627992,,,4576,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10446,CHEMBL627993,,,17582,,Intermediate,10116.0,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10447,CHEMBL622817,,,17651,,Intermediate,10116.0,Oral bioavailability at 1 mg/kg was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10448,CHEMBL622818,,,17651,,Intermediate,10116.0,Oral bioavailability at 10 mg/kg was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10449,CHEMBL622819,,,17670,,Intermediate,10116.0,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10450,CHEMBL872267,,,5045,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10451,CHEMBL622820,,,1696,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10452,CHEMBL622821,,,17764,,Intermediate,10116.0,Oral bioavailability after intravenous administration in rats at 24 uM/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10453,CHEMBL622822,,,6448,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10454,CHEMBL622823,,,6596,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10455,CHEMBL622824,,,17547,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10456,CHEMBL622825,,,17771,,Intermediate,10116.0,Oral bioavailability in rat at a dose of 3 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10457,CHEMBL622901,,,6495,,Intermediate,10116.0,Oral bioavailability in rat after oral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10458,CHEMBL622902,,,4558,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10459,CHEMBL621844,,,17596,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10460,CHEMBL621845,,,6827,,Intermediate,10116.0,Oral bioavailability in Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10461,CHEMBL621846,,,4026,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10462,CHEMBL621847,,,10,,Intermediate,10116.0,Oral bioavailability in rat (dose 30 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10463,CHEMBL877609,,,17717,,Intermediate,10116.0,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10464,CHEMBL621848,,,17717,,Intermediate,10116.0,Bioavailability in rat (dose 3 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10465,CHEMBL621849,,,17717,,Intermediate,10116.0,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10466,CHEMBL622030,,,17717,,Intermediate,10116.0,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10467,CHEMBL622031,,,4796,,Intermediate,10116.0,Percent oral bioavailability determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10468,CHEMBL622032,,,4883,,Intermediate,10116.0,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10469,CHEMBL622033,,,2137,,Intermediate,10116.0,The compound was evaluated for bioavailability in rats; 32-51,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10470,CHEMBL622034,,,2959,,Intermediate,10116.0,Bioavailability in rat (dose 20 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10471,CHEMBL622035,,,1361,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10472,CHEMBL882966,,,4727,,Intermediate,10116.0,Bioavailability percent in rat at the dose of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10473,CHEMBL622036,,,16423,,Intermediate,10116.0,Bioavailability was evaluated after 20 uM/kg of peroral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10474,CHEMBL622037,,,5206,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10475,CHEMBL622038,,,6448,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10476,CHEMBL622039,,,17723,,Intermediate,10116.0,Bioavailability in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10477,CHEMBL622040,Blood,,17738,178.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10478,CHEMBL622041,Blood,,17738,178.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10479,CHEMBL622042,Blood,,17738,178.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10480,CHEMBL622043,Blood,,17738,178.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10481,CHEMBL622044,Blood,,17738,178.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10482,CHEMBL622045,Bone,,17738,10000001.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10483,CHEMBL622046,Bone,,17738,10000001.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10484,CHEMBL622047,Bone,,17738,10000001.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10485,CHEMBL877610,Bone,,17738,10000001.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10486,CHEMBL622048,Brain,,17738,955.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10487,CHEMBL622049,Brain,,17738,955.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10488,CHEMBL622050,Brain,,17738,955.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10489,CHEMBL622051,Brain,,17738,955.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10490,CHEMBL622052,,,17738,,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10491,CHEMBL622053,,,17738,,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10492,CHEMBL622054,,,17738,,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10493,CHEMBL622055,,,17738,,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10494,CHEMBL622056,,,5237,,Intermediate,10116.0,Oral bioavailability in rats was determined; High,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10495,CHEMBL622057,,,5503,,Intermediate,10116.0,Oral bioavailability in the rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10496,CHEMBL628008,,,15765,,Intermediate,10116.0,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10497,CHEMBL622058,,,15660,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10498,CHEMBL622059,,,5978,,Intermediate,10116.0,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10499,CHEMBL622060,,,5978,,Intermediate,10116.0,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10500,CHEMBL622061,,,5978,,Intermediate,10116.0,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10501,CHEMBL622062,,,5978,,Intermediate,10116.0,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10502,CHEMBL622063,,,5656,,Intermediate,10116.0,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10503,CHEMBL877611,,,3598,,Expert,10116.0,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10504,CHEMBL622064,,,4216,,Intermediate,10116.0,Oral bioavailability of compound in Sprague Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10505,CHEMBL622065,,,17839,,Intermediate,10116.0,Oral bioavailability of compound in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10506,CHEMBL622066,,,6570,,Intermediate,10116.0,Oral bioavailability in rat (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10507,CHEMBL622067,,,5334,,Intermediate,10116.0,Oral bioavailability of compound in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10508,CHEMBL622068,,,6886,,Intermediate,10116.0,Oral bioavailability of compound in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10509,CHEMBL622069,,,5210,,Intermediate,10116.0,Oral bioavailability of compound was determined in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10510,CHEMBL624796,,,4170,,Intermediate,10116.0,Oral bioavailability at a dose of 30 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10511,CHEMBL624797,,,6028,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10512,CHEMBL623053,,,6028,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10513,CHEMBL623054,,,6078,,Intermediate,10116.0,Oral bioavailability evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10514,CHEMBL623055,,,6168,,Intermediate,10116.0,Oral bioavailability in fasted rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10515,CHEMBL623056,,,6168,,Intermediate,10116.0,Oral bioavailability in fed rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10516,CHEMBL623057,,,5160,,Intermediate,10116.0,Oral bioavailability in rat (mature male) (dose 30 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10517,CHEMBL623058,,,6057,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10518,CHEMBL623059,,,6535,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10519,CHEMBL623060,,,6535,,Intermediate,10116.0,Oral bioavailability in rat after administration of 10 mg/kg po,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10520,CHEMBL623061,,,4194,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10521,CHEMBL623062,,,6230,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10522,CHEMBL623063,,,6619,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10523,CHEMBL623064,,,17607,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10524,CHEMBL623065,,,4942,,Intermediate,10116.0,Oral bioavailability in ratrs,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10525,CHEMBL623066,,,4942,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10526,CHEMBL623067,,,6646,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10527,CHEMBL623068,,,5237,,Intermediate,10116.0,Oral bioavailability in rats was determined; High,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10528,CHEMBL623069,,,6646,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10529,CHEMBL623070,,,4449,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10530,CHEMBL623071,,,6057,,Intermediate,10116.0,Oral bioavailability was calculated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10531,CHEMBL623072,,,2552,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10532,CHEMBL623073,,,5496,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10533,CHEMBL623074,,,6484,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10534,CHEMBL623075,,,6485,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10535,CHEMBL623076,,,6616,,Intermediate,10116.0,Oral bioavailability after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10536,CHEMBL623077,,,4969,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10537,CHEMBL623078,,,5862,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10538,CHEMBL623079,,,4514,,Intermediate,10116.0,Oral bioavailability in Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10539,CHEMBL623080,,,4514,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10540,CHEMBL623081,,,4514,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10541,CHEMBL623082,,,5546,,Intermediate,10116.0,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10542,CHEMBL874400,,,6168,,Intermediate,10116.0,Oral bioavailability in fasted rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10543,CHEMBL623083,,,6168,,Intermediate,10116.0,Oral bioavailability in fed rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10544,CHEMBL623084,,,3624,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10545,CHEMBL623085,,,5213,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10546,CHEMBL623086,,,5496,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10547,CHEMBL623087,,,5553,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10548,CHEMBL623088,,,5833,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10549,CHEMBL623089,,,5836,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10550,CHEMBL623090,,,5865,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10551,CHEMBL623091,,,5960,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10552,CHEMBL623092,,,6249,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10553,CHEMBL623093,,,6448,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10554,CHEMBL874401,,,6453,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10555,CHEMBL623094,,,6640,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10556,CHEMBL623095,,,17607,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10557,CHEMBL623096,,,5939,,Intermediate,10116.0,Oral bioavailability in rat after peroral administration at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10558,CHEMBL624913,,,5939,,Intermediate,10116.0,Oral bioavailability in rat after peroral administration at 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10559,CHEMBL624914,,,6281,,Intermediate,10116.0,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10560,CHEMBL624915,,,5874,,Intermediate,10116.0,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10561,CHEMBL624916,,,5213,,Intermediate,10116.0,Oral bioavailability in rat; Not measured,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10562,CHEMBL624917,,,4964,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10563,CHEMBL625157,,,11020,,Intermediate,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10564,CHEMBL625158,Liver,,6251,2107.0,Intermediate,10116.0,In vitro metabolic potential in rat liver microsomes,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10565,CHEMBL625159,,,1568,,Intermediate,10116.0,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10566,CHEMBL625160,,,3032,,Intermediate,10116.0,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10567,CHEMBL625161,,,3748,,Intermediate,10116.0,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10568,CHEMBL625162,,,401,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10569,CHEMBL625163,,,6512,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10570,CHEMBL625164,,,17617,,Intermediate,10116.0,Oral bioavailability in rats at 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10571,CHEMBL625165,,,6679,,Intermediate,10116.0,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10572,CHEMBL625166,,,6742,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10573,CHEMBL625167,,,589,,Intermediate,10116.0,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10574,CHEMBL625168,,,589,,Intermediate,10116.0,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10575,CHEMBL625169,,,3185,,Intermediate,10116.0,Plasma clearance of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10576,CHEMBL626264,,,17596,,Intermediate,10116.0,Plasma clearance at 10 mg/kg in rat upon intravenous administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10577,CHEMBL626265,,,2713,,Intermediate,10116.0,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10578,CHEMBL626266,Plasma,,12500,1969.0,Intermediate,10116.0,The compound was tested for plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10579,CHEMBL626267,Plasma,,12500,1969.0,Intermediate,10116.0,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10580,CHEMBL626268,,,2713,,Intermediate,10116.0,Plasma concentration upon oral administration of 1 mg/Kg in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10581,CHEMBL626269,,,1446,,Intermediate,10116.0,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10582,CHEMBL626270,,,6227,,Intermediate,10116.0,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10583,CHEMBL626271,,,4709,,Intermediate,10116.0,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10584,CHEMBL626272,,,5510,,Intermediate,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10585,CHEMBL626273,,,5510,,Intermediate,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10586,CHEMBL875346,,,5510,,Intermediate,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10587,CHEMBL626274,,,5510,,Intermediate,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10588,CHEMBL626275,,,4514,,Intermediate,10116.0,Compound was tested for protein binding in rat plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10589,CHEMBL624646,,,2713,,Intermediate,10116.0,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10590,CHEMBL624647,,,2713,,Intermediate,10116.0,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10591,CHEMBL624648,Liver,,5340,2107.0,Intermediate,10116.0,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10592,CHEMBL624649,,,12058,,Intermediate,10116.0,Area under curve ratio was determined (po/iv) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10593,CHEMBL624650,,,11195,,Intermediate,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10594,CHEMBL624651,,,11195,,Intermediate,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10595,CHEMBL624652,,,11195,,Intermediate,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10596,CHEMBL624653,,,6495,,Intermediate,10116.0,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10597,CHEMBL624654,,,6078,,Intermediate,10116.0,Ratio of AUCbrain to AUCplasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10598,CHEMBL624655,,,5656,,Intermediate,10116.0,Ratio of brain to plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10599,CHEMBL624656,,,4910,,Intermediate,10116.0,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10600,CHEMBL624657,,,4910,,Intermediate,10116.0,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10601,CHEMBL624658,,,4910,,Intermediate,10116.0,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10602,CHEMBL624659,,,10130,,Intermediate,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10603,CHEMBL624660,,,10130,,Intermediate,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10604,CHEMBL624661,,,10130,,Intermediate,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10605,CHEMBL624662,,,5213,,Intermediate,10116.0,Steady state brain :blood ratio was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10606,CHEMBL625199,,,4910,,Intermediate,10116.0,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10607,CHEMBL625200,,,4910,,Intermediate,10116.0,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10608,CHEMBL625201,,,4910,,Intermediate,10116.0,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10609,CHEMBL625202,,,4910,,Intermediate,10116.0,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10610,CHEMBL625203,,,2083,,Intermediate,10116.0,Percentage recovery after 3h incubation with rat hapatocytes was determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10611,CHEMBL625204,,,2082,,Intermediate,10116.0,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10612,CHEMBL625205,,,2082,,Intermediate,10116.0,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10613,CHEMBL625206,,,6351,,Intermediate,10116.0,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,10614,CHEMBL625207,,,14583,,Autocuration,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",0,,22224,
,1,,,,,BAO_0000019,A,U,,10615,CHEMBL625208,,,14583,,Autocuration,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,0,,22224,
,1,Caco-2,,,Homo sapiens,BAO_0000218,A,N,,10616,CHEMBL625209,,,4608,,Intermediate,9606.0,In vivo absorption in Caco-2 cell line monolayers was determined,1,495.0,50587,
,1,,,,,BAO_0000100,P,U,,10617,CHEMBL625210,,,13668,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10618,CHEMBL625211,,,5669,,Intermediate,10116.0,Area under curve was determine after peroral administration at 10 mpk in Rat,1,,50597,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,10619,CHEMBL625212,,,5669,,Intermediate,9544.0,Area under curve was determine after peroral administration at 10 mpk in Rhesus,1,,50797,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10620,CHEMBL625213,,,5669,,Intermediate,10116.0,Area under curve was determine after peroral administration at 160 mpk in Rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10621,CHEMBL625214,,,5669,,Intermediate,10116.0,Area under curve was determine after peroral administration at 20 mpk in Rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10622,CHEMBL874542,,,5669,,Intermediate,10116.0,Area under curve was determine after peroral administration at 50 mpk in Rat,1,,50597,
,1,,,,,BAO_0000100,P,U,,10623,CHEMBL625215,,,6472,,Autocuration,,Calculated partition coefficient (clogP) (AlogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,10624,CHEMBL625216,,,15106,,Autocuration,,Activated partial thromboplastin time measured,0,,22224,
,1,,,,,BAO_0000100,P,U,,10625,CHEMBL625217,,,15207,,Autocuration,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),0,,22224,
,1,,,,,BAO_0000100,P,U,,10626,CHEMBL625218,,,15207,,Autocuration,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10627,CHEMBL622864,Plasma,,13941,1969.0,Intermediate,9615.0,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10628,CHEMBL622865,Plasma,,13941,1969.0,Intermediate,10116.0,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10629,CHEMBL622866,Plasma,,13941,1969.0,Intermediate,10116.0,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10630,CHEMBL622867,Plasma,,13941,1969.0,Intermediate,9615.0,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,1,,50588,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10631,CHEMBL876808,Plasma,,15240,1969.0,Intermediate,10141.0,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,1,,50512,
,1,,,,,BAO_0000019,A,U,,10632,CHEMBL627725,Brain,,10655,955.0,Autocuration,,AUC in brain,0,,22224,
,1,,,,,BAO_0000019,A,U,,10633,CHEMBL627726,Serum,,10655,1977.0,Autocuration,,AUC in serum,0,,22224,
,1,,,,,BAO_0000019,A,U,,10634,CHEMBL627727,Plasma,,6504,1969.0,Autocuration,,AUC was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,10635,CHEMBL627728,Plasma,,10615,1969.0,Autocuration,,AUC of the compound.,0,,22224,
,1,,,,,BAO_0000019,A,U,,10636,CHEMBL627729,Plasma,,10353,1969.0,Autocuration,,AUC value (0-4 hr),0,,22224,
,1,,,,,BAO_0000019,A,U,,10637,CHEMBL627730,Plasma,,14907,1969.0,Autocuration,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",0,,22224,
,1,,,,,BAO_0000019,A,U,,10638,CHEMBL627731,Plasma,,14907,1969.0,Autocuration,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,10639,CHEMBL627732,Plasma,,14907,1969.0,Autocuration,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",0,,22224,
,1,,,,,BAO_0000019,A,U,,10640,CHEMBL627733,Plasma,,14907,1969.0,Autocuration,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10641,CHEMBL627734,Plasma,,16359,1969.0,Intermediate,10116.0,AUC(area under curve) was determined after intravenous administration in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10642,CHEMBL627735,Plasma,,16359,1969.0,Intermediate,10116.0,AUC(area under curve) was determined after oral administration in rats,1,,50597,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,10643,CHEMBL627736,Plasma,,15240,1969.0,Intermediate,10141.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,1,,50512,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10644,CHEMBL876809,Plasma,,15240,1969.0,Intermediate,10116.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,1,,50597,
,1,,,,,BAO_0000019,A,U,,10645,CHEMBL627737,,,15469,,Autocuration,,Area Under Curve after oral dosing of 100 uM/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,10646,CHEMBL627738,,,15469,,Autocuration,,Area Under Curve after oral dosing of 30 uM/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,10647,CHEMBL627739,,,13520,,Autocuration,,Area Under Curve was measured by ploting the graph between concentration verses time,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10648,CHEMBL626143,,,17025,,Intermediate,9615.0,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,10649,CHEMBL626144,,,17025,,Autocuration,314293.0,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,10650,CHEMBL626145,,,17025,,Intermediate,9986.0,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,1,,50592,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10651,CHEMBL626146,,,17025,,Intermediate,10116.0,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10652,CHEMBL626147,Blood,,12032,178.0,Intermediate,10116.0,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,1,,50597,
,1,,,,,BAO_0000019,A,U,,10653,CHEMBL626148,,,10291,,Autocuration,,Area under curve (AUC) was determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,10654,CHEMBL626149,,,5767,,Autocuration,,Area under curve (AUC) following ip administration at 1 mg/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,10655,CHEMBL626150,,,1434,,Autocuration,,Area under curve (AUC) was determined; ND is Not determined,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10656,CHEMBL626151,,,14925,,Intermediate,9615.0,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10657,CHEMBL626152,,,14925,,Intermediate,9615.0,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10658,CHEMBL626153,,,14925,,Intermediate,9615.0,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,1,,50588,
,1,,,,,BAO_0000019,A,U,,10659,CHEMBL626154,,,1434,,Autocuration,,Area under curve (AUR) was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,10660,CHEMBL626155,,,11883,,Autocuration,,Area under curve at 1 uM/dg administered intravenously,0,,22224,
,1,,,,,BAO_0000019,A,U,,10661,CHEMBL626156,,,11883,,Autocuration,,Area under curve at 10 uM/dg administered perorally,0,,22224,
,1,,,,,BAO_0000019,A,U,,10662,CHEMBL626157,,,11883,,Autocuration,,Area under curve at 2 uM/dg administered intravenously,0,,22224,
,1,,,,,BAO_0000019,A,U,,10663,CHEMBL626158,,,11883,,Autocuration,,Area under curve at 20 uM/dg administered perorally,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10664,CHEMBL626159,,,15233,,Intermediate,9615.0,Area under curve at a peroral dose of 3 mg/kg in dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10665,CHEMBL626160,,,15233,,Intermediate,10116.0,Area under curve at a peroral dose of 3 mg/kg in rat,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10666,CHEMBL626161,,,15233,,Intermediate,9615.0,Area under curve at an iv dose of 1 mg/kg in dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10667,CHEMBL626162,,,15233,,Intermediate,10116.0,Area under curve at an iv dose of 1 mg/kg in rat,1,,50597,
,1,,,,,BAO_0000019,A,U,,10668,CHEMBL626163,,,12978,,Autocuration,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,0,,22224,
,1,,,,,BAO_0000019,A,U,,10669,CHEMBL626164,,,12978,,Autocuration,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,10670,CHEMBL626165,,,11355,,Intermediate,10090.0,Area under curve measured as conc vs time after intravenous administration to mice.,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,10671,CHEMBL626166,,,11355,,Intermediate,10090.0,Area under curve measured as conc vs time after peroral administration to mice.,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10672,CHEMBL626167,,,12923,,Intermediate,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10673,CHEMBL626168,,,12923,,Intermediate,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10674,CHEMBL877463,,,12923,,Intermediate,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10675,CHEMBL626169,,,12923,,Intermediate,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10676,CHEMBL626170,Heart,,17738,948.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10677,CHEMBL626171,Heart,,17738,948.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10678,CHEMBL626172,Heart,,17738,948.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10679,CHEMBL626173,Heart,,17738,948.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10680,CHEMBL626174,Kidney,,17738,2113.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10681,CHEMBL626175,Kidney,,17738,2113.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10682,CHEMBL626176,Kidney,,17738,2113.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10683,CHEMBL626177,Kidney,,17738,2113.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10684,CHEMBL622499,Kidney,,17738,2113.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10685,CHEMBL622500,Liver,,17738,2107.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10686,CHEMBL622501,Liver,,17738,2107.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10687,CHEMBL622502,Liver,,17738,2107.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10688,CHEMBL622503,Liver,,17738,2107.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10689,CHEMBL877614,Liver,,17738,2107.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10690,CHEMBL624839,Lung,,17738,2048.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10691,CHEMBL624840,Lung,,17738,2048.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10692,CHEMBL624841,Lung,,17738,2048.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10693,CHEMBL624842,Lung,,17738,2048.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10694,CHEMBL624843,Muscle tissue,,17738,2385.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10695,CHEMBL624844,Muscle tissue,,17738,2385.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10696,CHEMBL624845,Muscle tissue,,17738,2385.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10697,CHEMBL621904,Muscle tissue,,17738,2385.0,Intermediate,10116.0,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10698,CHEMBL621905,Blood,,11195,178.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10699,CHEMBL874382,Blood,,11195,178.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10700,CHEMBL621906,Blood,,11195,178.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10701,CHEMBL621907,Brain,,11195,955.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10702,CHEMBL622096,Brain,,11195,955.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10703,CHEMBL622097,Brain,,11195,955.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10704,CHEMBL622098,Heart,,11195,948.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10705,CHEMBL622099,Heart,,11195,948.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10706,CHEMBL622100,Heart,,11195,948.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10707,CHEMBL622101,Kidney,,11195,2113.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10708,CHEMBL622102,Kidney,,11195,2113.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10709,CHEMBL622103,Kidney,,11195,2113.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10710,CHEMBL622104,Liver,,11195,2107.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10711,CHEMBL622105,Liver,,11195,2107.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10712,CHEMBL622106,Liver,,11195,2107.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10713,CHEMBL622107,Lung,,11195,2048.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10714,CHEMBL622108,Lung,,11195,2048.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10715,CHEMBL622109,Lung,,11195,2048.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10716,CHEMBL622110,Muscle tissue,,11195,2385.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10717,CHEMBL622111,Muscle tissue,,11195,2385.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10718,CHEMBL874383,Muscle tissue,,11195,2385.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10719,CHEMBL622112,Zone of skin,,11195,14.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10720,CHEMBL622113,Zone of skin,,11195,14.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10721,CHEMBL622114,Zone of skin,,11195,14.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10722,CHEMBL622115,Spleen,,11195,2106.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10723,CHEMBL622116,Spleen,,11195,2106.0,Intermediate,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10724,CHEMBL622117,,,6193,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10725,CHEMBL622118,,,6803,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10726,CHEMBL622119,,,6647,,Intermediate,10116.0,Oral bioavailability in rats at 6 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10727,CHEMBL622120,,,6647,,Intermediate,10116.0,Oral bioavailability in rat (dose 6 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10728,CHEMBL622121,,,6647,,Intermediate,10116.0,Oral bioavailability in rats at 6 mg/kg dose; Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10729,CHEMBL622122,,,6640,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10730,CHEMBL622123,,,6641,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10731,CHEMBL622124,,,6641,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10732,CHEMBL622125,,,6642,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10733,CHEMBL622126,,,5472,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10734,CHEMBL620455,,,6141,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10735,CHEMBL620456,,,4390,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10736,CHEMBL620457,,,5472,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10737,CHEMBL620458,,,5472,,Intermediate,10116.0,Oral bioavailability was evaluated; Not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10738,CHEMBL620459,,,5438,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10739,CHEMBL620460,,,4883,,Intermediate,10116.0,Oral bioavailability in rat by oral dosing,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10740,CHEMBL620461,,,1908,,Intermediate,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10741,CHEMBL620462,,,4853,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10742,CHEMBL620463,,,4853,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10743,CHEMBL620464,,,4853,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10744,CHEMBL620465,,,4853,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10745,CHEMBL620466,,,4853,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10746,CHEMBL620467,,,4853,,Intermediate,10116.0,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10747,CHEMBL620468,,,4853,,Intermediate,10116.0,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10748,CHEMBL620469,,,12873,,Intermediate,10116.0,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10749,CHEMBL620470,,,12873,,Intermediate,10116.0,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10750,CHEMBL620471,,,3169,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10751,CHEMBL620472,,,6305,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10752,CHEMBL620473,,,4762,,Intermediate,10116.0,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10753,CHEMBL620474,,,17847,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10754,CHEMBL620475,,,6211,,Intermediate,10116.0,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10755,CHEMBL620476,,,6011,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10756,CHEMBL620477,,,6317,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10757,CHEMBL620478,,,6644,,Intermediate,10116.0,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10758,CHEMBL618768,,,6644,,Intermediate,10116.0,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10759,CHEMBL618769,,,6644,,Intermediate,10116.0,Oral bioavailability in rat after oral administration at 13 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10760,CHEMBL618770,,,6644,,Intermediate,10116.0,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10761,CHEMBL618771,,,6113,,Intermediate,10116.0,Oral bioavailability (dose 20 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10762,CHEMBL618772,,,5937,,Intermediate,10116.0,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10763,CHEMBL618773,,,5711,,Intermediate,10116.0,Oral bioavailability in rat at 10 mg/kg of the compound,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10764,CHEMBL875842,,,17717,,Intermediate,10116.0,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10765,CHEMBL618774,,,17717,,Intermediate,10116.0,Bioavailability in rat (dose 3 mg/kg i.v.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10766,CHEMBL618775,,,17717,,Intermediate,10116.0,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10767,CHEMBL618776,,,17717,,Intermediate,10116.0,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10768,CHEMBL618777,,,4722,,Intermediate,10116.0,Percent bioavailability (F) in rats after iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10769,CHEMBL618778,,,4722,,Intermediate,10116.0,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10770,CHEMBL618779,,,4353,,Intermediate,10116.0,Bioavailability in rat (dose 5 uM/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10771,CHEMBL618780,,,15662,,Intermediate,10116.0,Oral bioavailability,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10772,CHEMBL618781,,,4756,,Intermediate,10116.0,Bioavailability in rat (dose 2 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10773,CHEMBL618782,,,4756,,Intermediate,10116.0,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10774,CHEMBL618783,,,3436,,Intermediate,10116.0,Oral bioavailability in rat (dose 20 mg/kg),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10775,CHEMBL618784,,,17800,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10776,CHEMBL618785,,,15762,,Intermediate,10116.0,Percent oral bioavailability evaluated in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10777,CHEMBL618786,,,5089,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10778,CHEMBL618787,,,5089,,Intermediate,10116.0,Percent oral bioavailability in rat; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10779,CHEMBL618788,,,3185,,Intermediate,10116.0,Oral bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10780,CHEMBL618789,,,5145,,Intermediate,10116.0,Bioavailability in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10781,CHEMBL618790,,,3457,,Intermediate,10116.0,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10782,CHEMBL618791,,,3457,,Intermediate,10116.0,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10783,CHEMBL875843,,,5983,,Intermediate,10116.0,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10784,CHEMBL618792,,,5739,,Intermediate,10116.0,Oral bioavailability in rat (dose 20 mg/kg p.o.),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10785,CHEMBL623395,,,3579,,Intermediate,10116.0,Cmax at a dose of 30 mg/kg in rat,1,,50597,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,10786,CHEMBL623396,,,17788,,Autocuration,314293.0,Cmax in monkeys at a dose of 1 mg/kg,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10787,CHEMBL623397,,,14956,,Intermediate,10116.0,Cmax in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10788,CHEMBL623398,,,17788,,Intermediate,10116.0,Cmax in rats at a dose of 1 mg/kg,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10789,CHEMBL623399,,,9750,,Intermediate,10090.0,Cmax was measured in mice after an oral dose of 50 mg/kg.,1,,50594,
,1,,,In vivo,,BAO_0000218,A,U,,10790,CHEMBL623400,,,12767,,Autocuration,,"Cmax value at a dose of 12.7 uM/kg, po",0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10791,CHEMBL623401,,,12767,,Autocuration,,"Cmax value at a dose of 6.3 uM/kg, iv",0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10792,CHEMBL623402,,,12767,,Autocuration,,"Cmax value at a dose of 7.1 uM/kg, iv",0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10793,CHEMBL623403,,,12703,,Autocuration,,Cmax value of compound was determined after 1 hr,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10794,CHEMBL623404,,,15778,,Autocuration,,Cmax value of the compound,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10795,CHEMBL625997,,,12818,,Intermediate,10116.0,Cmax value administered intraintestinal in rats.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10796,CHEMBL625998,,,14964,,Intermediate,10116.0,Cmax value administered perorally was determined in rat; Not determined,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,10797,CHEMBL625999,,,15808,,Autocuration,,Cmax value at the dose of 2.3 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10798,CHEMBL626000,,,15808,,Autocuration,,Cmax value at the dose of 5 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10799,CHEMBL626001,,,15778,,Autocuration,,Cmax value in the period of 8 hr after dosing. ,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10800,CHEMBL626002,,,3715,,Autocuration,,Cmax value at a oral dose of 20 mg/kg; Not tested,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10801,CHEMBL626003,,,3715,,Autocuration,,Cmax value at a oral dose of 20 mg/kg,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10802,CHEMBL626004,,,1446,,Intermediate,10116.0,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,50597,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,10803,CHEMBL626005,,,15240,,Intermediate,10141.0,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,1,,50512,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10804,CHEMBL626006,,,15240,,Intermediate,10116.0,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10805,CHEMBL626007,Plasma,,14810,1969.0,Intermediate,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10806,CHEMBL626008,Plasma,,14239,1969.0,Intermediate,10090.0,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10807,CHEMBL626009,Liver,,12555,2107.0,Intermediate,9615.0,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10808,CHEMBL626010,,,10754,,Intermediate,9615.0,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,1,,50588,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10809,CHEMBL626011,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10810,CHEMBL626012,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10811,CHEMBL626013,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10812,CHEMBL626014,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10813,CHEMBL877496,Blood,,10754,178.0,Intermediate,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,F,N,,10814,CHEMBL626015,,,14600,,Intermediate,9615.0,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,F,N,,10815,CHEMBL626016,,,14600,,Intermediate,9615.0,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,F,N,,10816,CHEMBL626017,,,14600,,Intermediate,9615.0,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10817,CHEMBL626018,Plasma,,13543,1969.0,Intermediate,9615.0,Bioavailability as maximal plasma concentration in dogs,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10818,CHEMBL626692,Plasma,,13543,1969.0,Intermediate,9615.0,Bioavailability as maximal plasma concentration in dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10819,CHEMBL626693,Plasma,,13543,1969.0,Intermediate,10116.0,Bioavailability as maximal plasma concentration in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,10820,CHEMBL626694,Plasma,,13543,1969.0,Autocuration,10116.0,Bioavailability as maximal plasma concentration in rats,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10821,CHEMBL626695,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10822,CHEMBL626696,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10823,CHEMBL626697,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10824,CHEMBL626859,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10825,CHEMBL626860,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10826,CHEMBL626861,Blood,,14600,178.0,Intermediate,9615.0,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10827,CHEMBL626296,,,14681,,Intermediate,10116.0,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,10828,CHEMBL626297,,,15905,,Autocuration,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10829,CHEMBL626298,Plasma,,15905,1969.0,Autocuration,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10830,CHEMBL626299,Plasma,,13304,1969.0,Intermediate,10116.0,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10831,CHEMBL626300,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10832,CHEMBL626301,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10833,CHEMBL626962,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10834,CHEMBL626963,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10835,CHEMBL626964,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10836,CHEMBL626965,Plasma,,14839,1969.0,Intermediate,9541.0,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,1,,100710,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10837,CHEMBL626966,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10838,CHEMBL626967,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10839,CHEMBL626968,Plasma,,14839,1969.0,Intermediate,9541.0,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,1,,100710,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10840,CHEMBL626969,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10841,CHEMBL627126,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10842,CHEMBL631276,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10843,CHEMBL631277,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10844,CHEMBL631278,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10845,CHEMBL874457,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10846,CHEMBL631279,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10847,CHEMBL631280,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10848,CHEMBL631281,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10849,CHEMBL631968,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10850,CHEMBL631969,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10851,CHEMBL631970,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10852,CHEMBL631971,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10853,CHEMBL631972,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10854,CHEMBL630435,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10855,CHEMBL630436,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10856,CHEMBL630437,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10857,CHEMBL630438,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10858,CHEMBL630439,Heart,,8418,948.0,Intermediate,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10859,CHEMBL630440,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10860,CHEMBL630441,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10861,CHEMBL630442,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10862,CHEMBL625234,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10863,CHEMBL625235,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10864,CHEMBL625236,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10865,CHEMBL625237,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10866,CHEMBL626125,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10867,CHEMBL626126,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10868,CHEMBL626127,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10869,CHEMBL626128,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10870,CHEMBL626129,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10871,CHEMBL626130,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10872,CHEMBL626131,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10873,CHEMBL626132,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10874,CHEMBL626752,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10875,CHEMBL626753,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10876,CHEMBL626754,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10877,CHEMBL626755,Kidney,,8418,2113.0,Intermediate,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10878,CHEMBL626756,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10879,CHEMBL626757,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10880,CHEMBL626758,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10881,CHEMBL626759,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10882,CHEMBL626760,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10883,CHEMBL626394,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10884,CHEMBL626395,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10885,CHEMBL626396,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10886,CHEMBL626397,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10887,CHEMBL626398,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10888,CHEMBL626399,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10889,CHEMBL874653,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10890,CHEMBL626400,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10891,CHEMBL626401,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10892,CHEMBL626402,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10893,CHEMBL626403,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10894,CHEMBL626404,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10895,CHEMBL626405,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10896,CHEMBL625529,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10897,CHEMBL625530,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10898,CHEMBL625531,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10899,CHEMBL625532,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10900,CHEMBL625533,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10901,CHEMBL875474,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10902,CHEMBL625534,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10903,CHEMBL625535,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10904,CHEMBL625536,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10905,CHEMBL625537,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10906,CHEMBL625538,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10907,CHEMBL625539,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10908,CHEMBL625540,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10909,CHEMBL625541,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10910,CHEMBL625542,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10911,CHEMBL625543,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,10912,CHEMBL625544,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10913,CHEMBL625545,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10914,CHEMBL625546,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10915,CHEMBL625547,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10916,CHEMBL625548,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10917,CHEMBL625549,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10918,CHEMBL625550,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10919,CHEMBL625551,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10920,CHEMBL875475,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10921,CHEMBL625552,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10922,CHEMBL625553,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10923,CHEMBL625554,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10924,CHEMBL625555,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10925,CHEMBL625556,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10926,CHEMBL624986,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10927,CHEMBL624987,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,10928,CHEMBL624988,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10929,CHEMBL624989,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10930,CHEMBL624990,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10931,CHEMBL874391,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10932,CHEMBL624991,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10933,CHEMBL624992,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10934,CHEMBL624993,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10935,CHEMBL624994,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10936,CHEMBL624995,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10937,CHEMBL624996,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10938,CHEMBL624997,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10939,CHEMBL624998,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10940,CHEMBL624999,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10941,CHEMBL882955,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10942,CHEMBL625000,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10943,CHEMBL625001,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10944,CHEMBL625089,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10945,CHEMBL625090,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10946,CHEMBL625091,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10947,CHEMBL625092,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10948,CHEMBL625093,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10949,CHEMBL625094,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10950,CHEMBL625095,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10951,CHEMBL625096,,,2249,,Intermediate,9615.0,Compound was evaluated for its bioavailability in the dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10952,CHEMBL625097,,,2249,,Intermediate,10116.0,Compound was evaluated for its bioavailability in the rats,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,10953,CHEMBL882956,,,17515,,Autocuration,,Compound was evaluated for oral bioavailability,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10954,CHEMBL625098,,,14541,,Intermediate,10116.0,Compound was evaluated for percentage of Oral bioavailability in rats,1,,50597,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,U,,10955,CHEMBL625099,,,12797,,Autocuration,10141.0,Bioavailability in guinea pig,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10956,CHEMBL625100,,,12797,,Intermediate,10116.0,Compound was evaluated for the oral bioavailability in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10957,CHEMBL625101,,,12797,,Intermediate,9615.0,Compound was evaluated for the oral bioavailability in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10958,CHEMBL874396,,,12797,,Intermediate,10116.0,Compound was evaluated for the oral bioavailability in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,F,U,,10959,CHEMBL625102,,,11727,,Autocuration,9615.0,Bioavailability in dog (dosed i.v.),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,10960,CHEMBL625103,,,13249,,Intermediate,9615.0,Compound was tested for in vivo bioavailability in dog,1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,10961,CHEMBL625104,,,13249,,Intermediate,10026.0,Compound was tested for in vivo bioavailability in hamsters,1,,100712,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,10962,CHEMBL625105,,,13249,,Autocuration,314293.0,Compound was tested for in vivo bioavailability in monkey,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10963,CHEMBL625106,,,13249,,Intermediate,10116.0,Compound was tested for in vivo bioavailability in rat,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,U,,10964,CHEMBL625107,,,9552,,Autocuration,10090.0,Oral bioavailability in mouse,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10965,CHEMBL625108,,,9552,,Intermediate,10090.0,Compound was tested for percent of oral bioavailability in mice; 56-74,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,U,,10966,CHEMBL625109,,,14839,,Autocuration,10090.0,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,U,,10967,CHEMBL625110,,,14839,,Autocuration,9541.0,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,U,,10968,CHEMBL625111,,,14839,,Autocuration,9541.0,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10969,CHEMBL625112,,,14839,,Intermediate,10090.0,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10970,CHEMBL875334,,,14839,,Intermediate,10090.0,Oral bioavailability in nude mice,1,,50594,
,1,,,In vivo,Primates,BAO_0000218,A,U,,10971,CHEMBL628617,,,11219,,Autocuration,9443.0,Bioavailability in monkey (i.d. dosing),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,10972,CHEMBL628618,,,9552,,Autocuration,10116.0,Bioavailability in rat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10973,CHEMBL628619,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,10974,CHEMBL628620,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10975,CHEMBL628621,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,100710,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10976,CHEMBL628622,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,100710,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10977,CHEMBL628623,,,14839,,Intermediate,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,100710,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10978,CHEMBL628624,Plasma,,14839,1969.0,Intermediate,9541.0,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,1,,100710,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10979,CHEMBL628625,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,10980,CHEMBL628626,Plasma,,14839,1969.0,Intermediate,9541.0,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,1,,100710,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10981,CHEMBL627041,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10982,CHEMBL627042,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10983,CHEMBL627043,Plasma,,14839,1969.0,Intermediate,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,50594,
,1,,,In vivo,,BAO_0000218,A,U,,10984,CHEMBL627044,Plasma,,13932,1969.0,Autocuration,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10985,CHEMBL627045,Plasma,,11637,1969.0,Intermediate,10090.0,Cmax in mouse plasma,1,,50594,
,1,,,In vivo,,BAO_0000218,A,U,,10986,CHEMBL627046,Plasma,,11637,1969.0,Autocuration,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10987,CHEMBL627047,Plasma,,13960,1969.0,Intermediate,10116.0,Maximal plasma concentration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10988,CHEMBL627048,Plasma,,15905,1969.0,Intermediate,10116.0,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10989,CHEMBL627049,,,14062,,Intermediate,10116.0,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10990,CHEMBL627050,,,14062,,Intermediate,10116.0,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10991,CHEMBL627051,,,14062,,Intermediate,10116.0,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10992,CHEMBL627052,,,14062,,Intermediate,10116.0,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10993,CHEMBL627053,,,14062,,Intermediate,10116.0,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,10994,CHEMBL627054,,,14062,,Intermediate,10116.0,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10995,CHEMBL627055,,,15011,,Intermediate,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10996,CHEMBL627056,,,15011,,Intermediate,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10997,CHEMBL627057,,,15011,,Intermediate,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10998,CHEMBL627058,,,15011,,Intermediate,10090.0,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,10999,CHEMBL626211,,,15011,,Intermediate,10090.0,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,50594,
,1,,,In vivo,,BAO_0000218,A,U,,11000,CHEMBL626212,,,10291,,Autocuration,,Maximum Concentration of the compound.,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11001,CHEMBL626213,,,14599,,Intermediate,9615.0,Maximum Concentration was measured after iv administration into Beagle dog,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11002,CHEMBL626214,,,14599,,Intermediate,9615.0,Maximum Concentration was measured after iv administration into Beagle dog.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11003,CHEMBL626215,,,14599,,Intermediate,9615.0,Maximum Concentration was measured after po administration into Beagle dog,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11004,CHEMBL626216,,,14599,,Intermediate,9615.0,Maximum Concentration was measured after po administration into Beagle dog.,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11005,CHEMBL626217,Blood,,12767,178.0,Autocuration,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11006,CHEMBL626218,Blood,,12767,178.0,Autocuration,,Maximum blood level reached after an iv dose of 12.2 uM/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11007,CHEMBL626219,Blood,,12767,178.0,Autocuration,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11008,CHEMBL626220,Blood,,12767,178.0,Autocuration,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11009,CHEMBL626221,Blood,,12767,178.0,Autocuration,,Maximum blood level reached after an oral dose of 5.0 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11010,CHEMBL626222,Blood,,12767,178.0,Autocuration,,Maximum blood level reached at dose of 10.6 uM/kg orally,0,,22224,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,11011,CHEMBL626223,,,14706,,Intermediate,10141.0,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,1,,50512,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,11012,CHEMBL626224,,,14706,,Intermediate,10141.0,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,1,,50512,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11013,CHEMBL626225,Brain,,14793,955.0,Intermediate,10116.0,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11014,CHEMBL626226,Brain,,14793,955.0,Intermediate,10116.0,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11015,CHEMBL626227,Brain,,14793,955.0,Intermediate,10116.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11016,CHEMBL626228,Brain,,14793,955.0,Intermediate,10116.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11017,CHEMBL626229,,,14793,,Intermediate,10116.0,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11018,CHEMBL626921,,,14793,,Intermediate,10116.0,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11019,CHEMBL876793,,,14793,,Intermediate,10116.0,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11020,CHEMBL625309,,,14793,,Intermediate,10116.0,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Bacillus subtilis,BAO_0000218,A,N,,11021,CHEMBL625310,,,10524,,Intermediate,1423.0,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,50278,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11022,CHEMBL625311,,,11871,,Autocuration,314293.0,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11023,CHEMBL625312,,,11871,,Intermediate,10116.0,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11024,CHEMBL625313,,,3437,,Autocuration,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11025,CHEMBL625314,,,12038,,Intermediate,10090.0,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11026,CHEMBL625315,,,12038,,Intermediate,10116.0,Maximum concentration in male rats after iv administration of 20 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11027,CHEMBL625316,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11028,CHEMBL625317,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11029,CHEMBL625318,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11030,CHEMBL625319,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11031,CHEMBL625320,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11032,CHEMBL625321,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11033,CHEMBL625322,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11034,CHEMBL876801,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11035,CHEMBL625323,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11036,CHEMBL625324,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11037,CHEMBL625325,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11038,CHEMBL625326,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11039,CHEMBL625327,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11040,CHEMBL625328,Liver,,8418,2107.0,Intermediate,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11041,CHEMBL625329,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11042,CHEMBL625330,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11043,CHEMBL627774,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11044,CHEMBL627775,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11045,CHEMBL627949,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11046,CHEMBL627950,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11047,CHEMBL627951,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11048,CHEMBL627952,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11049,CHEMBL627953,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11050,CHEMBL627954,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11051,CHEMBL627955,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11052,CHEMBL627956,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11053,CHEMBL876802,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11054,CHEMBL627957,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11055,CHEMBL627958,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11056,CHEMBL627959,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11057,CHEMBL627960,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11058,CHEMBL627961,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11059,CHEMBL627962,Lung,,8418,2048.0,Intermediate,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11060,CHEMBL627963,,,9796,,Intermediate,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11061,CHEMBL624759,,,9796,,Intermediate,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11062,CHEMBL624760,,,9796,,Intermediate,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11063,CHEMBL624761,,,9796,,Intermediate,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11064,CHEMBL877607,,,9796,,Intermediate,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11065,CHEMBL624762,Liver,,9796,2107.0,Intermediate,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11066,CHEMBL624763,Liver,,9796,2107.0,Intermediate,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11067,CHEMBL624764,Liver,,9796,2107.0,Intermediate,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11068,CHEMBL624765,Liver,,9796,2107.0,Intermediate,10116.0,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11069,CHEMBL624766,Liver,,9796,2107.0,Intermediate,10116.0,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11070,CHEMBL624767,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11071,CHEMBL624768,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11072,CHEMBL624769,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11073,CHEMBL624770,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11074,CHEMBL624771,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11075,CHEMBL624772,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11076,CHEMBL624773,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11077,CHEMBL624774,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11078,CHEMBL624775,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11079,CHEMBL624776,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11080,CHEMBL624777,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11081,CHEMBL624778,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11082,CHEMBL624779,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11083,CHEMBL624780,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11084,CHEMBL624781,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11085,CHEMBL877608,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11086,CHEMBL624782,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11087,CHEMBL624783,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11088,CHEMBL624784,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11089,CHEMBL624785,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11090,CHEMBL624786,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11091,CHEMBL624787,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11092,CHEMBL628676,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11093,CHEMBL621842,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11094,CHEMBL621843,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11095,CHEMBL623873,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11096,CHEMBL623874,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11097,CHEMBL623875,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11098,CHEMBL623876,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11099,CHEMBL623877,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11100,CHEMBL623878,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11101,CHEMBL623879,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11102,CHEMBL623880,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11103,CHEMBL623881,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11104,CHEMBL623957,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11105,CHEMBL623958,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11106,CHEMBL623959,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11107,CHEMBL623960,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11108,CHEMBL623961,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11109,CHEMBL623962,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11110,CHEMBL624676,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11111,CHEMBL624677,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11112,CHEMBL624678,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11113,CHEMBL624679,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11114,CHEMBL624680,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11115,CHEMBL624849,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11116,CHEMBL624850,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11117,CHEMBL874399,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11118,CHEMBL624851,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11119,CHEMBL624852,,,11732,,Autocuration,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11120,CHEMBL624853,,,13359,,Autocuration,10116.0,Oral bioavailability in rat (dose 10 mg/kg),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11121,CHEMBL624854,,,16618,,Autocuration,10116.0,Oral bioavailability in rat (Sprague-Dawley),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11122,CHEMBL624855,,,13960,,Autocuration,10116.0,Oral bioavailability in rat,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11123,CHEMBL624856,,,13917,,Autocuration,10116.0,Oral bioavailability in rats was determined in vivo,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11124,CHEMBL882957,,,14266,,Autocuration,9615.0,Oral bioavailability in dog,0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11125,CHEMBL624857,,,12359,,Autocuration,314293.0,Oral bioavailability of compound in monkey,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11126,CHEMBL622202,,,12359,,Intermediate,10116.0,Oral bioavailability of compound in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11127,CHEMBL622203,,,12359,,Autocuration,10116.0,Bioavailability in rat of PMEA prodrug,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11128,CHEMBL625522,,,12359,,Intermediate,10116.0,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,11129,CHEMBL622868,,,10791,,Autocuration,9544.0,Serum conc at 3 hours following 25 mg/kg dose,0,,22224,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,11130,CHEMBL622869,Urine,,10791,1088.0,Autocuration,9544.0,Urine conc 0-5 hours following 25 mg/kg dose,0,,22224,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,11131,CHEMBL622870,Urine,,10791,1088.0,Autocuration,9544.0,Urine conc 0-24 hours following 25 mg/kg dose,0,,22224,
,1,,,In vivo,Chlorocebus aethiops,BAO_0000218,A,U,,11132,CHEMBL622871,,,138,,Autocuration,9534.0,Oral bioavailability in African green monkeys; 20-25,0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,11133,CHEMBL620560,,,14521,,Intermediate,9541.0,Oral bioavailability in cynomolgus monkey.,1,,100710,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11134,CHEMBL620561,,,13953,,Autocuration,9615.0,Oral bioavailability in dog,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11135,CHEMBL620562,,,12836,,Intermediate,9615.0,Oral bioavailability in dog at 10 mg/kg oral dose,1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,11136,CHEMBL620563,,,12836,,Intermediate,10026.0,Oral bioavailability in hamster at 10 mg/kg oral dose,1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11137,CHEMBL620564,,,12836,,Intermediate,10116.0,Oral bioavailability in rat at 10 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11138,CHEMBL872265,,,14521,,Autocuration,10116.0,Oral bioavailability in rat,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11139,CHEMBL620565,,,13953,,Autocuration,10116.0,Oral bioavailability in rat,0,,22224,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,11140,CHEMBL620566,,,6799,,Autocuration,9347.0,Oral bioavailability,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11141,CHEMBL620567,,,11311,,Autocuration,,Oral bioavailability was determined; range 49-102%,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11142,CHEMBL620568,,,4013,,Intermediate,9615.0,Oral bioavailability was determined in dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11143,CHEMBL620569,,,4013,,Autocuration,10116.0,Oral bioavailability in rat,0,,22224,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,11144,CHEMBL620570,,,17591,,Autocuration,9347.0,Oral bioavailability,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11145,CHEMBL620571,,,17591,,Autocuration,,Oral bioavailability was determined; Not orally available,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11146,CHEMBL620572,,,15011,,Intermediate,10090.0,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,U,,11147,CHEMBL620573,,,15011,,Autocuration,10090.0,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,U,,11148,CHEMBL620574,,,15011,,Autocuration,10090.0,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,0,,22224,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,U,,11149,CHEMBL620575,,,9552,,Autocuration,9544.0,Oral bioavailability in Rhesus monkey,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11150,CHEMBL620576,,,9552,,Autocuration,9615.0,Oral bioavailability in dog (female mongrel),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11151,CHEMBL875846,,,3639,,Autocuration,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11152,CHEMBL620577,,,13397,,Autocuration,9615.0,Oral bioavailability in dog,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11153,CHEMBL620578,,,3031,,Autocuration,,Percentage Bioavailability was evaluated.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11154,CHEMBL620579,,,12818,,Autocuration,10116.0,Bioavailability in rat administered i.d.,0,,22224,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,11155,CHEMBL621248,,,4847,,Autocuration,9347.0,Bioavailability,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11156,CHEMBL625390,,,12421,,Autocuration,9615.0,Bioavailability in dog (male Beagle) i.v. administration,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11157,CHEMBL625391,,,11966,,Autocuration,10116.0,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",0,,22224,
,1,,,In vivo,Primates,BAO_0000218,A,U,,11158,CHEMBL872266,,,11218,,Autocuration,9443.0,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11159,CHEMBL625392,,,13129,,Autocuration,10116.0,Oral bioavailability in rat (Sprague-Dawley) (male),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11160,CHEMBL625393,,,12350,,Intermediate,10116.0,The oral bioavailability was measured on rats after oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11161,CHEMBL625394,,,2231,,Intermediate,10116.0,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,11162,CHEMBL625395,,,2231,,Intermediate,9544.0,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,50797,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11163,CHEMBL625396,,,12187,,Autocuration,10116.0,Bioavailability in rat (dose 10 mg/kg i.d.),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11164,CHEMBL625397,,,12421,,Autocuration,9615.0,Bioavailability in dog (male Beagle) i.v. administration,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11165,CHEMBL625398,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11166,CHEMBL625399,Blood,,13256,178.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11167,CHEMBL626074,Cerebellum,,13256,2037.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11168,CHEMBL626075,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11169,CHEMBL626076,Plasma,,2231,1969.0,Intermediate,10116.0,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,11170,CHEMBL626077,Plasma,,2231,1969.0,Intermediate,9544.0,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,50797,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11171,CHEMBL626078,Blood,,12178,178.0,Intermediate,10116.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11172,CHEMBL625846,Blood,,12178,178.0,Autocuration,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11173,CHEMBL625847,Blood,,12178,178.0,Autocuration,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11174,CHEMBL625848,,,15633,,Expert,10116.0,Maximum concentration observed in rats at an oral dose of 50 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11175,CHEMBL625849,Plasma,,14258,1969.0,Intermediate,10116.0,Maximum concentration of compound in plasma administered orally to rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11176,CHEMBL626023,Plasma,,14224,1969.0,Intermediate,9615.0,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11177,CHEMBL626024,Plasma,,14224,1969.0,Intermediate,9615.0,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11178,CHEMBL626025,Plasma,,14224,1969.0,Intermediate,9615.0,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11179,CHEMBL626026,,,5566,,Autocuration,,Maximum concentration after 10 mg/kg by oral administration,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11180,CHEMBL626027,,,16935,,Autocuration,,Maximum concentration at a dose of 1.5 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11181,CHEMBL626028,,,16935,,Autocuration,,Maximum concentration at a dose of 2.0 mg/kg,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11182,CHEMBL626029,Plasma,,14224,1969.0,Intermediate,9615.0,Maximum concentration in dog plasma,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11183,CHEMBL626030,Plasma,,12536,1969.0,Autocuration,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11184,CHEMBL626031,Plasma,,12536,1969.0,Autocuration,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11185,CHEMBL626032,Plasma,,12536,1969.0,Autocuration,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11186,CHEMBL626033,Plasma,,12536,1969.0,Autocuration,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11187,CHEMBL626034,Plasma,,12536,1969.0,Autocuration,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11188,CHEMBL626035,Plasma,,9994,1969.0,Intermediate,9615.0,Maximum concentration in plasma after oral administration in dog (25 mg/kg),1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11189,CHEMBL626036,Plasma,,1434,1969.0,Autocuration,,Maximum concentration in plasma at Tmax,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11190,CHEMBL626037,Plasma,,12836,1969.0,Expert,9615.0,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,11191,CHEMBL626038,Plasma,,12836,1969.0,Intermediate,10026.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11192,CHEMBL626039,Plasma,,12836,1969.0,Intermediate,10116.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11193,CHEMBL626040,Plasma,,12545,1969.0,Intermediate,10116.0,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,1,,50597,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,N,,11194,CHEMBL626041,Plasma,,13856,1969.0,Intermediate,9986.0,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,1,,50592,
,1,,,In vivo,,BAO_0000218,A,U,,11195,CHEMBL626042,,,3550,,Autocuration,,Maximum concentration was calculated,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11196,CHEMBL626043,,,2632,,Autocuration,,Maximum concentration was calculated.,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11197,CHEMBL626044,,,5566,,Autocuration,,Maximum concentration at a peroral dose of 10 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11198,CHEMBL626045,,,11883,,Autocuration,,Maximum concentration of the drug at 10 uM/dg administered perorally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11199,CHEMBL626046,,,11883,,Autocuration,,Maximum concentration of the drug at 2 uM/dg administered intravenously,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11200,CHEMBL626047,Plasma,,14122,1969.0,Intermediate,9615.0,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,11201,CHEMBL626048,Plasma,,14122,1969.0,Intermediate,10026.0,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11202,CHEMBL626049,Plasma,,14122,1969.0,Intermediate,10116.0,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11203,CHEMBL626050,Plasma,,12542,1969.0,Intermediate,10116.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11204,CHEMBL874541,Plasma,,12542,1969.0,Intermediate,9615.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,11205,CHEMBL622826,Plasma,,12542,1969.0,Intermediate,10026.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,1,,100712,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,11206,CHEMBL622827,Plasma,,12542,1969.0,Intermediate,10026.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11207,CHEMBL622828,Plasma,,12542,1969.0,Intermediate,10116.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11208,CHEMBL622829,Plasma,,14080,1969.0,Intermediate,10116.0,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11209,CHEMBL876806,,,11911,,Intermediate,10116.0,Maximum concentration reached following intravenous administration in male rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11210,CHEMBL622830,,,13204,,Intermediate,9615.0,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11211,CHEMBL622831,,,13204,,Intermediate,10116.0,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11212,CHEMBL626794,,,14346,,Intermediate,9615.0,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11213,CHEMBL626795,,,14346,,Intermediate,10116.0,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11214,CHEMBL626796,,,14346,,Intermediate,10116.0,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11215,CHEMBL626797,,,14346,,Intermediate,10116.0,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11216,CHEMBL626798,,,14127,,Intermediate,10116.0,Maximum drug concentration is determined after oral dosing in rats.,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11217,CHEMBL626799,,,14339,,Intermediate,9615.0,Maximum observed concentration in oral (5 mg/kg) fasted dogs,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11218,CHEMBL626800,,,14339,,Intermediate,9615.0,Maximum observed concentration in oral (5 mg/kg) fed dogs,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11219,CHEMBL626801,Plasma,,13494,1969.0,Autocuration,,Maximum plasma concentration,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11220,CHEMBL876816,Plasma,,14925,1969.0,Intermediate,10116.0,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11221,CHEMBL626802,Plasma,,14474,1969.0,Intermediate,10116.0,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11222,CHEMBL626803,Plasma,,14474,1969.0,Intermediate,9615.0,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11223,CHEMBL626804,Plasma,,13917,1969.0,Autocuration,,Maximum plasma concentration following oral administration of 30 umol/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11224,CHEMBL626805,Plasma,,9796,1969.0,Intermediate,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11225,CHEMBL626309,Plasma,,9796,1969.0,Intermediate,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11226,CHEMBL626310,Plasma,,9796,1969.0,Intermediate,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11227,CHEMBL626311,Plasma,,9796,1969.0,Intermediate,10116.0,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11228,CHEMBL626312,Plasma,,9796,1969.0,Intermediate,10116.0,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11229,CHEMBL626313,Uterus,,9796,995.0,Intermediate,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11230,CHEMBL626314,Uterus,,9796,995.0,Intermediate,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11231,CHEMBL626315,Uterus,,9796,995.0,Intermediate,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11232,CHEMBL626316,Uterus,,9796,995.0,Intermediate,10116.0,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11233,CHEMBL626317,Uterus,,9796,995.0,Intermediate,10116.0,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11234,CHEMBL626318,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11235,CHEMBL626319,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11236,CHEMBL626320,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11237,CHEMBL875053,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11238,CHEMBL626321,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11239,CHEMBL626322,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11240,CHEMBL626323,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11241,CHEMBL626324,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11242,CHEMBL626325,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11243,CHEMBL626326,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11244,CHEMBL626327,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11245,CHEMBL626328,,,8363,,Intermediate,10116.0,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11246,CHEMBL626329,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11247,CHEMBL626330,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11248,CHEMBL626331,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11249,CHEMBL626332,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11250,CHEMBL626333,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11251,CHEMBL626334,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11252,CHEMBL626335,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11253,CHEMBL624798,Blood,,8684,178.0,Intermediate,10116.0,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11254,CHEMBL624799,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11255,CHEMBL624800,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11256,CHEMBL624801,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11257,CHEMBL624802,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11258,CHEMBL624803,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11259,CHEMBL624804,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11260,CHEMBL624805,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11261,CHEMBL624806,Brain,,8684,955.0,Intermediate,10116.0,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11262,CHEMBL624807,,,8684,,Intermediate,10116.0,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11263,CHEMBL624808,,,8684,,Intermediate,10116.0,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11264,CHEMBL624809,,,8684,,Intermediate,10116.0,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11265,CHEMBL624810,,,8684,,Intermediate,10116.0,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11266,CHEMBL877618,,,8684,,Intermediate,10116.0,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11267,CHEMBL624811,,,8684,,Intermediate,10116.0,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11268,CHEMBL624812,,,8684,,Intermediate,10116.0,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11269,CHEMBL624813,,,8684,,Intermediate,10116.0,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11270,CHEMBL624814,,,8684,,Intermediate,10116.0,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11271,CHEMBL624815,,,8684,,Intermediate,10116.0,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11272,CHEMBL624816,,,8684,,Intermediate,10116.0,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11273,CHEMBL624817,,,8684,,Intermediate,10116.0,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11274,CHEMBL624818,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11275,CHEMBL624819,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11276,CHEMBL624820,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11277,CHEMBL624821,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11278,CHEMBL624822,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11279,CHEMBL624823,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Escherichia coli,BAO_0000218,A,N,,11280,CHEMBL624824,,,15599,,Intermediate,562.0,Observed diffusion coefficient in organic solvent for Escherichia coli,1,,50212,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11281,CHEMBL624825,Blood,,9614,178.0,Intermediate,10116.0,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11282,CHEMBL624826,Blood,,9614,178.0,Intermediate,10116.0,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11283,CHEMBL876817,Cardiac atrium,,9614,2081.0,Intermediate,10116.0,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11284,CHEMBL624827,Cardiac atrium,,9614,2081.0,Intermediate,10116.0,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11285,CHEMBL624828,,,9614,,Intermediate,10116.0,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11286,CHEMBL624829,,,9614,,Intermediate,10116.0,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11287,CHEMBL624830,Liver,,9614,2107.0,Intermediate,10116.0,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11288,CHEMBL624831,Liver,,9614,2107.0,Intermediate,10116.0,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11289,CHEMBL624832,Cardiac atrium,,9614,2081.0,Intermediate,10116.0,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11290,CHEMBL624833,Cardiac atrium,,9614,2081.0,Intermediate,10116.0,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11291,CHEMBL624834,,,9614,,Intermediate,10116.0,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11292,CHEMBL624835,,,9614,,Intermediate,10116.0,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11293,CHEMBL624836,Spleen,,9614,2106.0,Intermediate,10116.0,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11294,CHEMBL624837,Spleen,,9614,2106.0,Intermediate,10116.0,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11295,CHEMBL624838,Blood,,9071,178.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11296,CHEMBL622188,Blood,,9071,178.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11297,CHEMBL622189,Heart,,9071,948.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11298,CHEMBL622190,Heart,,9071,948.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11299,CHEMBL625170,Heart,,9071,948.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11300,CHEMBL625171,Kidney,,9071,2113.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11301,CHEMBL625172,Kidney,,9071,2113.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11302,CHEMBL625173,Kidney,,9071,2113.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11303,CHEMBL625174,Liver,,9071,2107.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11304,CHEMBL625175,Liver,,9071,2107.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11305,CHEMBL625176,Liver,,9071,2107.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11306,CHEMBL625177,Lung,,9071,2048.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11307,CHEMBL625178,Lung,,9071,2048.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11308,CHEMBL625179,Lung,,9071,2048.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11309,CHEMBL625180,Lung,,9071,2048.0,Intermediate,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,50597,
,1,,,,,BAO_0000218,A,U,,11310,CHEMBL625181,,,10677,,Autocuration,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,11311,CHEMBL625182,Urine,,9750,1088.0,Intermediate,10090.0,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11312,CHEMBL625183,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11313,CHEMBL875848,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11314,CHEMBL622260,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11315,CHEMBL622261,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11316,CHEMBL622262,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11317,CHEMBL622263,Kidney,,8319,2113.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11318,CHEMBL622418,Kidney,,8319,2113.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11319,CHEMBL622419,Liver,,8319,2107.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11320,CHEMBL623388,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11321,CHEMBL623389,Liver,,13256,2107.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11322,CHEMBL623390,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11323,CHEMBL623391,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11324,CHEMBL623392,Blood,,13256,178.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11325,CHEMBL623393,Cerebellum,,13256,2037.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11326,CHEMBL623394,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11327,CHEMBL618885,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11328,CHEMBL618886,Liver,,13256,2107.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11329,CHEMBL618887,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11330,CHEMBL619535,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11331,CHEMBL619536,Blood,,13256,178.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11332,CHEMBL619537,Cerebellum,,13256,2037.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11333,CHEMBL619705,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11334,CHEMBL619706,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11335,CHEMBL619707,Liver,,13256,2107.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11336,CHEMBL619708,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11337,CHEMBL625219,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11338,CHEMBL625220,Blood,,13256,178.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11339,CHEMBL625221,Cerebellum,,13256,2037.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11340,CHEMBL625222,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11341,CHEMBL625223,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11342,CHEMBL625224,Liver,,13256,2107.0,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11343,CHEMBL625225,,,13256,,Intermediate,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11344,CHEMBL625226,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 24 hours of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11345,CHEMBL625227,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11346,CHEMBL625228,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 30 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11347,CHEMBL875354,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11348,CHEMBL625229,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 5 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11349,CHEMBL625230,Blood,,8829,178.0,Intermediate,10116.0,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11350,CHEMBL625231,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 24 hours of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11351,CHEMBL625900,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11352,CHEMBL625901,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 30 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11353,CHEMBL625902,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11354,CHEMBL625903,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 5 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11355,CHEMBL625904,Heart,,8829,948.0,Intermediate,10116.0,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11356,CHEMBL625905,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 24 hours of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11357,CHEMBL627861,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11358,CHEMBL627862,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11359,CHEMBL627863,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11360,CHEMBL627769,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11361,CHEMBL627770,Plasma,,13249,1969.0,Intermediate,9615.0,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,50588,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,11362,CHEMBL627771,,,13622,,Intermediate,9541.0,Cmax in cynomolgus monkey (PO dose),1,,100710,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11363,CHEMBL627772,,,13622,,Intermediate,10116.0,Cmax in rat (PO dose),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11364,CHEMBL627773,,,13622,,Intermediate,10116.0,Cmax in rat (PO dose),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11365,CHEMBL621922,Plasma,,13494,1969.0,Intermediate,10116.0,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11366,CHEMBL621923,Plasma,,12170,1969.0,Intermediate,10116.0,Cmax in rat plasma after oral dose (10 mg/kg),1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11367,CHEMBL621924,Plasma,,12170,1969.0,Autocuration,,Cmax in plasma after oral dose (10 mg/kg),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11368,CHEMBL621925,Plasma,,17025,1969.0,Intermediate,9615.0,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11369,CHEMBL621926,Plasma,,17025,1969.0,Autocuration,314293.0,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,N,,11370,CHEMBL621927,Plasma,,17025,1969.0,Intermediate,9986.0,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,1,,50592,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11371,CHEMBL621928,Plasma,,17025,1969.0,Intermediate,10116.0,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11372,CHEMBL621929,Plasma,,14187,1969.0,Intermediate,10116.0,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11373,CHEMBL621930,Plasma,,14816,1969.0,Intermediate,10090.0,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11374,CHEMBL621931,Plasma,,17820,1969.0,Intermediate,10116.0,Maximum plasma concentration after oral dosing in rat,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11375,CHEMBL621932,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11376,CHEMBL621933,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11377,CHEMBL621934,Plasma,,14691,1969.0,Intermediate,9615.0,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11378,CHEMBL621935,Plasma,,14691,1969.0,Intermediate,9615.0,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11379,CHEMBL621936,Plasma,,13375,1969.0,Intermediate,10116.0,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11380,CHEMBL621937,Plasma,,6236,1969.0,Autocuration,,Maximum plasma concentration was determined,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11381,CHEMBL621938,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11382,CHEMBL621939,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11383,CHEMBL621940,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11384,CHEMBL621941,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11385,CHEMBL621942,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11386,CHEMBL626178,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11387,CHEMBL626179,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11388,CHEMBL626180,Plasma,,14380,1969.0,Autocuration,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11389,CHEMBL626181,Plasma,,13622,1969.0,Intermediate,10116.0,Plasma Cmax in rat (PO dose),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11390,CHEMBL626182,,,15372,,Intermediate,10116.0,Maximum serum concentration after po dose of 5.22 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11391,CHEMBL626183,,,15372,,Intermediate,10116.0,Maximum serum concentration after po dose of 5.46 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11392,CHEMBL626184,,,15372,,Intermediate,10116.0,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11393,CHEMBL626185,,,15372,,Intermediate,10116.0,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11394,CHEMBL626186,Plasma,,14925,1969.0,Intermediate,9615.0,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11395,CHEMBL877589,Plasma,,14925,1969.0,Intermediate,9615.0,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,11396,CHEMBL626187,,,11883,,Autocuration,,Maximum concentration of the drug at 1 uM/dg administered intravenously,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11397,CHEMBL626188,,,11883,,Autocuration,,Maximum concentration of the drug at 20 uM/dg administered perorally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11398,CHEMBL626189,,,13391,,Autocuration,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11399,CHEMBL626855,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11400,CHEMBL623781,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11401,CHEMBL623782,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11402,CHEMBL623783,Plasma,,16360,1969.0,Intermediate,10116.0,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11403,CHEMBL623784,Plasma,,3673,1969.0,Intermediate,9615.0,Cmax in dog plasma after 1mg/kg oral dose,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11404,CHEMBL623785,Plasma,,14431,1969.0,Intermediate,9615.0,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11405,CHEMBL623786,Plasma,,14431,1969.0,Intermediate,10116.0,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11406,CHEMBL623787,,,14964,,Intermediate,10116.0,Oral maximum concentration in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11407,CHEMBL623788,,,14964,,Intermediate,10116.0,Oral maximum concentration in rat,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11408,CHEMBL623789,Plasma,,14209,1969.0,Intermediate,10090.0,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11409,CHEMBL623790,Blood,,11355,178.0,Intermediate,10090.0,Peak concentration in blood after intravenous administration to mice,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11410,CHEMBL623791,Blood,,11355,178.0,Intermediate,10090.0,Peak concentration in blood after peroral administration to mice,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11411,CHEMBL623792,Plasma,,11966,1969.0,Intermediate,10116.0,Peak concentration in rat plasma was determined,1,,50597,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11412,CHEMBL623793,Plasma,,8918,1969.0,Autocuration,314293.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11413,CHEMBL623794,Plasma,,8918,1969.0,Intermediate,10090.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11414,CHEMBL623795,Plasma,,8918,1969.0,Intermediate,10116.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11415,CHEMBL623796,,,8684,,Intermediate,10116.0,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11416,CHEMBL623797,,,8684,,Intermediate,10116.0,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11417,CHEMBL623798,,,8684,,Intermediate,10116.0,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11418,CHEMBL623799,,,8684,,Intermediate,10116.0,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11419,CHEMBL624490,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11420,CHEMBL624491,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11421,CHEMBL624492,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11422,CHEMBL624493,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11423,CHEMBL877595,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11424,CHEMBL624494,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11425,CHEMBL624495,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11426,CHEMBL624681,Intestine,,8684,160.0,Intermediate,10116.0,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11427,CHEMBL624682,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11428,CHEMBL624683,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11429,CHEMBL624684,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11430,CHEMBL624685,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11431,CHEMBL624686,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11432,CHEMBL624687,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11433,CHEMBL624688,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11434,CHEMBL627161,,,8684,,Intermediate,10116.0,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11435,CHEMBL622127,,,8684,,Intermediate,10116.0,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11436,CHEMBL622128,,,8684,,Intermediate,10116.0,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11437,CHEMBL874384,,,8684,,Intermediate,10116.0,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11438,CHEMBL624898,,,8684,,Intermediate,10116.0,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11439,CHEMBL624899,,,8684,,Intermediate,10116.0,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11440,CHEMBL624900,,,8684,,Intermediate,10116.0,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11441,CHEMBL624901,,,8684,,Intermediate,10116.0,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11442,CHEMBL624902,,,8684,,Intermediate,10116.0,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11443,CHEMBL624903,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11444,CHEMBL624904,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11445,CHEMBL624905,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11446,CHEMBL624906,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11447,CHEMBL624907,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11448,CHEMBL624908,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11449,CHEMBL624909,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11450,CHEMBL624910,,,8684,,Intermediate,10116.0,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11451,CHEMBL624911,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11452,CHEMBL874388,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11453,CHEMBL624912,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11454,CHEMBL622930,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11455,CHEMBL623121,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11456,CHEMBL623122,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11457,CHEMBL623123,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11458,CHEMBL623124,Muscle tissue,,8684,2385.0,Intermediate,10116.0,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11459,CHEMBL623125,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11460,CHEMBL623126,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11461,CHEMBL623127,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11462,CHEMBL623128,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11463,CHEMBL623129,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11464,CHEMBL623130,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11465,CHEMBL623131,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11466,CHEMBL623132,,,8684,,Intermediate,10116.0,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11467,CHEMBL623133,Liver,,8319,2107.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11468,CHEMBL623134,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11469,CHEMBL874389,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11470,CHEMBL623135,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11471,CHEMBL623136,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11472,CHEMBL623137,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11473,CHEMBL623138,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11474,CHEMBL623139,Kidney,,8319,2113.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11475,CHEMBL623140,Kidney,,8319,2113.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11476,CHEMBL623141,Liver,,8319,2107.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11477,CHEMBL623142,Liver,,8319,2107.0,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11478,CHEMBL623143,,,8319,,Intermediate,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11479,CHEMBL623144,Urine,,14571,1088.0,Intermediate,10090.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11480,CHEMBL623405,Urine,,14571,1088.0,Intermediate,10116.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11481,CHEMBL624074,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11482,CHEMBL624075,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11483,CHEMBL624076,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11484,CHEMBL624077,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11485,CHEMBL624078,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11486,CHEMBL624079,Kidney,,8319,2113.0,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11487,CHEMBL624261,Kidney,,8319,2113.0,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11488,CHEMBL624262,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11489,CHEMBL624263,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11490,CHEMBL624264,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11491,CHEMBL624265,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11492,CHEMBL624266,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11493,CHEMBL624267,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11494,CHEMBL624268,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11495,CHEMBL875227,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11496,CHEMBL624269,Kidney,,8319,2113.0,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11497,CHEMBL624270,Kidney,,8319,2113.0,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11498,CHEMBL624271,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11499,CHEMBL624272,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11500,CHEMBL624273,,,8319,,Intermediate,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11501,CHEMBL624274,Urine,,12064,1088.0,Intermediate,10116.0,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11502,CHEMBL624275,Urine,,12064,1088.0,Intermediate,10116.0,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11503,CHEMBL624276,Urine,,12064,1088.0,Intermediate,10116.0,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11504,CHEMBL624277,Urine,,12038,1088.0,Intermediate,10116.0,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,1,,50597,
,1,,,,,BAO_0000019,A,U,,11505,CHEMBL624278,,,14314,,Autocuration,,% dose converted to 2-amino-5-chlorophenyl sulfate,0,,22224,
,1,,,,,BAO_0000019,A,U,,11506,CHEMBL624279,,,14314,,Autocuration,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11507,CHEMBL624280,Feces,,11488,1988.0,Intermediate,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11508,CHEMBL624281,Feces,,11488,1988.0,Intermediate,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11509,CHEMBL622933,Feces,,11488,1988.0,Intermediate,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11510,CHEMBL622934,Feces,,11488,1988.0,Intermediate,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11511,CHEMBL622935,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11512,CHEMBL622936,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 5 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11513,CHEMBL875228,Liver,,8829,2107.0,Intermediate,10116.0,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11514,CHEMBL622937,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 24 hours of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11515,CHEMBL622938,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11516,CHEMBL619736,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 30 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11517,CHEMBL625117,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11518,CHEMBL625118,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 5 minutes of iv administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11519,CHEMBL625119,Lung,,8829,2048.0,Intermediate,10116.0,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11520,CHEMBL625120,Cerebellum,,14972,2037.0,Intermediate,10116.0,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11521,CHEMBL625121,,,14972,,Intermediate,10116.0,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11522,CHEMBL625122,Thalamus,,14972,10000006.0,Intermediate,10116.0,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11523,CHEMBL622204,Blood,,14608,178.0,Intermediate,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11524,CHEMBL877503,Blood,,14608,178.0,Intermediate,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11525,CHEMBL627127,Blood,,14608,178.0,Intermediate,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11526,CHEMBL627128,Hippocampus,,14608,10000000.0,Autocuration,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11527,CHEMBL627129,Hippocampus,,14608,10000000.0,Autocuration,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11528,CHEMBL627130,Hippocampus,,14608,10000000.0,Autocuration,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11529,CHEMBL627131,Brain,,14608,955.0,Intermediate,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11530,CHEMBL627132,Brain,,14608,955.0,Intermediate,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11531,CHEMBL627133,Brain,,14608,955.0,Intermediate,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11532,CHEMBL627134,Cerebellum,,14608,2037.0,Intermediate,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11533,CHEMBL627135,Cerebellum,,14608,2037.0,Intermediate,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11534,CHEMBL627136,Cerebellum,,14608,2037.0,Intermediate,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11535,CHEMBL628435,,,14608,,Intermediate,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11536,CHEMBL628436,,,14608,,Intermediate,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11537,CHEMBL628437,,,14608,,Intermediate,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11538,CHEMBL628438,Heart,,14608,948.0,Intermediate,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11539,CHEMBL628439,Heart,,14608,948.0,Intermediate,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11540,CHEMBL628440,Heart,,14608,948.0,Intermediate,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11541,CHEMBL628441,Hippocampus,,14608,10000000.0,Intermediate,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11542,CHEMBL628442,Hippocampus,,14608,10000000.0,Intermediate,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11543,CHEMBL628443,Hippocampus,,14608,10000000.0,Intermediate,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11544,CHEMBL628444,Kidney,,14608,2113.0,Intermediate,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11545,CHEMBL628445,Kidney,,14608,2113.0,Intermediate,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11546,CHEMBL877504,Kidney,,14608,2113.0,Intermediate,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11547,CHEMBL628446,Liver,,14608,2107.0,Intermediate,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11548,CHEMBL626874,Liver,,14608,2107.0,Intermediate,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11549,CHEMBL626875,Liver,,14608,2107.0,Intermediate,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11550,CHEMBL626876,Lung,,14608,2048.0,Intermediate,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11551,CHEMBL626877,Lung,,14608,2048.0,Intermediate,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11552,CHEMBL626878,Lung,,14608,2048.0,Intermediate,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11553,CHEMBL626879,Muscle tissue,,14608,2385.0,Intermediate,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11554,CHEMBL626880,Plasma,,8918,1969.0,Autocuration,314293.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11555,CHEMBL626881,Plasma,,8918,1969.0,Intermediate,10090.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11556,CHEMBL626882,Plasma,,8918,1969.0,Intermediate,10116.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11557,CHEMBL626883,Plasma,,14470,1969.0,Intermediate,9615.0,Peak plasma concentration was measured in dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11558,CHEMBL626884,,,14393,,Intermediate,10116.0,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11559,CHEMBL626885,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11560,CHEMBL626886,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11561,CHEMBL626887,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11562,CHEMBL626888,,,14393,,Intermediate,10116.0,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11563,CHEMBL626889,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11564,CHEMBL626761,,,13465,,Autocuration,314293.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11565,CHEMBL626762,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11566,CHEMBL626763,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11567,CHEMBL626764,,,13465,,Intermediate,10116.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11568,CHEMBL626765,,,13465,,Intermediate,10116.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11569,CHEMBL626766,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11570,CHEMBL626767,,,13465,,Intermediate,10116.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11571,CHEMBL626768,,,13465,,Intermediate,10116.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11572,CHEMBL626769,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11573,CHEMBL874463,,,13465,,Intermediate,9615.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11574,CHEMBL626770,,,13465,,Autocuration,314293.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11575,CHEMBL626771,,,13465,,Autocuration,314293.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11576,CHEMBL626772,,,13465,,Intermediate,10116.0,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,11577,CHEMBL626773,,,14731,,Intermediate,9541.0,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,100710,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11578,CHEMBL626774,,,14731,,Intermediate,10090.0,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11579,CHEMBL626775,,,13376,,Intermediate,9615.0,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11580,CHEMBL626776,,,13376,,Intermediate,9615.0,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11581,CHEMBL626777,,,14443,,Intermediate,10116.0,Maximum concentration (Cmax) in rat when administered orally,1,,50597,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11582,CHEMBL626778,Plasma,,13465,1969.0,Autocuration,314293.0,Maximal concentration in monkey plasma after 25 mg/kg oral dose,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11583,CHEMBL626779,,,16359,,Autocuration,10116.0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11584,CHEMBL626780,,,16359,,Autocuration,10116.0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,11585,CHEMBL626781,Plasma,,15618,1969.0,Autocuration,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11586,CHEMBL632164,,,14554,,Intermediate,10116.0,Pharmacokinetic profile Cmax was evaluated in rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11587,CHEMBL632165,,,11537,,Intermediate,9615.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),1,,50588,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11588,CHEMBL632166,,,11537,,Intermediate,10090.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11589,CHEMBL632167,,,11537,,Intermediate,9615.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),1,,50588,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11590,CHEMBL632168,,,11537,,Intermediate,10090.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,11591,CHEMBL632169,Plasma,,2021,1969.0,Autocuration,10116.0,Cmax in rat plasma,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11592,CHEMBL632170,Plasma,,5932,1969.0,Intermediate,9615.0,Cmax in dog plasma after 30mg/kg oral dose,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11593,CHEMBL632171,Plasma,,5932,1969.0,Intermediate,10116.0,Cmax in rat plasma after 30mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11594,CHEMBL632172,Plasma,,17320,1969.0,Intermediate,10116.0,Plasma level in rats at 30 mg/kg,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11595,CHEMBL632173,Plasma,,15831,1969.0,Intermediate,10090.0,Tested for maximum plasma concentration in mice,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11596,CHEMBL632174,,,15078,,Intermediate,10116.0,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11597,CHEMBL632175,,,14941,,Intermediate,10116.0,The Cmax values in female wistar rats.,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11598,CHEMBL632176,Plasma,,15343,1969.0,Intermediate,9615.0,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11599,CHEMBL632177,Plasma,,15343,1969.0,Intermediate,10116.0,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11600,CHEMBL632178,Plasma,,14856,1969.0,Intermediate,10116.0,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11601,CHEMBL632179,,,13129,,Intermediate,10116.0,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11602,CHEMBL632180,Blood,,13098,178.0,Intermediate,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11603,CHEMBL632181,Blood,,13098,178.0,Intermediate,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11604,CHEMBL632182,Blood,,13098,178.0,Intermediate,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,U,,11605,CHEMBL632183,Blood,,15478,178.0,Autocuration,10090.0,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11606,CHEMBL632184,,,15341,,Intermediate,9615.0,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11607,CHEMBL874470,,,15341,,Intermediate,10116.0,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11608,CHEMBL631302,,,8684,,Intermediate,10116.0,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11609,CHEMBL631303,,,8684,,Intermediate,10116.0,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11610,CHEMBL631304,,,8684,,Intermediate,10116.0,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11611,CHEMBL631305,,,8684,,Intermediate,10116.0,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11612,CHEMBL631306,,,8684,,Intermediate,10116.0,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11613,CHEMBL631307,,,8684,,Intermediate,10116.0,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11614,CHEMBL631308,,,8684,,Intermediate,10116.0,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11615,CHEMBL625557,,,8684,,Intermediate,10116.0,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11616,CHEMBL625558,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11617,CHEMBL625559,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11618,CHEMBL625560,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11619,CHEMBL625561,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11620,CHEMBL625562,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11621,CHEMBL875320,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11622,CHEMBL625563,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11623,CHEMBL625564,Spleen,,8684,2106.0,Intermediate,10116.0,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11624,CHEMBL625565,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11625,CHEMBL625566,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11626,CHEMBL625567,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11627,CHEMBL625568,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11628,CHEMBL628217,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11629,CHEMBL628218,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11630,CHEMBL628219,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11631,CHEMBL628220,Uterus,,8684,995.0,Intermediate,10116.0,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",1,,50597,
,1,,,,,BAO_0000019,A,U,,11632,CHEMBL628221,,,8926,,Autocuration,,Distribution in the blood after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11633,CHEMBL628222,,,8926,,Autocuration,,Distribution in the blood after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11634,CHEMBL628223,,,8926,,Autocuration,,Distribution in the blood after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11635,CHEMBL628224,,,8926,,Autocuration,,Distribution in the blood after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11636,CHEMBL628225,,,8926,,Autocuration,,Distribution in the blood after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11637,CHEMBL628226,,,8926,,Autocuration,,Distribution in the blood after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11638,CHEMBL628227,,,8926,,Autocuration,,Distribution in the bone after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11639,CHEMBL875481,,,8926,,Autocuration,,Distribution in the bone after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11640,CHEMBL628228,,,8926,,Autocuration,,Distribution in the bone after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11641,CHEMBL628229,,,8926,,Autocuration,,Distribution in the bone after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11642,CHEMBL628230,,,8926,,Autocuration,,Distribution in the bone after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11643,CHEMBL628231,,,8926,,Autocuration,,Distribution in the bone after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11644,CHEMBL628232,,,8926,,Autocuration,,Distribution in the heart after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11645,CHEMBL628233,,,8926,,Autocuration,,Distribution in the heart after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11646,CHEMBL628234,,,8926,,Autocuration,,Distribution in the heart after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11647,CHEMBL628235,,,8926,,Autocuration,,Distribution in the heart after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11648,CHEMBL628236,,,8926,,Autocuration,,Distribution in the heart after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11649,CHEMBL628237,,,8926,,Autocuration,,Distribution in the heart after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11650,CHEMBL628238,,,8926,,Autocuration,,Distribution in the kidneys after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11651,CHEMBL628239,,,8926,,Autocuration,,Distribution in the kidneys after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11652,CHEMBL628240,,,8926,,Autocuration,,Distribution in the kidneys after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11653,CHEMBL628241,,,8926,,Autocuration,,Distribution in the kidneys after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11654,CHEMBL628242,,,8926,,Autocuration,,Distribution in the kidneys after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11655,CHEMBL875482,,,8926,,Autocuration,,Distribution in the kidneys after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11656,CHEMBL628243,,,8926,,Autocuration,,Distribution in the liver after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11657,CHEMBL628244,,,8926,,Autocuration,,Distribution in the liver after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11658,CHEMBL628245,,,8926,,Autocuration,,Distribution in the liver after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11659,CHEMBL628246,,,8926,,Autocuration,,Distribution in the liver after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11660,CHEMBL628247,,,8926,,Autocuration,,Distribution in the liver after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11661,CHEMBL628248,,,8926,,Autocuration,,Distribution in the liver after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11662,CHEMBL628249,,,8926,,Autocuration,,Distribution in the lung after 120 min of intravenous administration,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,11663,CHEMBL625452,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11664,CHEMBL625453,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11665,CHEMBL625454,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11666,CHEMBL623844,,,14839,,Intermediate,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11667,CHEMBL623845,,,12178,,Intermediate,10116.0,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11668,CHEMBL623846,,,12178,,Intermediate,10116.0,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,50597,
,1,,,,,BAO_0000218,A,U,,11669,CHEMBL623847,,,12178,,Autocuration,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,0,,22224,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11670,CHEMBL623848,,,12186,,Intermediate,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11671,CHEMBL623849,,,12186,,Intermediate,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11672,CHEMBL623850,,,12186,,Intermediate,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11673,CHEMBL623851,,,12186,,Intermediate,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,100710,
,1,,,,Simiiformes,BAO_0000218,A,U,,11674,CHEMBL623852,,,12187,,Autocuration,314293.0,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,0,,22224,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,11675,CHEMBL624551,,,12187,,Intermediate,9669.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,11676,CHEMBL624552,,,12187,,Intermediate,9669.0,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,50506,
,1,,,,Simiiformes,BAO_0000218,A,U,,11677,CHEMBL624553,,,12187,,Autocuration,314293.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,11678,CHEMBL624554,,,12187,,Autocuration,314293.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11679,CHEMBL624555,,,12187,,Intermediate,10116.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11680,CHEMBL624741,,,12187,,Intermediate,10116.0,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11681,CHEMBL624742,,,14122,,Intermediate,9615.0,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",1,,50588,
,1,,,,Cricetinae,BAO_0000218,A,N,,11682,CHEMBL624743,,,14122,,Intermediate,10026.0,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",1,,100712,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11683,CHEMBL877606,,,14122,,Intermediate,10116.0,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",1,,50597,
,1,,,,,BAO_0000218,A,U,,11684,CHEMBL624744,,,13391,,Autocuration,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,0,,22224,
,1,,,,,BAO_0000218,A,U,,11685,CHEMBL624745,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,,,BAO_0000218,A,U,,11686,CHEMBL624746,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,,,BAO_0000218,A,U,,11687,CHEMBL624747,Blood,,13391,178.0,Autocuration,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,11688,CHEMBL624748,,,16360,,Autocuration,,Oral absorption expressed as Area under curve was determined,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11689,CHEMBL622504,,,3673,,Intermediate,9615.0,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11690,CHEMBL622505,,,14122,,Intermediate,9615.0,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",1,,50588,
,1,,,,Cricetinae,BAO_0000218,A,N,,11691,CHEMBL622506,,,14122,,Intermediate,10026.0,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,100712,
,1,,,,Cricetinae,BAO_0000218,A,N,,11692,CHEMBL622507,,,14122,,Intermediate,10026.0,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,100712,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11693,CHEMBL622508,,,14122,,Intermediate,10116.0,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",1,,50597,
,1,,,,,BAO_0000019,A,U,,11694,CHEMBL622509,,,13889,,Autocuration,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11695,CHEMBL622510,,,14393,,Intermediate,10116.0,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11696,CHEMBL622511,,,17279,,Intermediate,10116.0,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),1,,50597,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11697,CHEMBL622512,,,14548,,Intermediate,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11698,CHEMBL622513,,,14548,,Intermediate,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11699,CHEMBL622514,,,14548,,Intermediate,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,1,,100710,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11700,CHEMBL622515,,,14548,,Intermediate,9615.0,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11701,CHEMBL622516,,,14548,,Intermediate,9615.0,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11702,CHEMBL622517,,,14548,,Intermediate,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11703,CHEMBL622518,,,14548,,Intermediate,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11704,CHEMBL622519,,,14548,,Intermediate,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11705,CHEMBL622520,Muscle tissue,,14608,2385.0,Intermediate,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11706,CHEMBL622521,Muscle tissue,,14608,2385.0,Intermediate,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11707,CHEMBL625113,Zone of skin,,14608,14.0,Intermediate,10090.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11708,CHEMBL625114,Zone of skin,,14608,14.0,Intermediate,10116.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11709,CHEMBL874397,Zone of skin,,14608,14.0,Intermediate,10116.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11710,CHEMBL625115,Spleen,,14608,2106.0,Intermediate,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11711,CHEMBL625116,Spleen,,14608,2106.0,Intermediate,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11712,CHEMBL623932,Spleen,,14608,2106.0,Intermediate,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11713,CHEMBL623933,Striatum,,14608,2435.0,Intermediate,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11714,CHEMBL623934,Striatum,,14608,2435.0,Intermediate,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11715,CHEMBL623935,Striatum,,14608,2435.0,Intermediate,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11716,CHEMBL623936,Thyroid gland,,14608,2046.0,Intermediate,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11717,CHEMBL623937,Thyroid gland,,14608,2046.0,Intermediate,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11718,CHEMBL623938,Thyroid gland,,14608,2046.0,Intermediate,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11719,CHEMBL623939,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11720,CHEMBL623940,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11721,CHEMBL623941,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11722,CHEMBL627216,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11723,CHEMBL623942,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11724,CHEMBL618793,Brain,,15383,955.0,Intermediate,10090.0,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11725,CHEMBL618794,Brain,,15383,955.0,Intermediate,10090.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11726,CHEMBL618795,Brain,,15383,955.0,Intermediate,10090.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11727,CHEMBL618796,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11728,CHEMBL618797,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11729,CHEMBL618798,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11730,CHEMBL618799,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11731,CHEMBL618800,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11732,CHEMBL618801,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11733,CHEMBL618802,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11734,CHEMBL618803,Kidney,,15383,2113.0,Intermediate,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11735,CHEMBL618804,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11736,CHEMBL618805,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11737,CHEMBL618806,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11738,CHEMBL618807,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11739,CHEMBL618808,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11740,CHEMBL618809,Liver,,15383,2107.0,Intermediate,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11741,CHEMBL618810,Muscle tissue,,15383,2385.0,Intermediate,10090.0,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11742,CHEMBL618811,Muscle tissue,,15383,2385.0,Intermediate,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11743,CHEMBL875844,Muscle tissue,,15383,2385.0,Intermediate,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11744,CHEMBL618812,Muscle tissue,,15383,2385.0,Intermediate,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11745,CHEMBL618813,Muscle tissue,,15383,2385.0,Intermediate,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11746,CHEMBL618814,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11747,CHEMBL618815,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11748,CHEMBL618816,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11749,CHEMBL618817,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11750,CHEMBL620544,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11751,CHEMBL626230,,,15341,,Intermediate,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11752,CHEMBL626231,,,15341,,Intermediate,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11753,CHEMBL626232,,,15341,,Intermediate,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11754,CHEMBL626233,Plasma,,14906,1969.0,Intermediate,9615.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11755,CHEMBL626234,Plasma,,14906,1969.0,Intermediate,10116.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11756,CHEMBL875341,Plasma,,14906,1969.0,Intermediate,10116.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,1,,50597,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,11757,CHEMBL626235,Plasma,,14215,1969.0,Intermediate,9606.0,The maximum plasma concentration (100 mg/kg) administered orally in human,1,,50587,
,1,,,In vivo,Callithrix,BAO_0000218,A,U,,11758,CHEMBL626236,Plasma,,14215,1969.0,Autocuration,9481.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11759,CHEMBL626237,Plasma,,14215,1969.0,Autocuration,314293.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11760,CHEMBL626238,Plasma,,14215,1969.0,Intermediate,9615.0,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,1,,50588,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,11761,CHEMBL622412,Plasma,,14215,1969.0,Intermediate,9606.0,The maximum plasma concentration (200 mg/kg) administered orally in human,1,,50587,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11762,CHEMBL623114,Plasma,,14215,1969.0,Intermediate,10116.0,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,1,,50597,
,1,,,In vivo,Callithrix,BAO_0000218,A,U,,11763,CHEMBL623115,Plasma,,14215,1969.0,Autocuration,9481.0,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11764,CHEMBL623116,Plasma,,14215,1969.0,Autocuration,314293.0,The maximum plasma concentration (25 mg/kg) administered orally in monkey,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,11765,CHEMBL623117,Plasma,,14215,1969.0,Autocuration,9615.0,The maximum plasma concentration (30 mg/kg) administered orally in dog,0,,22224,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,11766,CHEMBL623118,Plasma,,14215,1969.0,Intermediate,9606.0,The maximum plasma concentration (400 mg/kg) administered orally in human,1,,50587,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11767,CHEMBL623119,Plasma,,14215,1969.0,Intermediate,10116.0,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11768,CHEMBL623120,Plasma,,14215,1969.0,Intermediate,10116.0,The maximum plasma concentration (50 mg/kg) administered orally in rat,1,,50597,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,11769,CHEMBL623286,Plasma,,14215,1969.0,Intermediate,9606.0,The maximum plasma concentration (800 mg/kg) administered orally in human,1,,50587,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11770,CHEMBL623287,Plasma,,14067,1969.0,Intermediate,10116.0,The maximum plasma concentration was measured on rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11771,CHEMBL623288,Plasma,,12350,1969.0,Intermediate,10116.0,The maximum plasma concentration was measured on rats after oral administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11772,CHEMBL623289,Plasma,,14813,1969.0,Intermediate,10116.0,Plasma drug Cmax in rat (PO dose),1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,11773,CHEMBL623290,,,12536,,Autocuration,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11774,CHEMBL623291,Plasma,,14169,1969.0,Intermediate,9615.0,maximum Plasma concentration in Dog was determined after Peroral administration,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11775,CHEMBL623292,Plasma,,14169,1969.0,Intermediate,10116.0,maximum Plasma concentration in Rats was determined after Peroral administration,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,11776,CHEMBL623293,Plasma,,15604,1969.0,Intermediate,9615.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,11777,CHEMBL623294,Plasma,,15604,1969.0,Autocuration,314293.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11778,CHEMBL623295,Plasma,,15604,1969.0,Intermediate,10116.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,11779,CHEMBL623296,,,14387,,Intermediate,10090.0,maximum concentration was measured when administered through oral route in mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11780,CHEMBL875349,,,15115,,Intermediate,10090.0,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,1,,50594,
,1,,,,Simiiformes,BAO_0000019,A,U,,11781,CHEMBL623297,,,15115,,Autocuration,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,0,,22224,
,1,,,,Simiiformes,BAO_0000019,A,U,,11782,CHEMBL623298,,,15115,,Autocuration,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,0,,22224,
,1,,,,Simiiformes,BAO_0000019,A,U,,11783,CHEMBL623299,,,15115,,Autocuration,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11784,CHEMBL623300,,,16359,,Intermediate,10116.0,Pharmacokinetic parameter was evaluated in rats,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11785,CHEMBL623301,,,12829,,Intermediate,10090.0,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11786,CHEMBL623302,,,12829,,Intermediate,10090.0,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11787,CHEMBL623303,,,12829,,Intermediate,10090.0,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11788,CHEMBL623304,,,12829,,Intermediate,10090.0,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11789,CHEMBL623305,,,12829,,Intermediate,10090.0,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11790,CHEMBL623306,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11791,CHEMBL623307,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11792,CHEMBL623308,Plasma,,15137,1969.0,Intermediate,10116.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11793,CHEMBL623309,Plasma,,15137,1969.0,Intermediate,10090.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11794,CHEMBL623310,,,13509,,Intermediate,10090.0,Plasma Concentration after 120 min of oral administration to mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11795,CHEMBL623311,,,13509,,Intermediate,10090.0,Plasma Concentration after 30 min of oral administration to mice,1,,50594,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11796,CHEMBL623312,,,13509,,Intermediate,9541.0,Plasma Concentration after 60 min of oral administration to mice,1,,100710,
,1,,,,Mus musculus,BAO_0000218,A,N,,11797,CHEMBL875350,,,13509,,Intermediate,10090.0,Plasma Concentration after 60 min of oral administration to mice; Not determined,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11798,CHEMBL628635,,,13509,,Intermediate,10090.0,Plasma Concentration after 90 min of oral administration to mice,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11799,CHEMBL628636,,,12064,,Intermediate,10116.0,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11800,CHEMBL628637,,,12064,,Intermediate,10116.0,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11801,CHEMBL628058,,,12064,,Intermediate,10116.0,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11802,CHEMBL628059,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11803,CHEMBL628060,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,1,,50597,
,1,,,,,BAO_0000019,A,U,,11804,CHEMBL628061,,,8926,,Autocuration,,Distribution in the lung after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11805,CHEMBL628062,,,8926,,Autocuration,,Distribution in the lung after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11806,CHEMBL628063,,,8926,,Autocuration,,Distribution in the lung after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11807,CHEMBL628064,,,8926,,Autocuration,,Distribution in the lung after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11808,CHEMBL628065,,,8926,,Autocuration,,Distribution in the lung after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11809,CHEMBL628066,Muscle tissue,,8926,2385.0,Autocuration,,Distribution in the muscle after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11810,CHEMBL628067,Muscle tissue,,8926,2385.0,Autocuration,,Distribution in the muscle after 15 min of intravenous administration,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,11811,CHEMBL874646,Muscle tissue,,8926,2385.0,Intermediate,10090.0,Distribution in the muscle after 30 min of intravenous administration,1,,50594,
,1,,,,,BAO_0000019,A,U,,11812,CHEMBL628068,Muscle tissue,,8926,2385.0,Autocuration,,Distribution in the muscle after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11813,CHEMBL628069,Muscle tissue,,8926,2385.0,Autocuration,,Distribution in the muscle after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11814,CHEMBL628070,Muscle tissue,,8926,2385.0,Autocuration,,Distribution in the muscle after 90 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11815,CHEMBL628071,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 120 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11816,CHEMBL628072,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 15 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11817,CHEMBL628073,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 30 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11818,CHEMBL628074,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 5 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11819,CHEMBL628075,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 60 min of intravenous administration,0,,22224,
,1,,,,,BAO_0000019,A,U,,11820,CHEMBL628076,Spleen,,8926,2106.0,Autocuration,,Distribution in the spleen after 90 min of intravenous administration,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11821,CHEMBL628077,Adrenal cortex,,7570,1235.0,Intermediate,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11822,CHEMBL628078,Blood,,7570,178.0,Intermediate,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11823,CHEMBL628079,Liver,,7570,2107.0,Intermediate,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11824,CHEMBL628080,Female gonad,,7570,992.0,Intermediate,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11825,CHEMBL628081,Thyroid gland,,7570,2046.0,Intermediate,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11826,CHEMBL628082,Adrenal cortex,,7570,1235.0,Intermediate,10116.0,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11827,CHEMBL874647,Blood,,7570,178.0,Intermediate,10116.0,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11828,CHEMBL626406,Liver,,7570,2107.0,Intermediate,10116.0,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11829,CHEMBL626407,Female gonad,,7570,992.0,Intermediate,10116.0,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11830,CHEMBL626408,Thyroid gland,,7570,2046.0,Intermediate,10116.0,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11831,CHEMBL626409,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11832,CHEMBL626410,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11833,CHEMBL626411,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11834,CHEMBL626412,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11835,CHEMBL626413,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11836,CHEMBL626414,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11837,CHEMBL626415,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11838,CHEMBL626416,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11839,CHEMBL627062,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11840,CHEMBL627063,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11841,CHEMBL627064,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11842,CHEMBL627227,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11843,CHEMBL627228,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11844,CHEMBL627229,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11845,CHEMBL625792,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11846,CHEMBL625793,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11847,CHEMBL625794,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11848,CHEMBL625795,Blood,,8608,178.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11849,CHEMBL625796,,,13792,,Intermediate,10090.0,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11850,CHEMBL625797,,,13376,,Intermediate,9615.0,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,11851,CHEMBL625798,,,13376,,Intermediate,9615.0,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,50588,
,1,,,,,BAO_0000218,A,U,,11852,CHEMBL875613,,,14380,,Autocuration,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000218,A,U,,11853,CHEMBL625799,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000218,A,U,,11854,CHEMBL625800,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000218,A,U,,11855,CHEMBL625801,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000218,A,U,,11856,CHEMBL625802,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000218,A,U,,11857,CHEMBL625803,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,,,BAO_0000019,A,U,,11858,CHEMBL625804,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,0,,22224,
,1,,,,,BAO_0000218,A,U,,11859,CHEMBL622530,,,14380,,Autocuration,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,11860,CHEMBL622531,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11861,CHEMBL622532,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11862,CHEMBL623176,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11863,CHEMBL623177,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11864,CHEMBL623178,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11865,CHEMBL623179,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11866,CHEMBL623180,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11867,CHEMBL623181,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11868,CHEMBL624131,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11869,CHEMBL624132,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11870,CHEMBL624133,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11871,CHEMBL624846,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11872,CHEMBL624847,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11873,CHEMBL624848,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11874,CHEMBL625012,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11875,CHEMBL625013,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11876,CHEMBL625014,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11877,CHEMBL625015,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11878,CHEMBL625016,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11879,CHEMBL625017,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11880,CHEMBL625018,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11881,CHEMBL625019,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11882,CHEMBL625020,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11883,CHEMBL625021,,,13701,,Intermediate,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11884,CHEMBL625022,,,14393,,Intermediate,10116.0,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,11885,CHEMBL625023,,,14731,,Intermediate,10090.0,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,1,,50594,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11886,CHEMBL625024,,,14731,,Intermediate,9541.0,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,11887,CHEMBL627626,,,14731,,Intermediate,9541.0,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,100710,
,1,,,,,BAO_0000218,A,U,,11888,CHEMBL627627,Brain,,13758,955.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,0,,22224,
,1,,,,,BAO_0000218,A,U,,11889,CHEMBL627628,Serum,,13758,1977.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,0,,22224,
,1,,,,,BAO_0000218,A,U,,11890,CHEMBL627629,Brain,,13758,955.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,0,,22224,
,1,,,,,BAO_0000218,A,U,,11891,CHEMBL627630,Serum,,13758,1977.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,0,,22224,
,1,,,,,BAO_0000019,A,U,,11892,CHEMBL627631,,,16359,,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),0,,22224,
,1,,,,,BAO_0000218,A,U,,11893,CHEMBL629515,,,16359,,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,11894,CHEMBL629516,Spleen,,15383,2106.0,Intermediate,10090.0,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11895,CHEMBL629517,Spleen,,15383,2106.0,Intermediate,10090.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11896,CHEMBL629518,Spleen,,15383,2106.0,Intermediate,10090.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11897,CHEMBL877499,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11898,CHEMBL629519,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11899,CHEMBL629520,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11900,CHEMBL629521,,,15383,,Intermediate,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11901,CHEMBL629522,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11902,CHEMBL629523,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11903,CHEMBL629524,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11904,CHEMBL629525,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11905,CHEMBL629526,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11906,CHEMBL629527,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11907,CHEMBL629528,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11908,CHEMBL629529,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11909,CHEMBL629530,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11910,CHEMBL629531,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11911,CHEMBL628656,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,11912,CHEMBL628657,,,14439,,Intermediate,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11913,CHEMBL628658,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11914,CHEMBL628659,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11915,CHEMBL877500,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11916,CHEMBL628660,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11917,CHEMBL628661,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11918,CHEMBL628662,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11919,CHEMBL628663,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11920,CHEMBL628664,,,13751,,Intermediate,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11921,CHEMBL628665,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11922,CHEMBL628666,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11923,CHEMBL628667,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11924,CHEMBL628668,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11925,CHEMBL628669,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11926,CHEMBL628670,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11927,CHEMBL628671,Blood,,13751,178.0,Intermediate,10116.0,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11928,CHEMBL628672,Bone,,13751,10000001.0,Intermediate,10116.0,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11929,CHEMBL630300,Bone,,13751,10000001.0,Intermediate,10116.0,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11930,CHEMBL629787,Bone,,13751,10000001.0,Intermediate,10116.0,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11931,CHEMBL629788,Bone,,13751,10000001.0,Intermediate,10116.0,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11932,CHEMBL629789,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11933,CHEMBL629790,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11934,CHEMBL629791,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11935,CHEMBL629792,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11936,CHEMBL629793,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11937,CHEMBL629794,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11938,CHEMBL874459,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11939,CHEMBL629795,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11940,CHEMBL629796,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11941,CHEMBL629797,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11942,CHEMBL629798,,,10677,,Intermediate,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11943,CHEMBL629799,Adrenal gland,,10911,2369.0,Intermediate,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11944,CHEMBL629800,Adrenal gland,,10911,2369.0,Intermediate,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11945,CHEMBL629801,Adrenal gland,,10911,2369.0,Intermediate,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11946,CHEMBL629802,Adrenal gland,,10911,2369.0,Intermediate,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11947,CHEMBL629803,Adrenal gland,,10911,2369.0,Intermediate,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11948,CHEMBL629804,Blood,,10911,178.0,Intermediate,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11949,CHEMBL629805,Blood,,10911,178.0,Intermediate,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11950,CHEMBL629806,Blood,,10911,178.0,Intermediate,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11951,CHEMBL629807,Blood,,10911,178.0,Intermediate,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11952,CHEMBL629808,Blood,,10911,178.0,Intermediate,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11953,CHEMBL629809,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11954,CHEMBL629810,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11955,CHEMBL629811,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11956,CHEMBL629812,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11957,CHEMBL629813,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11958,CHEMBL874460,Brain,,10911,955.0,Intermediate,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11959,CHEMBL629814,,,10911,,Intermediate,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11960,CHEMBL629815,,,10911,,Intermediate,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11961,CHEMBL629816,,,10911,,Intermediate,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11962,CHEMBL629817,,,10911,,Intermediate,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11963,CHEMBL626643,Kidney,,10911,2113.0,Intermediate,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11964,CHEMBL626644,Kidney,,10911,2113.0,Intermediate,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11965,CHEMBL626806,Kidney,,10911,2113.0,Intermediate,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11966,CHEMBL626807,Kidney,,10911,2113.0,Intermediate,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11967,CHEMBL627261,Liver,,10911,2107.0,Intermediate,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11968,CHEMBL627262,Liver,,10911,2107.0,Intermediate,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11969,CHEMBL627263,Liver,,10911,2107.0,Intermediate,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11970,CHEMBL627264,Liver,,10911,2107.0,Intermediate,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11971,CHEMBL627265,Lung,,10911,2048.0,Intermediate,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11972,CHEMBL627266,Lung,,10911,2048.0,Intermediate,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11973,CHEMBL627267,Lung,,10911,2048.0,Intermediate,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11974,CHEMBL627268,Lung,,10911,2048.0,Intermediate,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11975,CHEMBL627269,Muscle tissue,,10911,2385.0,Intermediate,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,11976,CHEMBL627270,Muscle tissue,,10911,2385.0,Intermediate,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11977,CHEMBL627271,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11978,CHEMBL627946,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11979,CHEMBL875472,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11980,CHEMBL627947,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11981,CHEMBL627948,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11982,CHEMBL628113,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11983,CHEMBL628114,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11984,CHEMBL628115,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11985,CHEMBL628116,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11986,CHEMBL628117,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11987,CHEMBL628118,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11988,CHEMBL628119,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11989,CHEMBL628120,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11990,CHEMBL628121,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11991,CHEMBL628122,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11992,CHEMBL627297,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11993,CHEMBL627298,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11994,CHEMBL627299,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11995,CHEMBL627300,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11996,CHEMBL627301,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11997,CHEMBL627302,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11998,CHEMBL627303,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,11999,CHEMBL627304,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12000,CHEMBL627305,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12001,CHEMBL627306,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12002,CHEMBL623982,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12003,CHEMBL623983,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12004,CHEMBL623984,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12005,CHEMBL623985,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12006,CHEMBL623986,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12007,CHEMBL623987,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12008,CHEMBL623988,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12009,CHEMBL623989,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12010,CHEMBL622215,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12011,CHEMBL622216,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12012,CHEMBL877481,,,8608,,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",1,,50597,
,1,,,,,BAO_0000218,A,U,,12013,CHEMBL622217,,,16359,,Autocuration,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,12014,CHEMBL622218,,,13701,,Intermediate,10090.0,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12015,CHEMBL622219,,,14554,,Intermediate,10116.0,Pharmacokinetic profile AUC was evaluated in rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,12016,CHEMBL622220,,,6241,,Autocuration,,Pharmacokinetic property (Area under curve),0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12017,CHEMBL622221,,,11537,,Intermediate,9615.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,12018,CHEMBL622222,,,11537,,Intermediate,10090.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12019,CHEMBL622223,,,11537,,Intermediate,9615.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,12020,CHEMBL622224,,,11537,,Intermediate,10090.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",1,,50594,
,1,,,,,BAO_0000019,A,U,,12021,CHEMBL622225,,,13118,,Autocuration,,Plasma concentration (AUC) was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12022,CHEMBL622226,,,13118,,Autocuration,,Plasma concentration (AUC) was determined; Not detectable,0,,22224,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,12023,CHEMBL624154,,,9562,,Intermediate,10141.0,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),1,,50512,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12024,CHEMBL624155,,,10363,,Intermediate,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12025,CHEMBL624156,,,10363,,Intermediate,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12026,CHEMBL624157,,,10363,,Intermediate,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12027,CHEMBL624158,,,10363,,Intermediate,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12028,CHEMBL624159,,,12504,,Intermediate,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12029,CHEMBL624160,,,12504,,Intermediate,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12030,CHEMBL624161,,,12504,,Intermediate,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12031,CHEMBL624162,,,12504,,Intermediate,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12032,CHEMBL624163,,,13317,,Intermediate,9615.0,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12033,CHEMBL624164,,,15078,,Intermediate,10116.0,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12034,CHEMBL624165,,,14941,,Intermediate,10116.0,The AUC(0-infinity) values in female wistar rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12035,CHEMBL624166,,,15078,,Intermediate,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12036,CHEMBL624167,,,15078,,Intermediate,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12037,CHEMBL624168,,,14941,,Intermediate,10116.0,The AUC(0-t)values in female wistar rats.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12038,CHEMBL624169,,,14067,,Intermediate,10116.0,The Area under the concentration time curve of compound was measured on rats,1,,50597,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12039,CHEMBL624170,,,14215,,Intermediate,9606.0,The area under curve (100 mg/kg) administered orally in humans,1,,50587,
,1,,,,Callithrix,BAO_0000218,A,U,,12040,CHEMBL624171,,,14215,,Autocuration,9481.0,The area under curve (12.5 mg/kg) administered intravenously in marmoset,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12041,CHEMBL624172,,,14215,,Autocuration,314293.0,The area under curve (12.5 mg/kg) administered intravenously in monkey,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12042,CHEMBL624173,,,14215,,Intermediate,9615.0,The area under curve (15 mg/kg) administered intravenously in dog,1,,50588,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12043,CHEMBL877488,,,14215,,Intermediate,9606.0,The area under curve (200 mg/kg) administered orally in humans,1,,50587,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12044,CHEMBL624174,,,14215,,Intermediate,10116.0,The area under curve (25 mg/kg) administered intravenously in rat,1,,50597,
,1,,,,Callithrix,BAO_0000218,A,U,,12045,CHEMBL624175,,,14215,,Autocuration,9481.0,The area under curve (25 mg/kg) administered orally in marmoset,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12046,CHEMBL624176,,,14215,,Autocuration,314293.0,The area under curve (25 mg/kg) administered orally in monkey,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12047,CHEMBL624177,,,14215,,Intermediate,9615.0,The area under curve (30 mg/kg) administered orally in dog,1,,50588,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12048,CHEMBL624178,,,14215,,Intermediate,9606.0,The area under curve (400 mg/kg) administered orally in humans,1,,50587,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12049,CHEMBL624179,,,14215,,Intermediate,10116.0,The area under curve (50 mg/kg) administered orally in fasted rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12050,CHEMBL627689,,,14215,,Intermediate,10116.0,The area under curve (50 mg/kg) administered orally in rat,1,,50597,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12051,CHEMBL627690,,,14215,,Intermediate,9606.0,The area under curve (800 mg/kg) administered orally in humans,1,,50587,
,1,,,,,BAO_0000019,A,U,,12052,CHEMBL627691,,,11324,,Autocuration,,The compound was evaluated for area under the curve,0,,22224,
,1,,,,Callithrix,BAO_0000019,A,U,,12053,CHEMBL627692,,,11324,,Autocuration,9481.0,The compound was evaluated for area under the curve in marmosets,0,,22224,
,1,,,,Callithrix,BAO_0000019,A,U,,12054,CHEMBL627693,,,11324,,Autocuration,9481.0,The compound was evaluated for area under the curve in marmosets,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12055,CHEMBL627694,,,13875,,Intermediate,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12056,CHEMBL627695,,,13875,,Intermediate,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,1,,50597,
,1,,,,,BAO_0000218,A,U,,12057,CHEMBL627696,,,13875,,Autocuration,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12058,CHEMBL627697,,,13875,,Intermediate,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12059,CHEMBL627698,,,13875,,Intermediate,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12060,CHEMBL627699,,,13875,,Intermediate,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12061,CHEMBL627700,,,13807,,Intermediate,10116.0,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12062,CHEMBL627701,,,14127,,Intermediate,10116.0,Total drug exposure is determined after oral dosing in rats.,1,,50597,
,1,,,,,BAO_0000218,A,U,,12063,CHEMBL627702,,,15116,,Autocuration,,Total drug exposure (5 mg/kg) when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12064,CHEMBL627703,,,15116,,Autocuration,,Total drug exposure (5 mg/kg) when administered orally,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12065,CHEMBL626873,,,15604,,Autocuration,314293.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12066,CHEMBL629583,,,15604,,Intermediate,10116.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12067,CHEMBL629584,,,15604,,Intermediate,9615.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12068,CHEMBL629585,,,15604,,Intermediate,9615.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12069,CHEMBL629586,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12070,CHEMBL629587,Brain,,13751,955.0,Intermediate,10116.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12071,CHEMBL629588,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12072,CHEMBL629589,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12073,CHEMBL629590,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12074,CHEMBL629591,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12075,CHEMBL629592,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12076,CHEMBL629593,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12077,CHEMBL629594,,,13751,,Intermediate,10116.0,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12078,CHEMBL629595,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12079,CHEMBL630290,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12080,CHEMBL627137,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12081,CHEMBL627138,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12082,CHEMBL627139,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12083,CHEMBL627140,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12084,CHEMBL627141,Heart,,13751,948.0,Intermediate,10116.0,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12085,CHEMBL627142,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12086,CHEMBL627143,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12087,CHEMBL874449,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12088,CHEMBL627144,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12089,CHEMBL627145,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12090,CHEMBL627146,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12091,CHEMBL627147,Kidney,,13751,2113.0,Intermediate,10116.0,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12092,CHEMBL627148,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12093,CHEMBL627149,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12094,CHEMBL632160,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12095,CHEMBL632161,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12096,CHEMBL632162,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12097,CHEMBL632163,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12098,CHEMBL874469,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12099,CHEMBL627182,Lung,,13751,2048.0,Intermediate,10116.0,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12100,CHEMBL627183,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12101,CHEMBL627184,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12102,CHEMBL627185,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12103,CHEMBL627186,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12104,CHEMBL627187,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12105,CHEMBL627188,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12106,CHEMBL627189,Muscle tissue,,13751,2385.0,Intermediate,10116.0,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12107,CHEMBL627190,,,13751,,Intermediate,10116.0,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12108,CHEMBL627191,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12109,CHEMBL627192,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12110,CHEMBL627193,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12111,CHEMBL874590,Muscle tissue,,10911,2385.0,Intermediate,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12112,CHEMBL627194,Muscle tissue,,10911,2385.0,Intermediate,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12113,CHEMBL627195,Muscle tissue,,10911,2385.0,Intermediate,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12114,CHEMBL627196,Female gonad,,10911,992.0,Intermediate,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12115,CHEMBL627197,Female gonad,,10911,992.0,Intermediate,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12116,CHEMBL627198,Female gonad,,10911,992.0,Intermediate,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12117,CHEMBL627199,Female gonad,,10911,992.0,Intermediate,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12118,CHEMBL627200,Female gonad,,10911,992.0,Intermediate,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12119,CHEMBL627201,Plasma,,10911,1969.0,Intermediate,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12120,CHEMBL627202,Plasma,,10911,1969.0,Intermediate,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12121,CHEMBL627203,Plasma,,10911,1969.0,Intermediate,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12122,CHEMBL627204,Plasma,,10911,1969.0,Intermediate,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12123,CHEMBL627205,Spleen,,10911,2106.0,Intermediate,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12124,CHEMBL627206,Spleen,,10911,2106.0,Intermediate,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12125,CHEMBL627207,Spleen,,10911,2106.0,Intermediate,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12126,CHEMBL627208,Spleen,,10911,2106.0,Intermediate,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12127,CHEMBL627209,Thyroid gland,,10911,2046.0,Intermediate,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12128,CHEMBL627210,Thyroid gland,,10911,2046.0,Intermediate,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12129,CHEMBL627211,Thyroid gland,,10911,2046.0,Intermediate,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12130,CHEMBL627212,Thyroid gland,,10911,2046.0,Intermediate,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12131,CHEMBL627213,Uterus,,10911,995.0,Intermediate,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12132,CHEMBL626599,Uterus,,10911,995.0,Intermediate,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12133,CHEMBL626600,Uterus,,10911,995.0,Intermediate,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12134,CHEMBL626601,Uterus,,10911,995.0,Intermediate,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,50597,
,1,,,,,BAO_0000019,A,U,,12135,CHEMBL627484,,,8081,,Autocuration,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,0,,22224,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12136,CHEMBL627485,Plasma,,17248,1969.0,Intermediate,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12137,CHEMBL628147,Plasma,,17248,1969.0,Intermediate,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12138,CHEMBL628148,Plasma,,17248,1969.0,Intermediate,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,1,,100710,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12139,CHEMBL628149,Plasma,,17248,1969.0,Intermediate,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12140,CHEMBL628150,Plasma,,17248,1969.0,Intermediate,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12141,CHEMBL628318,Plasma,,17248,1969.0,Intermediate,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12142,CHEMBL628319,Plasma,,17248,1969.0,Intermediate,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12143,CHEMBL875609,,,15592,,Intermediate,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,50588,
,1,,,,,BAO_0000019,A,U,,12144,CHEMBL628320,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,0,,22224,
,1,,,,,BAO_0000019,A,U,,12145,CHEMBL628321,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,0,,22224,
,1,,,,,BAO_0000019,A,U,,12146,CHEMBL628322,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,0,,22224,
,1,,,,,BAO_0000019,A,U,,12147,CHEMBL628323,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,0,,22224,
,1,,,,,BAO_0000019,A,U,,12148,CHEMBL628324,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,0,,22224,
,1,,,,,BAO_0000019,A,U,,12149,CHEMBL628325,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,0,,22224,
,1,,,,,BAO_0000019,A,U,,12150,CHEMBL628326,,,7040,,Autocuration,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12151,CHEMBL628327,Adrenal medulla,,9614,1236.0,Intermediate,9615.0,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12152,CHEMBL628328,Adrenal medulla,,9614,1236.0,Intermediate,9615.0,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12153,CHEMBL628329,Blood,,9614,178.0,Intermediate,9615.0,"Concentration of compound in blood of dog 1, after administering intravenously",1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12154,CHEMBL628330,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12155,CHEMBL628331,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12156,CHEMBL628332,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12157,CHEMBL628333,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12158,CHEMBL628334,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12159,CHEMBL628335,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12160,CHEMBL628336,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12161,CHEMBL628337,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12162,CHEMBL628338,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12163,CHEMBL875610,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12164,CHEMBL628339,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12165,CHEMBL628340,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12166,CHEMBL628341,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12167,CHEMBL622214,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12168,CHEMBL623167,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12169,CHEMBL623168,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12170,CHEMBL623169,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12171,CHEMBL623170,Liver,,8608,2107.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12172,CHEMBL627224,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12173,CHEMBL875634,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12174,CHEMBL627225,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12175,CHEMBL627226,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12176,CHEMBL626083,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12177,CHEMBL626084,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12178,CHEMBL626085,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12179,CHEMBL626086,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12180,CHEMBL626087,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12181,CHEMBL626088,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12182,CHEMBL626089,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12183,CHEMBL626090,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12184,CHEMBL626091,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12185,CHEMBL626092,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12186,CHEMBL626093,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12187,CHEMBL626094,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12188,CHEMBL626095,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12189,CHEMBL626096,Lung,,8608,2048.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",1,,50597,
,1,,,,Simiiformes,BAO_0000218,A,U,,12190,CHEMBL626097,,,15604,,Autocuration,314293.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12191,CHEMBL626098,,,15604,,Intermediate,10116.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,50597,
,1,,,,,BAO_0000218,A,U,,12192,CHEMBL626099,Plasma,,1806,1969.0,Autocuration,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,0,,22224,
,1,,,,,BAO_0000218,A,U,,12193,CHEMBL626100,Plasma,,1806,1969.0,Autocuration,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12194,CHEMBL626101,Plasma,,17237,1969.0,Intermediate,9615.0,AUC 0-inf in dog,1,,50588,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,12195,CHEMBL626102,Plasma,,17237,1969.0,Intermediate,10141.0,AUC 0-inf in guinea pig,1,,50512,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12196,CHEMBL626103,Plasma,,17237,1969.0,Intermediate,9615.0,AUC 0-t in dog,1,,50588,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,12197,CHEMBL628391,Plasma,,17237,1969.0,Intermediate,10141.0,AUC 0-t in guinea pig,1,,50512,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12198,CHEMBL628392,,,15194,,Intermediate,10116.0,The compound was tested for brain to plasma partition in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12199,CHEMBL628393,,,15194,,Intermediate,10116.0,The compound was tested for brain to plasma partition in rat.,1,,50597,
,1,,,,,BAO_0000019,A,U,,12200,CHEMBL628394,Blood,,8787,178.0,Autocuration,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12201,CHEMBL628395,,,17025,,Intermediate,9615.0,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,12202,CHEMBL628396,,,17025,,Autocuration,314293.0,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12203,CHEMBL628397,,,17025,,Intermediate,9986.0,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,50592,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12204,CHEMBL628398,,,17025,,Intermediate,10116.0,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,1,,50597,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,12205,CHEMBL628399,,,4236,,Intermediate,9544.0,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,50797,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12206,CHEMBL628400,,,15343,,Intermediate,9615.0,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12207,CHEMBL874907,,,15343,,Intermediate,10116.0,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,1,,50597,
,1,,,,,BAO_0000019,A,U,,12208,CHEMBL628401,,,17720,,Autocuration,,Area under curve of the compound was determined,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12209,CHEMBL628402,Plasma,,17788,1969.0,Autocuration,314293.0,AUC in monkeys at a dose of 1 mg/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12210,CHEMBL628403,Plasma,,17788,1969.0,Intermediate,10116.0,AUC in rats at a dose of 1 mg/kg,1,,50597,
,1,,,,,BAO_0000019,A,U,,12211,CHEMBL628404,,,8778,,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 2,0,,22224,
,1,,,,,BAO_0000019,A,U,,12212,CHEMBL628405,,,8778,,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 4,0,,22224,
,1,,,,,BAO_0000019,A,U,,12213,CHEMBL628406,,,8778,,Autocuration,,Compound was evaluated for the overall absorbance loss at pH of 7,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12214,CHEMBL628407,,,2249,,Intermediate,10116.0,Compound was evaluated for its absorption in the rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12215,CHEMBL628408,Urine,,8881,1088.0,Intermediate,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12216,CHEMBL629171,Urine,,8881,1088.0,Intermediate,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12217,CHEMBL629172,Urine,,8881,1088.0,Intermediate,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12218,CHEMBL629173,Urine,,8881,1088.0,Intermediate,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12219,CHEMBL629174,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12220,CHEMBL629175,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 10-17,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12221,CHEMBL629176,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 10-18,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12222,CHEMBL629177,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 10-19,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12223,CHEMBL629178,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 12-15,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12224,CHEMBL631869,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 13-19,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12225,CHEMBL631870,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 14-17,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12226,CHEMBL631871,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 15-18,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12227,CHEMBL631872,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 2-5,1,,50597,
,1,,,,,BAO_0000221,A,U,,12228,CHEMBL875775,Ileum,,15286,2116.0,Autocuration,,In vitro percent permeability into rat ileum; Range is 23-42,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12229,CHEMBL631873,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 28-36,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12230,CHEMBL631874,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 29-35,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12231,CHEMBL631875,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 46-66,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12232,CHEMBL631876,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 50-68,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12233,CHEMBL631877,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; Range is 78-81,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12234,CHEMBL631878,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12235,CHEMBL631879,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; nd indicates not detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12236,CHEMBL631880,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; nt indicates not detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12237,CHEMBL631881,,,15286,,Intermediate,10116.0,In vitro percent permeability into rat ileum; nt indicates not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12238,CHEMBL631882,,,13770,,Intermediate,10116.0,Compound was tested for oral absorption in bile-duct cannulated rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12239,CHEMBL630749,,,13770,,Intermediate,10116.0,Compound was tested for oral absorption in bile-duct cannulated rats.,1,,50597,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12240,CHEMBL630750,,,5202,,Intermediate,9606.0,Oral absorption using Caco-2 cell monolayers.,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12241,CHEMBL630253,,,14920,,Intermediate,9606.0,Percent of the drug absorbed after administration to humans was determined,1,,50587,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12242,CHEMBL630254,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12243,CHEMBL630255,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12244,CHEMBL630256,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12245,CHEMBL875781,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12246,CHEMBL630257,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12247,CHEMBL630258,Liver,,13751,2107.0,Intermediate,10116.0,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12248,CHEMBL630259,,,15807,,Intermediate,10116.0,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12249,CHEMBL630260,Striatum,,15807,2435.0,Intermediate,10116.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12250,CHEMBL630261,Striatum,,15807,2435.0,Intermediate,10116.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12251,CHEMBL630262,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12252,CHEMBL630263,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12253,CHEMBL630264,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12254,CHEMBL630265,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12255,CHEMBL630266,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12256,CHEMBL630267,Kidney,,14950,2113.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12257,CHEMBL630268,Kidney,,14950,2113.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12258,CHEMBL630269,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12259,CHEMBL630270,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12260,CHEMBL630141,Lung,,14950,2048.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12261,CHEMBL630142,Lung,,14950,2048.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12262,CHEMBL630143,Muscle tissue,,14950,2385.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12263,CHEMBL630144,Muscle tissue,,14950,2385.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12264,CHEMBL630145,Prostate gland,,14950,2367.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12265,CHEMBL630146,Prostate gland,,14950,2367.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12266,CHEMBL630147,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12267,CHEMBL630148,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12268,CHEMBL630149,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12269,CHEMBL630150,Spleen,,14950,2106.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12270,CHEMBL630151,Spleen,,14950,2106.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12271,CHEMBL632031,Thyroid gland,,14950,2046.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12272,CHEMBL632032,Thyroid gland,,14950,2046.0,Intermediate,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12273,CHEMBL632033,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12274,CHEMBL632034,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12275,CHEMBL632035,Muscle tissue,,14950,2385.0,Intermediate,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12276,CHEMBL632036,,,14950,,Intermediate,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12277,CHEMBL632037,Thyroid gland,,14950,2046.0,Intermediate,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12278,CHEMBL632038,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12279,CHEMBL632039,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12280,CHEMBL632040,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12281,CHEMBL632041,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12282,CHEMBL632042,Blood,,9614,178.0,Intermediate,9615.0,"Concentration of compound in blood of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12283,CHEMBL632043,,,9614,,Intermediate,9615.0,"Concentration of compound in left ventricle of dog 1, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12284,CHEMBL632044,,,9614,,Intermediate,9615.0,"Concentration of compound in left ventricle of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12285,CHEMBL632045,Liver,,9614,2107.0,Intermediate,9615.0,"Concentration of compound in liver of dog 1, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12286,CHEMBL632046,Liver,,9614,2107.0,Intermediate,9615.0,"Concentration of compound in liver of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12287,CHEMBL632047,Lung,,9614,2048.0,Intermediate,9615.0,"Concentration of compound in lung of dog 1, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12288,CHEMBL632048,Lung,,9614,2048.0,Intermediate,9615.0,"Concentration of compound in lung of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12289,CHEMBL632049,Muscle tissue,,9614,2385.0,Intermediate,9615.0,"Concentration of compound in muscle of dog 1, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12290,CHEMBL876418,Muscle tissue,,9614,2385.0,Intermediate,9615.0,"Concentration of compound in muscle of dog 2, after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12291,CHEMBL632050,Spleen,,9614,2106.0,Intermediate,9615.0,"Concentration of compound in spleen of dog 1,after administering intravenously",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12292,CHEMBL632051,Spleen,,9614,2106.0,Intermediate,9615.0,"Concentration of compound in spleen of dog 2, after administering intravenously",1,,50588,
,1,,,,,BAO_0000218,F,U,,12293,CHEMBL632052,,,10353,,Autocuration,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,0,,22224,
,1,,,,,BAO_0000218,F,U,,12294,CHEMBL632053,,,10353,,Autocuration,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,0,,22224,
,1,,,,,BAO_0000218,A,U,,12295,CHEMBL632054,,,10353,,Autocuration,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,0,,22224,
,1,,,,,BAO_0000218,F,U,,12296,CHEMBL632055,,,10353,,Autocuration,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,0,,22224,
,1,,,,,BAO_0000218,F,U,,12297,CHEMBL631181,,,10353,,Autocuration,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,0,,22224,
,1,,,,,BAO_0000218,A,U,,12298,CHEMBL631182,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12299,CHEMBL631183,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12300,CHEMBL631184,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12301,CHEMBL629774,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12302,CHEMBL629775,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12303,CHEMBL876549,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12304,CHEMBL628172,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12305,CHEMBL628173,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12306,CHEMBL628174,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12307,CHEMBL628175,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12308,CHEMBL628176,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12309,CHEMBL628177,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12310,CHEMBL628178,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12311,CHEMBL628179,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12312,CHEMBL628180,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,0,,22224,
,1,,,,,BAO_0000218,A,U,,12313,CHEMBL628181,,,9196,,Autocuration,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12314,CHEMBL628182,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12315,CHEMBL628183,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12316,CHEMBL628184,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12317,CHEMBL628185,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12318,CHEMBL875617,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12319,CHEMBL628186,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12320,CHEMBL628187,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12321,CHEMBL628188,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12322,CHEMBL628189,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12323,CHEMBL628190,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12324,CHEMBL628191,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12325,CHEMBL626513,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12326,CHEMBL626514,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12327,CHEMBL626515,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12328,CHEMBL626516,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12329,CHEMBL626517,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12330,CHEMBL626518,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12331,CHEMBL626519,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12332,CHEMBL626520,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12333,CHEMBL626521,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12334,CHEMBL626522,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12335,CHEMBL626523,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12336,CHEMBL626524,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12337,CHEMBL626688,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12338,CHEMBL626689,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12339,CHEMBL626690,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12340,CHEMBL626691,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12341,CHEMBL627319,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12342,CHEMBL624052,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12343,CHEMBL624053,Thyroid gland,,8608,2046.0,Intermediate,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12344,CHEMBL624054,,,8085,,Intermediate,10116.0,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12345,CHEMBL624055,,,8085,,Intermediate,10116.0,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12346,CHEMBL624056,,,8085,,Intermediate,10116.0,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12347,CHEMBL624057,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12348,CHEMBL622281,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12349,CHEMBL622282,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12350,CHEMBL622283,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12351,CHEMBL622284,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12352,CHEMBL622285,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12353,CHEMBL622286,Uterus,,8085,995.0,Intermediate,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,50597,
,1,,,,,BAO_0000100,P,U,,12354,CHEMBL622287,,,7657,,Autocuration,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,12355,CHEMBL622288,,,8935,,Intermediate,10090.0,Partition coefficient (logD7.4),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12356,CHEMBL622289,,,13792,,Intermediate,10090.0,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12357,CHEMBL622290,Brain,,13792,955.0,Intermediate,10090.0,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12358,CHEMBL622291,,,13792,,Intermediate,10090.0,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12359,CHEMBL622292,Brain,,13792,955.0,Intermediate,10090.0,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12360,CHEMBL622293,,,13792,,Intermediate,10090.0,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12361,CHEMBL622294,Brain,,13792,955.0,Intermediate,10090.0,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12362,CHEMBL622295,,,13792,,Intermediate,10090.0,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12363,CHEMBL622296,Brain,,13792,955.0,Intermediate,10116.0,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12364,CHEMBL874409,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12365,CHEMBL622297,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12366,CHEMBL622298,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12367,CHEMBL622299,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12368,CHEMBL622300,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12369,CHEMBL622301,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12370,CHEMBL622302,Plasma,,14103,1969.0,Intermediate,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12371,CHEMBL622303,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12372,CHEMBL622304,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12373,CHEMBL622305,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12374,CHEMBL622306,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12375,CHEMBL626864,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12376,CHEMBL626865,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12377,CHEMBL626866,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12378,CHEMBL626867,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12379,CHEMBL626868,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12380,CHEMBL626869,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12381,CHEMBL626870,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12382,CHEMBL626871,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12383,CHEMBL626872,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12384,CHEMBL632185,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12385,CHEMBL632186,Plasma,,14103,1969.0,Intermediate,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,1,,50597,
,1,,,,,BAO_0000019,A,U,,12386,CHEMBL629310,,,12904,,Autocuration,,Amount of acetic acid produced by the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,12387,CHEMBL629311,,,12904,,Autocuration,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12388,CHEMBL629312,,,9663,,Intermediate,10116.0,Log of (Cbrain/Cblood) in rats,1,,50597,
,1,,,,,BAO_0000221,A,U,,12389,CHEMBL629313,,,7652,,Autocuration,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000221,A,U,,12390,CHEMBL629314,,,7652,,Autocuration,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000221,A,U,,12391,CHEMBL629315,,,7652,,Autocuration,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000219,B,U,,12392,CHEMBL629316,,,7652,,Autocuration,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000221,A,U,,12393,CHEMBL629317,,,7652,,Autocuration,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12394,CHEMBL629318,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12395,CHEMBL877497,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12396,CHEMBL629319,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12397,CHEMBL629320,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12398,CHEMBL629496,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12399,CHEMBL629497,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12400,CHEMBL629498,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12401,CHEMBL629499,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12402,CHEMBL629500,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12403,CHEMBL629501,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),0,,22224,
,1,,,,,BAO_0000019,A,U,,12404,CHEMBL629502,,,7652,,Autocuration,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),0,,22224,
,1,,,In vivo,,BAO_0000218,F,U,,12405,CHEMBL629503,,,8267,,Autocuration,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12406,CHEMBL629504,,,8267,,Intermediate,9615.0,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,1,,50588,
,1,,,,,BAO_0000019,A,U,,12407,CHEMBL629505,,,14479,,Autocuration,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,0,,22224,
,1,,,,,BAO_0000019,A,U,,12408,CHEMBL629506,,,17515,,Autocuration,,Compound was evaluated for total body clearance,0,,22224,
,1,,,,,BAO_0000019,A,U,,12409,CHEMBL629507,,,17515,,Autocuration,,Compound was evaluated for volume of distribution at steady state,0,,22224,
,1,,,,,BAO_0000019,A,U,,12410,CHEMBL877498,,,8142,,Autocuration,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,0,,22224,
,1,,,,,BAO_0000019,A,U,,12411,CHEMBL629508,,,14849,,Autocuration,,Percentage of the diamine which is monoprotonated at pH 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,12412,CHEMBL629509,,,7653,,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12413,CHEMBL629510,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12414,CHEMBL629511,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12415,CHEMBL629512,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12416,CHEMBL629513,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12417,CHEMBL629514,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12418,CHEMBL628447,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12419,CHEMBL628448,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12420,CHEMBL628449,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12421,CHEMBL631119,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12422,CHEMBL631120,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12423,CHEMBL631121,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12424,CHEMBL874458,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12425,CHEMBL631122,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12426,CHEMBL631123,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12427,CHEMBL631124,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12428,CHEMBL631125,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12429,CHEMBL631290,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12430,CHEMBL631291,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12431,CHEMBL631292,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12432,CHEMBL631293,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12433,CHEMBL631294,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12434,CHEMBL631295,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12435,CHEMBL631296,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12436,CHEMBL631297,Blood,,8631,178.0,Intermediate,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,50597,
,1,,,,,BAO_0000218,A,U,,12437,CHEMBL631298,,,10263,,Autocuration,,Maximum biodistribution (Bmax) was determined.,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,12438,CHEMBL631299,,,12364,,Intermediate,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12439,CHEMBL631300,,,12364,,Intermediate,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12440,CHEMBL631301,,,12364,,Intermediate,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12441,CHEMBL630291,,,12364,,Intermediate,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,1,,50594,
,1,,,,,BAO_0000218,A,U,,12442,CHEMBL630292,,,14793,,Autocuration,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12443,CHEMBL630293,,,14793,,Autocuration,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12444,CHEMBL630294,,,14793,,Autocuration,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12445,CHEMBL630295,,,14793,,Autocuration,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12446,CHEMBL630296,,,14793,,Autocuration,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12447,CHEMBL626782,,,14793,,Autocuration,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12448,CHEMBL626783,,,14793,,Autocuration,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12449,CHEMBL626784,,,14793,,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12450,CHEMBL626785,,,14793,,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12451,CHEMBL626786,,,14793,,Autocuration,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12452,CHEMBL626787,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12453,CHEMBL626788,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12454,CHEMBL625927,,,9196,,Autocuration,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12455,CHEMBL625928,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12456,CHEMBL625929,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12457,CHEMBL625930,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12458,CHEMBL625931,Blood,,8374,178.0,Intermediate,10116.0,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12459,CHEMBL627230,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12460,CHEMBL627231,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12461,CHEMBL627232,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12462,CHEMBL627233,Blood,,8374,178.0,Intermediate,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12463,CHEMBL875470,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12464,CHEMBL627234,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12465,CHEMBL627235,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12466,CHEMBL627236,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12467,CHEMBL627237,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12468,CHEMBL627238,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12469,CHEMBL627239,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12470,CHEMBL627240,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12471,CHEMBL627241,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12472,CHEMBL627242,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12473,CHEMBL627243,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12474,CHEMBL627244,Blood,,8374,178.0,Intermediate,10116.0,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12475,CHEMBL627245,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12476,CHEMBL627246,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12477,CHEMBL627247,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12478,CHEMBL627248,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12479,CHEMBL627249,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12480,CHEMBL625569,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12481,CHEMBL625570,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12482,CHEMBL625571,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12483,CHEMBL625572,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12484,CHEMBL625573,Blood,,8374,178.0,Intermediate,10116.0,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12485,CHEMBL625574,Blood,,8374,178.0,Intermediate,10116.0,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12486,CHEMBL626245,Blood,,8374,178.0,Intermediate,10116.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12487,CHEMBL626246,Blood,,8374,178.0,Intermediate,10116.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,,BAO_0000218,A,U,,12488,CHEMBL626247,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12489,CHEMBL626248,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12490,CHEMBL626249,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12491,CHEMBL626420,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12492,CHEMBL626421,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12493,CHEMBL626422,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12494,CHEMBL626423,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12495,CHEMBL626424,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12496,CHEMBL626425,,,12023,,Intermediate,9615.0,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12497,CHEMBL875476,,,12023,,Intermediate,10116.0,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,1,,50597,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12498,CHEMBL626426,,,12023,,Intermediate,9541.0,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,1,,100710,
,1,,,,,BAO_0000100,P,U,,12499,CHEMBL626427,,,10580,,Autocuration,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,0,,22224,
,1,,,,,BAO_0000100,P,U,,12500,CHEMBL626428,,,10580,,Autocuration,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,0,,22224,
,1,,,,,BAO_0000019,A,U,,12501,CHEMBL626429,,,16032,,Autocuration,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,12502,CHEMBL625025,Urine,,16032,1088.0,Autocuration,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12503,CHEMBL625026,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12504,CHEMBL625027,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12505,CHEMBL874410,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12506,CHEMBL625028,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12507,CHEMBL625029,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12508,CHEMBL625030,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12509,CHEMBL625031,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12510,CHEMBL625032,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12511,CHEMBL625033,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12512,CHEMBL625034,Blood,,8594,178.0,Intermediate,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12513,CHEMBL624872,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12514,CHEMBL624873,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12515,CHEMBL624874,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12516,CHEMBL624875,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12517,CHEMBL624876,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12518,CHEMBL624877,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12519,CHEMBL624878,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12520,CHEMBL624879,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12521,CHEMBL624880,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12522,CHEMBL624881,Heart,,8594,948.0,Intermediate,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12523,CHEMBL624882,Heart,,8594,948.0,Intermediate,10116.0,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12524,CHEMBL624883,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12525,CHEMBL624884,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12526,CHEMBL624885,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12527,CHEMBL624886,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12528,CHEMBL624887,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12529,CHEMBL624888,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12530,CHEMBL624889,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12531,CHEMBL624890,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12532,CHEMBL621964,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12533,CHEMBL621965,Kidney,,8594,2113.0,Intermediate,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12534,CHEMBL621966,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12535,CHEMBL621967,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12536,CHEMBL622164,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,,BAO_0000019,A,U,,12537,CHEMBL623097,,,7653,,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),0,,22224,
,1,,,,,BAO_0000019,A,U,,12538,CHEMBL623098,,,7653,,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),0,,22224,
,1,,,,,BAO_0000019,A,U,,12539,CHEMBL623099,,,7653,,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,0,,22224,
,1,,,,,BAO_0000019,A,U,,12540,CHEMBL623100,,,7653,,Autocuration,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12541,CHEMBL628673,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12542,CHEMBL628674,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12543,CHEMBL628675,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12544,CHEMBL627644,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12545,CHEMBL627645,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12546,CHEMBL627646,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12547,CHEMBL627647,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12548,CHEMBL627648,,,9104,,Intermediate,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12549,CHEMBL627649,,,12902,,Intermediate,10116.0,Free level in rat plasma,1,,50597,
,1,,,,,BAO_0000019,A,U,,12550,CHEMBL628313,,,6614,,Autocuration,,Level reaching in blood plasma of rat or human was determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12551,CHEMBL628314,,,9663,,Intermediate,10116.0,Log (Cbrain/Cblood) in rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,12552,CHEMBL628315,,,17658,,Autocuration,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,0,,22224,
,1,,,,,BAO_0000019,A,U,,12553,CHEMBL628316,,,17658,,Autocuration,,Mean percentage of compound transport through membrane; expressed as membrane transport,0,,22224,
,1,,,,,BAO_0000218,A,U,,12554,CHEMBL628317,,,14314,,Autocuration,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,12555,CHEMBL628473,,,7385,,Autocuration,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,0,,22224,
,1,,,,,BAO_0000019,A,U,,12556,CHEMBL628474,,,7385,,Autocuration,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,12557,CHEMBL628475,,,7385,,Autocuration,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,0,,22224,
,1,,,,,BAO_0000019,A,U,,12558,CHEMBL628476,,,1329,,Autocuration,,Net water uptake by a carrier mediated transport (%cm) mechanism,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12559,CHEMBL628477,,,12187,,Autocuration,314293.0,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,0,,22224,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,12560,CHEMBL628478,,,12187,,Intermediate,9669.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,12561,CHEMBL628479,,,12187,,Intermediate,9669.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,50506,
,1,,,,Simiiformes,BAO_0000218,A,U,,12562,CHEMBL628480,,,12187,,Autocuration,314293.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,12563,CHEMBL628481,,,12187,,Autocuration,314293.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12564,CHEMBL628482,,,12187,,Intermediate,10116.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12565,CHEMBL628483,,,12187,,Intermediate,10116.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12566,CHEMBL628484,Plasma,,9278,1969.0,Intermediate,10116.0,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12567,CHEMBL628485,Plasma,,9278,1969.0,Intermediate,10116.0,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,50597,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12568,CHEMBL628486,Plasma,,9278,1969.0,Intermediate,9541.0,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",1,,100710,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12569,CHEMBL628487,Plasma,,9278,1969.0,Intermediate,9606.0,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",1,,50587,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12570,CHEMBL628488,Plasma,,9278,1969.0,Intermediate,10116.0,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12571,CHEMBL628489,Plasma,,9278,1969.0,Intermediate,10116.0,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12572,CHEMBL628490,Plasma,,9278,1969.0,Intermediate,10116.0,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,50597,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12573,CHEMBL628491,,,12186,,Intermediate,9541.0,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,100710,
,1,,,,Macaca fascicularis,BAO_0000218,A,N,,12574,CHEMBL877507,,,12186,,Intermediate,9541.0,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,100710,
,1,,,,,BAO_0000218,A,U,,12575,CHEMBL628492,,,12186,,Autocuration,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,0,,22224,
,1,,,,Simiiformes,BAO_0000019,A,U,,12576,CHEMBL628493,,,12041,,Autocuration,314293.0,% metabolized in monkey S-9 after 2 hours (10 ug/mL),0,,22224,
,1,,,,Simiiformes,BAO_0000019,A,U,,12577,CHEMBL628494,,,12041,,Autocuration,314293.0,% metabolized in monkey S-9 after 2 hours (1 ug/ml),0,,22224,
,1,,,,Simiiformes,BAO_0000019,A,U,,12578,CHEMBL628495,,,12041,,Autocuration,314293.0,% metabolized in monkey S-9 after 2 hours (10 ug/ml),0,,22224,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12579,CHEMBL628496,,,6737,,Intermediate,9606.0,Permeability in Caco-2 assay at 10E-6,1,,50587,
,1,,,,,BAO_0000218,A,U,,12580,CHEMBL628497,Brain,,13758,955.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,0,,22224,
,1,,,,,BAO_0000218,A,U,,12581,CHEMBL628498,Brain,,13758,955.0,Autocuration,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,0,,22224,
,1,,,,,BAO_0000019,A,U,,12582,CHEMBL628499,,,5676,,Autocuration,,Plasma protein binding was determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12583,CHEMBL627656,,,14793,,Autocuration,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12584,CHEMBL627657,,,14793,,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12585,CHEMBL626808,,,14793,,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12586,CHEMBL626809,,,14793,,Autocuration,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12587,CHEMBL626810,,,14793,,Autocuration,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12588,CHEMBL626811,,,14793,,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12589,CHEMBL874465,,,14793,,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,0,,22224,
,1,,,,,BAO_0000218,A,U,,12590,CHEMBL626812,,,14793,,Autocuration,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12591,CHEMBL626813,,,14793,,Autocuration,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000218,A,U,,12592,CHEMBL626814,,,14793,,Autocuration,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,0,,22224,
,1,,,,,BAO_0000019,A,U,,12593,CHEMBL626815,,,14000,,Autocuration,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,0,,22224,
,1,,,,,BAO_0000019,A,U,,12594,CHEMBL628566,,,5948,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,12595,CHEMBL628567,,,13824,,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),0,,22229,
,1,,,,,BAO_0000100,P,U,,12596,CHEMBL628568,,,10778,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12597,CHEMBL628569,,,17237,,Intermediate,9615.0,C max in dog,1,,50588,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,12598,CHEMBL628570,,,17237,,Intermediate,10141.0,C max in guinea pig,1,,50512,
,1,,,In vivo,,BAO_0000218,A,U,,12599,CHEMBL628571,,,2809,,Autocuration,,C max value was evaluated,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12600,CHEMBL628572,,,11954,,Autocuration,,Cmax value after oral dose of 0.1 mg//kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12601,CHEMBL628573,,,11954,,Autocuration,,Cmax value after oral dose of 0.3 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12602,CHEMBL628574,,,11954,,Autocuration,,Cmax value after oral dose of 1 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12603,CHEMBL628575,,,11954,,Autocuration,,Cmax value after oral dose of 10 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12604,CHEMBL628576,,,11954,,Autocuration,,Cmax value after oral dose of 23.4 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12605,CHEMBL628577,,,11954,,Autocuration,,Cmax value after oral dose of 3 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12606,CHEMBL628578,,,11954,,Autocuration,,Cmax value after oral dose of 3.87 mg/kg,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12607,CHEMBL874466,,,12768,,Intermediate,9615.0,Cmax value in female Beagle dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12608,CHEMBL628579,,,12768,,Intermediate,10116.0,Cmax value in male rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12609,CHEMBL628580,Plasma,,12780,1969.0,Intermediate,10116.0,Cmax value in rat plasma when administered 20 mg/kg perorally,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12610,CHEMBL628581,Plasma,,15592,1969.0,Intermediate,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12611,CHEMBL628582,Plasma,,15592,1969.0,Intermediate,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12612,CHEMBL628583,,,17025,,Intermediate,9615.0,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,12613,CHEMBL625782,,,17025,,Autocuration,314293.0,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12614,CHEMBL625783,,,17025,,Intermediate,9986.0,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,1,,50592,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12615,CHEMBL625784,,,17025,,Intermediate,10116.0,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,1,,50597,
,1,,,,Macaca mulatta,BAO_0000218,A,N,,12616,CHEMBL625785,Plasma,,4236,1969.0,Intermediate,9544.0,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,50797,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12617,CHEMBL625786,,,15791,,Intermediate,10116.0,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,1,,50597,
,1,,,,,BAO_0000019,A,U,,12618,CHEMBL874467,,,11149,,Autocuration,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12619,CHEMBL625787,,,15592,,Intermediate,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,50588,
,1,,,,Human immunodeficiency virus,BAO_0000218,A,N,,12620,CHEMBL625964,,,15778,,Intermediate,12721.0,cytotoxicity against HIV protease enzyme.,1,,50677,
,1,,,,Mus musculus,BAO_0000218,A,N,,12621,CHEMBL625965,,,12745,,Intermediate,10090.0,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12622,CHEMBL625966,,,12745,,Intermediate,10090.0,Apparent clearance in mice after oral administration of 100 mg/kg of dose,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12623,CHEMBL625967,Plasma,,13941,1969.0,Intermediate,9615.0,The plasma clearance in dog.,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12624,CHEMBL625968,Plasma,,13941,1969.0,Intermediate,10116.0,The plasma clearance in rat.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12625,CHEMBL625969,Plasma,,16449,1969.0,Intermediate,10116.0,Clearance from plasma in male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,12626,CHEMBL625970,Plasma,,16449,1969.0,Intermediate,9541.0,Clearance from plasma in male cynomolgus monkeys,1,,100710,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12627,CHEMBL625971,Plasma,,14224,1969.0,Intermediate,9615.0,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12628,CHEMBL625972,Plasma,,14224,1969.0,Intermediate,9615.0,Clearance of compound in dog plasma,1,,50588,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,12629,CHEMBL625973,Plasma,,14224,1969.0,Intermediate,9606.0,Clearance of compound in human plasma,1,,50587,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12630,CHEMBL625974,,,14317,,Intermediate,9615.0,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12631,CHEMBL625975,,,14317,,Intermediate,9615.0,Clearance of compound when administered intravenously as an individual dose to a single dog.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12632,CHEMBL625976,Plasma,,14224,1969.0,Intermediate,9615.0,"Clearance (10 mg/kg, intravenously) in dog plasma",1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12633,CHEMBL625977,,,17237,,Intermediate,9615.0,Clearance value in dog,1,,50588,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,12634,CHEMBL625978,,,17237,,Intermediate,10141.0,Clearance value in guinea pig,1,,50512,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12635,CHEMBL874468,,,14187,,Intermediate,10116.0,Clearance values in rats after iv administration.,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,12636,CHEMBL625421,Plasma,,4806,1969.0,Autocuration,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,N,,12637,CHEMBL625422,,,15025,,Intermediate,9986.0,In vivo clearance (5 mg/kg) was determined in rabbits,1,,50592,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12638,CHEMBL625423,,,13197,,Intermediate,10116.0,Plasma Clearance rate was determined for the compound in rats,1,,50597,
,1,,,In vivo,Saimiri,BAO_0000218,A,U,,12639,CHEMBL625424,,,13197,,Autocuration,9520.0,Plasma Clearance rate was determined for the compound in squirrel monkeys,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12640,CHEMBL625425,,,13960,,Intermediate,10116.0,Plasma clearance in rat,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,12641,CHEMBL625426,,,17820,,Autocuration,,Plasma clearance of the compound,0,,22224,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,12642,CHEMBL625427,,,14706,,Intermediate,10141.0,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,1,,50512,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,12643,CHEMBL625428,,,14706,,Intermediate,10141.0,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,1,,50512,
,1,,,In vivo,,BAO_0000218,A,U,,12644,CHEMBL625429,,,6504,,Autocuration,,Plasma clearance was determined,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12645,CHEMBL625430,,,14925,,Intermediate,9615.0,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12646,CHEMBL625431,,,13197,,Intermediate,10116.0,Plasma clearance rate was determined for the compound in rats,1,,50597,
,1,,,In vivo,Saimiri,BAO_0000218,A,U,,12647,CHEMBL627307,,,13197,,Autocuration,9520.0,Plasma clearance rate was determined for the compound in squirrel monkeys,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12648,CHEMBL627308,,,3437,,Autocuration,,Slow clearance (CL) was determined,0,,22224,
,1,,,,,BAO_0000218,A,U,,12649,CHEMBL627309,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12650,CHEMBL627310,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,0,,22224,
,1,,,,,BAO_0000218,A,U,,12651,CHEMBL627311,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12652,CHEMBL627312,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12653,CHEMBL627313,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12654,CHEMBL627314,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12655,CHEMBL627315,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12656,CHEMBL627316,,,9196,,Autocuration,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12657,CHEMBL627317,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12658,CHEMBL627318,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12659,CHEMBL627999,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12660,CHEMBL628000,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12661,CHEMBL628001,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12662,CHEMBL628002,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12663,CHEMBL625610,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12664,CHEMBL625611,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12665,CHEMBL625612,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12666,CHEMBL625613,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12667,CHEMBL875479,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12668,CHEMBL625614,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12669,CHEMBL625615,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,0,,22224,
,1,,,,,BAO_0000218,A,U,,12670,CHEMBL626302,,,9196,,Autocuration,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12671,CHEMBL626303,Blood,,8374,178.0,Intermediate,10116.0,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12672,CHEMBL627420,Blood,,8374,178.0,Intermediate,10116.0,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12673,CHEMBL627421,,,13477,,Intermediate,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12674,CHEMBL625695,,,13477,,Intermediate,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12675,CHEMBL625696,,,13477,,Intermediate,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,12676,CHEMBL875606,Brain,,10009,955.0,Intermediate,10090.0,Distribution of compound in mice brain was measured after 1 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12677,CHEMBL625697,Brain,,10009,955.0,Intermediate,10090.0,Distribution of compound in mice brain was measured after 24 hr r,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12678,CHEMBL625698,Brain,,10009,955.0,Intermediate,10090.0,Distribution of compound in mice brain was measured after 2 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12679,CHEMBL625699,Brain,,10009,955.0,Intermediate,10090.0,Distribution of compound in mice brain was measured after 3 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12680,CHEMBL625700,Brain,,10009,955.0,Intermediate,10090.0,Distribution of compound in mice brain was measured after 6 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12681,CHEMBL625701,,,10009,,Intermediate,10090.0,Distribution of compound in mice liver was measured after 1 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12682,CHEMBL625702,,,10009,,Intermediate,10090.0,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12683,CHEMBL625703,,,10009,,Intermediate,10090.0,Distribution of compound in mice liver was measured after 2 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12684,CHEMBL625704,,,10009,,Intermediate,10090.0,Distribution of compound in mice liver was measured after 3 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,12685,CHEMBL625705,,,10009,,Intermediate,10090.0,Distribution of compound in mice liver was measured after 6 hr,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12686,CHEMBL625706,Adrenal medulla,,8170,1236.0,Intermediate,9615.0,Distribution in dog adrenal medulla 30 min after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12687,CHEMBL625707,Adrenal medulla,,8170,1236.0,Intermediate,9615.0,Distribution in dog adrenal medulla 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12688,CHEMBL625708,,,8170,,Intermediate,9615.0,Distribution in female dog Ovary 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12689,CHEMBL625709,,,8170,,Intermediate,9615.0,Distribution in female dog Ovary 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12690,CHEMBL624180,,,8170,,Intermediate,9615.0,Distribution in female dog adipose 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12691,CHEMBL624181,,,8170,,Intermediate,9615.0,Distribution in female dog adipose 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12692,CHEMBL624182,Adrenal cortex,,8170,1235.0,Intermediate,9615.0,Distribution in female dog adrenal cortex 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12693,CHEMBL624183,Adrenal cortex,,8170,1235.0,Intermediate,9615.0,Distribution in female dog adrenal cortex 72 hours after administration.,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12694,CHEMBL624184,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12695,CHEMBL877489,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12696,CHEMBL624185,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12697,CHEMBL624186,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12698,CHEMBL624187,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12699,CHEMBL624188,Liver,,8594,2107.0,Intermediate,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12700,CHEMBL624189,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12701,CHEMBL624190,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12702,CHEMBL624191,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12703,CHEMBL624192,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12704,CHEMBL624193,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12705,CHEMBL624194,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12706,CHEMBL624891,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12707,CHEMBL624892,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12708,CHEMBL624893,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12709,CHEMBL627632,Lung,,8594,2048.0,Intermediate,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12710,CHEMBL627633,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12711,CHEMBL627634,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12712,CHEMBL627635,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12713,CHEMBL627636,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12714,CHEMBL626816,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12715,CHEMBL626817,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12716,CHEMBL626818,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12717,CHEMBL626819,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12718,CHEMBL626820,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12719,CHEMBL626821,,,8594,,Intermediate,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12720,CHEMBL626822,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12721,CHEMBL626823,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12722,CHEMBL626824,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12723,CHEMBL626825,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12724,CHEMBL626826,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12725,CHEMBL626827,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12726,CHEMBL626828,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12727,CHEMBL626829,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12728,CHEMBL626830,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12729,CHEMBL627150,,,8594,,Intermediate,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12730,CHEMBL627151,,,8594,,Intermediate,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12731,CHEMBL627152,,,8594,,Intermediate,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12732,CHEMBL627153,,,8594,,Intermediate,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,50597,
,1,,,,,BAO_0000019,A,U,,12733,CHEMBL627154,,,12904,,Autocuration,,Rate of acetate production by the compound was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12734,CHEMBL627155,,,12904,,Autocuration,,Rate of acetate production by the compound was determined; Not determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12735,CHEMBL627156,,,3730,,Autocuration,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,0,,22224,
,1,,,,,BAO_0000019,A,U,,12736,CHEMBL627157,,,3627,,Autocuration,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12737,CHEMBL627158,,,13799,,Intermediate,9986.0,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12738,CHEMBL627159,Plasma,,13799,1969.0,Intermediate,9986.0,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,50592,
,1,,,,Mus musculus,BAO_0000218,A,N,,12739,CHEMBL627160,,,13799,,Intermediate,10090.0,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12740,CHEMBL628540,,,13799,,Intermediate,10116.0,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12741,CHEMBL628541,Plasma,,13799,1969.0,Intermediate,10116.0,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12742,CHEMBL628542,Plasma,,13799,1969.0,Intermediate,10116.0,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,50597,
,1,,,,,BAO_0000100,P,U,,12743,CHEMBL628543,,,6629,,Autocuration,,Solubility after at a pH 1.2,0,,22229,
,1,,,,,BAO_0000100,P,U,,12744,CHEMBL628544,,,6629,,Autocuration,,Solubility after at pH 1.2,0,,22229,
,1,,,,,BAO_0000100,P,U,,12745,CHEMBL628545,,,6629,,Autocuration,,Solubility after injection of water,0,,22229,
,1,,,,,BAO_0000019,A,U,,12746,CHEMBL628546,,,14000,,Autocuration,,Statistical significance of IC 50 values; Expressed as R value,0,,22224,
,1,,,,,BAO_0000019,A,U,,12747,CHEMBL874455,,,8267,,Autocuration,,Systemic availability with respect to methyldopa was determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12748,CHEMBL628547,,,13799,,Intermediate,10116.0,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12749,CHEMBL628548,Plasma,,13799,1969.0,Intermediate,10116.0,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,1,,50597,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12750,CHEMBL628549,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12751,CHEMBL628550,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12752,CHEMBL628551,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12753,CHEMBL628552,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12754,CHEMBL628553,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12755,CHEMBL628554,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12756,CHEMBL628555,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12757,CHEMBL628556,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12758,CHEMBL628557,Kidney,,7132,2113.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12759,CHEMBL628558,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12760,CHEMBL628559,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12761,CHEMBL628560,Feces,,7132,1988.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12762,CHEMBL874456,Urine,,7132,1088.0,Intermediate,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12763,CHEMBL628561,Feces,,7132,1988.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12764,CHEMBL628562,Feces,,7132,1988.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12765,CHEMBL628563,Urine,,7132,1088.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12766,CHEMBL628564,Urine,,7132,1088.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12767,CHEMBL628565,Urine,,7132,1088.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12768,CHEMBL631248,Urine,,7132,1088.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12769,CHEMBL631249,Urine,,7132,1088.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12770,CHEMBL627214,Kidney,,7132,2113.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12771,CHEMBL874591,Feces,,7132,1988.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12772,CHEMBL627215,Feces,,7132,1988.0,Intermediate,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12773,CHEMBL625471,Feces,,7132,1988.0,Intermediate,9986.0,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12774,CHEMBL625472,,,7132,,Intermediate,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12775,CHEMBL625473,,,7132,,Intermediate,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,1,,50592,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12776,CHEMBL625474,,,13317,,Intermediate,9615.0,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12777,CHEMBL625475,,,15341,,Intermediate,9615.0,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12778,CHEMBL625476,,,15341,,Intermediate,10116.0,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12779,CHEMBL625477,,,15341,,Intermediate,10116.0,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12780,CHEMBL625478,,,15341,,Intermediate,10116.0,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,12781,CHEMBL625479,esophageal tunica muscularis mucosae,,12801,,Intermediate,10116.0,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,1,,50597,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,12782,CHEMBL625480,esophageal tunica muscularis mucosae,,12801,,Intermediate,10116.0,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12783,CHEMBL625481,Plasma,,14856,1969.0,Intermediate,10116.0,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12784,CHEMBL625482,,,14062,,Intermediate,10116.0,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12785,CHEMBL625483,,,14062,,Intermediate,10116.0,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12786,CHEMBL625484,,,14062,,Intermediate,10116.0,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12787,CHEMBL625485,,,14062,,Intermediate,10116.0,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12788,CHEMBL625486,Plasma,,14346,1969.0,Intermediate,9615.0,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12789,CHEMBL625487,Plasma,,14346,1969.0,Intermediate,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12790,CHEMBL625488,Plasma,,14346,1969.0,Intermediate,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12791,CHEMBL625489,Plasma,,14346,1969.0,Intermediate,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12792,CHEMBL625490,Plasma,,14346,1969.0,Intermediate,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12793,CHEMBL625491,Plasma,,14346,1969.0,Intermediate,9615.0,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12794,CHEMBL625492,Plasma,,14346,1969.0,Intermediate,10116.0,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,1,,50597,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,12795,CHEMBL625493,Plasma,,15711,1969.0,Intermediate,9606.0,plasma clearance in human,1,,50587,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12796,CHEMBL625494,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12797,CHEMBL625495,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12798,CHEMBL625496,,,14886,,Intermediate,10116.0,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,50597,
,1,,,,,BAO_0000100,P,U,,12799,CHEMBL625497,,,4115,,Autocuration,,1-Octanol/water partition coefficient measured at 7.4,0,,22229,
,1,,,,,BAO_0000100,P,U,,12800,CHEMBL625498,,,13733,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12801,CHEMBL625499,,,12102,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,12802,CHEMBL625500,,,12676,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12803,CHEMBL625501,,,13733,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12804,CHEMBL625502,,,13740,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12805,CHEMBL625503,,,12766,,Autocuration,,Calculated partition coefficient (clogP) (relative to BAY K 8644),0,,22229,
,1,,,,,BAO_0000100,P,U,,12806,CHEMBL625504,,,2764,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12807,CHEMBL625505,,,12355,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12808,CHEMBL625506,,,11314,,Autocuration,,Calculated partition coefficient of the compound,0,,22229,
,1,,,,,BAO_0000019,A,U,,12809,CHEMBL625507,,,12706,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,12810,CHEMBL625508,,,12645,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12811,CHEMBL625509,,,13668,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12812,CHEMBL625510,,,12819,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12813,CHEMBL883125,,,13668,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12814,CHEMBL625511,,,13017,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12815,CHEMBL874650,,,2448,,Autocuration,,Partition coefficient of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,12816,CHEMBL625512,,,11526,,Autocuration,,Partition coefficient of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,12817,CHEMBL625513,,,12426,,Autocuration,,Partition coefficient of compound was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12818,CHEMBL625514,,,2448,,Autocuration,,Partition coefficient was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,12819,CHEMBL625515,,,12001,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12820,CHEMBL625516,,,12426,,Autocuration,,partition coefficient of compound was determined,0,,22229,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12821,CHEMBL625517,,,13204,,Intermediate,9615.0,The total body administered intravenously in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12822,CHEMBL625518,,,13204,,Intermediate,10116.0,The total body administered intravenously in rats,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,12823,CHEMBL625519,,,13889,,Intermediate,10090.0,Time taken for the administration to female NIH mice weighing 25-30 g.,1,,50594,
,1,,,,,BAO_0000019,A,U,,12824,CHEMBL625520,,,13889,,Autocuration,,Time taken for the administration,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,12825,CHEMBL874651,,,17025,,Intermediate,9615.0,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,12826,CHEMBL625521,,,17025,,Autocuration,314293.0,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,0,,22224,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,N,,12827,CHEMBL623171,,,17025,,Intermediate,9986.0,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,50592,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,12828,CHEMBL623853,,,17025,,Intermediate,10116.0,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,1,,50597,
,1,,,,,BAO_0000019,A,U,,12829,CHEMBL623854,,,15067,,Autocuration,,Plasma clearance for the compound was determined.,0,,22224,
,1,,,,,BAO_0000100,P,U,,12830,CHEMBL874405,,,3091,,Autocuration,,CLog P value of the compound,0,,22224,
,1,,,,,BAO_0000100,P,U,,12831,CHEMBL623855,,,15592,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12832,CHEMBL623856,,,14738,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12833,CHEMBL623857,,,14738,,Autocuration,,ClogP value of the compound; nd ='no data',0,,22224,
,1,,,,,BAO_0000100,P,U,,12834,CHEMBL623858,,,14738,,Autocuration,,ClogP value of the compound; nd ='not determined',0,,22224,
,1,,,,,BAO_0000100,P,U,,12835,CHEMBL623859,,,6076,,Autocuration,,CLog P was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,12836,CHEMBL839829,,,17840,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12837,CHEMBL623860,,,13589,,Autocuration,,CLogP was calculated,0,,22224,
,1,,,,,BAO_0000019,A,U,,12838,CHEMBL623861,,,17655,,Autocuration,,CLogP value was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12839,CHEMBL623862,,,5867,,Autocuration,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,0,,22224,
,1,,,,,BAO_0000100,P,U,,12840,CHEMBL874406,,,5867,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12841,CHEMBL623863,,,10783,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12842,CHEMBL624021,,,14849,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12843,CHEMBL624022,Adrenal medulla,,8170,1236.0,Intermediate,9615.0,Distribution in female dog adrenal medulla 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12844,CHEMBL624023,Adrenal medulla,,8170,1236.0,Intermediate,9615.0,Distribution in female dog adrenal medulla 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12845,CHEMBL624024,,,8170,,Intermediate,9615.0,Distribution in female dog bile 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12846,CHEMBL624025,,,8170,,Intermediate,9615.0,Distribution in female dog bile 72 hr after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12847,CHEMBL624026,,,8170,,Intermediate,9615.0,Distribution in female dog blood 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12848,CHEMBL624027,,,8170,,Intermediate,9615.0,Distribution in female dog blood 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12849,CHEMBL624028,,,8170,,Intermediate,9615.0,Distribution in female dog heart 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12850,CHEMBL624029,,,8170,,Intermediate,9615.0,Distribution in female dog heart 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12851,CHEMBL624030,,,8170,,Intermediate,9615.0,Distribution in female dog kidney 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12852,CHEMBL624031,,,8170,,Intermediate,9615.0,Distribution in female dog kidney 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12853,CHEMBL624032,Intestine,,8170,160.0,Intermediate,9615.0,Distribution in female dog large intestine 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12854,CHEMBL874407,Intestine,,8170,160.0,Intermediate,9615.0,Distribution in female dog large intestine 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12855,CHEMBL624033,,,8170,,Intermediate,9615.0,Distribution in female dog liver 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12856,CHEMBL624034,,,8170,,Intermediate,9615.0,Distribution in female dog liver 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12857,CHEMBL624035,,,8170,,Intermediate,9615.0,Distribution in female dog lung 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12858,CHEMBL624036,,,8170,,Intermediate,9615.0,Distribution in female dog lung 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12859,CHEMBL624037,Muscle tissue,,8170,2385.0,Intermediate,9615.0,Distribution in female dog muscle 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12860,CHEMBL624038,Muscle tissue,,8170,2385.0,Intermediate,9615.0,Distribution in female dog muscle 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12861,CHEMBL624039,,,8170,,Intermediate,9615.0,Distribution in female dog pancreas 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12862,CHEMBL624040,,,8170,,Intermediate,9615.0,Distribution in female dog pancreas 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12863,CHEMBL624041,Intestine,,8170,160.0,Intermediate,9615.0,Distribution in female dog small intestine 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12864,CHEMBL624042,Intestine,,8170,160.0,Intermediate,9615.0,Distribution in female dog small intestine 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12865,CHEMBL624043,Spleen,,8170,2106.0,Intermediate,9615.0,Distribution in female dog spleen 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12866,CHEMBL624044,Spleen,,8170,2106.0,Intermediate,9615.0,Distribution in female dog spleen 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12867,CHEMBL624045,Stomach,,8170,945.0,Intermediate,9615.0,Distribution in female dog stomach 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12868,CHEMBL624046,Stomach,,8170,945.0,Intermediate,9615.0,Distribution in female dog stomach 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12869,CHEMBL624047,Thyroid gland,,8170,2046.0,Intermediate,9615.0,Distribution in female dog thyroid 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12870,CHEMBL624048,Thyroid gland,,8170,2046.0,Intermediate,9615.0,Distribution in female dog thyroid 72 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12871,CHEMBL874408,Urine,,8170,1088.0,Intermediate,9615.0,Distribution in female dog urine 24 hours after administration.,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12872,CHEMBL624049,Urine,,8170,1088.0,Intermediate,9615.0,Distribution in female dog urine 72 hr after administration.,1,,50588,
,1,,,,,BAO_0000218,A,U,,12873,CHEMBL624050,Plasma,,14283,1969.0,Autocuration,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,12874,CHEMBL624051,,,5623,,Autocuration,,Plasma concentration at 7 hr after intravenous dosing,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12875,CHEMBL623278,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12876,CHEMBL623279,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12877,CHEMBL623280,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 1 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12878,CHEMBL623963,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 2 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12879,CHEMBL623964,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 4 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12880,CHEMBL623965,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg iv after 6 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12881,CHEMBL623966,,,13477,,Intermediate,10116.0,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12882,CHEMBL874415,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12883,CHEMBL623967,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12884,CHEMBL623968,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12885,CHEMBL623969,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12886,CHEMBL628409,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12887,CHEMBL628410,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12888,CHEMBL628411,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12889,CHEMBL628412,,,13477,,Intermediate,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,1,,50597,
,1,,,,,BAO_0000019,A,U,,12890,CHEMBL628413,,,12553,,Autocuration,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,0,,22224,
,1,,,,,BAO_0000019,A,U,,12891,CHEMBL628414,Plasma,,14548,1969.0,Autocuration,,The concentration in plasmat; Not determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12892,CHEMBL628415,,,14393,,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in blood,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12893,CHEMBL628416,,,14393,,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in brown fat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12894,CHEMBL628417,,,14393,,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in heart,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12895,CHEMBL874908,Liver,,14393,2107.0,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in liver,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12896,CHEMBL628418,,,14393,,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in plasma,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12897,CHEMBL628419,Muscle tissue,,14393,2385.0,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12898,CHEMBL628420,,,14393,,Intermediate,10116.0,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,1,,50597,
,1,,,,,BAO_0000019,A,U,,12899,CHEMBL628421,,,1629,,Autocuration,,Water solubility at 37 degree C.,0,,22224,
,1,,,,,BAO_0000100,P,U,,12900,CHEMBL626726,,,8194,,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,12901,CHEMBL626727,,,8194,,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,0,,22229,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12902,CHEMBL626728,Blood,,8594,178.0,Intermediate,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12903,CHEMBL626729,Blood,,8594,178.0,Intermediate,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12904,CHEMBL626730,Blood,,8594,178.0,Intermediate,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12905,CHEMBL626731,Blood,,8594,178.0,Intermediate,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12906,CHEMBL626732,Blood,,8594,178.0,Intermediate,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12907,CHEMBL626733,Heart,,8594,948.0,Intermediate,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12908,CHEMBL626734,Heart,,8594,948.0,Intermediate,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12909,CHEMBL626735,Heart,,8594,948.0,Intermediate,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12910,CHEMBL874909,Heart,,8594,948.0,Intermediate,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12911,CHEMBL626736,Heart,,8594,948.0,Intermediate,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12912,CHEMBL626737,Kidney,,8594,2113.0,Intermediate,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12913,CHEMBL630999,Kidney,,8594,2113.0,Intermediate,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12914,CHEMBL631000,Kidney,,8594,2113.0,Intermediate,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12915,CHEMBL631001,Kidney,,8594,2113.0,Intermediate,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12916,CHEMBL631002,Kidney,,8594,2113.0,Intermediate,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12917,CHEMBL631003,Liver,,8594,2107.0,Intermediate,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12918,CHEMBL631004,Liver,,8594,2107.0,Intermediate,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12919,CHEMBL631005,Liver,,8594,2107.0,Intermediate,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12920,CHEMBL631006,Liver,,8594,2107.0,Intermediate,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12921,CHEMBL631007,Liver,,8594,2107.0,Intermediate,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12922,CHEMBL631008,Lung,,8594,2048.0,Intermediate,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12923,CHEMBL631009,Lung,,8594,2048.0,Intermediate,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12924,CHEMBL631010,Lung,,8594,2048.0,Intermediate,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12925,CHEMBL631011,Lung,,8594,2048.0,Intermediate,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12926,CHEMBL631012,Lung,,8594,2048.0,Intermediate,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12927,CHEMBL630271,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12928,CHEMBL630272,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12929,CHEMBL630273,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12930,CHEMBL630274,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12931,CHEMBL630275,Thyroid gland,,8594,2046.0,Intermediate,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12932,CHEMBL875782,,,8594,,Intermediate,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12933,CHEMBL630276,,,8594,,Intermediate,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12934,CHEMBL630277,,,8594,,Intermediate,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12935,CHEMBL630278,,,8594,,Intermediate,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12936,CHEMBL630279,,,8594,,Intermediate,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,1,,50597,
,1,,,,,BAO_0000019,A,U,,12937,CHEMBL630280,,,8151,,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,12938,CHEMBL630281,,,8151,,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12939,CHEMBL630282,,,7132,,Intermediate,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12940,CHEMBL630283,,,7132,,Intermediate,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,1,,50592,
,1,,,,,BAO_0000019,A,U,,12941,CHEMBL630284,,,5797,,Autocuration,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),0,,22224,
,1,,,,,BAO_0000019,A,U,,12942,CHEMBL630285,,,7849,,Autocuration,,Alkylating activity was determined,0,,22224,
,1,,,,,BAO_0000251,A,U,,12943,CHEMBL630286,,Microsomes,14220,,Autocuration,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12944,CHEMBL630069,,,8650,,Intermediate,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12945,CHEMBL630070,,,8650,,Intermediate,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12946,CHEMBL630071,,,8650,,Intermediate,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12947,CHEMBL630072,,,8650,,Intermediate,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12948,CHEMBL875110,,,8650,,Intermediate,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",1,,50592,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12949,CHEMBL630073,,,7116,,Intermediate,10116.0,Compound was tested for antidiuretic activity in rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,12950,CHEMBL630074,,,14131,,Autocuration,,Compound was tested for inactivation kinetic values,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,12951,CHEMBL630075,,,7415,,Autocuration,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,0,,22224,
,1,,,,,BAO_0000019,A,U,,12952,CHEMBL630076,,,13178,,Autocuration,,Dissociation rate calculated from the first-order equation using the t1/2 value,0,,22224,
,1,,,,,BAO_0000100,P,U,,12953,CHEMBL630077,,,8815,,Autocuration,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,0,,22229,
,1,,,,,BAO_0000100,P,U,,12954,CHEMBL630078,,,1450,,Autocuration,,Aqueous solubility was measured,0,,22229,
,1,,,,,BAO_0000100,P,U,,12955,CHEMBL630079,,,1450,,Autocuration,,Aqueous solubility was measured at a pH 4,0,,22229,
,1,,,,,BAO_0000100,P,U,,12956,CHEMBL630080,,,1450,,Autocuration,,Aqueous solubility (pH 7),0,,22229,
,1,,,,,BAO_0000100,P,U,,12957,CHEMBL630081,,,1450,,Autocuration,,Aqueous solubility was measured at a pH 9,0,,22229,
,1,,,,,BAO_0000019,A,U,,12958,CHEMBL630082,,,12711,,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",0,,22224,
,1,,,,,BAO_0000019,A,U,,12959,CHEMBL630083,,,12711,,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",0,,22224,
,1,,,,,BAO_0000019,A,U,,12960,CHEMBL630084,,,12711,,Autocuration,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",0,,22224,
,1,,,,,BAO_0000100,P,U,,12961,CHEMBL629198,,,15032,,Autocuration,,Aqueous solubility of the compound,0,,22229,
,1,,,,,BAO_0000100,P,U,,12962,CHEMBL629199,,,9964,,Autocuration,,Aqueous solubility at 37 degree Celsius at pH 7.38,0,,22229,
,1,,,,,BAO_0000100,P,U,,12963,CHEMBL629200,,,14962,,Autocuration,,Aqueous solubility in pH 7.4 phosphate buffer,0,,22229,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12964,CHEMBL629201,,,12487,,Intermediate,9615.0,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,12965,CHEMBL629202,,,12487,,Intermediate,9615.0,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,1,,50588,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12966,CHEMBL875111,,,10026,,Intermediate,9606.0,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12967,CHEMBL629203,,,10026,,Intermediate,9606.0,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12968,CHEMBL629204,,,10026,,Intermediate,9606.0,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12969,CHEMBL629205,,,10026,,Intermediate,9606.0,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,12970,CHEMBL629206,,,10026,,Intermediate,9606.0,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,1,,50587,
,1,,,,,BAO_0000019,A,U,,12971,CHEMBL631185,,,10026,,Autocuration,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,12972,CHEMBL631186,,,7415,,Intermediate,10116.0,Compound was evaluated for the average bile flow rat in rats,1,,50597,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12973,CHEMBL631187,,,17025,,Intermediate,9986.0,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,12974,CHEMBL631188,,,17025,,Intermediate,9986.0,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,50592,
,1,,,,,BAO_0000019,A,U,,12975,CHEMBL876419,,,10184,,Autocuration,,Average half life period was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,12976,CHEMBL631189,,,10184,,Autocuration,,Average half life period was determined,0,,22224,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12977,CHEMBL631190,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12978,CHEMBL631191,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12979,CHEMBL631192,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12980,CHEMBL632400,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12981,CHEMBL630564,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12982,CHEMBL630565,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12983,CHEMBL630566,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12984,CHEMBL631229,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,12985,CHEMBL631230,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,1,,50602,
,1,,,,,BAO_0000100,P,U,,12986,CHEMBL876428,,,6030,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12987,CHEMBL631231,,,6147,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12988,CHEMBL631232,,,14556,,Autocuration,,Calculated partition coefficient (clogP) (MacLogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12989,CHEMBL631233,,,768,,Autocuration,,Hydrophilicity was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,12990,CHEMBL631234,,,14452,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12991,CHEMBL883126,,,5237,,Autocuration,,Increased absorption was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,12992,CHEMBL631235,,,14378,,Autocuration,,Lipophilicity value was evaluated,0,,22224,
,1,,,,,BAO_0000100,P,U,,12993,CHEMBL631236,,,14418,,Autocuration,,Log P value of the compound.,0,,22224,
,1,,,,,BAO_0000019,A,U,,12994,CHEMBL631237,,,5249,,Autocuration,,Partition coefficient of compound was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,12995,CHEMBL631238,,,14621,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,12996,CHEMBL876429,,,12542,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,12997,CHEMBL631414,,,12542,,Autocuration,,Partition coefficient was measured by medchem software; Not calculated,0,,22224,
,1,,,,,BAO_0000100,P,U,,12998,CHEMBL631415,,,12542,,Autocuration,,Partition coefficient was measured by octanol-water using standard shake-flask method,0,,22224,
,1,,,,,BAO_0000100,P,U,,12999,CHEMBL631416,,,15462,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13000,CHEMBL631417,,,14884,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,13001,CHEMBL631418,,,16526,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13002,CHEMBL631419,,,13693,,Autocuration,,The Octanol/Water partition coefficient CLogP,0,,22229,
,1,,,,,BAO_0000019,A,U,,13003,CHEMBL631420,,,13693,,Autocuration,,The pharmacokinetic parameter C Log p was reported,0,,22224,
,1,,,,,BAO_0000100,P,U,,13004,CHEMBL631421,,,13779,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13005,CHEMBL631422,,,14772,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13006,CHEMBL631423,,,14393,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13007,CHEMBL876430,Plasma,,14793,1969.0,Intermediate,10116.0,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13008,CHEMBL631424,Plasma,,14793,1969.0,Intermediate,10116.0,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13009,CHEMBL631425,Plasma,,13744,1969.0,Intermediate,9615.0,Compound was administered intravenously in dog to evaluate plasma clearance values,1,,50588,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,13010,CHEMBL631426,Plasma,,13744,1969.0,Autocuration,314293.0,Compound was administered intravenously in monkey to evaluate plasma clearance values,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13011,CHEMBL631427,Plasma,,13744,1969.0,Intermediate,10090.0,Compound was administered intravenously in mouse to evaluate plasma clearance values,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13012,CHEMBL631428,Plasma,,13207,1969.0,Intermediate,9615.0,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,1,,50588,
,1,,,In vitro,Macaca mulatta,BAO_0000218,A,N,,13013,CHEMBL631429,Liver,Microsomes,5669,2107.0,Intermediate,9544.0,Intrinsic clearance in Rhesus liver microsome,1,,50797,
,1,,,In vitro,Canis lupus familiaris,BAO_0000218,A,N,,13014,CHEMBL631430,Liver,Microsomes,5669,2107.0,Intermediate,9615.0,Intrinsic clearance in dog liver microsome,1,,50588,
,1,,,In vitro,Rattus norvegicus,BAO_0000218,A,N,,13015,CHEMBL631431,Liver,Microsomes,5669,2107.0,Intermediate,10116.0,Intrinsic clearance in rat liver microsome,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,13016,CHEMBL631432,Plasma,,4853,1969.0,Intermediate,9544.0,Low plasma clearance was calculated in rhesus monkey,1,,50797,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13017,CHEMBL631433,,,16452,,Intermediate,9615.0,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,13018,CHEMBL631434,,,11954,,Autocuration,,Plasma clearance after intravenous dose of 0.3 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13019,CHEMBL631435,,,11954,,Autocuration,,Plasma clearance after intravenous dose of 1 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13020,CHEMBL631436,,,11954,,Autocuration,,Plasma clearance after intravenous dose of 3 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13021,CHEMBL631437,,,11954,,Autocuration,,Plasma clearance after intravenous dose of 3.87 mg/kg,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13022,CHEMBL631438,,,5669,,Intermediate,10116.0,Plasma clearance after peroral administration at 10 mpk in Rat,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,13023,CHEMBL876431,,,5669,,Intermediate,9544.0,Plasma clearance after peroral administration at 10 mpk in Rhesus,1,,50797,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13024,CHEMBL631439,,,5669,,Intermediate,9615.0,Plasma clearance after peroral administration at 10 mpk in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13025,CHEMBL631440,,,13662,,Intermediate,10116.0,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,1,,50597,
,1,,,,,BAO_0000019,A,U,,13026,CHEMBL631441,,,8272,,Autocuration,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),0,,22224,
,1,,,,,BAO_0000019,A,U,,13027,CHEMBL631442,,,13410,,Autocuration,,Critical Micellar concentration was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,13028,CHEMBL626525,,,13410,,Autocuration,,Critical Micellar concentration of the compound. was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,13029,CHEMBL627168,,,12628,,Autocuration,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,0,,22224,
,1,,,,,BAO_0000019,A,U,,13030,CHEMBL875618,,,9675,,Autocuration,,Critical micellar concentration was measured in water by the dye solubilization method,0,,22224,
,1,,,,,BAO_0000019,B,U,,13031,CHEMBL626612,,,12628,,Autocuration,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,0,,22224,
,1,,,,,BAO_0000019,A,U,,13032,CHEMBL626613,,,12766,,Autocuration,,CMR value (relative to BAY K 8644),0,,22224,
,1,,,,,BAO_0000019,A,U,,13033,CHEMBL626614,,,7849,,Autocuration,,Carbamoylating activity was determined,0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13034,CHEMBL626615,,,12187,,Autocuration,314293.0,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,0,,22224,
,1,,,,,BAO_0000019,A,U,,13035,CHEMBL626616,,,2040,,Autocuration,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,0,,22224,
,1,,,,,BAO_0000019,A,U,,13036,CHEMBL626617,,,2040,,Autocuration,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13037,CHEMBL626618,Plasma,,14180,1969.0,Intermediate,9615.0,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13038,CHEMBL626619,Plasma,,14180,1969.0,Intermediate,10116.0,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13039,CHEMBL626620,,,14474,,Intermediate,9615.0,"Clearance rate at 0.46 mg/kg, iv, in dogs",1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13040,CHEMBL626621,,,14474,,Intermediate,10116.0,"Clearance rate at 5.5 mg/kg, iv, in rat",1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,13041,CHEMBL626622,,,14548,,Intermediate,9541.0,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,100710,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,13042,CHEMBL626623,,,14548,,Intermediate,9541.0,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,100710,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13043,CHEMBL626624,,,14548,,Intermediate,9615.0,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13044,CHEMBL626625,,,14548,,Intermediate,10116.0,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,50597,
,1,,,Ex vivo,Rattus norvegicus,BAO_0000218,A,N,,13045,CHEMBL626626,Liver,,6125,2107.0,Intermediate,10116.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13046,CHEMBL626627,,,6874,,Autocuration,,Tested for the total clearance of the compound,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13047,CHEMBL626628,,,15343,,Intermediate,9615.0,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,13048,CHEMBL626629,,,6236,,Autocuration,,Total body clearance was determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13049,CHEMBL626630,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13050,CHEMBL626631,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,50597,
,1,,,,,BAO_0000100,P,U,,13051,CHEMBL626632,,,8194,,Autocuration,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,13052,CHEMBL626633,,,8194,,Autocuration,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,13053,CHEMBL626634,,,8194,,Autocuration,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,13054,CHEMBL626635,,,8194,,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,13055,CHEMBL626636,,,8194,,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,0,,22229,
,1,,,,,BAO_0000100,P,U,,13056,CHEMBL626637,,,8194,,Autocuration,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,0,,22229,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13057,CHEMBL626638,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13058,CHEMBL626639,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13059,CHEMBL626640,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13060,CHEMBL626641,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13061,CHEMBL627272,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13062,CHEMBL627273,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13063,CHEMBL627441,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13064,CHEMBL628355,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13065,CHEMBL628356,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13066,CHEMBL628357,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13067,CHEMBL628358,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),1,,50339,
,1,,,,Pneumocystis carinii,BAO_0000218,A,N,,13068,CHEMBL622307,,,13273,,Intermediate,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),1,,50339,
,1,,,,,BAO_0000019,A,U,,13069,CHEMBL622527,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,0,,22224,
,1,,,,,BAO_0000019,A,U,,13070,CHEMBL622528,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,0,,22224,
,1,,,,,BAO_0000019,A,U,,13071,CHEMBL622529,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,13072,CHEMBL622992,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,0,,22224,
,1,,,,,BAO_0000019,A,U,,13073,CHEMBL622993,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,0,,22224,
,1,,,,,BAO_0000019,A,U,,13074,CHEMBL622994,,,13118,,Autocuration,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13075,CHEMBL622995,,,10633,,Intermediate,10116.0,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13076,CHEMBL622996,,,10633,,Intermediate,10116.0,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13077,CHEMBL622997,,,10633,,Intermediate,10116.0,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13078,CHEMBL622998,,,10633,,Intermediate,10116.0,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",1,,50597,
,1,,,,,BAO_0000218,A,U,,13079,CHEMBL622999,,,5767,,Autocuration,,Cp max following ip administration at 1 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13080,CHEMBL623000,Plasma,,3302,1969.0,Autocuration,,Maximum concentration in plasma was reported at 0.5 hour,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13081,CHEMBL623001,Plasma,,3302,1969.0,Autocuration,,Maximum concentration in plasma was reported at 2 hour,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,13082,CHEMBL623002,,,12467,,Intermediate,10090.0,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,1,,50594,
,1,,,,,BAO_0000100,P,U,,13083,CHEMBL623003,,,11778,,Autocuration,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),0,,22229,
,1,,,,,BAO_0000019,A,U,,13084,CHEMBL623004,,,4321,,Autocuration,,Steady state concentration was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,13085,CHEMBL623005,,,14884,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000019,A,U,,13086,CHEMBL623006,,,15234,,Autocuration,,Partition coefficient (logD7.4),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13087,CHEMBL623007,Liver,,14198,2107.0,Intermediate,10116.0,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13088,CHEMBL623008,Bone,,14198,10000001.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13089,CHEMBL876654,Cerebellum,,14198,2037.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13090,CHEMBL623009,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13091,CHEMBL623010,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13092,CHEMBL623011,Heart,,14198,948.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13093,CHEMBL623012,Intestine,,14198,160.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,1,,50597,
,1,,,,,BAO_0000019,A,U,,13094,CHEMBL623013,,,8151,,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,13095,CHEMBL623014,,,8151,,Autocuration,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,13096,CHEMBL623015,Urine,,8151,1088.0,Autocuration,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,13097,CHEMBL623016,Urine,,8151,1088.0,Autocuration,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,0,,22224,
,1,,,,,BAO_0000019,A,U,,13098,CHEMBL624858,Urine,,8151,1088.0,Autocuration,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13099,CHEMBL624859,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13100,CHEMBL624860,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13101,CHEMBL624861,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13102,CHEMBL624862,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13103,CHEMBL624863,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13104,CHEMBL876655,,,8151,,Intermediate,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13105,CHEMBL624864,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13106,CHEMBL624865,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13107,CHEMBL624866,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,F,N,,13108,CHEMBL624867,,,6996,,Expert,9615.0,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13109,CHEMBL624868,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13110,CHEMBL628450,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13111,CHEMBL628451,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13112,CHEMBL628452,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13113,CHEMBL628453,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13114,CHEMBL628454,,,6996,,Intermediate,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13115,CHEMBL628455,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13116,CHEMBL628456,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13117,CHEMBL628457,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13118,CHEMBL877505,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13119,CHEMBL628458,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13120,CHEMBL628459,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13121,CHEMBL628460,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13122,CHEMBL628461,,,6996,,Intermediate,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,50588,
,1,,,,,BAO_0000218,B,U,,13123,CHEMBL628462,,,6996,,Autocuration,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13124,CHEMBL628463,,,6996,,Intermediate,9615.0,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,F,N,,13125,CHEMBL625666,,,6996,,Expert,10116.0,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",1,,50597,
,1,,,,,BAO_0000218,B,U,,13126,CHEMBL625667,,,6996,,Autocuration,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13127,CHEMBL625668,,,6996,,Expert,10116.0,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13128,CHEMBL625669,,,6996,,Intermediate,10116.0,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,50597,
,1,,,,,BAO_0000019,A,U,,13129,CHEMBL625670,,,7114,,Autocuration,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13130,CHEMBL625671,,,7114,,Intermediate,10116.0,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,1,,50597,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13131,CHEMBL625672,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13132,CHEMBL625673,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13133,CHEMBL625674,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13134,CHEMBL625675,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13135,CHEMBL627637,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13136,CHEMBL627638,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13137,CHEMBL627639,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13138,CHEMBL627640,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13139,CHEMBL627641,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13140,CHEMBL627642,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,13141,CHEMBL877506,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,50602,
,1,,,,Mus musculus,BAO_0000218,A,N,,13142,CHEMBL627275,,,8613,,Intermediate,10090.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,50594,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13143,CHEMBL627643,,,11219,,Intermediate,9669.0,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13144,CHEMBL631246,,,11219,,Intermediate,9669.0,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13145,CHEMBL631247,,,11219,,Intermediate,9669.0,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13146,CHEMBL629532,,,11219,,Intermediate,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13147,CHEMBL629533,,,11219,,Intermediate,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13148,CHEMBL629534,,,11219,,Intermediate,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,50506,
,1,,,,Mustela putorius furo,BAO_0000218,A,N,,13149,CHEMBL629535,,,11219,,Intermediate,9669.0,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,1,,50506,
,1,,,,,BAO_0000019,A,U,,13150,CHEMBL625932,,,14837,,Autocuration,,Pharmacokinetic parameter :drug bound to plasma was reported,0,,22224,
,1,,,,,BAO_0000019,A,U,,13151,CHEMBL625933,,,14837,,Autocuration,,compound was evaluated for drug bound in plasma,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13152,CHEMBL625934,,,15343,,Intermediate,10116.0,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,1,,50597,
,1,,,,Eutheria,BAO_0000218,A,U,,13153,CHEMBL625935,,,13761,,Autocuration,9347.0,Bioavailability,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13154,CHEMBL625936,,,14810,,Intermediate,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13155,CHEMBL625937,,,14810,,Intermediate,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13156,CHEMBL625938,,,13249,,Intermediate,9615.0,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13157,CHEMBL625939,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13158,CHEMBL625940,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13159,CHEMBL874464,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13160,CHEMBL625941,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13161,CHEMBL625942,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13162,CHEMBL625943,Bile,,9267,1970.0,Intermediate,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,1,,50597,
,1,,,,Homo sapiens,BAO_0000218,A,N,,13163,CHEMBL625944,Serum,,15549,1977.0,Intermediate,9606.0,In vitro protein binding in human serum at 5 ug/ml,1,,50587,
,1,,,,,BAO_0000019,A,U,,13164,CHEMBL625945,,,10929,,Autocuration,,Serum protein binding ability was measured,0,,22224,
,1,,,,,BAO_0000019,A,U,,13165,CHEMBL625946,,,15444,,Autocuration,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,13166,CHEMBL625947,,,12860,,Autocuration,9615.0,Oral bioavailability in dog,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13167,CHEMBL625948,,,12170,,Intermediate,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13168,CHEMBL625949,,,15173,,Autocuration,,Absolute oral bioavailability at an iv dose of 14 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13169,CHEMBL625950,,,15173,,Autocuration,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,0,,22224,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,13170,CHEMBL625951,,,15173,,Autocuration,9347.0,Oral bioavailability (dose 15 mg/kg i.v.),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13171,CHEMBL625952,,,15173,,Autocuration,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13172,CHEMBL625953,,,15173,,Autocuration,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13173,CHEMBL625954,,,15173,,Autocuration,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13174,CHEMBL882959,,,15173,,Autocuration,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13175,CHEMBL625955,,,11767,,Intermediate,9615.0,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,1,,50588,
,1,,,In vivo,Mustela putorius furo,BAO_0000218,A,U,,13176,CHEMBL625956,,,11219,,Autocuration,9669.0,Bioavailability in ferret,0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,13177,CHEMBL625957,,,12186,,Intermediate,9541.0,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,1,,100710,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13178,CHEMBL625958,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13179,CHEMBL625959,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13180,CHEMBL626642,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13181,CHEMBL631330,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13182,CHEMBL631331,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13183,CHEMBL631332,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13184,CHEMBL631333,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13185,CHEMBL632018,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13186,CHEMBL632019,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13187,CHEMBL632020,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13188,CHEMBL632021,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13189,CHEMBL632022,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13190,CHEMBL632023,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13191,CHEMBL632024,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13192,CHEMBL874472,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13193,CHEMBL632025,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13194,CHEMBL632026,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13195,CHEMBL632027,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13196,CHEMBL632028,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13197,CHEMBL626430,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13198,CHEMBL626431,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13199,CHEMBL626432,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13200,CHEMBL626433,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13201,CHEMBL626434,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13202,CHEMBL627280,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13203,CHEMBL627281,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13204,CHEMBL627282,,,11510,,Intermediate,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,50597,
,1,,,,,BAO_0000019,A,U,,13205,CHEMBL627283,,,7199,,Autocuration,,Total body clearance was measured at given dose,0,,22224,
,1,,,,,BAO_0000218,A,U,,13206,CHEMBL627284,,,7199,,Autocuration,,Total body clearance was measured at given dose.,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13207,CHEMBL627285,,,7095,,Intermediate,10116.0,Metabolic clearance from the body in rat,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13208,CHEMBL627286,,,7095,,Autocuration,,Renal clearance from the body,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13209,CHEMBL875477,,,7095,,Intermediate,10116.0,Renal clearance from the body in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13210,CHEMBL627287,,,12528,,Intermediate,10116.0,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13211,CHEMBL627288,,,12528,,Intermediate,9615.0,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13212,CHEMBL627289,,,7095,,Intermediate,10116.0,Total clearance from the body in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13213,CHEMBL627290,Plasma,,14223,1969.0,Intermediate,10116.0,Clearance into cortex from rat plasma or PBS,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13214,CHEMBL627291,,,13569,,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13215,CHEMBL627292,,,13569,,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13216,CHEMBL627293,,,13569,,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13217,CHEMBL627294,,,13569,,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13218,CHEMBL875478,,,13569,,Autocuration,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13219,CHEMBL627295,,,13979,,Autocuration,,Clearance was determined,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13220,CHEMBL627296,,,14315,,Intermediate,10090.0,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,1,,50594,
,1,,,In vivo,Oryctolagus cuniculus,BAO_0000218,A,N,,13221,CHEMBL626119,,,14315,,Intermediate,9986.0,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,1,,50592,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13222,CHEMBL626120,,,14315,,Intermediate,10116.0,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13223,CHEMBL626121,,,12174,,Intermediate,10116.0,Clearance in rat after iv dose (100 ug/kg),1,,50597,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,U,,13224,CHEMBL626122,,,12797,,Autocuration,10141.0,Clearance in guinea pig,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13225,CHEMBL626123,,,12797,,Intermediate,10116.0,Compound was evaluated for clearance in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13226,CHEMBL623456,,,12797,,Intermediate,9615.0,Compound was evaluated for the clearance in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13227,CHEMBL623457,,,12797,,Intermediate,10116.0,Compound was evaluated for the clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13228,CHEMBL623458,,,11500,,Intermediate,10116.0,Compound was tested in vivo for clearance after iv administration in the rat,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13229,CHEMBL623459,,,15173,,Autocuration,,IV clearance determined at an iv dose of 14 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13230,CHEMBL875484,,,15173,,Autocuration,,IV clearance determined at an iv dose of 15.2 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13231,CHEMBL623460,,,15173,,Autocuration,,IV clearance determined at an iv dose of 15 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13232,CHEMBL623461,,,15173,,Autocuration,,IV clearance determined at an peroral dose of 30 mg/kg.,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13233,CHEMBL623462,,,15173,,Autocuration,,IV clearance determined at an peroral dose of 30.2 mg/kg.,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13234,CHEMBL627386,,,15173,,Autocuration,,IV clearance determined at an peroral dose of 30.3 mg/kg.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13235,CHEMBL627387,Kidney,,14198,2113.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13236,CHEMBL627388,Liver,,14198,2107.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13237,CHEMBL627389,Lung,,14198,2048.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13238,CHEMBL627390,Muscle tissue,,14198,2385.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13239,CHEMBL627391,Plasma,,14198,1969.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13240,CHEMBL627392,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13241,CHEMBL627393,Spleen,,14198,2106.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13242,CHEMBL627394,Trachea,,14198,3126.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13243,CHEMBL627395,Bone,,14198,10000001.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13244,CHEMBL875485,Cerebellum,,14198,2037.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13245,CHEMBL627396,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13246,CHEMBL627397,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13247,CHEMBL627398,Heart,,14198,948.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13248,CHEMBL627399,Bone,,14198,10000001.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13249,CHEMBL627400,Kidney,,14198,2113.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13250,CHEMBL627401,Liver,,14198,2107.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13251,CHEMBL627402,Lung,,14198,2048.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13252,CHEMBL627403,Muscle tissue,,14198,2385.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13253,CHEMBL627404,Plasma,,14198,1969.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13254,CHEMBL623101,,,14198,,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13255,CHEMBL877480,Spleen,,14198,2106.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13256,CHEMBL623102,Trachea,,14198,3126.0,Intermediate,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13257,CHEMBL623103,Bone,,14198,10000001.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13258,CHEMBL623104,Cerebellum,,14198,2037.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13259,CHEMBL623105,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13260,CHEMBL623106,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13261,CHEMBL623107,Heart,,14198,948.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13262,CHEMBL623108,Intestine,,14198,160.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13263,CHEMBL623109,Kidney,,14198,2113.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13264,CHEMBL623110,Liver,,14198,2107.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13265,CHEMBL623111,Lung,,14198,2048.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13266,CHEMBL625060,Muscle tissue,,14198,2385.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13267,CHEMBL625061,Plasma,,14198,1969.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13268,CHEMBL625062,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13269,CHEMBL625063,Spleen,,14198,2106.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13270,CHEMBL625064,Trachea,,14198,3126.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13271,CHEMBL625065,Bone,,14198,10000001.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13272,CHEMBL625066,Cerebellum,,14198,2037.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13273,CHEMBL625067,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13274,CHEMBL625068,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13275,CHEMBL622159,Heart,,14198,948.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13276,CHEMBL622160,Intestine,,14198,160.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13277,CHEMBL622161,Kidney,,14198,2113.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13278,CHEMBL622162,Lung,,14198,2048.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13279,CHEMBL622163,Muscle tissue,,14198,2385.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13280,CHEMBL622313,Plasma,,14198,1969.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13281,CHEMBL622314,,,14198,,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13282,CHEMBL622315,Spleen,,14198,2106.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13283,CHEMBL622316,Trachea,,14198,3126.0,Intermediate,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,1,,50597,
,1,,,,Escherichia coli,BAO_0000218,A,N,,13284,CHEMBL877486,,,15599,,Intermediate,562.0,Normal diffusion coefficient in water for Escherichia coli,1,,50212,
,1,,,,,BAO_0000019,A,U,,13285,CHEMBL622317,,,8204,,Autocuration,,Average max percent decrease in RVR (renal vascular resistance) was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,13286,CHEMBL622318,,,8204,,Autocuration,,Average max percent decrease in RVR (renal vascular resistance) was determined.,0,,22224,
,1,,,,,BAO_0000019,A,U,,13287,CHEMBL622319,,,6154,,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13288,CHEMBL622320,,,6154,,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13289,CHEMBL622321,,,6154,,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13290,CHEMBL622322,,,6154,,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13291,CHEMBL622323,,,7114,,Autocuration,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13292,CHEMBL622324,,,7114,,Intermediate,10116.0,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13293,CHEMBL622325,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13294,CHEMBL622326,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13295,CHEMBL877487,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13296,CHEMBL622327,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13297,CHEMBL622328,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13298,CHEMBL622329,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13299,CHEMBL622330,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13300,CHEMBL622331,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13301,CHEMBL622332,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13302,CHEMBL622333,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,13303,CHEMBL627658,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13304,CHEMBL630428,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13305,CHEMBL630429,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13306,CHEMBL630430,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13307,CHEMBL630431,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13308,CHEMBL630432,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13309,CHEMBL630433,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13310,CHEMBL630434,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13311,CHEMBL629372,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13312,CHEMBL629553,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13313,CHEMBL629554,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13314,CHEMBL874447,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13315,CHEMBL629555,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13316,CHEMBL629556,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13317,CHEMBL629557,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13318,CHEMBL629558,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13319,CHEMBL629559,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13320,CHEMBL629560,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13321,CHEMBL629561,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13322,CHEMBL629562,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13323,CHEMBL629563,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13324,CHEMBL629564,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13325,CHEMBL629565,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13326,CHEMBL629566,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13327,CHEMBL629567,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13328,CHEMBL629568,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13329,CHEMBL629569,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13330,CHEMBL629570,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,13331,CHEMBL629571,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13332,CHEMBL629572,,,12170,,Autocuration,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13333,CHEMBL629573,,,12170,,Autocuration,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,0,,22224,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,13334,CHEMBL629574,,,4985,,Autocuration,9347.0,Bioavailability (dose 20 mg/kg),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,13335,CHEMBL629575,,,15145,,Autocuration,9615.0,Bioavailability in dog,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13336,CHEMBL874448,,,14080,,Autocuration,10116.0,Bioavailability in rat (Sprague-Dawley) (male),0,,22224,
,1,,,In vivo,Primates,BAO_0000218,A,U,,13337,CHEMBL629576,,,11219,,Autocuration,9443.0,Bioavailability in monkey (dose 10 mg/kg i.d.),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13338,CHEMBL629577,,,15145,,Autocuration,10116.0,Bioavailability in rat,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13339,CHEMBL629578,,,15145,,Autocuration,10116.0,Bioavailability in rat,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,13340,CHEMBL629579,,,1202,,Autocuration,9615.0,Bioavailability in dog (dose 3.0 mg/kg p.o.),0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,13341,CHEMBL882958,,,1202,,Autocuration,9615.0,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,0,,22224,
,1,,,In vivo,Pan troglodytes,BAO_0000218,A,N,,13342,CHEMBL629580,,,1202,,Intermediate,9598.0,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1,,50505,
,1,,,In vivo,Eutheria,BAO_0000218,A,U,,13343,CHEMBL629581,,,4026,,Autocuration,9347.0,Bioavailability,0,,22224,
,1,,,In vivo,Saimiri,BAO_0000218,A,U,,13344,CHEMBL629582,,,1492,,Autocuration,9520.0,Bioavailability in squirrel monkey,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13345,CHEMBL628522,,,12793,,Intermediate,9615.0,Bioavailability was evaluated in dog,1,,50588,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,13346,CHEMBL625432,,,12793,,Intermediate,10026.0,Bioavailability was evaluated in hamster,1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13347,CHEMBL625433,,,12793,,Autocuration,10116.0,Bioavailability in rat,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13348,CHEMBL625434,Plasma,,14793,1969.0,Intermediate,10116.0,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13349,CHEMBL625435,Plasma,,14793,1969.0,Intermediate,10116.0,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13350,CHEMBL625436,,,14793,,Autocuration,10116.0,Bioavailability in rat (dose 10 mg/kg p.o.),0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,13351,CHEMBL874588,,,14731,,Intermediate,9541.0,Bioavailability was measured in cynomolgus monkeys.,1,,100710,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13352,CHEMBL625437,,,14731,,Intermediate,10090.0,Bioavailability was measured in nude mice.,1,,50594,
,1,,,In vivo,Mustela putorius furo,BAO_0000218,A,U,,13353,CHEMBL625438,,,12187,,Autocuration,9669.0,Bioavailability in ferret (dose 10 mg/kg i.d.),0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,13354,CHEMBL625439,,,12187,,Autocuration,314293.0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,13355,CHEMBL625440,,,12187,,Autocuration,314293.0,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",0,,22224,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,13356,CHEMBL625441,,,12187,,Autocuration,314293.0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13357,CHEMBL625442,,,12187,,Autocuration,10116.0,Bioavailability in rat (dose 10 mg/kg i.d.),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13358,CHEMBL625443,,,12187,,Intermediate,10116.0,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13359,CHEMBL625444,,,17431,,Autocuration,,Bioavailability was determined; extremely poor,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13360,CHEMBL625445,,,13318,,Intermediate,10090.0,% bioavailability in mice after oral administration of prodrug,1,,50594,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13361,CHEMBL625446,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13362,CHEMBL882960,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13363,CHEMBL625447,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13364,CHEMBL625448,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13365,CHEMBL625449,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13366,CHEMBL874589,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13367,CHEMBL625450,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13368,CHEMBL625451,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13369,CHEMBL626584,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13370,CHEMBL626585,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13371,CHEMBL626586,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13372,CHEMBL626587,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13373,CHEMBL626588,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13374,CHEMBL626589,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13375,CHEMBL626590,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13376,CHEMBL626591,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13377,CHEMBL627181,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13378,CHEMBL628083,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,13379,CHEMBL628084,,,15173,,Autocuration,,IV clearance determined at an peroral dose of 15 mg/kg.,0,,22224,
,1,,,In vivo,Hymenolepis nana,BAO_0000218,F,N,,13380,CHEMBL628085,,,7732,,Expert,102285.0,Mouse oral clearance was measured against Hymenolepiasis nana.,1,,50064,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,F,N,,13381,CHEMBL628086,,,7732,,Expert,6339.0,Mouse oral clearance was measured against Nematospiroides dubius,1,,50545,
,1,,,In vivo,,BAO_0000218,F,U,,13382,CHEMBL628087,,,7732,,Autocuration,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13383,CHEMBL628088,,,7732,,Intermediate,10090.0,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,,50594,
,1,,,In vivo,,BAO_0000218,B,U,,13384,CHEMBL628089,,,7732,,Autocuration,,Mouse oral clearance was measured against N. nana; NT is Not Tested,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13385,CHEMBL628090,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13386,CHEMBL628091,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13387,CHEMBL628092,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13388,CHEMBL628093,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13389,CHEMBL875607,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13390,CHEMBL625710,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13391,CHEMBL625711,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13392,CHEMBL625712,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13393,CHEMBL625713,,,8328,,Autocuration,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13394,CHEMBL625714,,,13376,,Intermediate,9615.0,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,1,,50588,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,13395,CHEMBL625715,,,13477,,Intermediate,9544.0,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,1,,50797,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13396,CHEMBL625716,,,13477,,Intermediate,10116.0,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13397,CHEMBL625717,,,13477,,Intermediate,10116.0,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13398,CHEMBL625718,,,13313,,Intermediate,10116.0,Plasma clearance was determined for the compound in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13399,CHEMBL625719,,,12504,,Intermediate,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13400,CHEMBL625720,,,12504,,Intermediate,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13401,CHEMBL625721,,,12504,,Intermediate,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13402,CHEMBL625722,,,12504,,Intermediate,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13403,CHEMBL625723,,,13129,,Intermediate,10116.0,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,50597,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,A,N,,13404,CHEMBL625724,,,7732,,Intermediate,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,1,,50545,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,A,N,,13405,CHEMBL625725,,,7732,,Intermediate,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,1,,50545,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,A,N,,13406,CHEMBL625726,,,7732,,Intermediate,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,1,,50545,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,A,N,,13407,CHEMBL875608,,,7732,,Intermediate,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,1,,50545,
,1,,,In vivo,Heligmosomoides polygyrus,BAO_0000218,A,N,,13408,CHEMBL625727,,,7732,,Intermediate,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,1,,50545,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13409,CHEMBL625728,Urine,,9278,1088.0,Autocuration,10116.0,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13410,CHEMBL625729,,,9278,,Autocuration,10116.0,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13411,CHEMBL625730,,,9278,,Autocuration,10116.0,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13412,CHEMBL625731,Urine,,9278,1088.0,Autocuration,10116.0,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,13413,CHEMBL626417,Urine,,9278,1088.0,Autocuration,10116.0,Urinary clearance was determined in rat at 25 mg/kg os dosage,0,,22224,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,13414,CHEMBL626418,Urine,,9278,1088.0,Intermediate,9606.0,Urinary clearance was determined at 100 mg/kg oral dosage in human,1,,50587,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13415,CHEMBL626419,Urine,,9278,1088.0,Intermediate,9615.0,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13416,CHEMBL626592,Plasma,,5932,1969.0,Intermediate,9615.0,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13417,CHEMBL626593,Plasma,,5932,1969.0,Intermediate,10116.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13418,CHEMBL626594,,,5182,,Intermediate,10116.0,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13419,CHEMBL625035,,,10499,,Intermediate,9615.0,Clearance rate in dogs,1,,50588,
,1,,,In vitro,,BAO_0000019,A,U,,13420,CHEMBL625036,,,6051,,Autocuration,,Compound was measured for intrinsic clearance,0,,22224,
,1,,,,,BAO_0000100,P,U,,13421,CHEMBL625037,,,17508,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13422,CHEMBL625038,,,6228,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13423,CHEMBL625039,,,6231,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13424,CHEMBL625040,,,17740,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13425,CHEMBL625041,,,6495,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13426,CHEMBL625042,,,2171,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13427,CHEMBL874411,,,3255,,Autocuration,,Partition coefficient of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,13428,CHEMBL625043,,,6821,,Autocuration,,Permeability,0,,22224,
,1,,,,,BAO_0000100,P,U,,13429,CHEMBL625044,,,2685,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13430,CHEMBL625045,,,17584,,Autocuration,,Partition coefficient (logD),0,,22224,
,1,,,,,BAO_0000100,P,U,,13431,CHEMBL625046,,,13824,,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),0,,22229,
,1,,,,,BAO_0000100,P,U,,13432,CHEMBL625047,,,13824,,Autocuration,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),0,,22229,
,1,,,,,BAO_0000100,P,U,,13433,CHEMBL625048,,,16479,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13434,CHEMBL625049,,,11997,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13435,CHEMBL625050,,,2988,,Autocuration,,Calculated logarithm of partition coefficient (P) was determined,0,,22229,
,1,,,,,BAO_0000100,P,U,,13436,CHEMBL625051,,,931,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13437,CHEMBL874412,,,4381,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13438,CHEMBL625052,,,4397,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13439,CHEMBL625053,,,5889,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13440,CHEMBL623250,,,6154,,Autocuration,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13441,CHEMBL623251,,,6154,,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13442,CHEMBL623252,,,6154,,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13443,CHEMBL623253,,,6154,,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13444,CHEMBL623254,,,6154,,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13445,CHEMBL623255,,,6154,,Autocuration,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,0,,22224,
,1,,,,,BAO_0000019,A,U,,13446,CHEMBL626831,,,6887,,Autocuration,,Percent degradation of compound at a pH of 1 over a 18 hr period,0,,22224,
,1,,,,,BAO_0000019,A,U,,13447,CHEMBL877494,,,6887,,Autocuration,,Percent degradation of compound at pH of 1 over an 18 hr period,0,,22224,
,1,,,,,BAO_0000019,A,U,,13448,CHEMBL626832,,,14116,,Autocuration,,Delta Logarithm of Partition Coefficient value was determined.,0,,22224,
,1,,,,,BAO_0000019,A,U,,13449,CHEMBL626833,,,11137,,Autocuration,,Delta logPoct-cyc,0,,22224,
,1,,,,,BAO_0000100,P,U,,13450,CHEMBL626834,,,7230,,Autocuration,,Lipophilicity estimated on reversed phase TLC,0,,22224,
,1,,,,,BAO_0000019,A,U,,13451,CHEMBL626835,,,15741,,Autocuration,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,0,,22224,
,1,,,,,BAO_0000019,A,U,,13452,CHEMBL626836,,,9663,,Autocuration,,Delta logPoct-cyc,0,,22224,
,1,,,,,BAO_0000100,P,U,,13453,CHEMBL626837,,,9663,,Autocuration,,Change in logarithm of partition coefficient of the compound,0,,22229,
,1,,,,,BAO_0000019,A,U,,13454,CHEMBL626838,,,13807,,Autocuration,,Delta logD (pH 6.5),0,,22224,
,1,,,,,BAO_0000100,P,U,,13455,CHEMBL626839,,,13807,,Autocuration,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",0,,22224,
,1,,,,,BAO_0000019,A,U,,13456,CHEMBL626840,,,17425,,Autocuration,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,0,,22224,
,1,,,,,BAO_0000019,A,U,,13457,CHEMBL626841,,,12143,,Autocuration,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),0,,22224,
,1,,,,,BAO_0000219,A,U,,13458,CHEMBL626842,,,12608,,Autocuration,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,0,,22224,
,1,,,,,BAO_0000219,A,U,,13459,CHEMBL626843,,,12608,,Autocuration,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13460,CHEMBL626844,,,8649,,Intermediate,10116.0,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13461,CHEMBL877495,,,8649,,Intermediate,10116.0,Amount of deuterium retained was reported after normal workup in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13462,CHEMBL626845,,,8649,,Intermediate,10116.0,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13463,CHEMBL626846,,,8649,,Intermediate,10116.0,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13464,CHEMBL626847,,,8649,,Intermediate,10116.0,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13465,CHEMBL628677,,,8649,,Intermediate,10116.0,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13466,CHEMBL628678,,,8649,,Intermediate,10116.0,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,1,,50597,
,1,,,,,BAO_0000019,A,U,,13467,CHEMBL628679,,,9659,,Autocuration,,Compound was subjected to electrochemical oxidation,0,,22224,
,1,,,,,BAO_0000019,A,U,,13468,CHEMBL628680,,,9659,,Autocuration,,Compound was subjected to photochemical oxidation,0,,22224,
,1,,,,,BAO_0000019,A,U,,13469,CHEMBL628681,,,9659,,Autocuration,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,0,,22224,
,1,,,,,BAO_0000019,A,U,,13470,CHEMBL628682,,,9659,,Autocuration,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,0,,22224,
,1,,,,,BAO_0000019,A,U,,13471,CHEMBL628683,,,9659,,Autocuration,,Oxidation of compound by methemoglobin in presence of hydroperoxide,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13472,CHEMBL628684,,,9607,,Intermediate,10116.0,Percent diffusion through fuzzy rat skin after 48 h of incubation,1,,50597,
,1,,,,,BAO_0000100,P,U,,13473,CHEMBL877501,,,7057,,Autocuration,,Dissociation constant (pKa),0,,22229,
,1,,,,,BAO_0000100,P,U,,13474,CHEMBL628685,,,7057,,Autocuration,,Dissociation constant value of the compound; ND means not determined.,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13475,CHEMBL628686,Blood,,7911,178.0,Intermediate,10116.0,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13476,CHEMBL628687,Blood,,7911,178.0,Intermediate,10116.0,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13477,CHEMBL628688,,,7911,,Intermediate,10116.0,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13478,CHEMBL628689,,,7911,,Intermediate,10116.0,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13479,CHEMBL628690,Liver,,7911,2107.0,Intermediate,10116.0,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13480,CHEMBL629363,Liver,,7911,2107.0,Intermediate,10116.0,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13481,CHEMBL629364,Spleen,,7911,2106.0,Intermediate,10116.0,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13482,CHEMBL629365,Spleen,,7911,2106.0,Intermediate,10116.0,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13483,CHEMBL629366,,,7911,,Intermediate,10116.0,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13484,CHEMBL629367,Urine,,7911,1088.0,Intermediate,10116.0,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13485,CHEMBL629368,Feces,,7911,1988.0,Intermediate,10116.0,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13486,CHEMBL877502,Urine,,7911,1088.0,Intermediate,10116.0,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,13487,CHEMBL629369,Cerebellum,,13792,2037.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13488,CHEMBL629370,Brain,,13792,955.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,1,,50594,
,1,,,,Simiiformes,BAO_0000218,A,U,,13489,CHEMBL629371,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13490,CHEMBL626276,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13491,CHEMBL626277,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13492,CHEMBL631250,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13493,CHEMBL631251,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13494,CHEMBL631252,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13495,CHEMBL631253,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13496,CHEMBL631254,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13497,CHEMBL631255,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13498,CHEMBL631256,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13499,CHEMBL631257,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13500,CHEMBL628009,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13501,CHEMBL628010,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13502,CHEMBL628011,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13503,CHEMBL628012,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13504,CHEMBL628013,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13505,CHEMBL628014,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13506,CHEMBL628015,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13507,CHEMBL628016,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13508,CHEMBL874461,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13509,CHEMBL628017,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13510,CHEMBL628018,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13511,CHEMBL628019,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13512,CHEMBL628020,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13513,CHEMBL628021,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13514,CHEMBL628022,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13515,CHEMBL628023,Urine,,8133,1088.0,Intermediate,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,50588,
,1,,,,Simiiformes,BAO_0000218,A,U,,13516,CHEMBL628024,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13517,CHEMBL628025,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13518,CHEMBL628026,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13519,CHEMBL628027,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",0,,22224,
,1,,,,Simiiformes,BAO_0000218,A,U,,13520,CHEMBL628028,Urine,,8133,1088.0,Autocuration,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13521,CHEMBL628029,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13522,CHEMBL628030,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13523,CHEMBL628031,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13524,CHEMBL628032,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13525,CHEMBL628033,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13526,CHEMBL628034,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13527,CHEMBL628035,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13528,CHEMBL628036,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13529,CHEMBL874462,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13530,CHEMBL628037,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13531,CHEMBL628123,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13532,CHEMBL628124,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13533,CHEMBL628125,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13534,CHEMBL628126,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13535,CHEMBL628127,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13536,CHEMBL628128,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13537,CHEMBL628129,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13538,CHEMBL628130,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13539,CHEMBL628131,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13540,CHEMBL628132,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13541,CHEMBL628133,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13542,CHEMBL628134,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13543,CHEMBL628135,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13544,CHEMBL628136,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13545,CHEMBL628137,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13546,CHEMBL628138,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13547,CHEMBL628139,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13548,CHEMBL628140,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13549,CHEMBL628141,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13550,CHEMBL628142,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13551,CHEMBL628143,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13552,CHEMBL628144,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13553,CHEMBL628145,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13554,CHEMBL628146,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13555,CHEMBL625355,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13556,CHEMBL625356,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13557,CHEMBL625357,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13558,CHEMBL625527,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13559,CHEMBL875473,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),1,,50588,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13560,CHEMBL625528,,,9025,,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13561,CHEMBL626304,,,9025,,Intermediate,10116.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13562,CHEMBL624138,Artery,,9025,1637.0,Intermediate,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,1,,50588,
,1,,,,,BAO_0000100,P,U,,13563,CHEMBL624139,,,6448,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13564,CHEMBL624140,,,17221,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13565,CHEMBL624141,,,6545,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13566,CHEMBL624142,,,577,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13567,CHEMBL624143,,,6285,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13568,CHEMBL624144,,,6500,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13569,CHEMBL624145,,,6716,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13570,CHEMBL624146,,,13658,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13571,CHEMBL624147,,,6549,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13572,CHEMBL883123,,,14685,,Autocuration,,Calculated partition coefficient (clogP) (MacLogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13573,CHEMBL624148,,,6893,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000019,A,U,,13574,CHEMBL874416,,,3687,,Autocuration,,Kinetic parameter was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13575,CHEMBL624149,,,4207,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13576,CHEMBL624150,,,4626,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13577,CHEMBL624151,,,1021,,Autocuration,,Lipophilicity was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13578,CHEMBL624152,,,3777,,Autocuration,,Lipophilicity was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13579,CHEMBL622139,,,17533,,Autocuration,,Lipophilicity was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13580,CHEMBL622140,,,6524,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13581,CHEMBL622141,,,17533,,Autocuration,,Lipophilicity was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13582,CHEMBL622142,,,6480,,Autocuration,,Lipophilicity in octanol-water,0,,22224,
,1,,,,,BAO_0000100,P,U,,13583,CHEMBL622143,,,17606,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000100,P,U,,13584,CHEMBL622144,,,6863,,Autocuration,,Octanol-water partition coefficient was determined,0,,22229,
,1,,,,,BAO_0000019,A,U,,13585,CHEMBL877473,,,1356,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,13586,CHEMBL622145,,,3326,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13587,CHEMBL622146,,,1356,,Autocuration,,Partition coefficient was determined; ND means not determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13588,CHEMBL622147,,,12984,,Autocuration,,Calculated partition coefficient (clogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,13589,CHEMBL622148,,,17363,,Autocuration,,Partition coefficient of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,13590,CHEMBL883124,,,6827,,Autocuration,,Permeability was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13591,CHEMBL622149,,,261,,Autocuration,,The compound was evaluated for the partition coefficient,0,,22229,
,1,,,,,BAO_0000019,A,U,,13592,CHEMBL622150,,,2685,,Autocuration,,Partition coefficient (logP),0,,22224,
,1,,,,,BAO_0000100,P,U,,13593,CHEMBL622151,,,414,,Autocuration,,The lipophilicity was reported,0,,22224,
,1,,,,,BAO_0000100,P,U,,13594,CHEMBL622152,,,15769,,Autocuration,,logarithm of the octanol-water partition coefficient for the compound,0,,22229,
,1,,,,,BAO_0000019,A,U,,13595,CHEMBL622153,,,17248,,Autocuration,,Clogp value was determined,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13596,CHEMBL877474,,,16935,,Autocuration,,Clp at a dose of 1.5 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13597,CHEMBL622154,,,16935,,Autocuration,,Clp at a dose of 2.0 mg/kg,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13598,CHEMBL622155,Plasma,,14832,1969.0,Autocuration,,"Clp, plasma clearance at a dose of 10 mg/kg",0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13599,CHEMBL622156,Plasma,,14832,1969.0,Autocuration,,"Clp, plasma clearance at a dose of 50 mg/kg",0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13600,CHEMBL622157,Plasma,,2399,1969.0,Intermediate,10116.0,Compound was tested for plasma clearance in rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13601,CHEMBL622158,Plasma,,2399,1969.0,Intermediate,10116.0,Compound was tested for plasma clearance in rat; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13602,CHEMBL622807,,,6227,,Intermediate,10116.0,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,13603,CHEMBL622808,,,6227,,Intermediate,9544.0,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,1,,50797,
,1,,,In vivo,,BAO_0000218,A,U,,13604,CHEMBL622809,,,5623,,Autocuration,,Plasma clearance by iv administration at a dose 0.003 ug/mL,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13605,CHEMBL622810,,,4854,,Autocuration,,Plasma clearance determined,0,,22224,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,13606,CHEMBL876653,,,4493,,Intermediate,10026.0,Plasma clearance after iv administration at 3 mg/kg in hamster,1,,100712,
,1,,,In vivo,Cricetinae,BAO_0000218,A,N,,13607,CHEMBL622811,,,4493,,Intermediate,10026.0,Plasma clearance after iv administration at 4 mg/kg in hamster,1,,100712,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13608,CHEMBL622986,,,14956,,Intermediate,10116.0,Rate of clearance in rat was determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13609,CHEMBL622987,Plasma,,15372,1969.0,Intermediate,10116.0,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13610,CHEMBL622988,Plasma,,15372,1969.0,Intermediate,10116.0,Total plasma clearance after iv dose of 5.10 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13611,CHEMBL622989,Plasma,,15372,1969.0,Intermediate,10116.0,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13612,CHEMBL622990,Plasma,,15372,1969.0,Intermediate,10116.0,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,50597,
,1,,,In vivo,Simiiformes,BAO_0000218,A,U,,13613,CHEMBL622991,Plasma,,15604,1969.0,Autocuration,314293.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13614,CHEMBL622227,Plasma,,15604,1969.0,Intermediate,10116.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,50597,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13615,CHEMBL622228,Plasma,,15604,1969.0,Intermediate,9615.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13616,CHEMBL622229,,,14964,,Intermediate,10116.0,Clpl value in rat,1,,50597,
,1,,,In vivo,Cavia porcellus,BAO_0000218,A,N,,13617,CHEMBL622230,,,15240,,Intermediate,10141.0,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,1,,50512,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13618,CHEMBL622231,,,16449,,Intermediate,10116.0,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,1,,50597,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,N,,13619,CHEMBL622232,,,16449,,Intermediate,9541.0,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,1,,100710,
,1,,,In vivo,,BAO_0000218,A,U,,13620,CHEMBL622233,,,12902,,Autocuration,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13621,CHEMBL622234,,,12902,,Autocuration,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13622,CHEMBL622235,,,12902,,Autocuration,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13623,CHEMBL622236,,,12902,,Autocuration,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13624,CHEMBL622237,,,12902,,Autocuration,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13625,CHEMBL877482,,,12902,,Autocuration,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13626,CHEMBL622238,,,12902,,Autocuration,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13627,CHEMBL622239,,,12902,,Autocuration,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13628,CHEMBL622240,Blood,,11149,178.0,Autocuration,,Cmax was calculated as maximum concentration reached in the blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,13629,CHEMBL622241,Blood,,11149,178.0,Autocuration,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13630,CHEMBL631013,,,5669,,Intermediate,10116.0,Cmax was determine after peroral administration at 10 mpk in Rat,1,,50597,
,1,,,In vivo,Macaca mulatta,BAO_0000218,A,N,,13631,CHEMBL631014,,,5669,,Intermediate,9544.0,Cmax was determine after peroral administration at 10 mpk in Rhesus,1,,50797,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,13632,CHEMBL631015,,,5669,,Intermediate,9615.0,Cmax was determine after peroral administration at 10 mpk in dog,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13633,CHEMBL631016,,,5669,,Intermediate,10116.0,Cmax was determine after peroral administration at 160 mpk in Rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13634,CHEMBL631017,,,5669,,Intermediate,10116.0,Cmax was determine after peroral administration at 20 mpk in Rat,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13635,CHEMBL631018,,,5669,,Intermediate,10116.0,Cmax was determine after peroral administration at 50 mpk in Rat,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,13636,CHEMBL631019,,,4236,,Autocuration,,Cmax was determined,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,13637,CHEMBL875761,Brain,,13792,955.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13638,CHEMBL631020,Brain,,13792,955.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13639,CHEMBL631669,Brain,,13792,955.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13640,CHEMBL631670,Brain,,13792,955.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13641,CHEMBL631671,Striatum,,13792,2435.0,Intermediate,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13642,CHEMBL631672,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13643,CHEMBL631673,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13644,CHEMBL631856,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13645,CHEMBL631857,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13646,CHEMBL631858,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13647,CHEMBL631859,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13648,CHEMBL631860,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13649,CHEMBL631861,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13650,CHEMBL631862,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13651,CHEMBL631863,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13652,CHEMBL631864,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13653,CHEMBL631865,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13654,CHEMBL631866,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13655,CHEMBL629360,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13656,CHEMBL629361,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13657,CHEMBL629362,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13658,CHEMBL630740,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13659,CHEMBL630741,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13660,CHEMBL630742,Blood,,8418,178.0,Intermediate,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13661,CHEMBL630743,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13662,CHEMBL630744,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13663,CHEMBL630745,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13664,CHEMBL630746,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13665,CHEMBL630747,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13666,CHEMBL630748,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13667,CHEMBL632056,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13668,CHEMBL632057,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13669,CHEMBL632058,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13670,CHEMBL632059,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13671,CHEMBL632060,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13672,CHEMBL632061,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13673,CHEMBL629207,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13674,CHEMBL629208,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13675,CHEMBL629209,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13676,CHEMBL629210,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13677,CHEMBL629211,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13678,CHEMBL629212,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13679,CHEMBL629213,,,8418,,Intermediate,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13680,CHEMBL629214,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13681,CHEMBL629215,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13682,CHEMBL635154,Urine,,8133,1088.0,Intermediate,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13683,CHEMBL629216,,,6996,,Intermediate,10116.0,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13684,CHEMBL629217,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13685,CHEMBL629218,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13686,CHEMBL629219,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13687,CHEMBL629220,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13688,CHEMBL629221,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13689,CHEMBL631127,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13690,CHEMBL631128,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13691,CHEMBL631129,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13692,CHEMBL631130,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13693,CHEMBL631131,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13694,CHEMBL631132,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13695,CHEMBL631133,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13696,CHEMBL631134,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13697,CHEMBL875120,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13698,CHEMBL631135,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13699,CHEMBL631136,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13700,CHEMBL631137,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13701,CHEMBL631138,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13702,CHEMBL631139,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13703,CHEMBL631140,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13704,CHEMBL631141,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13705,CHEMBL631142,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13706,CHEMBL631143,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13707,CHEMBL631144,,,6996,,Intermediate,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13708,CHEMBL631145,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13709,CHEMBL631146,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13710,CHEMBL631147,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13711,CHEMBL631148,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13712,CHEMBL631149,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13713,CHEMBL631150,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13714,CHEMBL631151,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13715,CHEMBL631152,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13716,CHEMBL631443,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13717,CHEMBL631444,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13718,CHEMBL631445,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13719,CHEMBL631446,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13720,CHEMBL631447,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13721,CHEMBL631448,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13722,CHEMBL631449,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13723,CHEMBL631450,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13724,CHEMBL629724,,,6996,,Intermediate,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,50588,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13725,CHEMBL629725,Zone of skin,,9716,14.0,Intermediate,10090.0,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13726,CHEMBL629726,Zone of skin,,9716,14.0,Intermediate,10090.0,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13727,CHEMBL629727,Spleen,,9716,2106.0,Intermediate,10090.0,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13728,CHEMBL630404,Spleen,,9716,2106.0,Intermediate,10090.0,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13729,CHEMBL630405,Spleen,,9716,2106.0,Intermediate,10090.0,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13730,CHEMBL630406,Spleen,,9716,2106.0,Intermediate,10090.0,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13731,CHEMBL630407,Stomach,,9716,945.0,Intermediate,10090.0,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13732,CHEMBL630573,Stomach,,9716,945.0,Intermediate,10090.0,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13733,CHEMBL630574,Stomach,,9716,945.0,Intermediate,10090.0,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13734,CHEMBL630575,Stomach,,9716,945.0,Intermediate,10090.0,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13735,CHEMBL630576,,,9716,,Intermediate,10090.0,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13736,CHEMBL630577,,,9716,,Intermediate,10090.0,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13737,CHEMBL630578,,,9716,,Intermediate,10090.0,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,13738,CHEMBL630579,,,9716,,Intermediate,10090.0,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13739,CHEMBL630580,Kidney,,12192,2113.0,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13740,CHEMBL630581,Kidney,,12192,2113.0,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13741,CHEMBL630582,Kidney,,12192,2113.0,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13742,CHEMBL630583,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13743,CHEMBL630584,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13744,CHEMBL630585,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13745,CHEMBL630586,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13746,CHEMBL630587,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13747,CHEMBL630588,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13748,CHEMBL630589,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13749,CHEMBL630590,,,12192,,Intermediate,10090.0,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),1,,50594,
,1,,,,,BAO_0000019,A,U,,13750,CHEMBL630591,Feces,,12192,1988.0,Autocuration,,Removal of 238-Plutonium(IV) in feces at 24 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,13751,CHEMBL630592,Feces,,12192,1988.0,Autocuration,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13752,CHEMBL630593,,,12192,,Autocuration,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,13753,CHEMBL630594,,,12192,,Autocuration,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13754,CHEMBL630595,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13755,CHEMBL630596,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13756,CHEMBL630597,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 0-24 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,13757,CHEMBL630598,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13758,CHEMBL630599,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 0-4 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,13759,CHEMBL630600,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13760,CHEMBL630601,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 4-24 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,13761,CHEMBL630602,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13762,CHEMBL630603,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),0,,22224,
,1,,,,,BAO_0000019,A,U,,13763,CHEMBL630604,Urine,,12192,1088.0,Autocuration,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13764,CHEMBL624869,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13765,CHEMBL624870,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13766,CHEMBL623189,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13767,CHEMBL623190,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13768,CHEMBL623191,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13769,CHEMBL623192,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13770,CHEMBL623193,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13771,CHEMBL623194,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13772,CHEMBL623195,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13773,CHEMBL623196,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13774,CHEMBL623197,,,11836,,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13775,CHEMBL623198,,,11836,,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13776,CHEMBL623199,,,11836,,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13777,CHEMBL623200,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13778,CHEMBL623201,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13779,CHEMBL623202,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13780,CHEMBL623203,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13781,CHEMBL623204,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13782,CHEMBL623205,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13783,CHEMBL623206,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13784,CHEMBL623207,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13785,CHEMBL623208,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13786,CHEMBL623209,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13787,CHEMBL623210,Muscle tissue,,11836,2385.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13788,CHEMBL623211,,,11836,,Intermediate,10116.0,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13789,CHEMBL623212,Uterus,,11836,995.0,Intermediate,10116.0,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,50597,
,1,,,,,BAO_0000019,A,U,,13790,CHEMBL623213,,,12640,,Autocuration,,Tested in vitro for intrinsic activity relative to quinpirole,0,,22224,
,1,,,,,BAO_0000019,A,U,,13791,CHEMBL623214,,,14218,,Autocuration,,"Relative ion enhancement, determined in pulsed ultrafiltration",0,,22224,
,1,,,,,BAO_0000019,A,U,,13792,CHEMBL623215,,,11296,,Autocuration,,% ionization at the pH 7.4 at 37 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,13793,CHEMBL623216,,,10929,,Autocuration,,Percentage ionization was measured,0,,22224,
,1,,,,Bos taurus,BAO_0000218,A,N,,13794,CHEMBL623217,,,13841,,Intermediate,9913.0,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,1,,50591,
,1,,,,,BAO_0000019,A,U,,13795,CHEMBL623218,,,10431,,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,0,,22224,
,1,,,,,BAO_0000019,A,U,,13796,CHEMBL623913,,,10431,,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,0,,22224,
,1,,,,,BAO_0000019,A,U,,13797,CHEMBL623914,,,10431,,Autocuration,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,0,,22224,
,1,,,,,BAO_0000100,P,U,,13798,CHEMBL623915,,,8826,,Autocuration,,Compound was evaluated for the partition coefficient in octanol/water,0,,22229,
,1,,,,,BAO_0000100,P,U,,13799,CHEMBL624080,,,8826,,Autocuration,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),0,,22229,
,1,,,,,BAO_0000019,A,U,,13800,CHEMBL624081,,,9884,,Autocuration,,Equilibrium constant measured by the pulse radiolysis at pH 7,0,,22224,
,1,,,,Homo sapiens,BAO_0000218,A,N,,13801,CHEMBL624082,,,9827,,Intermediate,9606.0,In vitro hydrolytic rate constant determined in human blood,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,13802,CHEMBL625054,,,10009,,Intermediate,9606.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,1,,50587,
,1,,,,,BAO_0000019,A,U,,13803,CHEMBL877485,,,10009,,Autocuration,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,13804,CHEMBL625055,,,10009,,Intermediate,10090.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13805,CHEMBL625056,,,10009,,Intermediate,10090.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,1,,50594,
,1,,,,Homo sapiens,BAO_0000218,A,N,,13806,CHEMBL625057,,,10009,,Intermediate,9606.0,In vitro oxidation of compound in presence of human plasma,1,,50587,
,1,,,,,BAO_0000019,A,U,,13807,CHEMBL625058,,,10009,,Autocuration,,In vitro oxidation of compound in presence of hydrogen peroxide,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,13808,CHEMBL625059,,,10009,,Intermediate,10090.0,In vitro oxidation of compound in presence of mouse brain homogenate,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13809,CHEMBL629536,,,10009,,Intermediate,10090.0,In vitro oxidation of compound in presence of mouse liver homogenate,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13810,CHEMBL629537,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13811,CHEMBL629538,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13812,CHEMBL629539,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13813,CHEMBL874445,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13814,CHEMBL629540,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13815,CHEMBL629541,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13816,CHEMBL629542,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13817,CHEMBL630243,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13818,CHEMBL630244,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13819,CHEMBL630245,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13820,CHEMBL630246,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13821,CHEMBL630247,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13822,CHEMBL630248,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13823,CHEMBL630249,Blood,,13100,178.0,Intermediate,10116.0,Biodistribution in rat blood at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13824,CHEMBL630250,Blood,,13100,178.0,Intermediate,10116.0,Biodistribution in rat blood at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13825,CHEMBL630251,Blood,,13100,178.0,Intermediate,10116.0,Biodistribution in rat blood at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13826,CHEMBL630252,Blood,,13100,178.0,Intermediate,10116.0,Biodistribution in rat blood at 3 hr after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13827,CHEMBL630408,Blood,,13100,178.0,Intermediate,10116.0,Biodistribution in rat blood at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13828,CHEMBL630409,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13829,CHEMBL874446,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13830,CHEMBL630410,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13831,CHEMBL630411,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13832,CHEMBL630412,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13833,CHEMBL630413,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13834,CHEMBL630414,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 3 hr after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13835,CHEMBL630415,Cerebellum,,13100,2037.0,Intermediate,10116.0,Biodistribution in rat cerebellum at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13836,CHEMBL630416,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13837,CHEMBL630417,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13838,CHEMBL630418,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13839,CHEMBL630419,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13840,CHEMBL630420,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13841,CHEMBL630421,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13842,CHEMBL630422,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 3 hr after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13843,CHEMBL630423,,,13100,,Intermediate,10116.0,Biodistribution in rat cortex at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13844,CHEMBL630424,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13845,CHEMBL630425,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13846,CHEMBL629462,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13847,CHEMBL630426,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13848,CHEMBL630427,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13849,CHEMBL625877,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 3 hr after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13850,CHEMBL625878,Heart,,13100,948.0,Intermediate,10116.0,Biodistribution in rat heart at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13851,CHEMBL625879,Hippocampus,,13100,10000000.0,Intermediate,10116.0,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13852,CHEMBL625880,Hippocampus,,13100,10000000.0,Intermediate,10116.0,Biodistribution in rat hippocampus at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13853,CHEMBL625881,Hippocampus,,13100,10000000.0,Intermediate,10116.0,Biodistribution in rat hippocampus at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13854,CHEMBL625882,Hippocampus,,13100,10000000.0,Intermediate,10116.0,Biodistribution in rat hippocampus at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13855,CHEMBL625883,Hippocampus,,13100,10000000.0,Intermediate,10116.0,Biodistribution in rat hippocampus at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13856,CHEMBL625884,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13857,CHEMBL625885,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13858,CHEMBL628649,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13859,CHEMBL628650,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13860,CHEMBL628651,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13861,CHEMBL628652,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13862,CHEMBL628653,Kidney,,13100,2113.0,Intermediate,10116.0,Biodistribution in rat kidney at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13863,CHEMBL628654,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13864,CHEMBL628655,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13865,CHEMBL625238,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13866,CHEMBL625239,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13867,CHEMBL625240,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13868,CHEMBL625241,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13869,CHEMBL625242,Liver,,13100,2107.0,Intermediate,10116.0,Biodistribution in rat liver at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13870,CHEMBL874587,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13871,CHEMBL625405,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13872,CHEMBL625406,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13873,CHEMBL625407,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13874,CHEMBL625408,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13875,CHEMBL625409,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 360 minutes after dose administration.,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13876,CHEMBL625410,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13877,CHEMBL625411,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13878,CHEMBL625412,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13879,CHEMBL625413,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13880,CHEMBL625414,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips v,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13881,CHEMBL625415,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13882,CHEMBL625416,Thoracic aorta,,12361,1515.0,Intermediate,10116.0,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13883,CHEMBL625417,Urine,,12712,1088.0,Intermediate,10116.0,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13884,CHEMBL625418,Feces,,7415,1988.0,Intermediate,10116.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13885,CHEMBL625419,Urine,,7415,1088.0,Intermediate,10116.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13886,CHEMBL625420,,,7415,,Intermediate,10116.0,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13887,CHEMBL626996,,,7415,,Intermediate,10116.0,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13888,CHEMBL626997,Feces,,7415,1988.0,Intermediate,10116.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13889,CHEMBL626998,Urine,,7415,1088.0,Intermediate,10116.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13890,CHEMBL626999,,,7415,,Intermediate,10116.0,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",1,,50597,
,1,,,,Mus musculus,BAO_0000218,A,N,,13891,CHEMBL627000,,,8050,,Intermediate,10090.0,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13892,CHEMBL627001,,,8050,,Intermediate,10090.0,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13893,CHEMBL627002,,,8050,,Intermediate,10090.0,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13894,CHEMBL627003,,,8050,,Intermediate,10090.0,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13895,CHEMBL627004,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13896,CHEMBL627005,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13897,CHEMBL874594,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13898,CHEMBL627006,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13899,CHEMBL627007,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13900,CHEMBL627884,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13901,CHEMBL627885,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13902,CHEMBL627886,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13903,CHEMBL627887,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13904,CHEMBL627888,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13905,CHEMBL628057,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,13906,CHEMBL627405,Urine,,8050,1088.0,Intermediate,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13907,CHEMBL627406,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13908,CHEMBL627407,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13909,CHEMBL627408,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13910,CHEMBL627409,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13911,CHEMBL875486,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13912,CHEMBL627410,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13913,CHEMBL627411,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13914,CHEMBL627412,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13915,CHEMBL627413,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13916,CHEMBL627414,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13917,CHEMBL627415,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13918,CHEMBL627416,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13919,CHEMBL627417,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13920,CHEMBL627418,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13921,CHEMBL627419,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13922,CHEMBL627320,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,13923,CHEMBL627321,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,50588,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13924,CHEMBL627322,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13925,CHEMBL627323,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13926,CHEMBL627491,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13927,CHEMBL627492,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13928,CHEMBL627493,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13929,CHEMBL627494,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13930,CHEMBL627495,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13931,CHEMBL627496,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13932,CHEMBL627497,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13933,CHEMBL627498,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13934,CHEMBL627499,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13935,CHEMBL627500,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13936,CHEMBL627501,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13937,CHEMBL625616,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13938,CHEMBL625617,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13939,CHEMBL625618,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13940,CHEMBL625619,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13941,CHEMBL625620,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13942,CHEMBL625621,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13943,CHEMBL625622,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13944,CHEMBL625788,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13945,CHEMBL625789,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13946,CHEMBL625790,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13947,CHEMBL625791,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13948,CHEMBL622334,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13949,CHEMBL622335,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13950,CHEMBL622336,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13951,CHEMBL622337,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13952,CHEMBL622338,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13953,CHEMBL622339,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13954,CHEMBL624153,,,12017,,Intermediate,10116.0,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13955,CHEMBL628430,,,12017,,Intermediate,10116.0,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13956,CHEMBL628431,,,12017,,Intermediate,10116.0,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13957,CHEMBL628432,,,12017,,Intermediate,10116.0,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13958,CHEMBL628433,,,12017,,Intermediate,10116.0,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13959,CHEMBL628434,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13960,CHEMBL626789,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13961,CHEMBL626790,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13962,CHEMBL626791,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13963,CHEMBL626792,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,13964,CHEMBL626793,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13965,CHEMBL627436,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13966,CHEMBL627437,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13967,CHEMBL627438,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13968,CHEMBL627439,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13969,CHEMBL627440,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13970,CHEMBL627602,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13971,CHEMBL627603,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13972,CHEMBL627604,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13973,CHEMBL627605,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13974,CHEMBL627606,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13975,CHEMBL627607,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13976,CHEMBL627608,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13977,CHEMBL627609,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13978,CHEMBL627610,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13979,CHEMBL627611,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,13980,CHEMBL627612,,,11510,,Intermediate,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,50597,
,1,,,,,BAO_0000100,P,U,,13981,CHEMBL627613,,,8362,,Autocuration,,Octanol:water partition coefficient is evaluated,0,,22229,
,1,,,,,BAO_0000100,P,U,,13982,CHEMBL627614,,,8257,,Autocuration,,Partition coefficient in 1-octanol/water system,0,,22224,
,1,,,,,BAO_0000100,P,U,,13983,CHEMBL627615,,,8257,,Autocuration,,Partition coefficient in 1-octanol/water system measured using radio active compounds,0,,22224,
,1,,,,,BAO_0000100,P,U,,13984,CHEMBL627616,,,9468,,Autocuration,,Partition coefficient in octanol/water system was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,13985,CHEMBL627617,,,9468,,Autocuration,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,0,,22224,
,1,,,,,BAO_0000019,A,U,,13986,CHEMBL627618,,,10568,,Autocuration,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,13987,CHEMBL627619,,,10568,,Autocuration,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,13988,CHEMBL627620,,,15359,,Autocuration,,Pseudo-first-order rate constant of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,13989,CHEMBL627621,,,15359,,Autocuration,,Pseudo-first-order rate constant with 1-min time point,0,,22224,
,1,,,,,BAO_0000019,A,U,,13990,CHEMBL627622,,,15359,,Autocuration,,Pseudo-first-order rate constant without 1-min time point,0,,22224,
,1,,,,,BAO_0000019,A,U,,13991,CHEMBL627623,,,10431,,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,0,,22224,
,1,,,,,BAO_0000019,A,U,,13992,CHEMBL627624,,,10431,,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,0,,22224,
,1,,,,,BAO_0000019,A,U,,13993,CHEMBL627625,,,10431,,Autocuration,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,0,,22224,
,1,,,,,BAO_0000019,A,U,,13994,CHEMBL628523,,,15704,,Autocuration,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,13995,CHEMBL628524,,,15287,,Autocuration,,The alkaline hydrolysis second order rate constant(K OH) of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,13996,CHEMBL628525,,,7516,,Autocuration,,The efflux rate constant of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,13997,CHEMBL625732,,,12973,,Autocuration,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,0,,22224,
,1,,,,,BAO_0000019,A,U,,13998,CHEMBL625733,,,12973,,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,0,,22224,
,1,,,,,BAO_0000019,F,U,,13999,CHEMBL625734,,,12973,,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,0,,22224,
,1,,,,,BAO_0000019,A,U,,14000,CHEMBL625913,,,12973,,Autocuration,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14001,CHEMBL625914,,,8696,,Autocuration,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,0,,22224,
,1,,,,,BAO_0000019,A,U,,14002,CHEMBL625915,,,15052,,Autocuration,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,0,,22224,
,1,,,,,BAO_0000019,A,U,,14003,CHEMBL625916,,,15052,,Autocuration,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,0,,22224,
,1,,,,,BAO_0000019,A,U,,14004,CHEMBL625917,,,10503,,Autocuration,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),0,,22224,
,1,,,,,BAO_0000019,A,U,,14005,CHEMBL625918,,,8354,,Autocuration,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14006,CHEMBL625919,,,8354,,Autocuration,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14007,CHEMBL625920,,,8354,,Autocuration,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14008,CHEMBL874453,,,8354,,Autocuration,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14009,CHEMBL625921,,,8354,,Autocuration,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14010,CHEMBL625922,,,10503,,Autocuration,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,0,,22224,
,1,,,,,BAO_0000019,A,U,,14011,CHEMBL625923,,,8354,,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14012,CHEMBL625924,,,8354,,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14013,CHEMBL625925,,,8354,,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,14014,CHEMBL625926,,,8354,,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14015,CHEMBL627704,Lung,,13100,2048.0,Intermediate,10116.0,Biodistribution in rat lung at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14016,CHEMBL627705,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14017,CHEMBL627706,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14018,CHEMBL627707,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14019,CHEMBL627708,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14020,CHEMBL628361,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14021,CHEMBL628362,,,13100,,Intermediate,10116.0,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14022,CHEMBL628363,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14023,CHEMBL628364,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14024,CHEMBL628365,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14025,CHEMBL874454,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14026,CHEMBL628531,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14027,CHEMBL628532,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14028,CHEMBL628533,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 3 hr after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14029,CHEMBL628534,Striatum,,13100,2435.0,Intermediate,10116.0,Biodistribution in rat striatum at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14030,CHEMBL628535,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14031,CHEMBL628536,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14032,CHEMBL628537,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14033,CHEMBL628538,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14034,CHEMBL628539,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14035,CHEMBL630297,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14036,CHEMBL630298,Thyroid gland,,13100,2046.0,Intermediate,10116.0,Biodistribution in rat thyroid at 60 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14037,CHEMBL630299,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat 120 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14038,CHEMBL628094,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14039,CHEMBL628095,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14040,CHEMBL874648,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14041,CHEMBL628096,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14042,CHEMBL628097,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14043,CHEMBL628098,Brain,,13100,955.0,Intermediate,10116.0,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,1,,50597,
,1,,,,,BAO_0000019,A,U,,14044,CHEMBL628099,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14045,CHEMBL628100,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14046,CHEMBL628101,,,13331,,Autocuration,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),0,,22224,
,1,,,,,BAO_0000019,A,U,,14047,CHEMBL628102,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14048,CHEMBL628103,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14049,CHEMBL628104,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14050,CHEMBL628105,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14051,CHEMBL628106,,,13331,,Autocuration,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14052,CHEMBL628107,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,,50597,
,1,,,,,BAO_0000218,F,U,,14053,CHEMBL628108,Urine,,10086,1088.0,Autocuration,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14054,CHEMBL628109,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,,50597,
,1,,,,,BAO_0000218,F,U,,14055,CHEMBL625299,Urine,,10086,1088.0,Autocuration,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14056,CHEMBL625300,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14057,CHEMBL625301,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14058,CHEMBL625302,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14059,CHEMBL874649,Urine,,10086,1088.0,Intermediate,10116.0,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14060,CHEMBL625303,,,13248,,Intermediate,10116.0,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14061,CHEMBL625463,,,13248,,Intermediate,10116.0,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,1,,50597,
,1,,,,Homo sapiens,BAO_0000218,A,N,,14062,CHEMBL625464,Liver,,14527,2107.0,Intermediate,9606.0,In vitro metabolism in human liver microsomes,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,14063,CHEMBL625465,,,3008,,Intermediate,9606.0,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,1,,50587,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14064,CHEMBL625466,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14065,CHEMBL625467,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14066,CHEMBL625468,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14067,CHEMBL625469,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14068,CHEMBL625470,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14069,CHEMBL632418,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14070,CHEMBL627250,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14071,CHEMBL627251,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14072,CHEMBL627252,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14073,CHEMBL627253,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14074,CHEMBL627254,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14075,CHEMBL875471,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14076,CHEMBL627255,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14077,CHEMBL627256,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14078,CHEMBL627257,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14079,CHEMBL627258,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14080,CHEMBL627259,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14081,CHEMBL627260,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14082,CHEMBL623256,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14083,CHEMBL874413,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14084,CHEMBL623257,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14085,CHEMBL623258,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14086,CHEMBL623259,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14087,CHEMBL623260,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14088,CHEMBL623261,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14089,CHEMBL623262,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14090,CHEMBL623263,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14091,CHEMBL623264,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14092,CHEMBL623265,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14093,CHEMBL623266,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14094,CHEMBL623267,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14095,CHEMBL623268,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14096,CHEMBL623269,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14097,CHEMBL623270,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14098,CHEMBL623271,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14099,CHEMBL623272,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14100,CHEMBL623273,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14101,CHEMBL623274,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14102,CHEMBL874414,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14103,CHEMBL623275,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14104,CHEMBL629150,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14105,CHEMBL623276,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14106,CHEMBL623277,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14107,CHEMBL623112,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14108,CHEMBL623113,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14109,CHEMBL623800,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14110,CHEMBL623801,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14111,CHEMBL623802,Spleen,,12017,2106.0,Intermediate,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14112,CHEMBL623803,Uterus,,12017,995.0,Intermediate,10116.0,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14113,CHEMBL623970,Uterus,,12017,995.0,Intermediate,10116.0,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14114,CHEMBL623971,Uterus,,12017,995.0,Intermediate,10116.0,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14115,CHEMBL623972,Blood,,14045,178.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14116,CHEMBL623973,Blood,,14045,178.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14117,CHEMBL623974,Blood,,14045,178.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14118,CHEMBL623975,Blood,,14045,178.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14119,CHEMBL623976,Brain,,14045,955.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14120,CHEMBL623977,Brain,,14045,955.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14121,CHEMBL623978,Brain,,14045,955.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14122,CHEMBL623979,Brain,,14045,955.0,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14123,CHEMBL623980,,,14045,,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14124,CHEMBL623981,,,14045,,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14125,CHEMBL626278,,,14045,,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14126,CHEMBL626279,,,14045,,Intermediate,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14127,CHEMBL626280,,,14045,,Intermediate,10090.0,Biodistribution in mice bladder plus excreted urine was determined,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14128,CHEMBL626281,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse blood, 10 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14129,CHEMBL626282,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse blood, 30 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14130,CHEMBL626283,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse blood, 5 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14131,CHEMBL626284,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse blood, 60 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14132,CHEMBL626285,Brain,,14045,955.0,Intermediate,10090.0,"Percentage biodistribution in mouse brain, 10 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14133,CHEMBL626286,Brain,,14045,955.0,Intermediate,10090.0,"Percentage biodistribution in mouse brain, 30 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14134,CHEMBL626287,Brain,,14045,955.0,Intermediate,10090.0,"Percentage biodistribution in mouse brain, 5 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14135,CHEMBL626288,Brain,,14045,955.0,Intermediate,10090.0,"Percentage biodistribution in mouse brain, 60 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14136,CHEMBL626289,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse heart, 10 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14137,CHEMBL626290,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse heart, 30 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14138,CHEMBL626291,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse heart, 5 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14139,CHEMBL839888,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse heart, 60 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14140,CHEMBL626292,Intestine,,14045,160.0,Intermediate,10090.0,"Percentage biodistribution in mouse intestine, 10 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14141,CHEMBL626293,Intestine,,14045,160.0,Intermediate,10090.0,"Percentage biodistribution in mouse intestine, 30 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14142,CHEMBL626294,Intestine,,14045,160.0,Intermediate,10090.0,"Percentage biodistribution in mouse intestine, 5 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14143,CHEMBL626295,Intestine,,14045,160.0,Intermediate,10090.0,"Percentage biodistribution in mouse intestine, 60 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14144,CHEMBL627659,Liver,,14045,2107.0,Intermediate,10090.0,"Percentage biodistribution in mouse liver, 10 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14145,CHEMBL627660,Liver,,14045,2107.0,Intermediate,10090.0,"Percentage biodistribution in mouse liver, 30 minutes of post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14146,CHEMBL627661,Liver,,14045,2107.0,Intermediate,10090.0,"Percentage biodistribution in mouse liver, 5 minutes post injection",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14147,CHEMBL627662,Liver,,14045,2107.0,Intermediate,10090.0,Biodistribution in mice liver at 60 minutes of post injection,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14148,CHEMBL627663,Lung,,14045,2048.0,Intermediate,10090.0,Biodistribution in mice lungs at 10 min of post injection,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14149,CHEMBL627664,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mouse lung, 30 minutes post injection",1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14150,CHEMBL627665,,,14045,,Intermediate,10090.0,"Percentage biodistribution in mousee lung, 5 minutes post injection",1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14151,CHEMBL627666,Lung,,14045,2048.0,Intermediate,10090.0,Biodistribution in mice lungs at 60 min of post injection,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14152,CHEMBL627667,Spleen,,14045,2106.0,Intermediate,10090.0,Percentage biodistribution in mouse spleen,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14153,CHEMBL627668,Stomach,,14045,945.0,Intermediate,10090.0,Percentage biodistribution in mouse stomach,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14154,CHEMBL627669,Urine,,11745,1088.0,Intermediate,10090.0,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,1,,50594,
,1,,,In vivo,,BAO_0000218,A,U,,14155,CHEMBL627670,Urinary bladder,,13257,1255.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14156,CHEMBL627671,Blood,,13257,178.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14157,CHEMBL627672,Bone element,,13257,1474.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14158,CHEMBL627673,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14159,CHEMBL627674,Kidney,,13257,2113.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14160,CHEMBL627675,Liver,,13257,2107.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14161,CHEMBL627676,Lung,,13257,2048.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14162,CHEMBL627677,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,0,,22224,
,1,,,,,BAO_0000019,A,U,,14163,CHEMBL627678,,,8354,,Autocuration,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14164,CHEMBL627679,Serum,,7095,1977.0,Intermediate,10116.0,Affinity for protein binding expressed as association constant in fresh rat serum,1,,50597,
,1,,,,,BAO_0000019,A,U,,14165,CHEMBL627680,,,12185,,Autocuration,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,0,,22224,
,1,,,,,BAO_0000019,A,U,,14166,CHEMBL627681,,,12185,,Autocuration,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,0,,22224,
,1,,,,,BAO_0000019,A,U,,14167,CHEMBL627682,,,12185,,Autocuration,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,0,,22224,
,1,,,,,BAO_0000019,A,U,,14168,CHEMBL627683,,,12185,,Autocuration,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,0,,22224,
,1,,,,,BAO_0000019,A,U,,14169,CHEMBL627684,,,12686,,Autocuration,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,14170,CHEMBL874441,,,12686,,Autocuration,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",0,,22224,
,1,,,,,BAO_0000019,A,U,,14171,CHEMBL627685,,,12686,,Autocuration,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,0,,22224,
,1,,,,,BAO_0000019,A,U,,14172,CHEMBL627686,,,12686,,Autocuration,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",0,,22224,
,1,,,,,BAO_0000019,A,U,,14173,CHEMBL627687,,,8057,,Autocuration,,Apparent rate constant Koff for inactivation of dTMP synthase.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14174,CHEMBL627688,,,15778,,Autocuration,,The irreversible inhibitor activity by second order rate equation.,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14175,CHEMBL628038,,,12375,,Intermediate,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14176,CHEMBL628039,,,12375,,Intermediate,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14177,CHEMBL628040,,,12375,,Intermediate,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,1,,50597,
,1,,,,,BAO_0000019,A,U,,14178,CHEMBL628041,,,13588,,Autocuration,,Dissociation rate calculated from the first-order equation using t1/2 value,0,,22224,
,1,,,,,BAO_0000019,A,U,,14179,CHEMBL630226,,,15039,,Autocuration,,The compound was tested for Binding constant against DNA,0,,22224,
,1,,,,,BAO_0000019,A,U,,14180,CHEMBL628042,,,9500,,Autocuration,,First order rate constant for cyclization of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14181,CHEMBL625232,,,10014,,Autocuration,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,0,,22224,
,1,,,,,BAO_0000019,A,U,,14182,CHEMBL625233,,,10014,,Autocuration,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,0,,22224,
,1,,,,,BAO_0000019,A,U,,14183,CHEMBL625979,,,568,,Autocuration,,Hydrolysis rate constant was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14184,CHEMBL625980,,,10026,,Autocuration,,Observed first order rate constant,0,,22224,
,1,,,,,BAO_0000019,A,U,,14185,CHEMBL625981,,,10281,,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,14186,CHEMBL625982,,,10281,,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,14187,CHEMBL625983,,,9680,,Autocuration,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14188,CHEMBL625984,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14189,CHEMBL625985,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14190,CHEMBL625986,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14191,CHEMBL625987,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14192,CHEMBL625988,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14193,CHEMBL625989,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14194,CHEMBL625990,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14195,CHEMBL625991,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14196,CHEMBL625992,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14197,CHEMBL625993,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14198,CHEMBL631973,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14199,CHEMBL632143,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14200,CHEMBL632144,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14201,CHEMBL632145,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14202,CHEMBL632146,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14203,CHEMBL632147,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14204,CHEMBL632148,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14205,CHEMBL632149,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14206,CHEMBL632150,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14207,CHEMBL632151,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,Homo sapiens,BAO_0000218,A,N,,14208,CHEMBL632152,,,3008,,Intermediate,9606.0,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,14209,CHEMBL632153,,,4509,,Intermediate,9606.0,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,50587,
,1,,,,Homo sapiens,BAO_0000218,A,N,,14210,CHEMBL632154,,,4509,,Intermediate,9606.0,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,50587,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14211,CHEMBL632155,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14212,CHEMBL632156,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14213,CHEMBL632157,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14214,CHEMBL632158,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14215,CHEMBL632159,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14216,CHEMBL626305,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14217,CHEMBL626306,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14218,CHEMBL626307,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14219,CHEMBL626308,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14220,CHEMBL626479,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,Human herpesvirus 1,BAO_0000218,A,N,,14221,CHEMBL626480,,,8613,,Intermediate,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,1,,50602,
,1,,,,,BAO_0000100,P,U,,14222,CHEMBL626481,,,6021,,Autocuration,,Calculated partition coefficient (clogP) (MlogP),0,,22229,
,1,,,,,BAO_0000019,A,U,,14223,CHEMBL626482,,,9348,,Autocuration,,Equipotent potent ratio relative to carbachol (nicotinic activity),0,,22224,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14224,CHEMBL626483,,,15592,,Intermediate,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14225,CHEMBL626484,,,15592,,Intermediate,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",1,,50588,
,1,,,,,BAO_0000100,P,U,,14226,CHEMBL626485,,,15592,,Autocuration,,Solubility at pH 7.4 in micro g/mL;NA denotes available,0,,22229,
,1,,,,,BAO_0000100,P,U,,14227,CHEMBL626486,,,15592,,Autocuration,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,0,,22229,
,1,,,,,BAO_0000100,P,U,,14228,CHEMBL626487,,,15592,,Autocuration,,Solubility at pH 7.4 in ug/mL;NA denotes not available,0,,22229,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,N,,14229,CHEMBL626488,Plasma,,15592,1969.0,Intermediate,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14230,CHEMBL626489,Serum,,7095,1977.0,Intermediate,10116.0,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,1,,50597,
,1,,,,,BAO_0000019,A,U,,14231,CHEMBL626490,,,16618,,Autocuration,,Area under the MAP curve measured over 5 min; ND means Not determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14232,CHEMBL626491,,,16835,,Autocuration,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,0,,22224,
,1,,,,,BAO_0000100,P,U,,14233,CHEMBL626492,,,15284,,Autocuration,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,0,,22229,
,1,,,,,BAO_0000019,A,U,,14234,CHEMBL626493,,,15750,,Autocuration,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14235,CHEMBL626494,,,16618,,Intermediate,10116.0,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,14236,CHEMBL626495,,,16618,,Autocuration,,Half life after oral tested,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14237,CHEMBL626496,Plasma,,15812,1969.0,Intermediate,10116.0,Half life was determined in plasma of rat; NT indicates not tested,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14238,CHEMBL626497,,,16618,,Intermediate,10116.0,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,14239,CHEMBL626498,,,16618,,Autocuration,,Oral bioavailability after oral tested,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14240,CHEMBL626499,,,13098,,Intermediate,10116.0,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14241,CHEMBL626500,,,13098,,Intermediate,10116.0,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14242,CHEMBL626501,Plasma,,15812,1969.0,Intermediate,10116.0,half life was determined in plasma of rat; NT indicates not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14243,CHEMBL626502,Plasma,,15812,1969.0,Intermediate,10116.0,half life was determined in plasma of rat; NT means not tested,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14244,CHEMBL626503,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14245,CHEMBL626504,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); inactive,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14246,CHEMBL626505,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14247,CHEMBL626506,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14248,CHEMBL626507,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14249,CHEMBL626508,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14250,CHEMBL626509,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14251,CHEMBL875480,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14252,CHEMBL626510,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14253,CHEMBL626511,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14254,CHEMBL626512,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14255,CHEMBL628208,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14256,CHEMBL628209,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14257,CHEMBL628210,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14258,CHEMBL628211,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14259,CHEMBL628212,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14260,CHEMBL628213,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14261,CHEMBL628214,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14262,CHEMBL628215,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14263,CHEMBL628216,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14264,CHEMBL626595,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14265,CHEMBL626596,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14266,CHEMBL626597,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14267,CHEMBL626598,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14268,CHEMBL622242,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14269,CHEMBL622243,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14270,CHEMBL622244,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14271,CHEMBL622245,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14272,CHEMBL622246,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14273,CHEMBL622247,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14274,CHEMBL622248,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14275,CHEMBL877483,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14276,CHEMBL622249,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14277,CHEMBL622250,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14278,CHEMBL622251,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14279,CHEMBL622252,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14280,CHEMBL622253,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14281,CHEMBL622254,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14282,CHEMBL622255,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14283,CHEMBL622256,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14284,CHEMBL622257,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14285,CHEMBL622258,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14286,CHEMBL622259,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14287,CHEMBL622927,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14288,CHEMBL622928,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14289,CHEMBL622929,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14290,CHEMBL623182,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14291,CHEMBL623183,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14292,CHEMBL623184,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14293,CHEMBL623185,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14294,CHEMBL877484,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14295,CHEMBL627274,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14296,CHEMBL623186,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14297,CHEMBL623187,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14298,CHEMBL623188,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14299,CHEMBL628055,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14300,CHEMBL628056,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14301,CHEMBL628200,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14302,CHEMBL628201,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14303,CHEMBL628202,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14304,CHEMBL628203,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14305,CHEMBL628204,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14306,CHEMBL628205,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14307,CHEMBL628206,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,50597,
,1,,,In vivo,,BAO_0000218,A,U,,14308,CHEMBL628207,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14309,CHEMBL627220,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14310,CHEMBL627221,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14311,CHEMBL627222,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14312,CHEMBL627223,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14313,CHEMBL632062,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14314,CHEMBL632063,Spleen,,13257,2106.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14315,CHEMBL632064,Urinary bladder,,13257,1255.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14316,CHEMBL632065,Blood,,13257,178.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14317,CHEMBL632066,Bone element,,13257,1474.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14318,CHEMBL632067,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14319,CHEMBL629188,Kidney,,13257,2113.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14320,CHEMBL629189,Liver,,13257,2107.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14321,CHEMBL629190,Lung,,13257,2048.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14322,CHEMBL629191,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14323,CHEMBL629192,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14324,CHEMBL629193,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14325,CHEMBL629194,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14326,CHEMBL629195,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14327,CHEMBL629373,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14328,CHEMBL629374,Spleen,,13257,2106.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14329,CHEMBL629375,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14330,CHEMBL629376,Urinary bladder,,13257,1255.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14331,CHEMBL629377,Blood,,13257,178.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14332,CHEMBL629378,Bone element,,13257,1474.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14333,CHEMBL629379,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14334,CHEMBL629151,Kidney,,13257,2113.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14335,CHEMBL629152,Liver,,13257,2107.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14336,CHEMBL629153,Lung,,13257,2048.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14337,CHEMBL629154,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14338,CHEMBL629155,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14339,CHEMBL629156,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14340,CHEMBL629157,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14341,CHEMBL629158,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14342,CHEMBL629159,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14343,CHEMBL629160,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14344,CHEMBL629161,Spleen,,13257,2106.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14345,CHEMBL629162,Urinary bladder,,13257,1255.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14346,CHEMBL629163,Blood,,13257,178.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14347,CHEMBL629164,Bone element,,13257,1474.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14348,CHEMBL629165,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14349,CHEMBL629166,Liver,,13257,2107.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14350,CHEMBL629167,Lung,,13257,2048.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14351,CHEMBL629168,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,0,,22224,
,1,,,,,BAO_0000019,A,U,,14352,CHEMBL629169,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14353,CHEMBL629170,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,0,,22224,
,1,,,,,BAO_0000019,A,U,,14354,CHEMBL631153,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14355,CHEMBL875121,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,0,,22224,
,1,,,,,BAO_0000019,A,U,,14356,CHEMBL631154,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14357,CHEMBL631155,,,2193,,Autocuration,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,0,,22224,
,1,,,,,BAO_0000019,A,U,,14358,CHEMBL631156,,,568,,Autocuration,,Hydrolysis rate constant was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14359,CHEMBL631157,,,9680,,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14360,CHEMBL631158,,,9680,,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14361,CHEMBL631159,,,9680,,Autocuration,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14362,CHEMBL631160,,,10026,,Autocuration,,Observed second order rate constant,0,,22224,
,1,,,,,BAO_0000019,A,U,,14363,CHEMBL631161,,,10281,,Autocuration,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,14364,CHEMBL631162,,,10014,,Autocuration,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,0,,22224,
,1,,,,,BAO_0000019,A,U,,14365,CHEMBL630313,,,10014,,Autocuration,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,0,,22224,
,1,,,,,BAO_0000019,A,U,,14366,CHEMBL630314,,,9680,,Autocuration,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14367,CHEMBL630315,,,9680,,Autocuration,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14368,CHEMBL630316,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14369,CHEMBL630986,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14370,CHEMBL630987,,,13028,,Autocuration,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14371,CHEMBL630988,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14372,CHEMBL630989,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14373,CHEMBL630990,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14374,CHEMBL630991,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14375,CHEMBL630992,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14376,CHEMBL630993,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,,BAO_0000019,A,U,,14377,CHEMBL630994,,,13028,,Autocuration,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14378,CHEMBL630995,,,10014,,Intermediate,10116.0,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,1,,50597,
,1,,,,,BAO_0000019,A,U,,14379,CHEMBL629252,,,9962,,Autocuration,,Association constant for compound at 31 degree C was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14380,CHEMBL629253,,,12029,,Autocuration,,Calculated antagonist equilibrium dissociation constant of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14381,CHEMBL629944,,,12029,,Autocuration,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,0,,22224,
,1,,,,Cavia porcellus,BAO_0000218,A,N,,14382,CHEMBL629945,Trachea,,10583,3126.0,Intermediate,10141.0,Dissociation constants vs LTE4 on guinea pig trachea,1,,50512,
,1,,,,,BAO_0000019,A,U,,14383,CHEMBL629946,,,568,,Autocuration,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",0,,22224,
,1,,,,,BAO_0000019,A,U,,14384,CHEMBL629947,,,568,,Autocuration,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",0,,22224,
,1,,,,,BAO_0000019,A,U,,14385,CHEMBL629948,,,568,,Autocuration,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",0,,22224,
,1,,,,,BAO_0000019,A,U,,14386,CHEMBL856024,,,568,,Autocuration,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",0,,22224,
,1,,,,,BAO_0000019,A,U,,14387,CHEMBL629949,,,7493,,Autocuration,,Affinity constant KD value was derived from TMP,0,,22224,
,1,,,,,BAO_0000019,A,U,,14388,CHEMBL629950,,,8371,,Autocuration,,Apparent dissociation (binding) rate constant was evaluated,0,,22224,
,1,,,,,BAO_0000100,P,U,,14389,CHEMBL630127,,,13114,,Autocuration,,Dissociation constant (KD) of the compound,0,,22224,
,1,,,,,BAO_0000100,P,U,,14390,CHEMBL630128,,,15515,,Autocuration,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,0,,22224,
,1,,,,,BAO_0000100,P,U,,14391,CHEMBL630129,,,522,,Autocuration,,Dissociation constant from ESR titration experiments,0,,22224,
,1,,,,,BAO_0000019,,U,,14392,CHEMBL630130,,,13888,,Autocuration,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),0,,22224,
,1,,,,,BAO_0000100,P,U,,14393,CHEMBL875234,,,2616,,Autocuration,,Dissociation constant was evaluated.,0,,22224,
,1,,,,,BAO_0000100,P,U,,14394,CHEMBL630131,,,3798,,Autocuration,,Dissociation constant was reported,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14395,CHEMBL630132,,,8731,,Intermediate,10116.0,Dissociation constant was determined in rat pituitary cells.,1,,50597,
,1,,,,,BAO_0000019,A,U,,14396,CHEMBL630133,,,11892,,Autocuration,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14397,CHEMBL630134,,,11892,,Autocuration,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14398,CHEMBL630135,,,2582,,Autocuration,,Equilibrium dissociation constant of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14399,CHEMBL630136,,,11892,,Autocuration,,Equilibrium dissociation constant was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14400,CHEMBL630137,,,13396,,Autocuration,,Kinetic constant KD was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14401,CHEMBL630138,,,603,,Autocuration,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,0,,22224,
,1,,,,,BAO_0000019,A,U,,14402,CHEMBL630139,,,15673,,Autocuration,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,0,,22224,
,1,,,,,BAO_0000019,A,U,,14403,CHEMBL630140,,,10368,,Autocuration,,Rate constant for hydrolysis in aqueous acetone.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14404,CHEMBL875235,,,14228,,Autocuration,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14405,CHEMBL876439,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14406,CHEMBL630605,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14407,CHEMBL630606,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14408,CHEMBL630607,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14409,CHEMBL630608,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14410,CHEMBL630609,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14411,CHEMBL630610,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14412,CHEMBL630611,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14413,CHEMBL629552,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14414,CHEMBL629733,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14415,CHEMBL629734,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14416,CHEMBL629735,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14417,CHEMBL629736,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14418,CHEMBL629737,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14419,CHEMBL629738,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14420,CHEMBL629739,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14421,CHEMBL629740,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14422,CHEMBL629741,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14423,CHEMBL629742,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14424,CHEMBL629743,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14425,CHEMBL629744,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14426,CHEMBL629745,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14427,CHEMBL629746,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14428,CHEMBL629747,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14429,CHEMBL629748,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14430,CHEMBL629749,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14431,CHEMBL629750,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14432,CHEMBL629751,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14433,CHEMBL629752,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14434,CHEMBL629753,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14435,CHEMBL629754,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14436,CHEMBL629755,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14437,CHEMBL629756,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14438,CHEMBL629757,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14439,CHEMBL629758,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14440,CHEMBL629759,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14441,CHEMBL629760,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14442,CHEMBL876443,,,11510,,Intermediate,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14443,CHEMBL629761,,,8310,,Intermediate,9615.0,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14444,CHEMBL629762,,,8310,,Intermediate,9615.0,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,14445,CHEMBL629763,,,8310,,Intermediate,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14446,CHEMBL629764,,,8310,,Intermediate,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14447,CHEMBL629765,,,8310,,Intermediate,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14448,CHEMBL629766,,,8310,,Intermediate,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14449,CHEMBL629767,,,8310,,Intermediate,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14450,CHEMBL629768,,,8310,,Intermediate,9615.0,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,14451,CHEMBL629769,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,1,,50594,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14452,CHEMBL629770,,,8310,,Intermediate,9615.0,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14453,CHEMBL629771,,,8310,,Intermediate,9615.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,1,,50588,
,1,,,,Mus musculus,BAO_0000218,A,N,,14454,CHEMBL629772,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14455,CHEMBL629773,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14456,CHEMBL625455,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14457,CHEMBL625456,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14458,CHEMBL625457,,,8310,,Intermediate,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14459,CHEMBL625458,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14460,CHEMBL625459,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14461,CHEMBL875483,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14462,CHEMBL634779,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14463,CHEMBL625460,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14464,CHEMBL626117,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14465,CHEMBL626118,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14466,CHEMBL628342,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14467,CHEMBL628343,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14468,CHEMBL628344,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14469,CHEMBL628345,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14470,CHEMBL628346,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14471,CHEMBL628347,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14472,CHEMBL628348,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14473,CHEMBL628349,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14474,CHEMBL875611,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14475,CHEMBL628350,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14476,CHEMBL628351,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14477,CHEMBL628352,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14478,CHEMBL628353,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14479,CHEMBL628354,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14480,CHEMBL626667,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14481,CHEMBL626668,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14482,CHEMBL626669,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14483,CHEMBL626670,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14484,CHEMBL626671,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14485,CHEMBL626672,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14486,CHEMBL626673,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14487,CHEMBL626674,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14488,CHEMBL626675,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14489,CHEMBL626676,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14490,CHEMBL626677,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14491,CHEMBL626678,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14492,CHEMBL626679,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14493,CHEMBL875612,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14494,CHEMBL626680,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14495,CHEMBL626681,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14496,CHEMBL626682,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14497,CHEMBL626683,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14498,CHEMBL626684,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14499,CHEMBL626685,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14500,CHEMBL626686,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14501,CHEMBL626687,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14502,CHEMBL624978,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14503,CHEMBL624979,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14504,CHEMBL624980,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14505,CHEMBL624981,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14506,CHEMBL624982,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,50588,
,1,,,In vivo,,BAO_0000218,A,U,,14507,CHEMBL627564,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14508,CHEMBL627565,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14509,CHEMBL627566,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14510,CHEMBL627567,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14511,CHEMBL627568,Spleen,,13257,2106.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14512,CHEMBL627569,Kidney,,13257,2113.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14513,CHEMBL627570,Urinary bladder,,13257,1255.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14514,CHEMBL627571,Blood,,13257,178.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14515,CHEMBL627572,Bone element,,13257,1474.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14516,CHEMBL627573,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14517,CHEMBL627574,Kidney,,13257,2113.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14518,CHEMBL627575,Liver,,13257,2107.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14519,CHEMBL627576,Lung,,13257,2048.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14520,CHEMBL627577,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14521,CHEMBL627578,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14522,CHEMBL627579,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14523,CHEMBL627580,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14524,CHEMBL627581,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14525,CHEMBL627582,,,13257,,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14526,CHEMBL627583,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14527,CHEMBL627584,Spleen,,13257,2106.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14528,CHEMBL627585,Prostate gland,,13257,2367.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,0,,22224,
,1,,,In vivo,,BAO_0000218,A,U,,14529,CHEMBL627586,Muscle tissue,,13257,2385.0,Autocuration,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14530,CHEMBL627587,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14531,CHEMBL627588,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14532,CHEMBL628250,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14533,CHEMBL628251,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14534,CHEMBL628252,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14535,CHEMBL628253,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14536,CHEMBL628254,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14537,CHEMBL877493,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14538,CHEMBL628255,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14539,CHEMBL628256,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14540,CHEMBL628257,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14541,CHEMBL628258,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14542,CHEMBL628259,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14543,CHEMBL628429,,,15413,,Intermediate,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14544,CHEMBL626862,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14545,CHEMBL626863,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14546,CHEMBL625886,Cerebellum,,15413,2037.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14547,CHEMBL625887,Cerebellum,,15413,2037.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14548,CHEMBL625888,,,15413,,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cortex,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14549,CHEMBL625889,,,15413,,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14550,CHEMBL625890,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14551,CHEMBL625891,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14552,CHEMBL625892,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14553,CHEMBL625893,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14554,CHEMBL625894,Cerebellum,,15413,2037.0,Intermediate,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14555,CHEMBL625895,,,15413,,Intermediate,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat cortex,1,,50597,
,1,,,,,BAO_0000019,A,U,,14556,CHEMBL625896,,,12404,,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,0,,22224,
,1,,,,,BAO_0000019,A,U,,14557,CHEMBL625897,,,568,,Autocuration,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14558,CHEMBL625898,,,568,,Autocuration,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14559,CHEMBL625899,,,568,,Autocuration,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",0,,22224,
,1,,,,,BAO_0000019,A,U,,14560,CHEMBL626124,,,12404,,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,0,,22224,
,1,,,,Escherichia coli,BAO_0000218,A,N,,14561,CHEMBL628500,,,7624,,Intermediate,562.0,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,1,,50212,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14562,CHEMBL857856,,,7624,,Intermediate,10116.0,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14563,CHEMBL628501,,,7624,,Intermediate,10116.0,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",1,,50597,
,1,,,,,BAO_0000019,A,U,,14564,CHEMBL628502,,,4643,,Autocuration,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",0,,22224,
,1,,,,,BAO_0000019,A,U,,14565,CHEMBL628503,,,11532,,Autocuration,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14566,CHEMBL628504,,,11018,,Autocuration,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14567,CHEMBL628505,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14568,CHEMBL874452,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14569,CHEMBL628506,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14570,CHEMBL628507,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14571,CHEMBL628508,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14572,CHEMBL628509,,,8949,,Autocuration,,Michaelis constant (KM) was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14573,CHEMBL628510,,,12404,,Autocuration,,Reaction rate parameter value for phosphate with transfer with respect to ATP,0,,22224,
,1,,,,,BAO_0000019,B,U,,14574,CHEMBL628511,,,7625,,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,0,,22224,
,1,,,,,BAO_0000019,B,U,,14575,CHEMBL628512,,,7625,,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,0,,22224,
,1,,,,,BAO_0000019,B,U,,14576,CHEMBL628513,,,7625,,Autocuration,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,0,,22224,
,1,,,,,BAO_0000019,B,U,,14577,CHEMBL628514,,,7625,,Autocuration,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,0,,22224,
,1,,,,,BAO_0000019,A,U,,14578,CHEMBL628515,,,12908,,Autocuration,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14579,CHEMBL628516,,,10368,,Autocuration,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,0,,22224,
,1,,,,,BAO_0000019,A,U,,14580,CHEMBL628517,,,13108,,Autocuration,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),0,,22224,
,1,,,,,BAO_0000019,A,U,,14581,CHEMBL628518,,,13108,,Autocuration,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),0,,22224,
,1,,,,,BAO_0000019,A,U,,14582,CHEMBL628519,,,15217,,Autocuration,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,0,,22224,
,1,,,,,BAO_0000019,A,U,,14583,CHEMBL628520,,,15217,,Autocuration,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,0,,22224,
,1,,,,,BAO_0000019,A,U,,14584,CHEMBL628521,,,10933,,Autocuration,,Binding constant was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14585,CHEMBL630443,,,2363,,Autocuration,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14586,CHEMBL630444,,,2363,,Autocuration,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14587,CHEMBL857732,,,2276,,Autocuration,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,0,,22224,
,1,,,,,BAO_0000100,P,U,,14588,CHEMBL630445,,,14915,,Autocuration,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14589,CHEMBL630446,,,8847,,Autocuration,,Catalytic rate constant of the compound,0,,22224,
,1,,,,,BAO_0000019,B,U,,14590,CHEMBL630447,,,15357,,Autocuration,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,0,,22224,
,1,,,,,BAO_0000019,A,U,,14591,CHEMBL630448,,,2869,,Autocuration,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),0,,22224,
,1,,,,,BAO_0000019,A,U,,14592,CHEMBL630449,,,3484,,Autocuration,,Catalytic rate constant against phospholipase A2 was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14593,CHEMBL630450,,,1373,,Autocuration,,"Compound was evaluated for catalytic constant, Kcat",0,,22224,
,1,,,,,BAO_0000019,A,U,,14594,CHEMBL630451,,,8142,,Autocuration,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14595,CHEMBL630452,,,14131,,Autocuration,,Kcat calculated from 0.693/T1/2,0,,22224,
,1,,,,,BAO_0000019,A,U,,14596,CHEMBL630453,,,17269,,Autocuration,,Kcat was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14597,CHEMBL630454,,,3485,,Autocuration,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,0,,22224,
,1,,,,,BAO_0000019,A,U,,14598,CHEMBL630455,,,3485,,Autocuration,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,0,,22224,
,1,,,,,BAO_0000019,A,U,,14599,CHEMBL631487,,,3485,,Autocuration,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,0,,22224,
,1,,,,,BAO_0000019,A,U,,14600,CHEMBL631488,,,5962,,Autocuration,,Kcat value was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14601,CHEMBL876440,,,3133,,Autocuration,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14602,CHEMBL631489,,,3133,,Autocuration,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14603,CHEMBL857742,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14604,CHEMBL631490,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",0,,22224,
,1,,,,,BAO_0000019,A,U,,14605,CHEMBL631491,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14606,CHEMBL631492,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14607,CHEMBL631493,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",0,,22224,
,1,,,,,BAO_0000019,A,U,,14608,CHEMBL631494,,,4892,,Autocuration,,Kinetic parameter for rate of conversion to PABA was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14609,CHEMBL631495,,,3133,,Autocuration,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14610,CHEMBL631496,Feces,,11488,1988.0,Intermediate,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14611,CHEMBL631497,Urine,,11488,1088.0,Intermediate,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14612,CHEMBL631498,Urine,,11488,1088.0,Intermediate,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14613,CHEMBL629776,Urine,,11488,1088.0,Intermediate,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14614,CHEMBL629777,Urine,,11488,1088.0,Intermediate,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14615,CHEMBL629778,Urine,,11488,1088.0,Intermediate,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14616,CHEMBL630456,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14617,CHEMBL630457,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14618,CHEMBL630458,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14619,CHEMBL630459,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14620,CHEMBL630460,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14621,CHEMBL876550,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14622,CHEMBL630461,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14623,CHEMBL630462,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14624,CHEMBL630463,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14625,CHEMBL630464,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14626,CHEMBL630465,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14627,CHEMBL630466,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14628,CHEMBL630467,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14629,CHEMBL630633,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14630,CHEMBL630634,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14631,CHEMBL630635,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14632,CHEMBL630636,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14633,CHEMBL630637,,,11488,,Intermediate,10116.0,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,1,,50597,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14634,CHEMBL630638,Feces,,7132,1988.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14635,CHEMBL630639,Feces,,7132,1988.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14636,CHEMBL630640,Feces,,7132,1988.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14637,CHEMBL876551,Feces,,7132,1988.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14638,CHEMBL630641,Urine,,7132,1088.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14639,CHEMBL630642,Urine,,7132,1088.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14640,CHEMBL630643,Urine,,7132,1088.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14641,CHEMBL630644,Urine,,7132,1088.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14642,CHEMBL630645,Urine,,7132,1088.0,Intermediate,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14643,CHEMBL625599,Feces,,7132,1988.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14644,CHEMBL625600,Feces,,7132,1988.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14645,CHEMBL625601,Feces,,7132,1988.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14646,CHEMBL625602,Feces,,7132,1988.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14647,CHEMBL627470,Urine,,7132,1088.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14648,CHEMBL627471,Urine,,7132,1088.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14649,CHEMBL627472,Urine,,7132,1088.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14650,CHEMBL627473,Urine,,7132,1088.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,50592,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14651,CHEMBL627474,Urine,,7132,1088.0,Intermediate,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,50592,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14652,CHEMBL627475,Blood,,13925,178.0,Intermediate,10116.0,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14653,CHEMBL627476,Blood,,13925,178.0,Intermediate,10116.0,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14654,CHEMBL627477,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14655,CHEMBL627478,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14656,CHEMBL627479,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14657,CHEMBL627480,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14658,CHEMBL627481,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14659,CHEMBL627482,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14660,CHEMBL627483,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14661,CHEMBL875636,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14662,CHEMBL625764,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14663,CHEMBL625765,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14664,CHEMBL625766,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14665,CHEMBL625767,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14666,CHEMBL625768,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14667,CHEMBL625769,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14668,CHEMBL625770,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14669,CHEMBL625771,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14670,CHEMBL625772,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,1,,50588,
,1,,,,Canis lupus familiaris,BAO_0000218,A,N,,14671,CHEMBL625773,Urine,,12582,1088.0,Intermediate,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,50588,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14672,CHEMBL625774,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14673,CHEMBL625775,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14674,CHEMBL625776,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14675,CHEMBL625777,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14676,CHEMBL625778,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14677,CHEMBL625779,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14678,CHEMBL625780,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14679,CHEMBL625781,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14680,CHEMBL875637,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14681,CHEMBL626473,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14682,CHEMBL626474,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14683,CHEMBL626475,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14684,CHEMBL626476,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14685,CHEMBL634397,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14686,CHEMBL626477,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14687,CHEMBL631069,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14688,CHEMBL631070,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14689,CHEMBL631071,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14690,CHEMBL631072,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14691,CHEMBL631073,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14692,CHEMBL631074,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14693,CHEMBL631075,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14694,CHEMBL631725,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14695,CHEMBL631726,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14696,CHEMBL631727,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14697,CHEMBL631728,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14698,CHEMBL631729,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14699,CHEMBL631730,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14700,CHEMBL631731,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14701,CHEMBL631910,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14702,CHEMBL631911,Hippocampus,,15413,10000000.0,Intermediate,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14703,CHEMBL631912,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14704,CHEMBL631913,Hypothalamus,,15413,1898.0,Intermediate,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14705,CHEMBL631914,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14706,CHEMBL631915,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14707,CHEMBL875778,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14708,CHEMBL631916,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14709,CHEMBL631917,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14710,CHEMBL631918,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14711,CHEMBL631919,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14712,CHEMBL631920,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14713,CHEMBL631921,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14714,CHEMBL631922,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14715,CHEMBL631923,Blood,,12017,178.0,Intermediate,10116.0,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14716,CHEMBL631924,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14717,CHEMBL630234,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14718,CHEMBL630235,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14719,CHEMBL630236,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14720,CHEMBL630237,,,12017,,Intermediate,10116.0,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14721,CHEMBL630238,,,12017,,Intermediate,10116.0,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14722,CHEMBL630239,,,12017,,Intermediate,10116.0,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14723,CHEMBL630303,,,12017,,Intermediate,10116.0,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14724,CHEMBL630304,,,12017,,Intermediate,10116.0,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14725,CHEMBL630305,,,12017,,Intermediate,10116.0,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14726,CHEMBL630306,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14727,CHEMBL630307,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14728,CHEMBL630308,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14729,CHEMBL630309,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14730,CHEMBL629309,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14731,CHEMBL629993,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14732,CHEMBL629994,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14733,CHEMBL629995,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14734,CHEMBL631993,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14735,CHEMBL631994,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14736,CHEMBL631995,Kidney,,12017,2113.0,Intermediate,10116.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14737,CHEMBL631996,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14738,CHEMBL631997,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14739,CHEMBL631998,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14740,CHEMBL631999,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14741,CHEMBL632000,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14742,CHEMBL632001,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14743,CHEMBL874424,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14744,CHEMBL632002,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14745,CHEMBL632003,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,,,BAO_0000019,A,U,,14746,CHEMBL632004,,,3133,,Autocuration,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14747,CHEMBL632005,,,2742,,Autocuration,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14748,CHEMBL632006,,,2742,,Autocuration,,Compound was tested for amidase rate in the presence of N62C screen enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14749,CHEMBL632007,,,2742,,Autocuration,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14750,CHEMBL632008,,,2742,,Autocuration,,Compound was tested for amidase rate in the presence of S166C screen enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14751,CHEMBL632009,,,2742,,Autocuration,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14752,CHEMBL632010,,,2742,,Autocuration,,Compound was tested for esterase rate in the presence of N62C screen enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14753,CHEMBL857750,,,2742,,Autocuration,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14754,CHEMBL632011,,,2742,,Autocuration,,Compound was tested for esterase rate in the presence of S166C screen enzyme,0,,22224,
,1,,,,,BAO_0000019,A,U,,14755,CHEMBL632012,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14756,CHEMBL632013,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14757,CHEMBL632014,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14758,CHEMBL629622,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14759,CHEMBL629623,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14760,CHEMBL629624,,,2276,,Autocuration,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",0,,22224,
,1,,,,,BAO_0000019,A,U,,14761,CHEMBL629625,,,17269,,Autocuration,,Ratio of Kcat to that of Km was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14762,CHEMBL629626,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",0,,22224,
,1,,,,,BAO_0000019,A,U,,14763,CHEMBL629627,,,2276,,Autocuration,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",0,,22224,
,1,,,,,BAO_0000019,A,U,,14764,CHEMBL629628,,,15917,,Autocuration,,"Compound was evaluated for constant, Kd",0,,22224,
,1,,,,,BAO_0000019,A,U,,14765,CHEMBL629629,,,10933,,Autocuration,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,0,,22224,
,1,,,,,BAO_0000019,A,U,,14766,CHEMBL629630,,,10933,,Autocuration,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,0,,22224,
,1,,,,,BAO_0000019,A,U,,14767,CHEMBL856030,,,14293,,Autocuration,,Dissociation Constant of compound determined,0,,22224,
,1,,,,,BAO_0000019,B,U,,14768,CHEMBL629631,,,6698,,Autocuration,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,0,,22224,
,1,,,,,BAO_0000019,B,U,,14769,CHEMBL629632,,,6698,,Autocuration,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,0,,22224,
,1,,,,,BAO_0000100,P,U,,14770,CHEMBL629633,,,4318,,Autocuration,,Dissociation constant of compound with Fructose was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14771,CHEMBL629634,,,4318,,Autocuration,,Dissociation constant of compound with Fructose was determined; Not determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14772,CHEMBL629635,,,4318,,Autocuration,,Dissociation constant of compound with Lactulose was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14773,CHEMBL629636,,,4318,,Autocuration,,Dissociation constant of compound with Lactulose was determined; Not determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14774,CHEMBL629637,,,14959,,Autocuration,,Dissociation constant of the Compound,0,,22224,
,1,,,,,BAO_0000100,P,U,,14775,CHEMBL629638,,,5913,,Autocuration,,Dissociation constant by non-linear regression analysis,0,,22224,
,1,,,,,BAO_0000100,P,U,,14776,CHEMBL629639,,,14218,,Autocuration,,Dissociation constant was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14777,CHEMBL629640,,,10689,,Autocuration,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,0,,22224,
,1,,,,,BAO_0000100,P,U,,14778,CHEMBL629641,,,13925,,Autocuration,,Dissociation constant was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14779,CHEMBL631344,,,16359,,Autocuration,,Dissociation constant was determined,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14780,CHEMBL631345,Muscle tissue,,10944,2385.0,Intermediate,10116.0,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,1,,50597,
,1,,,,,BAO_0000019,A,U,,14781,CHEMBL631346,,,11080,,Autocuration,,The dissociation constant determined by fluorescence displacement assay,0,,22224,
,1,,,,,BAO_0000019,A,U,,14782,CHEMBL631524,,,17805,,Autocuration,,kd value surface plasmon resonance (SPR) method,0,,22224,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14783,CHEMBL631525,Muscle tissue,,10944,2385.0,Intermediate,10116.0,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,1,,50597,
,1,,,,,BAO_0000019,F,U,,14784,CHEMBL631526,,,16645,,Autocuration,,First dissociation constant of the binding of compound to V30M TTR,0,,22224,
,1,,,,,BAO_0000019,F,U,,14785,CHEMBL631527,,,16645,,Autocuration,,Second dissociation constant of the binding of compound to V30M TTR,0,,22224,
,1,,,,,BAO_0000019,A,U,,14786,CHEMBL631528,,,7793,,Autocuration,,"Compound was evaluated for equilibrium constant, Ke",0,,22224,
,1,,,,,BAO_0000019,A,U,,14787,CHEMBL631529,Hypothalamus,,12199,1898.0,Autocuration,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,0,,22224,
,1,,,,,BAO_0000019,A,U,,14788,CHEMBL631530,Hypothalamus,,12199,1898.0,Autocuration,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,0,,22224,
,1,,,,,BAO_0000019,A,U,,14789,CHEMBL631531,,,9680,,Autocuration,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14790,CHEMBL631532,,,9680,,Autocuration,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14791,CHEMBL631533,,,9680,,Autocuration,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,0,,22224,
,1,,,,Mus musculus,BAO_0000218,A,N,,14792,CHEMBL876552,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14793,CHEMBL631534,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14794,CHEMBL631535,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14795,CHEMBL631536,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14796,CHEMBL631537,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14797,CHEMBL631538,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14798,CHEMBL631539,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,1,,50594,
,1,,,,Mus musculus,BAO_0000218,A,N,,14799,CHEMBL631540,,,13758,,Intermediate,10090.0,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14800,CHEMBL625637,,,14393,,Intermediate,10116.0,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14801,CHEMBL625638,,,14393,,Intermediate,10116.0,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14802,CHEMBL625639,,,15078,,Intermediate,10116.0,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14803,CHEMBL625640,Brain,,13925,955.0,Intermediate,10116.0,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14804,CHEMBL625641,Brain,,13925,955.0,Intermediate,10116.0,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14805,CHEMBL625642,Heart,,13925,948.0,Intermediate,10116.0,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14806,CHEMBL625643,Heart,,13925,948.0,Intermediate,10116.0,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14807,CHEMBL625644,Kidney,,13925,2113.0,Intermediate,10116.0,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14808,CHEMBL625645,Kidney,,13925,2113.0,Intermediate,10116.0,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14809,CHEMBL625646,Liver,,13925,2107.0,Intermediate,10116.0,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14810,CHEMBL625647,Liver,,13925,2107.0,Intermediate,10116.0,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14811,CHEMBL625648,Lung,,13925,2048.0,Intermediate,10116.0,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14812,CHEMBL625649,Lung,,13925,2048.0,Intermediate,10116.0,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14813,CHEMBL625650,Muscle tissue,,13925,2385.0,Intermediate,10116.0,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14814,CHEMBL625651,Muscle tissue,,13925,2385.0,Intermediate,10116.0,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14815,CHEMBL625652,Zone of skin,,13925,14.0,Intermediate,10116.0,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14816,CHEMBL625653,Zone of skin,,13925,14.0,Intermediate,10116.0,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14817,CHEMBL625654,Spleen,,13925,2106.0,Intermediate,10116.0,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14818,CHEMBL625655,Spleen,,13925,2106.0,Intermediate,10116.0,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14819,CHEMBL625656,Blood,,9712,178.0,Intermediate,10116.0,Biodistribution of Compound in rat blood after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14820,CHEMBL625657,Blood,,9712,178.0,Intermediate,10116.0,Biodistribution of Compound in rat blood after 2 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14821,CHEMBL625658,Brain,,9712,955.0,Intermediate,10116.0,Biodistribution of Compound in rat brain after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14822,CHEMBL625659,Brain,,9712,955.0,Intermediate,10116.0,Biodistribution of Compound in rat brain after 2 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14823,CHEMBL625660,Heart,,9712,948.0,Intermediate,10116.0,Biodistribution of Compound in rat heart after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14824,CHEMBL625661,Heart,,9712,948.0,Intermediate,10116.0,Biodistribution of Compound in rat heart after 2 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14825,CHEMBL625662,Liver,,9712,2107.0,Intermediate,10116.0,Biodistribution of Compound in rat liver after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14826,CHEMBL625663,Liver,,9712,2107.0,Intermediate,10116.0,Biodistribution of Compound in rat liver after 2 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14827,CHEMBL875621,Lung,,9712,2048.0,Intermediate,10116.0,Biodistribution of Compound in rat lung after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14828,CHEMBL628382,Lung,,9712,2048.0,Intermediate,10116.0,Biodistribution of Compound in rat lung after 2 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14829,CHEMBL628383,Muscle tissue,,9712,2385.0,Intermediate,10116.0,Biodistribution of Compound in rat muscle after 15 minutes of administration,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14830,CHEMBL628384,Muscle tissue,,9712,2385.0,Intermediate,10116.0,Biodistribution of Compound in rat muscle after 2 minutes of administration,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14831,CHEMBL628385,,,13925,,Intermediate,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14832,CHEMBL875753,,,13925,,Intermediate,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14833,CHEMBL628386,,,13925,,Intermediate,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14834,CHEMBL628387,,,6941,,Intermediate,10116.0,Organ distribution in rat blood 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14835,CHEMBL628388,,,6941,,Intermediate,10116.0,Organ distribution in rat blood 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14836,CHEMBL628389,,,6941,,Intermediate,10116.0,Organ distribution in rat blood 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14837,CHEMBL632756,,,6941,,Intermediate,10116.0,Organ distribution in rat blood 30 min after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14838,CHEMBL628390,,,6941,,Intermediate,10116.0,Organ distribution in rat brain 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14839,CHEMBL631811,,,6941,,Intermediate,10116.0,Organ distribution in rat brain 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14840,CHEMBL631812,,,6941,,Intermediate,10116.0,Organ distribution in rat brain 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14841,CHEMBL631813,,,6941,,Intermediate,10116.0,Organ distribution in rat heart 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14842,CHEMBL631814,,,6941,,Intermediate,10116.0,Organ distribution in rat heart 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14843,CHEMBL631815,,,6941,,Intermediate,10116.0,Organ distribution in rat heart 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14844,CHEMBL631816,,,6941,,Intermediate,10116.0,Organ distribution in rat kidney 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14845,CHEMBL875758,,,6941,,Intermediate,10116.0,Organ distribution in rat kidney 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14846,CHEMBL631817,,,6941,,Intermediate,10116.0,Organ distribution in rat kidney 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14847,CHEMBL631818,Liver,,6941,2107.0,Intermediate,10116.0,Organ distribution in rat liver 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14848,CHEMBL631819,Liver,,6941,2107.0,Intermediate,10116.0,Organ distribution in rat liver 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14849,CHEMBL631820,Liver,,6941,2107.0,Intermediate,10116.0,Organ distribution in rat liver 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14850,CHEMBL631821,,,6941,,Intermediate,10116.0,Organ distribution in rat lung 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14851,CHEMBL631822,,,6941,,Intermediate,10116.0,Organ distribution in rat lung 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14852,CHEMBL631823,,,6941,,Intermediate,10116.0,Organ distribution in rat lung 30 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14853,CHEMBL631824,Muscle tissue,,6941,2385.0,Intermediate,10116.0,Organ distribution in rat muscle 2 minutes after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14854,CHEMBL631825,Muscle tissue,,6941,2385.0,Intermediate,10116.0,Organ distribution in rat muscle 2 hr after intravenous injection,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14855,CHEMBL631826,Muscle tissue,,6941,2385.0,Intermediate,10116.0,Organ distribution in rat muscle 30 minutes after intravenous injection,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14856,CHEMBL631827,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14857,CHEMBL631828,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14858,CHEMBL631829,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),1,,50594,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14859,CHEMBL875759,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14860,CHEMBL631830,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14861,CHEMBL631831,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14862,CHEMBL631832,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14863,CHEMBL631833,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14864,CHEMBL631834,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14865,CHEMBL631835,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14866,CHEMBL631836,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14867,CHEMBL631837,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14868,CHEMBL631838,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14869,CHEMBL631839,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14870,CHEMBL631840,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14871,CHEMBL631841,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14872,CHEMBL631842,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14873,CHEMBL631843,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14874,CHEMBL631844,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14875,CHEMBL631845,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14876,CHEMBL631846,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14877,CHEMBL875760,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14878,CHEMBL632199,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14879,CHEMBL631847,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14880,CHEMBL631848,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14881,CHEMBL628707,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14882,CHEMBL628708,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14883,CHEMBL628709,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14884,CHEMBL628710,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14885,CHEMBL628711,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14886,CHEMBL628712,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14887,CHEMBL628713,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14888,CHEMBL628714,Urine,,12582,1088.0,Intermediate,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14889,CHEMBL628715,,,7415,,Intermediate,10116.0,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",1,,50597,
,1,,,,,BAO_0000019,A,U,,14890,CHEMBL629179,,,7313,,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14891,CHEMBL629180,,,7313,,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14892,CHEMBL875108,,,7313,,Autocuration,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,0,,22224,
,1,,,,,BAO_0000019,A,U,,14893,CHEMBL629181,Adrenal cortex,,7570,1235.0,Autocuration,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14894,CHEMBL629182,Adrenal cortex,,7570,1235.0,Autocuration,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14895,CHEMBL629183,,,7570,,Autocuration,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14896,CHEMBL629184,,,7570,,Autocuration,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14897,CHEMBL629185,Adrenal cortex,,7570,1235.0,Autocuration,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14898,CHEMBL629186,Adrenal cortex,,7570,1235.0,Autocuration,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14899,CHEMBL629187,,,7570,,Autocuration,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14900,CHEMBL629887,,,7570,,Autocuration,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14901,CHEMBL629888,,,7570,,Autocuration,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14902,CHEMBL629889,,,7570,,Autocuration,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14903,CHEMBL629890,Adrenal cortex,,7570,1235.0,Autocuration,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14904,CHEMBL629891,,,7570,,Autocuration,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14905,CHEMBL629892,,,7570,,Autocuration,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14906,CHEMBL629893,Adrenal cortex,,7570,1235.0,Autocuration,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14907,CHEMBL629894,,,7570,,Autocuration,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14908,CHEMBL629895,,,7570,,Autocuration,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,0,,22224,
,1,,,In vivo,Canis lupus familiaris,BAO_0000218,A,U,,14909,CHEMBL875109,,,14122,,Autocuration,9615.0,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",0,,22224,
,1,,,In vivo,Macaca fascicularis,BAO_0000218,A,U,,14910,CHEMBL629896,,,16449,,Autocuration,9541.0,Absolute bioavailability in male cynomolgus monkeys,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,U,,14911,CHEMBL629897,,,16449,,Autocuration,10116.0,Absolute bioavailability in maleSprague-Dawley rats,0,,22224,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14912,CHEMBL629898,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14913,CHEMBL630057,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14914,CHEMBL630058,Liver,,12017,2107.0,Intermediate,10116.0,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14915,CHEMBL630059,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14916,CHEMBL630060,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14917,CHEMBL630061,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14918,CHEMBL630062,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14919,CHEMBL630063,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14920,CHEMBL630064,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14921,CHEMBL630065,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14922,CHEMBL630066,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14923,CHEMBL630067,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14924,CHEMBL630068,Lung,,12017,2048.0,Intermediate,10116.0,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14925,CHEMBL631113,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14926,CHEMBL631114,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14927,CHEMBL631115,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14928,CHEMBL631116,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14929,CHEMBL630528,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14930,CHEMBL630529,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14931,CHEMBL630530,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14932,CHEMBL630531,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14933,CHEMBL630532,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14934,CHEMBL630533,Muscle tissue,,12017,2385.0,Intermediate,10116.0,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14935,CHEMBL630534,Blood,,15045,178.0,Intermediate,10090.0,Biodistribution in normal mice blood after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14936,CHEMBL630535,Blood,,15045,178.0,Intermediate,10090.0,Biodistribution in normal mice blood after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14937,CHEMBL630536,Blood,,15045,178.0,Intermediate,10090.0,Biodistribution in normal mice blood after 4 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14938,CHEMBL630537,Bone,,15045,10000001.0,Intermediate,10090.0,Biodistribution in normal mice bone after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14939,CHEMBL630538,Bone,,15045,10000001.0,Intermediate,10090.0,Biodistribution in normal mice bone after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14940,CHEMBL630539,Bone,,15045,10000001.0,Intermediate,10090.0,Biodistribution in normal mice bone after 4 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14941,CHEMBL630540,Heart,,15045,948.0,Intermediate,10090.0,Biodistribution in normal mice heart after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14942,CHEMBL630541,Heart,,15045,948.0,Intermediate,10090.0,Biodistribution in normal mice heart after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14943,CHEMBL630542,Heart,,15045,948.0,Intermediate,10090.0,Biodistribution in normal mice heart after 4 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14944,CHEMBL630543,Kidney,,15045,2113.0,Intermediate,10090.0,Biodistribution in normal mice kidney after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14945,CHEMBL630544,Kidney,,15045,2113.0,Intermediate,10090.0,Biodistribution in normal mice kidney after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14946,CHEMBL630545,Kidney,,15045,2113.0,Intermediate,10090.0,Biodistribution in normal mice kidney after 4 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14947,CHEMBL630546,Liver,,15045,2107.0,Intermediate,10090.0,Biodistribution in normal mice liver after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14948,CHEMBL630547,Liver,,15045,2107.0,Intermediate,10090.0,Biodistribution in normal mice liver after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14949,CHEMBL630548,Liver,,15045,2107.0,Intermediate,10090.0,Biodistribution in normal mice liver after 4 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14950,CHEMBL630549,Spleen,,15045,2106.0,Intermediate,10090.0,Biodistribution in normal mice spleen after 120 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14951,CHEMBL630550,Spleen,,15045,2106.0,Intermediate,10090.0,Biodistribution in normal mice spleen after 24 hr,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,14952,CHEMBL876426,Spleen,,15045,2106.0,Intermediate,10090.0,Biodistribution in normal mice spleen after 4 hr,1,,50594,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14953,CHEMBL630551,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14954,CHEMBL630552,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14955,CHEMBL630553,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14956,CHEMBL630554,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14957,CHEMBL630555,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14958,CHEMBL630556,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14959,CHEMBL630557,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14960,CHEMBL630558,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14961,CHEMBL630559,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14962,CHEMBL630560,Spleen,,12017,2106.0,Intermediate,10116.0,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,In vivo,Rattus norvegicus,BAO_0000218,A,N,,14963,CHEMBL876427,Thyroid gland,,12017,2046.0,Intermediate,10116.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,50597,
,1,,,,Rattus norvegicus,BAO_0000218,A,N,,14964,CHEMBL630561,,,14941,,Intermediate,10116.0,The Kel values in female wistar rats.,1,,50597,
,1,,,,,BAO_0000019,A,U,,14965,CHEMBL630562,,,4646,,Autocuration,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14966,CHEMBL630563,,,8847,,Autocuration,,Hydrolysis rate constant of the compound,0,,22224,
,1,,,,,BAO_0000100,P,U,,14967,CHEMBL629673,,,11778,,Autocuration,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,0,,22229,
,1,,,,,BAO_0000019,A,U,,14968,CHEMBL629674,,,2363,,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14969,CHEMBL629675,,,2363,,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",0,,22224,
,1,,,,,BAO_0000019,A,U,,14970,CHEMBL629676,,,2363,,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",0,,22224,
,1,,,,,BAO_0000019,A,U,,14971,CHEMBL629677,,,2363,,Autocuration,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",0,,22224,
,1,,,,,BAO_0000019,A,U,,14972,CHEMBL629678,,,8371,,Autocuration,,Apparent inactivation rate constant was evaluated,0,,22224,
,1,,,,,BAO_0000019,A,U,,14973,CHEMBL629679,,,14883,,Autocuration,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14974,CHEMBL629680,,,14883,,Autocuration,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,0,,22224,
,1,,,,,BAO_0000019,A,U,,14975,CHEMBL629681,,,4643,,Autocuration,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,0,,22224,
,1,,,,,BAO_0000019,A,U,,14976,CHEMBL629682,,,3519,,Autocuration,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,0,,22224,
,1,,,,,BAO_0000019,A,U,,14977,CHEMBL629683,,,10600,,Autocuration,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,0,,22224,
,1,,,,,BAO_0000019,F,U,,14978,CHEMBL629684,,,8501,,Autocuration,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,0,,22224,
,1,,,,,BAO_0000100,P,U,,14979,CHEMBL629685,,,8505,,Autocuration,,Dissociation constant was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14980,CHEMBL629686,,,9778,,Autocuration,,Dissociation constant was determined,0,,22224,
,1,,,,,BAO_0000100,P,U,,14981,CHEMBL872932,,,9778,,Autocuration,,Dissociation constant at pH 7.4,0,,22224,
,1,,,,,BAO_0000100,P,U,,14982,CHEMBL629687,,,9778,,Autocuration,,Dissociation constant in presence of 1 mM dithiothreitol,0,,22224,
,1,,,,,BAO_0000019,A,U,,14983,CHEMBL872931,,,13007,,Autocuration,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,0,,22224,
,1,,,,,BAO_0000019,A,U,,14984,CHEMBL628151,,,13007,,Autocuration,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,0,,22224,
,1,,,,,BAO_0000019,A,U,,14985,CHEMBL628152,,,13007,,Autocuration,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,0,,22224,
,1,,,,,BAO_0000019,A,U,,14986,CHEMBL628153,,,13007,,Autocuration,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,0,,22224,
,1,,,,,BAO_0000019,A,U,,14987,CHEMBL628154,,,11482,,Autocuration,,Kinetic constant for aromatization of androstenedione,0,,22224,
,1,,,,,BAO_0000019,A,U,,14988,CHEMBL628155,,,11482,,Autocuration,,Kinetic constant for aromatization of testosterone,0,,22224,
,1,,,,,BAO_0000019,A,U,,14989,CHEMBL628156,,,2303,,Autocuration,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,0,,22224,
,1,,,,,BAO_0000019,A,U,,14990,CHEMBL628157,,,11964,,Autocuration,,Local inhibition constant was determined,0,,22224,
,1,,,,Saccharomyces cerevisiae,BAO_0000218,A,N,,14991,CHEMBL857533,,,3140,,Intermediate,4932.0,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,1,,50347,
,1,,,,,BAO_0000100,P,U,,14992,CHEMBL628158,,,10650,,Autocuration,,Dissociation constant value of the compound,0,,22224,
,1,,,,,BAO_0000019,A,U,,14993,CHEMBL628159,Cornea,,4667,964.0,Autocuration,,In vitro permeability through cornea without epithelium,0,,22224,
,1,,,,,BAO_0000019,A,U,,14994,CHEMBL875616,Cornea,,4667,964.0,Autocuration,,In vitro permeability through intact cornea,0,,22224,
,1,,,,Oryctolagus cuniculus,BAO_0000218,A,N,,14995,CHEMBL628160,Cornea,,9199,964.0,Intermediate,9986.0,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,1,,50592,
,1,,,,,BAO_0000019,A,U,,14996,CHEMBL628161,,,11966,,Autocuration,,Rate of enzyme inactivation for the compound was determined,0,,22224,
,1,,,,,BAO_0000019,A,U,,14997,CHEMBL628162,Cornea,,4667,964.0,Autocuration,,In vitro permeability through cornea without epithelium,0,,22224,
,1,,,,,BAO_0000019,A,U,,14998,CHEMBL628163,Cornea,,4667,964.0,Autocuration,,In vitro permeability through intact cornea,0,,22224,
,1,,,,,BAO_0000019,A,U,,14999,CHEMBL628164,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15000,CHEMBL628165,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15001,CHEMBL628166,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15002,CHEMBL628167,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15003,CHEMBL628168,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15004,CHEMBL628169,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15005,CHEMBL628170,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15006,CHEMBL628171,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15007,CHEMBL627434,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15008,CHEMBL627435,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15009,CHEMBL628110,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15010,CHEMBL628111,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15011,CHEMBL628112,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15012,CHEMBL628260,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,,,BAO_0000019,A,U,,15013,CHEMBL628261,,,8354,,Autocuration,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",0,,22224,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15014,CHEMBL628262,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),1,,50594,
,1,,,In vivo,Homo sapiens,BAO_0000218,A,N,,15015,CHEMBL628263,,,14439,,Intermediate,9606.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,1,,50587,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15016,CHEMBL628264,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15017,CHEMBL628265,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15018,CHEMBL628266,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15019,CHEMBL628267,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15020,CHEMBL628268,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15021,CHEMBL628269,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15022,CHEMBL628270,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15023,CHEMBL628271,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),1,,50594,
,1,,,In vivo,Mus musculus,BAO_0000218,A,N,,15024,CHEMBL628272,,,14439,,Intermediate,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),1,,50594,
